apiLogger::2021-10-06 00:55:19,303::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 00:55:19,344::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 00:55:19,344::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp33kb4pv1 
apiLogger::2021-10-06 00:55:19,346::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 00:55:19,346::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 00:55:20,280::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 00:55:20,280::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp33kb4pv1
apiLogger::2021-10-06 00:55:22,035::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 00:55:22,035::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 00:55:22,036::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 00:55:22,036::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 00:55:22,040::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 00:55:22,041::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 00:55:22,041::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 00:55:22,041::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 00:55:22,041::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410003\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-06 00:55:22,041::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 00:55:22,041::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 00:55:22,041::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 00:55:22,041::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 00:55:22,041::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 00:56:26,984::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 00:56:26,985::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 00:56:27,087::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 00:56:27,143::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 00:56:27,143::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp857hcu0w 
apiLogger::2021-10-06 00:56:27,146::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 00:56:27,146::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 00:56:30,106::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 00:56:30,106::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp857hcu0w
apiLogger::2021-10-06 00:56:31,673::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 00:56:31,673::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 00:56:31,673::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 00:56:31,673::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 00:56:31,678::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 00:56:31,678::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 00:56:31,678::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 00:56:31,678::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 00:56:31,678::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410004\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-06 00:56:31,678::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 00:56:31,678::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 00:56:31,678::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 00:56:31,678::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 00:56:31,678::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 00:57:42,984::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 00:57:42,984::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 01:07:20,332::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 01:07:20,389::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 01:07:20,389::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqz0mxtxm 
apiLogger::2021-10-06 01:07:20,392::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 01:07:20,392::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 01:07:23,347::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 01:07:23,347::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqz0mxtxm
apiLogger::2021-10-06 01:07:24,909::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 01:07:24,909::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 01:07:24,909::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 01:07:24,909::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 01:07:24,914::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 01:07:24,914::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 01:07:24,915::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 01:07:24,915::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 01:07:24,915::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410004\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-06 01:07:24,915::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 01:07:24,915::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 01:07:24,915::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 01:07:24,915::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 01:07:24,915::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 01:08:35,905::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 01:08:35,905::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 01:08:36,005::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 01:08:36,045::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 01:08:36,046::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuls19j9h 
apiLogger::2021-10-06 01:08:36,048::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 01:08:36,048::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 01:08:36,980::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 01:08:36,980::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuls19j9h
apiLogger::2021-10-06 01:08:38,736::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 01:08:38,736::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 01:08:38,736::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 01:08:38,736::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 01:08:38,741::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 01:08:38,742::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 01:08:38,742::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 01:08:38,742::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 01:08:38,742::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410003\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-06 01:08:38,742::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 01:08:38,742::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 01:08:38,742::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 01:08:38,742::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 01:08:38,742::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 01:09:43,702::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 01:09:43,702::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 02:13:18,700::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 02:13:18,703::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 02:13:18,703::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpss8s4bf1 
apiLogger::2021-10-06 02:13:18,704::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 02:13:18,704::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 02:13:18,735::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 02:13:18,735::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpss8s4bf1
apiLogger::2021-10-06 02:13:19,325::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 02:13:19,325::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 02:13:19,325::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 02:13:19,325::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 02:13:19,330::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 02:13:19,331::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 02:13:19,331::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 02:13:19,331::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 02:13:19,335::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 02:13:19,335::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 02:13:19,335::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 02:13:19,335::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-06 02:13:19,336::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 02:13:19,336::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 02:13:19,700::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 02:13:19,701::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 02:13:19,701::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppqnuxrbt 
apiLogger::2021-10-06 02:13:19,702::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 02:13:19,702::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 02:13:19,708::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 02:13:19,708::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppqnuxrbt
apiLogger::2021-10-06 02:13:19,726::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 02:13:19,727::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 02:13:19,727::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 02:13:19,727::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 02:13:19,731::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 02:13:19,732::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 02:13:19,732::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 02:13:19,732::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 02:11:20 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - Marc Lamberti\nScenario 1: 05-Oct-2021 \n \n \nMarc Lamberti \n617.515.6030 \n ']
apiLogger::2021-10-06 02:13:19,732::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 02:13:19,732::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 03:13:18,702::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 03:13:18,705::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 03:13:18,705::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgla_j199 
apiLogger::2021-10-06 03:13:18,706::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 03:13:18,706::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 03:13:18,738::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 03:13:18,738::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgla_j199
apiLogger::2021-10-06 03:13:19,305::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 03:13:19,305::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 03:13:19,305::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 03:13:19,305::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 03:13:19,310::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 03:13:19,310::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 03:13:19,310::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 03:13:19,310::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 03:13:19,315::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 03:13:19,315::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 03:13:19,315::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 03:13:19,315::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-06 03:13:19,316::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 03:13:19,316::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 03:13:19,627::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 03:13:19,628::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 03:13:19,629::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsc810h94 
apiLogger::2021-10-06 03:13:19,629::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 03:13:19,629::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 03:13:19,634::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 03:13:19,634::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsc810h94
apiLogger::2021-10-06 03:13:19,648::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 03:13:19,649::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 03:13:19,649::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 03:13:19,649::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 03:13:19,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 03:13:19,653::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 03:13:19,654::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 03:13:19,654::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 06-Oct-2021 03:12:50 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - Prashant Kapoor\nScenario 1 10-Oct-2021 \n ']
apiLogger::2021-10-06 03:13:19,654::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 03:13:19,654::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 05:03:19,136::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 05:03:19,295::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 05:03:19,296::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbu9epw_z 
apiLogger::2021-10-06 05:03:19,302::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 05:03:19,302::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 05:03:19,936::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 05:03:19,936::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbu9epw_z
apiLogger::2021-10-06 05:03:20,198::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 05:03:20,199::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 05:03:20,199::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 05:03:20,199::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 05:03:20,203::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:20,203::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 05:03:20,203::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 05:03:20,203::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 05:03:20,206::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:20,206::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 05:03:20,206::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 05:03:20,207::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 05:03:20,210::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:20,210::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 05:03:20,210::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 05:03:20,210::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 05:03:20,213::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:20,213::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 05:03:20,214::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 05:03:20,214::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 05:03:20,217::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:20,217::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 05:03:20,217::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 05:03:20,217::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-06 05:03:20,217::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-06 05:03:20,217::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 05:03:21,652::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 05:03:21,653::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 05:03:21,653::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_yfhc4ac 
apiLogger::2021-10-06 05:03:21,653::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 05:03:21,653::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 05:03:21,658::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 05:03:21,658::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_yfhc4ac
apiLogger::2021-10-06 05:03:21,670::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 05:03:21,670::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 05:03:21,670::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 05:03:21,670::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 05:03:21,674::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 05:03:21,675::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 05:03:21,675::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 05:03:21,675::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 06-Oct-2021 05:03:06 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : fup testing\n ']
apiLogger::2021-10-06 05:03:21,675::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 05:03:21,675::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 05:19:18,682::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 05:19:18,686::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 05:19:18,686::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmho0f0rq 
apiLogger::2021-10-06 05:19:18,686::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 05:19:18,686::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 05:19:18,690::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 05:19:18,690::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmho0f0rq
apiLogger::2021-10-06 05:19:19,776::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 05:19:19,776::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 05:19:19,776::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 05:19:19,776::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 05:19:19,781::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-06 05:19:19,781::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 05:19:19,781::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 05:19:19,781::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 05:19:19,781::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(1)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-06 05:19:19,781::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 05:19:19,781::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-06 05:19:19,782::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 05:19:19,782::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 05:19:19,782::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 05:19:30,923::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 05:19:30,923::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 06:01:19,245::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 06:01:19,252::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 06:01:19,259::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpne6yw5se 
apiLogger::2021-10-06 06:01:19,260::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 06:01:19,260::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 06:01:19,291::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 06:01:19,291::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpne6yw5se
apiLogger::2021-10-06 06:01:19,858::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 06:01:19,858::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 06:01:19,858::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 06:01:19,858::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 06:01:19,866::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 06:01:19,866::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 06:01:19,866::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 06:01:19,866::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 06:01:19,870::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 06:01:19,870::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 06:01:19,870::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 06:01:19,870::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-06 06:01:19,871::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 06:01:19,871::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 06:01:19,952::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 06:01:20,043::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 06:01:20,044::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk3sj12ai 
apiLogger::2021-10-06 06:01:20,048::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 06:01:20,048::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 06:01:20,748::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 06:01:20,748::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk3sj12ai
apiLogger::2021-10-06 06:01:21,685::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 06:01:21,685::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 06:01:21,685::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 06:01:21,685::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 06:01:21,690::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-06 06:01:21,690::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 06:01:21,690::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 06:01:21,690::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 06:01:21,690::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-06 06:01:21,690::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 06:01:21,690::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-06 06:01:21,690::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 06:01:21,690::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 06:01:21,690::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 06:01:54,947::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 06:01:54,947::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 06:01:55,042::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 06:01:55,043::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 06:01:55,050::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpifdyov9t 
apiLogger::2021-10-06 06:01:55,050::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 06:01:55,050::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 06:01:55,055::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 06:01:55,055::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpifdyov9t
apiLogger::2021-10-06 06:01:55,067::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 06:01:55,068::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 06:01:55,068::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 06:01:55,068::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 06:01:55,072::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 06:01:55,073::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 06:01:55,073::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 06:01:55,073::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 06-Oct-2021 06:01:08 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial\n ']
apiLogger::2021-10-06 06:01:55,073::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 06:01:55,073::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 06:17:18,900::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 06:17:18,983::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 06:17:18,986::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp7is23u8 
apiLogger::2021-10-06 06:17:18,988::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 06:17:18,988::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 06:17:19,929::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 06:17:19,929::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp7is23u8
apiLogger::2021-10-06 06:17:21,538::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 06:17:21,539::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 06:17:21,539::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 06:17:21,539::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 06:17:21,544::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-06 06:17:21,544::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 06:17:21,544::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 06:17:21,544::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 06:17:21,544::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-06 06:17:21,544::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 06:17:21,544::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-06 06:17:21,544::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 06:17:21,544::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 06:17:21,544::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 06:17:45,196::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 06:17:45,196::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:11:18,668::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:11:18,672::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:11:18,672::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpf_n72m1y 
apiLogger::2021-10-06 08:11:18,673::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:11:18,673::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:11:18,706::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:11:18,706::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpf_n72m1y
apiLogger::2021-10-06 08:11:19,318::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:11:19,318::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:11:19,318::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:11:19,318::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:11:19,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:11:19,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:11:19,324::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:11:19,324::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 08:11:19,329::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:11:19,329::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 08:11:19,329::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 08:11:19,329::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 08:11:19,333::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:11:19,333::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 08:11:19,333::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 08:11:19,333::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88286 (v.2)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88286 (v.2)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88286 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-06 08:11:19,333::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:11:19,333::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:11:19,608::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:11:19,609::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:11:19,609::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqzkznz2f 
apiLogger::2021-10-06 08:11:19,610::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:11:19,610::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:11:19,615::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:11:19,615::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqzkznz2f
apiLogger::2021-10-06 08:11:19,628::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:11:19,628::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:11:19,628::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:11:19,628::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:11:19,633::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:11:19,633::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:11:19,633::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:11:19,633::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 06-Oct-2021 08:10:38 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Reshabh Reshabh\nFollow Up 06-Oct-2021 \n ']
apiLogger::2021-10-06 08:11:19,633::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:11:19,633::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:25:18,716::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:25:18,719::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:25:18,720::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfqc1weer 
apiLogger::2021-10-06 08:25:18,720::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:25:18,720::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:25:18,753::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:25:18,753::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfqc1weer
apiLogger::2021-10-06 08:25:19,359::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:25:19,360::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:25:19,360::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:25:19,360::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:25:19,365::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:25:19,365::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:25:19,365::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:25:19,365::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 08:25:19,370::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:25:19,370::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 08:25:19,370::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 08:25:19,370::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 08:25:19,374::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:25:19,374::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 08:25:19,374::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 08:25:19,374::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88286 (v.2)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88286 (v.2)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88286 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-06 08:25:19,374::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:25:19,374::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:25:19,653::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:25:19,654::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:25:19,654::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0w64lmyj 
apiLogger::2021-10-06 08:25:19,654::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:25:19,654::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:25:19,659::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:25:19,659::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0w64lmyj
apiLogger::2021-10-06 08:25:19,673::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:25:19,674::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:25:19,674::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:25:19,674::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:25:19,678::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:25:19,678::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:25:19,678::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:25:19,678::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 06-Oct-2021 08:23:19 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 - Prashant Kapoor\nScenario 1 Follow Up 06-Oct-2021 \n ']
apiLogger::2021-10-06 08:25:19,678::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:25:19,678::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:37:18,651::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:37:18,658::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:37:18,659::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmk2r7wkq 
apiLogger::2021-10-06 08:37:18,659::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:37:18,659::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:37:18,665::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:37:18,665::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmk2r7wkq
apiLogger::2021-10-06 08:37:19,163::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:37:19,164::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:37:19,164::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:37:19,164::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:37:19,169::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,169::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:37:19,169::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:37:19,169::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 08:37:19,174::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,174::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 08:37:19,174::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 08:37:19,174::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 08:37:19,178::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,178::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 08:37:19,178::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 08:37:19,178::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 08:37:19,183::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,183::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 08:37:19,183::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 08:37:19,183::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 08:37:19,187::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,187::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 08:37:19,187::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 08:37:19,187::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External R2810-ONC-1788_Initial_036018003_Sepsis\nReceived Time : Tue Aug 24 20:02:32 EDT 2021\nSender Address : STUDY-PVSS-0456-0232@iconplc.com\nTo Address : Medical Safety - Contact (EXTERNAL)\n[Medical.Safety@regeneron.com]; [quasheeda.fields@regeneron.com];\n[emmanuel.okoye@regeneron.com]; [simon.eng@regeneron.com]; Hyunsil Han\nRegeneron (EXTERNAL) [hyunsil.han@regeneron.com];Matthew Fury - Regeneron\n(EXTERNAL) [matthew.fury@regeneron.com];Diana Horton - Regeneron\n(EXTERNAL) [diana.horton@regeneron.com]; Fionnuala Gallagher - Regeneron\n(EXTERNAL) [fionnuala.gallagher@regeneron.com];\n[Lukasz.Kubarek@iconplc.com];Ait Yakoub, Tassadit\n[Tassadit.AitYakoub@iconplc.com]; [laurel.monismith@regeneron.com];Priscila\nGoncalves - Regeneron (EXTERNAL) [priscila.goncalves@regeneron.com];\nCc Address : .STUDY-PVSS-DL-0456-0232 [STUDY-PVSS-DL-0456-\n0232@iconplc.com]; Breier, Ana [Ana.Breier@iconplc.com];\nNo. of Attachments : 1\nR2810-ONC-1788_036018003_Initial_SAE Package_Sepsis_23Aug2021.pdf\nMessage content follows :\nEXTERNAL MESSAGE\nDear All,\n \nPlease find enclosed the InitialSAE Package for above named event of patient 036018003, received on\n23Aug2021, applicable for study R810-ONC-1788 (ICON # 0456-0232).\n \n \nR2810-ONC-1788\nProtocol: \nSite # / Investigator: 036018\nSubject #: 003\nSAE Term: Sepsis\nOnset Date: 23Aug2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related Country: Australia\nPI Name and mail address: Palmieri, David J.      dpalmieri@riverinacancercare.com.au\nDay 0 23Aug2021\n \n \n \nKind Regards !\n \nLucia Flores\nDrug Safety Associate\nICON Clinical Research\nInternal Tel: 7240 4787\nExternal Tel: +52 55 5063 4787\nEmail: Lucia.Flores@iconplc.com\nWeb: www.iconplc.com\nICON plc made the following annotations.\n------------------------------------------------------------------------------\nThis e-mail transmission may contain confidential or legally privileged information\nthat is intended only for the individual or entity named in the e-mail address. If you are\nnot the intended recipient, you are hereby notified that any disclosure, copying,\ndistribution, or reliance upon the contents of this e-mail is strictly prohibited. If you\nhave received this e-mail transmission in error, please reply to the sender, so that\nICON plc can arrange for proper delivery, and then please delete the message.\nThank You,\nICON plc\nSouth County Business Park\nLeopardstown Dublin 18\nIreland\nRegistered number: 145835 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Monday, August 23, 2021 8:33 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/SqqBCmQR5CjXOXYWUGuJ9e?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Tuesday, August 24, 2021 3:29 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/8LCBC7L8RCAJxgYlH8fMLC?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1']
apiLogger::2021-10-06 08:37:19,187::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:37:19,188::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 08:37:19,620::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 08:37:19,621::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 08:37:19,622::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpymwxknne 
apiLogger::2021-10-06 08:37:19,622::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 08:37:19,622::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 08:37:19,630::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 08:37:19,630::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpymwxknne
apiLogger::2021-10-06 08:37:19,665::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 08:37:19,665::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 08:37:19,665::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 08:37:19,665::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 08:37:19,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 08:37:19,670::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 08:37:19,670::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 08:37:19,670::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 06-Oct-2021 08:35:54 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: 1788 data parsing\n \n \nFrom: Reshabh Reshabh-External Sent: Tuesday, October 5, 2021 5:23 PM To:\nlavit.goswami@rxlogix.com Cc: ritu.sharma@rxlogix.com Subject: 1788 data parsing \n \nHi Lavit, \n \nCan you please analyze this one also. The data is not parsing but we are able to copy the text\nfrom the PDF. \n \n \nSame error on postman. \n \n \nThanks &regards \nReshabh ']
apiLogger::2021-10-06 08:37:19,670::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 08:37:19,670::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 09:41:18,743::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 09:41:18,749::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 09:41:18,749::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9jcah7oy 
apiLogger::2021-10-06 09:41:18,750::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 09:41:18,750::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 09:41:18,861::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 09:41:18,862::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9jcah7oy
apiLogger::2021-10-06 09:41:19,677::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 09:41:19,677::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 09:41:19,677::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 09:41:19,677::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 09:41:19,682::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 09:41:19,682::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 09:41:19,682::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 09:41:19,682::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 09:41:19,687::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 09:41:19,687::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 09:41:19,687::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 09:41:19,687::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 09:41:19,691::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 09:41:19,691::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 09:41:19,691::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 09:41:19,691::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 09:41:19,691::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-06 09:41:19,691::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 09:41:19,691::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 09:41:19,691::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 09:41:19,691::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 09:41:19,692::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 09:41:34,210::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 09:41:34,210::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 09:53:18,817::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 09:53:18,844::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 09:53:18,844::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_4uq0rao 
apiLogger::2021-10-06 09:53:18,846::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 09:53:18,846::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 09:53:19,220::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 09:53:19,220::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_4uq0rao
apiLogger::2021-10-06 09:53:21,562::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 09:53:21,563::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 09:53:21,563::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 09:53:21,563::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 09:53:21,568::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 09:53:21,568::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 09:53:21,568::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 09:53:21,568::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 09:53:21,568::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM']
apiLogger::2021-10-06 09:53:21,568::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 09:53:21,568::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 09:53:21,568::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 09:53:21,568::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 09:53:21,568::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 09:53:41,952::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 09:53:41,952::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 10:01:19,111::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 10:01:19,260::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 10:01:19,260::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4auxt88u 
apiLogger::2021-10-06 10:01:19,266::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 10:01:19,266::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 10:01:19,899::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 10:01:19,899::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4auxt88u
apiLogger::2021-10-06 10:01:20,161::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 10:01:20,161::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 10:01:20,161::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 10:01:20,161::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 10:01:20,165::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:20,165::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 10:01:20,165::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 10:01:20,165::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 10:01:20,168::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:20,169::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 10:01:20,169::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 10:01:20,169::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 10:01:20,172::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:20,172::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 10:01:20,172::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 10:01:20,172::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 10:01:20,175::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:20,175::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 10:01:20,175::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 10:01:20,176::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 10:01:20,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:20,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 10:01:20,179::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 10:01:20,179::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-06 10:01:20,179::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-06 10:01:20,179::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 10:01:21,589::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 10:01:21,590::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 10:01:21,590::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpl2bq51ny 
apiLogger::2021-10-06 10:01:21,591::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 10:01:21,591::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 10:01:21,596::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 10:01:21,596::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpl2bq51ny
apiLogger::2021-10-06 10:01:21,606::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 10:01:21,606::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 10:01:21,606::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 10:01:21,606::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 10:01:21,611::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:01:21,611::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 10:01:21,611::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 10:01:21,611::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 06-Oct-2021 10:00:29 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\n ']
apiLogger::2021-10-06 10:01:21,611::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 10:01:21,611::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 10:22:53,681::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 10:22:53,732::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 10:22:53,732::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_2z18_p8 
apiLogger::2021-10-06 10:22:55,114::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 10:22:55,114::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 10:22:56,338::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 10:22:56,338::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_2z18_p8
apiLogger::2021-10-06 10:22:59,245::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 10:22:59,246::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 10:22:59,246::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 10:22:59,246::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 10:22:59,253::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:22:59,253::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 10:22:59,253::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 10:22:59,253::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 10:22:59,256::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:22:59,256::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 10:22:59,256::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 10:22:59,256::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 10:22:59,259::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 10:22:59,259::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 10:22:59,259::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 10:22:59,259::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 10:22:59,259::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked']
apiLogger::2021-10-06 10:22:59,259::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 10:22:59,259::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 10:22:59,260::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 10:22:59,260::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 10:22:59,260::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fd85a44a6d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 10:23:26,669::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 10:23:26,669::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 10:28:58,796::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 10:28:58,805::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 10:28:58,806::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo141frnu 
apiLogger::2021-10-06 10:28:58,806::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 10:28:58,806::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 10:28:58,811::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 10:28:58,812::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo141frnu
apiLogger::2021-10-06 10:28:59,311::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 10:28:59,312::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 10:28:59,312::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 10:28:59,312::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 10:28:59,315::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:28:59,315::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 10:28:59,315::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 10:28:59,316::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 10:28:59,318::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:28:59,318::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 10:28:59,319::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 10:28:59,319::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 10:28:59,321::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:28:59,321::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 10:28:59,321::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 10:28:59,321::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 10:28:59,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:28:59,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 10:28:59,324::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 10:28:59,324::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 10:28:59,326::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:28:59,326::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 10:28:59,326::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 10:28:59,326::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External R2810-ONC-1788_Initial_036018003_Sepsis\nReceived Time : Tue Aug 24 20:02:32 EDT 2021\nSender Address : STUDY-PVSS-0456-0232@iconplc.com\nTo Address : Medical Safety - Contact (EXTERNAL)\n[Medical.Safety@regeneron.com]; [quasheeda.fields@regeneron.com];\n[emmanuel.okoye@regeneron.com]; [simon.eng@regeneron.com]; Hyunsil Han\nRegeneron (EXTERNAL) [hyunsil.han@regeneron.com];Matthew Fury - Regeneron\n(EXTERNAL) [matthew.fury@regeneron.com];Diana Horton - Regeneron\n(EXTERNAL) [diana.horton@regeneron.com]; Fionnuala Gallagher - Regeneron\n(EXTERNAL) [fionnuala.gallagher@regeneron.com];\n[Lukasz.Kubarek@iconplc.com];Ait Yakoub, Tassadit\n[Tassadit.AitYakoub@iconplc.com]; [laurel.monismith@regeneron.com];Priscila\nGoncalves - Regeneron (EXTERNAL) [priscila.goncalves@regeneron.com];\nCc Address : .STUDY-PVSS-DL-0456-0232 [STUDY-PVSS-DL-0456-\n0232@iconplc.com]; Breier, Ana [Ana.Breier@iconplc.com];\nNo. of Attachments : 1\nR2810-ONC-1788_036018003_Initial_SAE Package_Sepsis_23Aug2021.pdf\nMessage content follows :\nEXTERNAL MESSAGE\nDear All,\n \nPlease find enclosed the InitialSAE Package for above named event of patient 036018003, received on\n23Aug2021, applicable for study R810-ONC-1788 (ICON # 0456-0232).\n \n \nR2810-ONC-1788\nProtocol: \nSite # / Investigator: 036018\nSubject #: 003\nSAE Term: Sepsis\nOnset Date: 23Aug2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related Country: Australia\nPI Name and mail address: Palmieri, David J.      dpalmieri@riverinacancercare.com.au\nDay 0 23Aug2021\n \n \n \nKind Regards !\n \nLucia Flores\nDrug Safety Associate\nICON Clinical Research\nInternal Tel: 7240 4787\nExternal Tel: +52 55 5063 4787\nEmail: Lucia.Flores@iconplc.com\nWeb: www.iconplc.com\nICON plc made the following annotations.\n------------------------------------------------------------------------------\nThis e-mail transmission may contain confidential or legally privileged information\nthat is intended only for the individual or entity named in the e-mail address. If you are\nnot the intended recipient, you are hereby notified that any disclosure, copying,\ndistribution, or reliance upon the contents of this e-mail is strictly prohibited. If you\nhave received this e-mail transmission in error, please reply to the sender, so that\nICON plc can arrange for proper delivery, and then please delete the message.\nThank You,\nICON plc\nSouth County Business Park\nLeopardstown Dublin 18\nIreland\nRegistered number: 145835 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Monday, August 23, 2021 8:33 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/SqqBCmQR5CjXOXYWUGuJ9e?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Tuesday, August 24, 2021 3:29 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/8LCBC7L8RCAJxgYlH8fMLC?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1']
apiLogger::2021-10-06 10:28:59,326::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 10:28:59,327::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 10:40:53,402::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 10:40:53,517::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 10:40:53,518::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxmfw5rur 
apiLogger::2021-10-06 10:40:53,971::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 10:40:53,971::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 10:40:55,192::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 10:40:55,192::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxmfw5rur
apiLogger::2021-10-06 10:40:59,840::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 10:40:59,841::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 10:40:59,841::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 10:40:59,841::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 10:40:59,848::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:40:59,849::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 10:40:59,849::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 10:40:59,849::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 10:40:59,852::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 10:40:59,852::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 10:40:59,852::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 10:40:59,852::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 10:40:59,855::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 10:40:59,855::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 10:40:59,855::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 10:40:59,856::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 10:40:59,856::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n1 AUGMENTIN Adverse Event - - 1000 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n2 CIPRINOL Adverse Event - - 0.4 g - BID\nINFECTION_25 JAN\n2021\n1_HYPERTENSION_\n3 COVALSACOR Medical History - - 160+12.5 mg - QD\nUNK\nHYPERURICEMIA\n4 MILURIT Prophylaxis - - 100 mg - QD\nPROPHYLAXIS\n2_OSTEOARTHRITI\n5 DORETA Medical History - - 75 mg - QD\nS_UNK\nPremedication for\n6 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n7 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n8 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n9 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n10 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n11 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n25 JAN 09 FEB\nTID - Oral - unchecked unchecked\n2021 2021\n25 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nUN UNK\nQD - Oral - unchecked - checked\n2010\nUN UNK\nQD - Oral - unchecked - checked\n2017\nUN UNK\nQD - Oral - unchecked - checked\n2018\n04 NOV 04 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n05 NOV 05 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n16 NOV 16 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n17 NOV 17 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n23 NOV 23 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 NOV 30 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n12 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n13 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n14 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n15 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n16 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n17 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n18 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n1_RESPIRATORY\nFRAXIPARINE TRACT\n19 Adverse Event - - 0.8 mL - QD\nMULTI INFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n20 CLEMASTIN Adverse Event - - 1 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n21 TRIMESOLPHAR Adverse Event - - 1920 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n22 VORYCONAZOOL Adverse Event - - 200 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n23 MORFINA Adverse Event - - 5 mg - PRN\nINFECTION_25 JAN\n2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n07 DEC 07 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n14 DEC 14 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n21 DEC 21 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n28 DEC 28 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n04 JAN 04 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n11 JAN 11 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n18 JAN 18 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\nSubcutaneo 25 JAN 09 FEB\nQD - - unchecked unchecked\nus 2021 2021\n25 JAN 09 FEB\nQD - Oral - unchecked unchecked\n2021 2021\n05 FEB 09 FEB\nTID - Intravenous - unchecked unchecked\n2021 2021\n30 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nSubcutaneo 08 FEB 09 FEB\nPRN - - unchecked unchecked\nus 2021 2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n24 ATROVENT Adverse Event - - 40 Drop - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n25 PULMICORT Adverse Event - - 1 g - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n26 VENTOLIN Adverse Event - - 2.5 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n27 FUROSEMID Adverse Event - - 20 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n28 HEVIRAN Adverse Event - - 400 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n29 BISEPTOL Adverse Event - - 1920 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n30 BUDEZONID Adverse Event - - 0.5 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n31 METOCARD Adverse Event - - 25 mg - Unknown\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n32 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n33 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n34 NEOPARIN Adverse Event - - 40 mg - QD\nINFECTION_25 JAN\n2021']
apiLogger::2021-10-06 10:40:59,856::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 10:40:59,856::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 10:40:59,856::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 10:40:59,856::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 10:40:59,856::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4da58dd748>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 10:41:27,692::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 10:41:27,692::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 11:02:25,500::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 11:02:25,510::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 11:02:25,510::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpycgp6tax 
apiLogger::2021-10-06 11:02:25,510::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 11:02:25,511::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 11:02:25,516::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 11:02:25,516::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpycgp6tax
apiLogger::2021-10-06 11:02:26,940::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 11:02:26,940::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 11:02:26,940::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 11:02:26,940::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 11:02:26,944::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:02:26,944::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 11:02:26,944::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 11:02:26,944::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 11:02:26,947::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:02:26,947::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 11:02:26,947::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 11:02:26,947::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 11:02:26,949::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:02:26,949::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 11:02:26,949::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 11:02:26,950::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 11:02:26,952::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:02:26,952::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 11:02:26,952::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 11:02:26,952::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 11:02:26,955::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:02:26,955::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 11:02:26,955::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 11:02:26,955::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-06 11:02:26,957::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 11:02:26,957::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-06 11:02:26,958::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 11:02:26,958::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 5
apiLogger::2021-10-06 11:02:26,958::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-06 11:02:26,958::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 11:02:26,958::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 11:02:26,958::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 11:02:26,958::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 11:02:26,958::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 11:02:42,557::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 11:02:42,557::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 11:03:18,634::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 11:03:18,641::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 11:03:18,641::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8gyz3_bc 
apiLogger::2021-10-06 11:03:18,642::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 11:03:18,642::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 11:03:18,752::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 11:03:18,752::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8gyz3_bc
apiLogger::2021-10-06 11:03:20,375::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 11:03:20,375::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 11:03:20,375::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 11:03:20,375::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 11:03:20,378::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:03:20,378::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 11:03:20,378::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 11:03:20,378::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 11:03:20,381::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:03:20,381::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 11:03:20,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 11:03:20,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 11:03:20,384::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 11:03:20,384::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 11:03:20,384::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 11:03:20,384::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 11:03:20,384::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-06 11:03:20,384::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 11:03:20,384::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 11:03:20,384::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 11:03:20,384::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 11:03:20,384::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 11:03:34,467::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 11:03:34,467::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 11:15:18,738::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 11:15:18,743::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 11:15:18,744::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpavuk0l3w 
apiLogger::2021-10-06 11:15:18,744::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 11:15:18,744::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 11:15:18,834::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 11:15:18,835::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpavuk0l3w
apiLogger::2021-10-06 11:15:20,691::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 11:15:20,691::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 11:15:20,691::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 11:15:20,691::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 11:15:20,694::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:15:20,694::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 11:15:20,695::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 11:15:20,695::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 11:15:20,697::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 11:15:20,697::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 11:15:20,697::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 11:15:20,697::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 11:15:20,697::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-06 11:15:20,698::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 11:15:20,698::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 11:15:20,698::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 11:15:20,698::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 11:15:20,698::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 11:15:34,992::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 11:15:34,992::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 11:19:18,657::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 11:19:18,662::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 11:19:18,662::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj86i95g7 
apiLogger::2021-10-06 11:19:18,662::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 11:19:18,663::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 11:19:18,736::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 11:19:18,736::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj86i95g7
apiLogger::2021-10-06 11:19:20,774::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 11:19:20,774::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 11:19:20,774::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 11:19:20,774::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 11:19:20,777::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 11:19:20,777::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 11:19:20,777::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 11:19:20,778::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 11:19:20,778::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-06 11:19:20,778::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 11:19:20,778::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 11:19:20,778::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 11:19:20,778::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 11:19:20,778::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 11:19:35,276::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 11:19:35,277::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 11:27:47,521::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 11:27:47,529::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 11:27:47,530::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpegwuv099 
apiLogger::2021-10-06 11:27:47,530::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 11:27:47,530::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 11:27:47,621::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 11:27:47,622::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpegwuv099
apiLogger::2021-10-06 11:27:49,475::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 11:27:49,475::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 11:27:49,476::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 11:27:49,476::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 11:27:49,479::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 11:27:49,479::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 11:27:49,479::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 11:27:49,479::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 11:27:49,482::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 11:27:49,482::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 11:27:49,482::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 11:27:49,482::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 11:27:49,482::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-06 11:27:49,482::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 11:27:49,482::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 11:27:49,482::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 11:27:49,482::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 11:27:49,482::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 11:28:03,881::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 11:28:03,881::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 12:19:18,694::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 12:19:18,700::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 12:19:18,700::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptlxb9m2j 
apiLogger::2021-10-06 12:19:18,701::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 12:19:18,701::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 12:19:18,800::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 12:19:18,800::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptlxb9m2j
apiLogger::2021-10-06 12:19:21,758::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 12:19:21,758::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 12:19:21,758::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 12:19:21,758::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 12:19:21,762::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 12:19:21,762::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 12:19:21,762::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 12:19:21,762::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 12:19:21,765::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 12:19:21,765::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 12:19:21,765::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 12:19:21,765::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 12:19:21,765::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 12:19:21,766::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 12:19:21,766::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 12:19:21,766::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 12:19:21,766::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 12:19:21,766::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 12:19:41,079::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 12:19:41,079::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 12:25:35,801::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 12:25:35,809::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 12:25:35,809::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpa5b_6brn 
apiLogger::2021-10-06 12:25:35,810::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 12:25:35,810::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 12:25:35,909::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 12:25:35,909::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpa5b_6brn
apiLogger::2021-10-06 12:25:38,843::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 12:25:38,843::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 12:25:38,843::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 12:25:38,843::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 12:25:38,846::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 12:25:38,847::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 12:25:38,847::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 12:25:38,847::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 12:25:38,849::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 12:25:38,850::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 12:25:38,850::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 12:25:38,850::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 12:25:38,850::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 12:25:38,850::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 12:25:38,850::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 12:25:38,850::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 12:25:38,850::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 12:25:38,850::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f4d50410a58>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 12:25:57,976::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 12:25:57,976::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 13:15:36,105::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 13:15:36,154::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 13:15:36,155::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp72z_7tzl 
apiLogger::2021-10-06 13:15:36,626::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 13:15:36,626::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 13:15:37,891::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 13:15:37,891::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp72z_7tzl
apiLogger::2021-10-06 13:15:42,692::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 13:15:42,692::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 13:15:42,692::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 13:15:42,692::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 13:15:42,700::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:15:42,700::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 13:15:42,700::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 13:15:42,700::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 13:15:42,703::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:15:42,703::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 13:15:42,703::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 13:15:42,703::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 13:15:42,706::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-06 13:15:42,706::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 13:15:42,706::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 13:15:42,706::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 13:15:42,706::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n1 AUGMENTIN Adverse Event - - 1000 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n2 CIPRINOL Adverse Event - - 0.4 g - BID\nINFECTION_25 JAN\n2021\n1_HYPERTENSION_\n3 COVALSACOR Medical History - - 160+12.5 mg - QD\nUNK\nHYPERURICEMIA\n4 MILURIT Prophylaxis - - 100 mg - QD\nPROPHYLAXIS\n2_OSTEOARTHRITI\n5 DORETA Medical History - - 75 mg - QD\nS_UNK\nPremedication for\n6 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n7 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n8 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n9 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n10 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n11 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n25 JAN 09 FEB\nTID - Oral - unchecked unchecked\n2021 2021\n25 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nUN UNK\nQD - Oral - unchecked - checked\n2010\nUN UNK\nQD - Oral - unchecked - checked\n2017\nUN UNK\nQD - Oral - unchecked - checked\n2018\n04 NOV 04 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n05 NOV 05 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n16 NOV 16 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n17 NOV 17 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n23 NOV 23 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 NOV 30 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n12 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n13 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n14 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n15 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n16 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n17 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n18 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n1_RESPIRATORY\nFRAXIPARINE TRACT\n19 Adverse Event - - 0.8 mL - QD\nMULTI INFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n20 CLEMASTIN Adverse Event - - 1 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n21 TRIMESOLPHAR Adverse Event - - 1920 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n22 VORYCONAZOOL Adverse Event - - 200 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n23 MORFINA Adverse Event - - 5 mg - PRN\nINFECTION_25 JAN\n2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n07 DEC 07 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n14 DEC 14 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n21 DEC 21 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n28 DEC 28 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n04 JAN 04 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n11 JAN 11 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n18 JAN 18 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\nSubcutaneo 25 JAN 09 FEB\nQD - - unchecked unchecked\nus 2021 2021\n25 JAN 09 FEB\nQD - Oral - unchecked unchecked\n2021 2021\n05 FEB 09 FEB\nTID - Intravenous - unchecked unchecked\n2021 2021\n30 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nSubcutaneo 08 FEB 09 FEB\nPRN - - unchecked unchecked\nus 2021 2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n24 ATROVENT Adverse Event - - 40 Drop - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n25 PULMICORT Adverse Event - - 1 g - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n26 VENTOLIN Adverse Event - - 2.5 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n27 FUROSEMID Adverse Event - - 20 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n28 HEVIRAN Adverse Event - - 400 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n29 BISEPTOL Adverse Event - - 1920 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n30 BUDEZONID Adverse Event - - 0.5 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n31 METOCARD Adverse Event - - 25 mg - Unknown\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n32 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n33 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n34 NEOPARIN Adverse Event - - 40 mg - QD\nINFECTION_25 JAN\n2021']
apiLogger::2021-10-06 13:15:42,707::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 13:15:42,707::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-06 13:15:42,707::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 13:15:42,707::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 13:15:42,707::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc2ba8b32e8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 13:16:10,674::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 13:16:10,674::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 13:27:18,829::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 13:27:18,835::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 13:27:18,836::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn00emw9q 
apiLogger::2021-10-06 13:27:18,836::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 13:27:18,837::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 13:27:18,952::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 13:27:18,952::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn00emw9q
apiLogger::2021-10-06 13:27:20,662::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 13:27:20,662::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 13:27:20,662::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 13:27:20,662::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 13:27:20,666::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:27:20,666::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 13:27:20,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 13:27:20,666::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 13:27:20,669::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:27:20,669::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 13:27:20,669::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 13:27:20,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 13:27:20,672::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 13:27:20,672::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 13:27:20,672::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 13:27:20,672::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-06 13:27:20,672::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-06 13:27:20,673::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 13:27:20,673::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 13:27:20,673::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 13:27:20,673::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 13:27:20,673::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 13:27:34,874::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 13:27:34,874::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 13:39:18,778::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 13:39:18,784::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 13:39:18,785::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5aiiv6gu 
apiLogger::2021-10-06 13:39:18,785::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 13:39:18,785::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 13:39:18,888::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 13:39:18,888::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5aiiv6gu
apiLogger::2021-10-06 13:39:21,942::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 13:39:21,942::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 13:39:21,942::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 13:39:21,942::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 13:39:21,945::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:39:21,946::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 13:39:21,946::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 13:39:21,946::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 13:39:21,948::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 13:39:21,949::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 13:39:21,949::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 13:39:21,949::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 13:39:21,949::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 13:39:21,949::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 13:39:21,949::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 13:39:21,949::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 13:39:21,949::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 13:39:21,949::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 13:39:40,955::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 13:39:40,955::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 13:59:18,737::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 13:59:18,743::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 13:59:18,744::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuxw_8q64 
apiLogger::2021-10-06 13:59:18,744::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 13:59:18,744::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 13:59:18,847::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 13:59:18,847::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuxw_8q64
apiLogger::2021-10-06 13:59:21,876::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 13:59:21,876::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 13:59:21,876::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 13:59:21,876::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 13:59:21,880::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 13:59:21,880::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 13:59:21,880::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 13:59:21,880::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 13:59:21,883::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 13:59:21,883::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 13:59:21,883::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 13:59:21,883::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 13:59:21,883::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 13:59:21,883::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 13:59:21,883::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 13:59:21,883::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 13:59:21,883::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 13:59:21,883::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 13:59:40,992::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 13:59:40,992::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 14:01:18,723::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 14:01:18,730::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 14:01:18,730::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9aw_fxvh 
apiLogger::2021-10-06 14:01:18,731::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 14:01:18,731::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 14:01:18,833::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 14:01:18,833::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9aw_fxvh
apiLogger::2021-10-06 14:01:21,865::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 14:01:21,865::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 14:01:21,865::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 14:01:21,865::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 14:01:21,869::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 14:01:21,869::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 14:01:21,869::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 14:01:21,869::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 14:01:21,872::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 14:01:21,872::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 14:01:21,872::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 14:01:21,872::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 14:01:21,872::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 14:01:21,872::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 14:01:21,872::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 14:01:21,872::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 14:01:21,872::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 14:01:21,872::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 14:01:40,898::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 14:01:40,899::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 14:07:18,770::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 14:07:18,775::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 14:07:18,776::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr61dftut 
apiLogger::2021-10-06 14:07:18,776::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 14:07:18,776::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 14:07:18,870::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 14:07:18,870::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr61dftut
apiLogger::2021-10-06 14:07:20,786::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 14:07:20,787::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 14:07:20,787::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 14:07:20,787::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 14:07:20,790::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 14:07:20,790::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 14:07:20,790::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 14:07:20,790::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 14:07:20,793::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 14:07:20,793::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 14:07:20,793::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 14:07:20,793::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 14:07:20,793::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-06 14:07:20,794::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 14:07:20,794::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 14:07:20,794::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 14:07:20,794::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 14:07:20,794::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 14:07:34,954::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 14:07:34,954::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 16:09:18,894::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 16:09:18,958::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 16:09:18,959::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpf7jvt1jz 
apiLogger::2021-10-06 16:09:18,961::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 16:09:18,961::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 16:09:21,030::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 16:09:21,030::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpf7jvt1jz
apiLogger::2021-10-06 16:09:25,156::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 16:09:25,157::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 16:09:25,157::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 16:09:25,157::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 16:09:25,160::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,160::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 16:09:25,160::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 16:09:25,160::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 16:09:25,163::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,164::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 16:09:25,164::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 16:09:25,164::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-06 16:09:25,167::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,167::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-06 16:09:25,167::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-06 16:09:25,167::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-06 16:09:25,170::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,170::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-06 16:09:25,170::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-06 16:09:25,170::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-06 16:09:25,173::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,173::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-06 16:09:25,173::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-06 16:09:25,173::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-06 16:09:25,176::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,176::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-06 16:09:25,176::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-06 16:09:25,176::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-06 16:09:25,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-06 16:09:25,179::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-06 16:09:25,179::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-06 16:09:25,182::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,182::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-06 16:09:25,182::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-06 16:09:25,182::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-06 16:09:25,185::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,185::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-06 16:09:25,185::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-06 16:09:25,185::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-06 16:09:25,188::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,188::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-06 16:09:25,188::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-06 16:09:25,188::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24 \x00\x01\x02\x02\x03ÿ\x05\x06\x07\x08\t\n\x0b\x0c\rÿ\x0eÿ\x0f\x02\x10\x11\x01ÿ\x0f\x11\x12\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x13\x1eÿ\x11\x0b\n\x03\x02\n\t\x14!\n\x16\x11\nÿ\x11 \x1b\x11\x0b\x07ÿ\x02\x1e "\t\n\t\x0b\x1dÿ#\x11\n \x00\x01\x02\x02\x03 (\n\x18\x11\x0c\x0b\x11\x0b\x07 (\x01\x11\x14\t\x14\x07\n\x1a\x07\x11\n\x02\x14 &\x01$\x10\x02\n\x07\n\x13\x14\n\x0b\x11\x14\x10\x07 \x17\x11\x08\x18\x01\x07 \x1c\x0b\x06\x07\x0c\x1d \x05\x02\x01\x01\x07\x10\x0b\t\x02\x14 \x0b\x06\x07 %\x02\x0b\x11\n\n\t$ )\x02\x0b\x11\x01 \x05\x0c\x07\x11\x0b\t\x14\t $\x0c\x07\x11 (\x08\t\x14\x02\x0b\x0c\x11\x14 (\x08\t\x14\x02\x0b\x0c\x11\x14\n\x15\x02\x0b \x17\x02\x03\t$\x08 \x05\x06\x01\x02\x0c\t\x03\x07 \x05\x11\x01\x10\t$\x08 \x1f\x15\x02\x14\x0e (\x01\x12$\x08\t\x14 *\x0c\x07\x11\n\x15\x11\x08\x07 \x05\x02\x01\x01\x07\x10\x0b\x07 \x17\x18\x07\x10\t\x1e\r \x1f\x03\x03\x0e\x08\x02\x14\x0e \n\x11\x08\x18\x01\x07 \x08 %\x0c\x02\x0b\x07\t\x14 \x14\x07 \x14\t\x0b\x0c\x02!\x07\x14 \n\x1e\x07\x0c\x11\n\x07 \n\x1e\x07\x0c\x11\n\x07\n\x1b\x02\x14\x07 \'\x11\n\x0b\t\x14! \n\x03\x19 \r\r\r\r  \x10\x02\x01\x01\x07\x10\x0b\x07\x03 \x1f\x00*\x15  \x1f(\x17)  \x1f(\x0f) \n\x18\x0c\t\x02\x0cÿ\x0b\x02\n\x03\x02\n\t\x14!\x19\n/;<\n+,-.. 67ÿ+.9 6DEFG JKLFGG 677FG :KDFGG 67MFGN JKJFNH MK:FNH 6K6MFG LJFGNH\n234 5 5 =>>?@ABC? FGNHOI 6EFPHI 6QKDFPHI\n/0/1 :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\n3\nRS3B<G3\nT<ÿU33V 6Jÿ+.9 6DMFG JKDFGG E[FGG :KDFGG 666FGN JKDFNH MK:FNH 6K7JFG JMFGNH\n234 5 5 234 FGNHOI :DFPHI :DFPHI\n6ÿWBXÿ6 :7:6 G;?HI ;?HI ;?HI ;?HI HOI OI OI NHOI OI\nY6Z\nRS3B<G3\nT<ÿU33V 6Lÿ+.9 6DQFG JKDFGG 67:FG :K:FGG 6QMFGN JKDFNH LKLFNH 6K6LFG M6FGNH\n234 5 5 234 FGNHOI :MK6FPHI :7FPHI\n6ÿWBXÿ: :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\nY6Z REG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x01\x02\x03\x01\x04 \x1f\x14\x06\x03\x0c\x04\x05\x04\n!\x03\x1d\x1d\x03" \x1f\t\x14\x14\x06\x10\x0c\x06\n\x05\x06 \x0e\x03\x10\x0c\x03\x0c\x06 \x07\x08\t\n\x0b\x08 \x1f\x14\x06\x03\x0c\x04\x05\x06 \x17\x14\x04\x15\x01\x12\x10\x06 \x05\x06\n\x1f\x14\x06\x03\x0c\x04\x05\x06 \x15\x01\x19\x0c\x03\x1d\x12\x01 \x13ÿ&\x06\x14\x19\x1d\n\x07\x08\t\n \x11\x06\x08\x12\x13\x14\t \x17\t\x0c\x03\x01 \x11\x04\x14\x06\x10\x0c \x1b\x05\n\x0c\x03\x05\x10\x06 \x1e\x14\x04\x10 \t\x14\x19\n \x0b\x08\t\n\x0b\x08 \x14\x04\x13\x06\n \x18\x04\x10\x03\x14\x1a\t \x1f\x03\x14\x1a\t\x05 \x1f\x01\x06\x03\x14\x03\x05\n \x04\x05\x03\n\x06 \x0c\x14\x03\x05\n#\x06\x14 \x1f\x03\x01\x10\x04\x19\x1d\n\x0b\x08\x03\x0c\x03 \x15\x06\x05\x03\n\x06 \x18\x04\x01\x04\x14\x19\x1a\x04\x05 \x1a\x04\x01\x04\x14\x19\x1a\x04\x05 \x1c\x03\x1d\x06 \x00\x10\x04\x13 \r\x07\x08\t\n\x0b\x08 \t\x02\x04\x05\x03\n\x06 \r\x05\t\x05" \x05\x03\x0c\x06 \x13\x04\t$\x04\x13\x06 \x10\x06\n\r\x1f \x0f \x03\n\x06 \r\x13\x06\x14\x04\'\x06\x13\n\n\x06 \r\x0e\x11\x16\x0f \x03\x0c\x06\x0f \r\x1f\x07 \x0f #\x03\n\x0c\x04\x05\x15\x0f \r\x13\x06\x14\x04\'\x06\x13\n\r!!\x17\x0f \x0f\n\r\x00\x0e\x07\x0f \x0f\n()*+ )/*+,- *01+23- 56788 (*0(+2 (0((+2 )((0>+ 1)+23- )10?+2\n+23-4. + )1+,-. + )0)) >@0>?\n,-. . 4. 9:9; 3-4. 2<=-. ,-. 4. 2<=-.\nABCDE2C\n((?+ )>?+,- *0/+23- FEÿHCCI ?0/+23- (0*1+2 )>(01+ O?+23- )>0/+2\n+23-4. + N1+,-. + )0)> //0(@\n,-. . 4. (ÿJDKÿ( 4. 2<=-. ,-. 4. 2<=-.\nL(M\nABCDE2C\n@N+, ))?+,- *0/+23- FEÿHCCI *0)+23- (0N)+2 )>101+ O/+23- ))0O+2\n+23-4. + N)+,-. + )0(> >@0@(\n-. . 4. (ÿJDKÿ) 4. 2<=-. ,-. 4. 2<=-.\nL(M \x06\x07\x08\t\n\x0b\tÿ\x0c\x08\t\x05\r\x0b\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n$\x1aÿ\x11\x1b\r\x0f\x11\x14\t\n\x04\x0b\n\x06\x0c \x06\x0c\n\x02\x03\x04\x05 \x1d\t\x0f\x11\x08\t\n\t\x07\n\x16\t\x19\t\x0f\rÿ\x04\x1a \x0b\x1b\x0b\x10\t\x0f\r\t\x07 \x0b\x1b\x0b\x10\t\x0f\r\t\x07 $\x1aÿ\x18\t\x0b%\n\x06\x07\x08\t\n\x0b\t \x16\r\x03\n\rÿ\x07\x03\r\t \'\x1d\t\x0b\x11\x19\x08\t\x07 \x1d\t\x0b\x11\x19\x1b\r\x04\x11\x05\n\x06\x0cÿ\x04\x0b \r\x11ÿ\x1c\t \r\x11ÿ\x1c\t \x0b\x10\t\x0f\x04\x1a\x18 &\x1b\r\x0f\x11\x14\t\nÿ\x01 \x0c\x08\t\x05\r \x12\x07\x07\x17\x14\x11\x05\x17 (\x04\r) \x07\x03\r\tÿ\x12\x07\x07\x17\n\x04\x05\r\t\n\x14\x04\r\r\t\x05 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0b\r\x1b\x07\x18 \x11\x1aÿ\x06\x0c\n\x0e\t\x0b\x0f\n\x04\x10\r\x04\x11 \x18\x18\x18\x18\x15 \x16\t*\x1b\t\x19\x03\t+ \x14\x11\x05\x17\x18\x18\x18\x18\x15\n\r \x1d\x0c\x1e\x1f !"! \x0b\r\x1b\x07\x18 \x0f\x11\x05\x07\x1b\x0f\r\n\x05ÿ\x12\x13\t\n\x14\x15 \x16\x10\t\x0f\x04\x1a\x18\n# \x0f\x11\x05\x07\x1b\x0f\r#\n\r)\t\n\x0b\t*\x1b\t\x19\x03\t,\n/AB\n./0.123 89ÿ;.1 C?DAE?C?FG\n- > 7?@ /A > >\n4513627 <=<8 /AB\nC?@AHE?F \x00\x01\x02\x03\x04\x05\x03ÿ\x07\x02\x03\x08\tÿ\n\x03\t\x0b\x0c\r\x05\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x07ÿ\x0c\x08\x0c\t\x0c\x0b\rÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x10\x11\x12\x13\x14ÿ\x16\n\x00\x07ÿ\x17\x18\x05\tÿ\x03\x19\t\x04\x03\x17\x03ÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x1a\x04\x0b\x01\x03ÿ\x1b\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ\x1c\x03\x1d\x0b\x17\x03ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ\x18\x04ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ ÿ\x0c!ÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n$\x01\x01 \x17\x18\x08 \x0e\x0e\x0e\x0e%\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03 \'\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\r\x03\x05\x05\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n\x00\x1d\t\x0c\x18\x08ÿ\t\x0b(\x03\x08ÿ)\x0c\t\x1fÿ*\x07\x1a&+,-, ./0ÿ122345\x1263\x14\n\n\x18\x03\x05ÿ\t\x1f\x0c\x05ÿ\x00\x07ÿ78\x0b\r\x0c!\x0eÿ\x0b\x05ÿ9\x03\x04\x0c\x188\x05: ;\x14<\n=\x05ÿ\t\x1f\x0c\x05ÿ\x0b\x08ÿ\x00\x07ÿ\x18!ÿ9"\x03\x1d\x0c\x0b\rÿ\x0c\x08\t\x03\x04\x03\x05\tÿ$\x00\x079=%: ./\n9\x03\x04\x0c\x188\x08\x03\x05\x05ÿ>\x04\x0c\t\x03\x04\x0c\x0b\n=\tÿ\x04\x03\x058\r\t\x03\x01ÿ\x0c\x08ÿ\x01\x03\x0b\t\x1f ./\n=\tÿ)\x0b\x05ÿ\r\x0c!\x03 \t\x1f\x04\x03\x0b\t\x03\x08\x0c\x08\x0f ./\n=\tÿ\x04\x0378\x0c\x04\x03\x01ÿ\x18\x04ÿ"\x04\x18\r\x18\x08\x0f\x03\x01ÿ\x0c\x08"\x0b\t\x0c\x03\x08\tÿ\x1f\x18\x05"\x0c\t\x0b\r\x0c?\x0b\t\x0c\x18\x08 @\x03\x05\nA\x03\x04\x05\x0c\x05\t\x03\x08\tÿ\x18\x04ÿ\x05\x0c\x0f\x08\x0c!\x0c\x1d\x0b\x08\tÿ\x01\x0c\x05\x0b#\x0c\r\x0c\t\x0eÿBÿ\x0c\x08\x1d\x0b"\x0b\x1d\x0c\t\x0e ./\n=\tÿ\x0c\x05ÿ\x0bÿ\x1d\x18\x08\x0f\x03\x08\x0c\t\x0b\rÿ\x0b\x08\x18\x17\x0b\r\x0eB#\x0c\x04\t\x1fÿ\x01\x03!\x03\x1d\tÿ\x0c\x08ÿ\x18!!\x05"\x04\x0c\x08\x0fÿ\x18!\n./\n\x05\t8\x01\x0eÿ\x058#C\x03\x1d\t\nD\t\x1f\x03\x04ÿ\x17\x03\x01\x0c\x1d\x0b\r\r\x0eÿ\x05\x03\x04\x0c\x188\x05ÿ\x0c\x17"\x18\x04\t\x0b\x08\tÿ\x03\x02\x03\x08\t ./ \x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\r\x0e\x08\x0b\x00\x0f\n\x08\x0bÿ\x10\x05\x11\x12\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\rÿ\x14\x01\x06\x15\x02\x03\x16\r\x03\x04\x0cÿ\x17\x18\x01\x02\x11\x19 \x13\n\x00\r$\x02\rÿ\x14$\r\x01 \x1a\x1b\x1c\x1a\x1d\x1e\x1f !\x1d\x1f"\x1e#\n\x14$\r\x01ÿ\x01\n\x01\x0c\rÿ\x12\x01\x15$\x11\x01ÿ\x06\x01\x02\x03\x04\x05\x06ÿ\x17\t\t+\x11\x04\x0c+,,,,\x19 %&ÿ(\x1a\x1dÿ)*)%\n-\r.\x01\x02ÿ\x06\x05\x06\x16\x01\x15\r\x01\tÿ\x15$\x05\x06\x01\x06 %&ÿ(\x1a\x1dÿ)*)%\n/\x08\x18\x0f-\x10\x080\x0bÿ1-/ÿ2\x083\x00\x080\x0f\x184ÿ\x08\x00\x00\x0b\x00\x005\x0b\x10\x18\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ/$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ2$\x05\x06$7\x03\r,ÿ\r\x04\n/\x0b8\x109:;:\n!"\x1e\x1a<ÿ\x1c\x1f=(\x1a(ÿ\x1f<\x1aÿ\x1c \x1f<>?>\x1a@\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ\x02$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ\x15$\x05\x06$7\x03\r,ÿ\r\x04ÿ\x06\r\x05\t,\n\x15\x04\x0c\t\x05\x15\r\n>\x1bÿ"\x1e\x1aÿ\x1aB\x1a\x1b>\x1bCÿ !\x1c\x1f  #ÿ@>(!<>\x1a\x1b"\x1a@ÿ\x1f\x1b@ÿ=\x1b("\x1a\x1f@#ÿ>\x1bÿC\x1f>"DÿE<>">\x1bCÿ>(\n\x1c!\x1b(\x1d>\x1c=!=(Dÿ>\x1c\x1aÿ"\x1a("ÿ&ÿ\x1d!>\x1b"(Fÿ>\x1c\x1f\x1b(ÿ)\n\x00\x08\x0b\x0e\x08\x0b\x00\x0fÿ\x10\x08//\x08\x18\x0fA\x0b']
apiLogger::2021-10-06 16:09:25,188::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 16:09:25,188::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 16:09:25,893::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 16:09:25,894::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 16:09:25,894::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9_z3skm3 
apiLogger::2021-10-06 16:09:25,894::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 16:09:25,894::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 16:09:25,899::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 16:09:25,900::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9_z3skm3
apiLogger::2021-10-06 16:09:25,912::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 16:09:25,912::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 16:09:25,913::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 16:09:25,913::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 16:09:25,916::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:09:25,916::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 16:09:25,916::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 16:09:25,916::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 06-Oct-2021 16:07:19 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : 1625\n ']
apiLogger::2021-10-06 16:09:25,916::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 16:09:25,916::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 16:53:18,804::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 16:53:18,817::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 16:53:18,818::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp_jw6z11 
apiLogger::2021-10-06 16:53:18,818::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 16:53:18,818::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 16:53:18,966::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 16:53:18,966::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp_jw6z11
apiLogger::2021-10-06 16:53:19,462::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 16:53:19,463::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 16:53:19,463::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 16:53:19,463::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 16:53:19,467::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:53:19,467::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 16:53:19,467::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 16:53:19,467::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086H8u4M5aI1nn9ac  .  Pag0e0O 1f 0 01 \nHumaSnpae cPihaalrtAmyda vceyEr vse&enP  tr odCuocmtp lFaoirnmt  \nRepoIrntfeorr HmuamtaSinpoaen c Pihaalrtmya cy1 1M1e rcShtSa,pn rti nOgH4d $a2l4e6,  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 16:53:19,474::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 16:53:19,474::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 16:53:19,721::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 16:53:19,734::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 16:53:19,734::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpz5txngp7 
apiLogger::2021-10-06 16:53:19,736::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 16:53:19,736::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 16:53:20,965::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 16:53:20,965::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpz5txngp7
apiLogger::2021-10-06 16:53:22,219::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 16:53:22,220::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 16:53:22,220::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 16:53:22,220::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 16:53:22,224::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:53:22,224::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 16:53:22,224::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 16:53:22,224::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 16:53:22,227::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:53:22,227::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 16:53:22,227::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 16:53:22,227::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 16:53:22,227::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 16:53:22,227::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 16:53:22,629::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 16:53:22,630::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 16:53:22,630::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6trs9dri 
apiLogger::2021-10-06 16:53:22,630::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 16:53:22,630::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 16:53:22,637::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 16:53:22,638::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6trs9dri
apiLogger::2021-10-06 16:53:22,738::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 16:53:22,738::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 16:53:22,738::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 16:53:22,738::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 16:53:22,742::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 16:53:22,742::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 16:53:22,742::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 16:53:22,742::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 16:52:36 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88291 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88291 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88291, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 16:53:22,742::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 16:53:22,742::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:09:18,784::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:09:18,796::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:09:18,796::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpz7zgqhtd 
apiLogger::2021-10-06 17:09:18,797::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:09:18,797::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:09:18,945::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:09:18,946::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpz7zgqhtd
apiLogger::2021-10-06 17:09:19,423::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:09:19,423::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:09:19,423::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:09:19,423::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:09:19,427::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:09:19,427::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:09:19,427::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:09:19,427::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086H8u4M5aI1nn9ac  .  Pag0e0O 1f 0 01 \nHumaSnpae cPihaalrtAmyda vceyEr vse&enP  tr odCuocmtp lFaoirnmt  \nRepoIrntfeorr HmuamtaSinpoaen c Pihaalrtmya cy1 1M1e rcShtSa,pn rti nOgH4d $a2l4e6,  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:09:19,427::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:09:19,427::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:09:19,691::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:09:19,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:09:19,707::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_kiq_7ma 
apiLogger::2021-10-06 17:09:19,708::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:09:19,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:09:21,266::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:09:21,266::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_kiq_7ma
apiLogger::2021-10-06 17:09:22,389::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:09:22,389::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:09:22,389::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:09:22,389::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:09:22,393::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:09:22,393::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:09:22,393::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:09:22,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:09:22,396::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:09:22,396::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:09:22,396::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:09:22,396::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88292 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88292 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88292 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:09:22,396::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:09:22,396::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:09:22,881::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:09:22,882::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:09:22,882::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphd7il9y2 
apiLogger::2021-10-06 17:09:22,882::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:09:22,882::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:09:22,889::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:09:22,890::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphd7il9y2
apiLogger::2021-10-06 17:09:22,977::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:09:22,978::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:09:22,978::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:09:22,978::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:09:22,982::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:09:22,982::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:09:22,982::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:09:22,982::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:08:47 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88292 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88292 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88292, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:09:22,982::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:09:22,982::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:19,055::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:19,067::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:19,068::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5v796acc 
apiLogger::2021-10-06 17:17:19,068::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:19,068::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:19,217::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:19,217::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5v796acc
apiLogger::2021-10-06 17:17:19,693::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:19,693::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:19,693::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:19,693::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:19,697::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:19,697::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:19,697::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:19,697::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086H8u4M5aI1nn9ac  .  Pag0e0O 1f 0 01 \nHumaSnpae cPihaalrtAmyda vceyEr vse&enP  tr odCuocmtp lFaoirnmt  \nRepoIrntfeorr HmuamtaSinpoaen c Pihaalrtmya cy1 1M1e rcShtSa,pn rti nOgH4d $a2l4e6,  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:17:19,698::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:19,698::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:19,765::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:19,777::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:19,777::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8t6w2x7_ 
apiLogger::2021-10-06 17:17:19,778::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:19,778::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:19,927::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:19,927::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8t6w2x7_
apiLogger::2021-10-06 17:17:20,403::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:20,403::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:20,404::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:20,404::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:20,407::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:20,408::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:20,408::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:20,408::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086H8u4M5aI1nn9ac  .  Pag0e0O 1f 0 01 \nHumaSnpae cPihaalrtAmyda vceyEr vse&enP  tr odCuocmtp lFaoirnmt  \nRepoIrntfeorr HmuamtaSinpoaen c Pihaalrtmya cy1 1M1e rcShtSa,pn rti nOgH4d $a2l4e6,  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:17:20,408::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:20,408::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:20,476::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:20,492::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:20,492::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuzgv_ty1 
apiLogger::2021-10-06 17:17:20,493::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:20,493::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:22,051::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:22,051::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuzgv_ty1
apiLogger::2021-10-06 17:17:23,287::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:23,287::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:23,287::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:23,287::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:23,291::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:23,291::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:23,291::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:23,291::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:17:23,294::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:23,294::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:17:23,294::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:17:23,294::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88294 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88294 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88294 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:17:23,295::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:23,295::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:23,368::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:23,384::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:23,385::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpf3bfr3co 
apiLogger::2021-10-06 17:17:23,386::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:23,386::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:24,946::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:24,947::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpf3bfr3co
apiLogger::2021-10-06 17:17:26,071::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:26,071::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:26,071::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:26,071::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:26,075::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:26,075::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:26,075::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:26,076::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:17:26,078::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:26,079::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:17:26,079::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:17:26,079::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88295 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88295 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88295 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:17:26,079::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:26,079::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:26,151::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:26,151::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:26,152::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphs6sm_06 
apiLogger::2021-10-06 17:17:26,152::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:26,152::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:26,159::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:26,159::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphs6sm_06
apiLogger::2021-10-06 17:17:26,251::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:26,251::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:26,251::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:26,251::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:26,255::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:26,255::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:26,255::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:26,255::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:15:20 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : RE: <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88294\nVersion 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88294 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88294, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:17:26,255::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:26,255::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:17:26,855::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:17:26,856::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:17:26,856::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp64ar137l 
apiLogger::2021-10-06 17:17:26,856::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:17:26,857::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:17:26,864::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:17:26,864::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp64ar137l
apiLogger::2021-10-06 17:17:26,952::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:17:26,952::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:17:26,952::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:17:26,952::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:17:26,956::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:17:26,956::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:17:26,956::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:17:26,956::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:16:34 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88295 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:17:26,956::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:17:26,956::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:23:18,724::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:23:18,731::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:23:18,731::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpz0z6lez8 
apiLogger::2021-10-06 17:23:18,732::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:23:18,732::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:23:18,815::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:23:18,815::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpz0z6lez8
apiLogger::2021-10-06 17:23:21,192::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:23:21,192::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:23:21,192::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:23:21,192::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:23:21,196::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-06 17:23:21,196::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:23:21,196::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 17:23:21,196::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 17:23:21,196::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-06 17:23:21,196::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 17:23:21,196::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-06 17:23:21,196::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 17:23:21,196::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 17:23:21,196::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 17:23:31,623::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 17:23:31,623::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:29:18,856::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:29:18,872::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:29:18,872::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp4n_d587 
apiLogger::2021-10-06 17:29:18,874::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:29:18,874::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:29:20,439::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:29:20,439::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp4n_d587
apiLogger::2021-10-06 17:29:21,560::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:29:21,561::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:29:21,561::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:29:21,561::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:29:21,565::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:29:21,565::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:29:21,565::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:29:21,565::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:29:21,568::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:29:21,568::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:29:21,568::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:29:21,568::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88295 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88295 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88295 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:29:21,568::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:29:21,568::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:29:21,902::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:29:21,917::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:29:21,917::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpizcgxxu4 
apiLogger::2021-10-06 17:29:21,918::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:29:21,918::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:29:22,067::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:29:22,067::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpizcgxxu4
apiLogger::2021-10-06 17:29:22,568::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:29:22,568::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:29:22,569::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:29:22,569::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:29:22,572::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:29:22,573::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:29:22,573::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:29:22,573::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:29:22,573::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:29:22,573::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:29:23,157::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:29:23,158::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:29:23,159::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm95j2ifh 
apiLogger::2021-10-06 17:29:23,159::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:29:23,159::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:29:23,173::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:29:23,174::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm95j2ifh
apiLogger::2021-10-06 17:29:23,264::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:29:23,264::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:29:23,264::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:29:23,264::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:29:23,268::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:29:23,268::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:29:23,268::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:29:23,268::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:28:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88295 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:29:23,268::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:29:23,268::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:19,166::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:19,182::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:19,183::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp84kxzwz_ 
apiLogger::2021-10-06 17:31:19,184::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:19,184::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:20,747::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:20,747::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp84kxzwz_
apiLogger::2021-10-06 17:31:21,873::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:21,873::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:21,874::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:21,874::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:21,877::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:21,878::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:21,878::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:21,878::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:31:21,881::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:21,881::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:31:21,881::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:31:21,881::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88293 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88293 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88293 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:31:21,881::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:21,881::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:21,956::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:22,019::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:22,020::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpcu8izj7m 
apiLogger::2021-10-06 17:31:22,022::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:22,022::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:22,999::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:22,999::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpcu8izj7m
apiLogger::2021-10-06 17:31:26,439::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:26,439::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:26,439::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:26,439::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:26,443::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-06 17:31:26,443::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:26,443::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 17:31:26,443::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 17:31:26,443::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-06 17:31:26,443::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 17:31:26,443::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-06 17:31:26,443::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 17:31:26,443::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 17:31:26,443::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 17:31:49,349::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 17:31:49,349::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:49,443::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:49,457::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:49,458::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp09cui7g9 
apiLogger::2021-10-06 17:31:49,459::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:49,459::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:49,607::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:49,608::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp09cui7g9
apiLogger::2021-10-06 17:31:50,107::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:50,107::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:50,107::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:50,107::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:50,111::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:50,111::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:50,111::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:50,111::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:31:50,111::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:50,111::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:50,182::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:50,196::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:50,196::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplb_86fgl 
apiLogger::2021-10-06 17:31:50,197::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:50,197::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:50,346::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:50,346::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplb_86fgl
apiLogger::2021-10-06 17:31:50,846::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:50,846::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:50,850::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:50,850::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:50,854::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:50,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:50,854::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:50,854::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:31:50,854::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:50,854::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:50,926::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:50,942::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:50,942::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmps72ipj6u 
apiLogger::2021-10-06 17:31:50,943::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:50,943::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:52,505::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:52,505::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmps72ipj6u
apiLogger::2021-10-06 17:31:53,744::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:53,744::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:53,744::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:53,744::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:53,748::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:53,748::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:53,748::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:53,748::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:31:53,752::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:53,752::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:31:53,752::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:31:53,752::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88294 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88294 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88294 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:31:53,752::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:53,752::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:53,829::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:53,830::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:53,830::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3ulgfn2l 
apiLogger::2021-10-06 17:31:53,830::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:53,830::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:53,845::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:53,845::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3ulgfn2l
apiLogger::2021-10-06 17:31:53,935::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:53,935::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:53,935::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:53,935::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:53,939::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:53,939::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:53,939::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:53,939::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:30:14 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88293 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88293 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88293, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:31:53,939::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:53,939::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:31:54,371::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:31:54,372::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:31:54,373::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp9gnkeeh 
apiLogger::2021-10-06 17:31:54,373::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:31:54,373::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:31:54,388::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:31:54,388::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp9gnkeeh
apiLogger::2021-10-06 17:31:54,478::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:31:54,478::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:31:54,478::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:31:54,478::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:31:54,482::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:31:54,482::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:31:54,482::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:31:54,482::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:29:21 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88294 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88294 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88294, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:31:54,482::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:31:54,482::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:19,083::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:19,097::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:19,097::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxb2n1_8r 
apiLogger::2021-10-06 17:35:19,098::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:19,098::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:19,248::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:19,248::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxb2n1_8r
apiLogger::2021-10-06 17:35:19,748::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:19,748::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:19,748::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:19,748::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:19,752::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:19,753::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:19,753::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:19,753::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:35:19,753::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:19,753::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:19,825::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:19,839::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:19,840::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8_oj6c5e 
apiLogger::2021-10-06 17:35:19,840::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:19,840::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:19,990::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:19,990::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8_oj6c5e
apiLogger::2021-10-06 17:35:20,489::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:20,489::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:20,489::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:20,489::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:20,493::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:20,493::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:20,493::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:20,493::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 17:35:20,493::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:20,493::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:20,567::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:20,583::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:20,583::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp98praasd 
apiLogger::2021-10-06 17:35:20,584::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:20,584::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:22,140::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:22,141::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp98praasd
apiLogger::2021-10-06 17:35:23,261::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:23,261::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:23,261::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:23,261::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:23,265::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:23,265::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:23,265::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:23,265::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:35:23,268::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:23,268::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:35:23,268::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:35:23,269::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88292 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88292 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88292 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:35:23,269::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:23,269::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:23,342::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:23,356::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:23,356::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnxlrc_7p 
apiLogger::2021-10-06 17:35:23,357::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:23,357::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:24,582::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:24,582::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnxlrc_7p
apiLogger::2021-10-06 17:35:25,816::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:25,816::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:25,816::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:25,816::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:25,820::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:25,820::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:25,820::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:25,820::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 17:35:25,823::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:25,823::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 17:35:25,823::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 17:35:25,823::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 17:35:25,824::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:25,824::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:25,899::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:25,900::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:25,901::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphw7l6fo2 
apiLogger::2021-10-06 17:35:25,901::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:25,901::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:25,915::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:25,916::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphw7l6fo2
apiLogger::2021-10-06 17:35:26,005::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:26,006::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:26,006::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:26,006::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:26,010::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:26,010::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:26,010::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:26,010::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:33:04 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88292 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88292 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88292, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:35:26,010::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:26,010::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 17:35:26,357::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 17:35:26,358::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 17:35:26,358::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvlrrv8ms 
apiLogger::2021-10-06 17:35:26,359::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 17:35:26,359::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 17:35:26,373::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 17:35:26,373::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvlrrv8ms
apiLogger::2021-10-06 17:35:26,463::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 17:35:26,463::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 17:35:26,463::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 17:35:26,463::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 17:35:26,467::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 17:35:26,467::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 17:35:26,467::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 17:35:26,468::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 17:33:48 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88291 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88291 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88291, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 17:35:26,468::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 17:35:26,468::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:19,081::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:19,095::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:19,096::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppcnhhnky 
apiLogger::2021-10-06 18:19:19,097::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:19,097::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:19,245::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:19,246::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppcnhhnky
apiLogger::2021-10-06 18:19:19,743::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:19,743::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:19,744::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:19,744::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:19,747::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:19,748::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:19,748::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:19,748::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 18:19:19,748::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:19,748::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:19,819::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:19,833::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:19,834::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0fxa5sak 
apiLogger::2021-10-06 18:19:19,834::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:19,835::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:19,984::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:19,984::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0fxa5sak
apiLogger::2021-10-06 18:19:20,484::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:20,484::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:20,484::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:20,484::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:20,488::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:20,488::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:20,488::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:20,488::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 18:19:20,488::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:20,489::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:20,560::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:20,576::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:20,576::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpim9j3h8_ 
apiLogger::2021-10-06 18:19:20,577::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:20,577::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:21,925::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:21,925::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpim9j3h8_
apiLogger::2021-10-06 18:19:23,275::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:23,276::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:23,276::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:23,276::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:23,280::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:23,280::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:23,280::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:23,280::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 18:19:23,283::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:23,283::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 18:19:23,283::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 18:19:23,283::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 18:19:23,283::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:23,283::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:23,359::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:23,376::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:23,376::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwwqqoemg 
apiLogger::2021-10-06 18:19:23,377::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:23,378::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:25,051::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:25,051::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwwqqoemg
apiLogger::2021-10-06 18:19:26,292::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:26,292::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:26,292::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:26,292::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:26,296::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:26,296::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:26,296::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:26,296::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 18:19:26,299::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:26,299::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 18:19:26,299::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 18:19:26,299::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88292 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88292 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88292 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 18:19:26,299::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:26,299::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:26,378::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:26,379::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:26,380::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzkf6nqet 
apiLogger::2021-10-06 18:19:26,380::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:26,380::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:26,395::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:26,395::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzkf6nqet
apiLogger::2021-10-06 18:19:26,497::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:26,497::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:26,498::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:26,498::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:26,502::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:26,502::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:26,502::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:26,502::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 18:18:24 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88291 Version 1\nFrom: Marc Lamberti-External Sent: Wednesday, October 6, 2021 1:34 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: <External> Regeneron Adverse Event Report for Eylea\nVial: REGEMC-88291 Version 1 \n \nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88291 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88291, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 18:19:26,502::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:26,502::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:19:26,824::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:19:26,825::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:19:26,825::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx5zb105e 
apiLogger::2021-10-06 18:19:26,825::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:19:26,825::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:19:26,840::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:19:26,840::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx5zb105e
apiLogger::2021-10-06 18:19:26,930::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:19:26,931::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:19:26,931::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:19:26,931::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:19:26,935::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:19:26,935::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:19:26,935::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:19:26,935::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 18:19:13 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88292 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88292 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88292, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 18:19:26,935::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:19:26,935::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:19,081::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:19,096::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:19,096::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpehjobfw_ 
apiLogger::2021-10-06 18:21:19,097::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:19,097::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:19,247::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:19,247::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpehjobfw_
apiLogger::2021-10-06 18:21:19,746::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:19,746::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:19,746::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:19,746::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:19,750::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:19,750::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:19,750::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:19,750::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 18:21:19,750::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:19,750::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:19,821::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:19,836::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:19,836::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv6a8x24n 
apiLogger::2021-10-06 18:21:19,837::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:19,837::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:19,986::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:19,986::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv6a8x24n
apiLogger::2021-10-06 18:21:20,488::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:20,488::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:20,488::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:20,488::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:20,492::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:20,492::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:20,492::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:20,492::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 18:21:20,492::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:20,492::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:20,564::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:20,582::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:20,583::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjccc0bjt 
apiLogger::2021-10-06 18:21:20,584::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:20,584::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:22,260::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:22,260::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjccc0bjt
apiLogger::2021-10-06 18:21:23,498::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:23,498::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:23,498::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:23,498::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:23,502::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:23,502::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:23,502::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:23,502::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 18:21:23,505::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:23,505::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 18:21:23,505::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 18:21:23,505::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88293 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88293 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88293 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 18:21:23,505::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:23,505::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:23,580::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:23,597::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:23,597::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp0er9cma 
apiLogger::2021-10-06 18:21:23,599::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:23,599::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:25,274::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:25,274::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp0er9cma
apiLogger::2021-10-06 18:21:26,622::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:26,623::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:26,623::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:26,623::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:26,626::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:26,627::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:26,627::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:26,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 18:21:26,630::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:26,630::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 18:21:26,630::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 18:21:26,630::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88294 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88294 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88294 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 18:21:26,630::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:26,630::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:26,704::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:26,705::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:26,705::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1f5hexc7 
apiLogger::2021-10-06 18:21:26,706::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:26,706::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:26,720::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:26,720::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1f5hexc7
apiLogger::2021-10-06 18:21:26,810::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:26,810::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:26,810::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:26,810::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:26,814::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:26,814::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:26,814::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:26,814::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 18:20:01 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88293 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88293 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88293, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 18:21:26,814::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:26,814::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:21:27,180::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:21:27,180::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:21:27,181::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp48y8y70k 
apiLogger::2021-10-06 18:21:27,181::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:21:27,181::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:21:27,196::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:21:27,196::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp48y8y70k
apiLogger::2021-10-06 18:21:27,286::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:21:27,286::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:21:27,286::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:21:27,286::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:21:27,290::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:21:27,290::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:21:27,290::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:21:27,290::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 18:20:39 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88294 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88294 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88294, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 18:21:27,290::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:21:27,290::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:23:18,833::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:23:18,851::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:23:18,852::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2ogpgy39 
apiLogger::2021-10-06 18:23:18,853::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:23:18,853::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:23:20,524::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:23:20,524::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2ogpgy39
apiLogger::2021-10-06 18:23:21,761::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:23:21,762::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:23:21,762::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:23:21,762::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:23:21,766::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:23:21,766::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:23:21,766::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:23:21,766::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 18:23:21,769::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:23:21,769::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 18:23:21,769::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-06 18:23:21,769::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88295 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88295 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88295 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-06 18:23:21,769::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:23:21,769::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:23:22,083::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:23:22,097::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:23:22,097::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkz8tzvlr 
apiLogger::2021-10-06 18:23:22,098::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:23:22,098::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:23:22,247::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:23:22,247::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkz8tzvlr
apiLogger::2021-10-06 18:23:22,746::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:23:22,746::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:23:22,746::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:23:22,747::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:23:22,750::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:23:22,751::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:23:22,751::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:23:22,751::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-06 18:23:22,751::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:23:22,751::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 18:23:23,145::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 18:23:23,146::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 18:23:23,147::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoi196d3j 
apiLogger::2021-10-06 18:23:23,147::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 18:23:23,147::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 18:23:23,161::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 18:23:23,162::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoi196d3j
apiLogger::2021-10-06 18:23:23,252::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 18:23:23,252::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 18:23:23,252::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 18:23:23,252::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 18:23:23,256::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 18:23:23,256::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 18:23:23,257::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 18:23:23,257::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 06-Oct-2021 18:21:35 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88295 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-06 18:23:23,257::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 18:23:23,257::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 19:23:18,843::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 19:23:18,844::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 19:23:18,844::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_1pn4mhf 
apiLogger::2021-10-06 19:23:18,844::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 19:23:18,844::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 19:23:18,849::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 19:23:18,850::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_1pn4mhf
apiLogger::2021-10-06 19:23:18,863::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 19:23:18,863::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 19:23:18,863::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 19:23:18,863::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 19:23:18,866::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 19:23:18,867::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 19:23:18,867::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 19:23:18,867::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Spam Daily Digest <digest@regeneron.com>\nReceived Date : 06-Oct-2021 15:21:43 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Spam Daily Digest: 0 New Messages  (1 Valid Emails)\nProofpoint']
apiLogger::2021-10-06 19:23:18,867::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-06 19:23:18,867::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 21:51:18,718::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 21:51:18,720::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 21:51:18,721::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpaxyk1nh8 
apiLogger::2021-10-06 21:51:18,721::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 21:51:18,721::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 21:51:18,724::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 21:51:18,724::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpaxyk1nh8
apiLogger::2021-10-06 21:51:19,840::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 21:51:19,841::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 21:51:19,841::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 21:51:19,841::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 21:51:19,844::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-06 21:51:19,844::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 21:51:19,844::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 21:51:19,845::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-06 21:51:19,845::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(1)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-06 21:51:19,845::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 21:51:19,845::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-06 21:51:19,845::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 21:51:19,845::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 21:51:19,845::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 21:51:49,756::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 21:51:49,756::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 22:21:18,695::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 22:21:18,701::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 22:21:18,701::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3kiht3ts 
apiLogger::2021-10-06 22:21:18,702::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 22:21:18,702::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 22:21:18,805::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 22:21:18,805::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3kiht3ts
apiLogger::2021-10-06 22:21:21,847::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 22:21:21,847::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 22:21:21,847::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 22:21:21,848::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 22:21:21,851::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 22:21:21,851::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 22:21:21,851::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 22:21:21,851::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 22:21:21,854::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 22:21:21,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 22:21:21,854::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 22:21:21,854::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 22:21:21,854::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 22:21:21,854::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 22:21:21,855::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 22:21:21,855::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 22:21:21,855::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 22:21:21,855::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 22:21:41,509::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 22:21:41,509::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-06 22:35:18,687::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-06 22:35:18,694::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-06 22:35:18,694::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsio73bkj 
apiLogger::2021-10-06 22:35:18,694::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-06 22:35:18,695::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-06 22:35:18,798::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-06 22:35:18,798::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsio73bkj
apiLogger::2021-10-06 22:35:21,830::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-06 22:35:21,830::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-06 22:35:21,830::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-06 22:35:21,830::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-06 22:35:21,834::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-06 22:35:21,834::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-06 22:35:21,834::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-06 22:35:21,834::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-06 22:35:21,837::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-06 22:35:21,837::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-06 22:35:21,837::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-06 22:35:21,837::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-06 22:35:21,837::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-06 22:35:21,837::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-06 22:35:21,837::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-06 22:35:21,837::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-06 22:35:21,837::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-06 22:35:21,838::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-06 22:35:41,382::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-06 22:35:41,382::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:05:18,971::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:05:18,977::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:05:18,978::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt3jzv06r 
apiLogger::2021-10-07 01:05:18,978::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:05:18,978::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:05:19,053::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:05:19,053::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt3jzv06r
apiLogger::2021-10-07 01:05:20,018::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:05:20,019::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:05:20,019::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:05:20,019::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:05:20,022::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,022::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:05:20,022::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:05:20,022::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:05:20,025::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,025::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:05:20,025::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:05:20,025::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:05:20,028::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,028::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:05:20,028::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:05:20,028::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:05:20,031::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,031::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:05:20,031::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:05:20,031::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:05:20,034::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,034::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:05:20,034::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:05:20,034::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:05:20,037::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,037::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:05:20,037::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:05:20,037::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:05:20,040::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,040::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:05:20,040::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:05:20,040::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:05:20,043::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,043::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:05:20,043::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:05:20,043::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:05:20,046::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,046::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:05:20,046::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:05:20,046::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:05:20,049::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:20,049::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:05:20,049::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:05:20,049::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 10 September 2021 18:38\nTo: .STUDY-PVSS-DL-0456-0300; .STUDY-DM-DL-0456-0300-DM-Blinded\nSubject: [EXTERNAL] SAE from Study R668-ABPA-1923\nFollow Up Flag: Follow up\nFlag Status: Flagged\nCategories: Red Category\n348002002\nAn SAE of LOWER RESPIRATORY TRACK INFECTION has been reported for Subject Number   with \nRelationship to investigational product : NOT RELATED and Required or prolongs hospitalization : CHECKED \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R668-ABPA-1923\nIcon Study Code 0456/0300\nEnvironment Prod\nSite Name 348002- Semmelweis Egyetem\nSubject Details\nSubject Name 348002002\nDemographic Details\nYear of Birth 1980\nAge 41\nSex Male\nEthnicity Not Hispanic or Latino\nRace White\nIf Other, specify\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent Details\nInformed Consent/Assent1\nProtocol version in effect at\nDate Informed consent/ Did the child's parents sign\ntime of informed consent/\nassent signed and date informed consent?\nassent\n02 SEP 2021 Amendment 2 Not applicable\nInformed Consent\nDate of Informed Consent\nProtocol Reconsented to\nFirst Visit Performed Under Adult\nConsent\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nSubject Eligibility Details\nIs the subject eligible to participate\nin this study?\nIf No, provide the date the subject\nscreen failed\nIf the subject was not eligible, please\nprovide primary reason\nIf reason is Adverse Event, specify\nthe AE line number\nIf reason is Sponsor Request,\nspecify\nIf reason is Subject Decision, specify\nIf reason is Death, enter date of\nDeath\nIf reason is Other, specify\nSpecify the criteria Criteria Number Comment\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nMedical History Details\nDoes subject have any Medical\nHistory?\nHas the subject been currently\nsmoking, vaping or chewing tobacco\nor cessation of any of these within 6\nmonths prior to screening?\nDoes subject have a >10 Pack-\nyears smoking history?\nDisorder/Diagnosis Start Date Ongoing End date\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nSurgical Medical History Details\nDoes subject have any Surgical\nMedical History to report?\nSurgical History Term Start Date Date resolved (End date)\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior and Concomitant Medications\nIs Concomitant Is ConMed for Is ConMed for If Yes, enter the sequence #\nIf Yes, enter the sequence # If Topical,\nMedication Name Indication Start date Medication Stop date treatment of treatment of on the medical history Dose Dose unit If Other, specify Frequency If Other, specify Route If Other, specify\non AE corresponding pages specify\nongoing? AE? medical history? corresponding pages\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nOral Corticosteroid Medications\nIs this a dose\nMedication Name Reason for Use Start Date End date Ongoing Dose Dose Unit Frequency\ntitration?\nUNCHECKED\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior and Concomitant Procedures\nWere there any Prior / Concomitant\nProcedures?\nFor the treatment of For the\nAllergic For the treatment of If Yes, specify AE treatment of If Yes, specify MH\nProcedure Description Start Date End Date Other If Other, please specify\nBronchopulmonary AE? number Medical number\nAspergillosis? History?\nUNCHECKED\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nStudy Drug Administration\nWhere was study\nIf Not Done, provide Date of Study Drug Time of Study Drug Was the total dose Reason for not\nFolder Name drug administered Record Position Injection Number\nreason Injection Injection injected? administering total dose\nfor this visit?\nVisit 2/\nRandomization\nBaseline Visit\nProgrammatic SAE/AESI Output Report_13-SEP-2021"]
apiLogger::2021-10-07 01:05:20,049::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:05:20,049::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:05:20,126::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:05:20,133::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:05:20,133::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1poea1ls 
apiLogger::2021-10-07 01:05:20,134::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:05:20,134::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:05:20,209::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:05:20,209::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1poea1ls
apiLogger::2021-10-07 01:05:21,151::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:05:21,152::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:05:21,152::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:05:21,152::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:05:21,155::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,155::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:05:21,155::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:05:21,155::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:05:21,158::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,158::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:05:21,158::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:05:21,158::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:05:21,161::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,161::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:05:21,161::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:05:21,161::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:05:21,164::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,164::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:05:21,164::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:05:21,164::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:05:21,167::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,167::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:05:21,167::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:05:21,167::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:05:21,170::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,170::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:05:21,170::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:05:21,170::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:05:21,173::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,173::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:05:21,173::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:05:21,173::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:05:21,176::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,176::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:05:21,176::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:05:21,176::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:05:21,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:05:21,179::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:05:21,179::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:05:21,182::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,182::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:05:21,182::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:05:21,182::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 10 September 2021 18:38\nTo: .STUDY-PVSS-DL-0456-0300; .STUDY-DM-DL-0456-0300-DM-Blinded\nSubject: [EXTERNAL] SAE from Study R668-ABPA-1923\nFollow Up Flag: Follow up\nFlag Status: Flagged\nCategories: Red Category\n348002003\nAn SAE of LOWER RESPIRATORY TRACK INFECTION has been reported for Subject Number   with \nRelationship to investigational product : NOT RELATED and Required or prolongs hospitalization : CHECKED \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R668-ABPA-1923\nIcon Study Code 0456/0300\nEnvironment Prod\nSite Name 348002- Semmelweis Egyetem\nSubject Details\nSubject Name 348002003\nDemographic Details\nYear of Birth 1980\nAge 41\nSex Male\nEthnicity Not Hispanic or Latino\nRace White\nIf Other, specify\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent Details\nInformed Consent/Assent1\nProtocol version in effect at\nDate Informed consent/ Did the child's parents sign\ntime of informed consent/\nassent signed and date informed consent?\nassent\n02 SEP 2021 Amendment 2 Not applicable\nInformed Consent\nDate of Informed Consent\nProtocol Reconsented to\nFirst Visit Performed Under Adult\nConsent\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nSubject Eligibility Details\nIs the subject eligible to participate\nin this study?\nIf No, provide the date the subject\nscreen failed\nIf the subject was not eligible, please\nprovide primary reason\nIf reason is Adverse Event, specify\nthe AE line number\nIf reason is Sponsor Request,\nspecify\nIf reason is Subject Decision, specify\nIf reason is Death, enter date of\nDeath\nIf reason is Other, specify\nSpecify the criteria Criteria Number Comment\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nMedical History Details\nDoes subject have any Medical\nHistory?\nHas the subject been currently\nsmoking, vaping or chewing tobacco\nor cessation of any of these within 6\nmonths prior to screening?\nDoes subject have a >10 Pack-\nyears smoking history?\nDisorder/Diagnosis Start Date Ongoing End date\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nSurgical Medical History Details\nDoes subject have any Surgical\nMedical History to report?\nSurgical History Term Start Date Date resolved (End date)\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior and Concomitant Medications\nIs Concomitant Is ConMed for Is ConMed for If Yes, enter the sequence #\nIf Yes, enter the sequence # If Topical,\nMedication Name Indication Start date Medication Stop date treatment of treatment of on the medical history Dose Dose unit If Other, specify Frequency If Other, specify Route If Other, specify\non AE corresponding pages specify\nongoing? AE? medical history? corresponding pages\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nOral Corticosteroid Medications\nIs this a dose\nMedication Name Reason for Use Start Date End date Ongoing Dose Dose Unit Frequency\ntitration?\nUNCHECKED\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior and Concomitant Procedures\nWere there any Prior / Concomitant\nProcedures?\nFor the treatment of For the\nAllergic For the treatment of If Yes, specify AE treatment of If Yes, specify MH\nProcedure Description Start Date End Date Other If Other, please specify\nBronchopulmonary AE? number Medical number\nAspergillosis? History?\nUNCHECKED\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nStudy Drug Administration\nWhere was study\nIf Not Done, provide Date of Study Drug Time of Study Drug Was the total dose Reason for not\nFolder Name drug administered Record Position Injection Number\nreason Injection Injection injected? administering total dose\nfor this visit?\nVisit 2/\nRandomization\nBaseline Visit\nProgrammatic SAE/AESI Output Report_13-SEP-2021"]
apiLogger::2021-10-07 01:05:21,182::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:05:21,182::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:05:21,260::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:05:21,261::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:05:21,261::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt8etry0h 
apiLogger::2021-10-07 01:05:21,262::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:05:21,262::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:05:21,276::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:05:21,276::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt8etry0h
apiLogger::2021-10-07 01:05:21,407::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:05:21,407::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:05:21,407::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:05:21,407::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:05:21,411::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,411::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:05:21,411::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:05:21,411::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:05:21,414::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,414::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:05:21,414::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:05:21,414::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:04:03 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R668-ABPA-1923_INITIAL_348002002_LOWER RESPIRATORY TRACK INFECTION-\n10Sep2021\nFrom: .STUDY-PVSS-0456-0300 <STUDY-PVSS-0456-0300@iconplc.com> Sent: Tuesday,\nSeptember 14, 2021 2:47 AM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>;\nVimal Thohan <vimal.thohan@regeneron.com>; David Lederer <david.lederer@regeneron.com>;\nHeather Paleczny <heather.paleczny@regeneron.com>; Faisal Khokhar\n<faisal.khokhar@regeneron.com>; Joseph Wolken <joseph.wolken@regeneron.com> Cc:\n.STUDY-PVSS-DL-0456-0300 <STUDY-PVSS-DL-0456-0300@iconplc.com>; Flynn, Nicola\n<Nicola.Flynn@iconplc.com> Subject: <External> R668-ABPA-\n1923_INITIAL_348002002_LOWER RESPIRATORY TRACK INFECTION-10Sep2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Team, ICON has received notification of the following INITIAL SAE on\n10Sep2021\nProtocol: R668-ABPA-1923\nSite # / Subject ID: 348002\nSubject: 002\nEvent: LOWER RESPIRATORY TRACK INFECTION\nOnset Date: 09-SEP-2021\nSAE Criteria: Hospitalization\nRelationship to the Study Drug: Not Related\nRelationship to Study Procedure: Not Related\nHungary\nCountry:\nMuller, Veronika\nPI Name:\nmuller.veronika@med.semmelweis-univ.hu\nDay 0 10Sep2021\n \n \n \n \n \n \n \n \n \n \n \n \n \nBest Regards,\nSheba Roshan Joseph Drug Safety Associate E/L  Tel: 91 44 6612 4719\nShebaRoshan.Joseph@iconplc.com\nwww.ICONplc.com\n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-07 01:05:21,414::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:05:21,414::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:05:21,502::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:05:21,503::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:05:21,503::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpswb7acph 
apiLogger::2021-10-07 01:05:21,504::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:05:21,504::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:05:21,518::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:05:21,518::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpswb7acph
apiLogger::2021-10-07 01:05:21,640::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:05:21,640::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:05:21,640::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:05:21,640::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:05:21,643::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,644::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:05:21,644::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:05:21,644::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:05:21,647::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:05:21,647::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:05:21,647::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:05:21,647::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:04:37 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R668-ABPA-1923_INITIAL_348002003_LOWER RESPIRATORY TRACK INFECTION-\n10Sep2021\nFrom: .STUDY-PVSS-0456-0300 <STUDY-PVSS-0456-0300@iconplc.com> Sent: Tuesday,\nSeptember 14, 2021 2:47 AM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>;\nVimal Thohan <vimal.thohan@regeneron.com>; David Lederer <david.lederer@regeneron.com>;\nHeather Paleczny <heather.paleczny@regeneron.com>; Faisal Khokhar\n<faisal.khokhar@regeneron.com>; Joseph Wolken <joseph.wolken@regeneron.com> Cc:\n.STUDY-PVSS-DL-0456-0300 <STUDY-PVSS-DL-0456-0300@iconplc.com>; Flynn, Nicola\n<Nicola.Flynn@iconplc.com> Subject: <External> R668-ABPA-\n1923_INITIAL_348002003_LOWER RESPIRATORY TRACK INFECTION-10Sep2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Team, ICON has received notification of the following INITIAL SAE on\n10Sep2021\nProtocol: R668-ABPA-1923\nSite # / Subject ID: 348002\nSubject: 003\nEvent: LOWER RESPIRATORY TRACK INFECTION\nOnset Date: 09-SEP-2021\nSAE Criteria: Hospitalization\nRelationship to the Study Drug: Not Related\nRelationship to Study Procedure: Not Related\nHungary\nCountry:\nMuller, Veronika\nPI Name:\nmuller.veronika@med.semmelweis-univ.hu\nDay 0 10Sep2021\n \n \n \n \n \n \n \n \n \n \n \n \n \nBest Regards,\nSheba Roshan Joseph Drug Safety Associate E/L  Tel: 91 44 6612 4719\nShebaRoshan.Joseph@iconplc.com\nwww.ICONplc.com\n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-07 01:05:21,647::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:05:21,647::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:11:19,144::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:11:19,154::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:11:19,154::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwi9cy08y 
apiLogger::2021-10-07 01:11:19,154::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:11:19,155::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:11:19,395::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:11:19,395::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwi9cy08y
apiLogger::2021-10-07 01:11:24,266::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:11:24,267::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:11:24,267::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:11:24,267::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:11:24,270::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,270::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:11:24,270::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:11:24,271::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:11:24,273::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,274::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:11:24,274::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:11:24,274::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:11:24,277::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,277::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:11:24,277::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:11:24,277::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:11:24,280::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,280::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:11:24,280::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:11:24,280::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:11:24,283::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,283::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:11:24,283::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:11:24,283::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:11:24,286::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,286::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:11:24,286::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:11:24,286::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:11:24,291::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,291::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:11:24,291::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:11:24,291::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:11:24,293::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,294::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:11:24,294::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:11:24,294::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:11:24,296::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,296::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:11:24,296::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:11:24,297::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:11:24,299::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:24,299::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:11:24,299::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:11:24,300::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:33 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-16111. \nPlease review ASAP at https://protect-eu.mimecast.com/s/M_vbC7L8RCA1Wq81H8TvXl?\ndomain=login.imedidata.com\nAn SAE of ENTEROCOLITIS has been reported for Subject Number 840024006 with Start Date (dd-mon-\nyyyy) : 13 APR 2021  with AE suspected to be caused by REGN2810? : NOT APPLICABLE  and It required or \nprolonged inpatient hospitalization : CHECKED  with If Other, specify : BLANK \nWWRD (GMT): 15 Apr 2021 17:32:21 \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:37 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/NAlzCvoq1S7zyGMKSQQtap?domain=login.imedidata.com\nIs this an AE of Special interest (AESI)?  (If YES, complete SAE/AESI Form) :  has been updated from BLANK \nto NO,  for SAE ENTEROCOLITIS for Subject Number 840024006 WWRD (GMT): 15 Apr 2021 17:36:25 \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:43 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/Hhn3CVPpRHxoPDGQtGv-k1?domain=login.imedidata.com\nAction taken with REGN2810 :  has been updated from NOT APPLICABLE to BLANK,  for SAE \nENTEROCOLITIS for Subject Number 840024006 WWRD (GMT): 15 Apr 2021 17:41:57 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16111\nICON Study code 0456/0145\nenvironmentName Prod\nSite 840024- Pinellas Hematology and Oncology\nSubject details\nSubject Number 5\nSubject ID 840024006\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nstudy? Yes\nDate Subject Signed the First Informed\nConsent (dd-mon-yyyy) 31 OCT 2018\nHas the subject consented to\nparticipate in the genomics sub study? Yes\nDate of Genomics Consent (dd-mon-yyyy) 31 OCT 2018\nInformed Consent Version Version 1\nDemographic details\nDate of Birth (dd-mon-yyyy) 1958\nAge 59\nSex Female\nRace (choose only one primary race) White\n If Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 42\nNumber of Cigarettes Per Day 15\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking\nInformed\nDate subject Consent\nProtocol IRB signed Informed Approval Date\nProtocol version Approval Date Consent (dd- from IRB (dd-\nRecordPosition (Global) (dd-mon-yyyy) mon-yyyy) Consent Type mon-yyyy)\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nIf Ongoing\n Medical History /  Unknown Start Specify CTCAE Unknown\nRecordPosition Finding (Abnormality) Start Date Date Ongoing? Grade End Date End Date\n1 CHOLECYSTECTOMY UN UNK 2013 UNCHECKED Resolved UN UNK 2013 UNCHECKED\n2 TUBAL LIGATION UN UNK 1994 UNCHECKED Resolved UN UNK 1994 UNCHECKED\n3 SPINE SURGERY FOR SPO UN UNK 2016 UNCHECKED Resolved UN UNK 2016 UNCHECKED\n4 CATARACT UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n5 POLLEN ALLERGY UN UNK 1978 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n6 DRY THROAT 01 AUG 2018 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n7 HEMORRHOIDS UN UNK 1979 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n8 ERVICAL HERNIATED DISC UN UNK 2014 UNCHECKED Ongoing Grade 2 - Moderate UNCHECKED\n9 FATIGUE UN UNK 2014 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n10 LOW BACK PAIN UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n13 RIGHT HAND TINGLING  UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n14 RIGHT ARM PAIN UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n15 EVEL LUMBAR SPINE SPON UN UNK 2016 UNCHECKED Ongoing Grade 2 - Moderate UNCHECKED\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nIf Indication is If Indication is\nMedical History, Adverse Event,\nPlease select the Please select the\nappropriate appropriate\nStart Date (dd- Stop Date (dd- If Other, Medical History Adverse Event If Other, If Other, If Other,\nRecordPosition Drug Name mon-yyyy) Unknown mon-yyyy) Unknown Ongoing Indication specify record. record. Dose Dose Unit specify Frequency specify Route specify\n2 EXAMETHAS 15 NOV 2018 UNCHECKED 15 NOV 2018 UNCHECKED UNCHECKED Pre Med 4 mg OTO Oral\n3 NDANSETRO 16 NOV 2018 UNCHECKED 16 NOV 2018 UNCHECKED UNCHECKED Pre Med 8 mg OTO Oral\n4 DONE/ACETA UN UNK 2016 UNCHECKED UNCHECKED CHECKED Medical History 10_LOW BACK PAIN 5/325 mg PRN Oral\n5 SENNA-S 19 NOV 2018 UNCHECKED 27 NOV 2018 UNCHECKED UNCHECKED Adverse Event 1_CONSTIPATION 8.6-50 mg PRN Oral\n6 ALEVE 28 JAN 2019 UNCHECKED 01 FEB 2019 UNCHECKED UNCHECKED Adverse Event 3_HEADACHE 220 mg PRN Oral\n7 ZYRTEC 21 FEB 2019 UNCHECKED UNCHECKED CHECKED Medical History 5_POLLEN ALLERGY 10 mg PRN Oral\n8 EVOFLOXACI 12 APR 2019 UNCHECKED 16 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 750 mg QD Oral\n9 REDNISONE  13 APR 2019 UNCHECKED 15 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 60 mg QD Oral\n10 ZOFRAN 12 APR 2019 UNCHECKED UNCHECKED CHECKED Adverse Event 8_NAUSEA 4 mg Other RN FOR NAU Oral\n11 STRENGTH T 10 APR 2019 UNCHECKED 20 APR 2019 UNCHECKED UNCHECKED Adverse Event _FLU LIKE SYMPTOMS 500 mg PRN Oral\n12 REDNISONE  16 APR 2019 UNCHECKED 18 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 20 mg QD Oral\n13 NEULASTA 15 NOV 2018 UNCHECKED 16 NOV 2018 UNCHECKED UNCHECKED Other ROPHALAXIS 6 mg PRN Subcutaneous\n15 PREDNISONE 19 APR 2019 UNCHECKED 03 MAY 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 30 mg QD Oral\n16 PREDNISONE 07 MAY 2019 UNCHECKED 14 MAY 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 20 mg QD Oral\n17 COTINE PAT 15 MAR 2019 UNCHECKED 01 JAN 2020 UNCHECKED UNCHECKED Other OKING CESS 21 mg QD Transdermal\n18 PREDNISONE 15 MAY 2019 UNCHECKED 18 JUN 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 10 mg QD Oral\n19 PREDNISONE 19 JUN 2019 UNCHECKED 09 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 5 mg QD Oral\n20 MEPRAZOLE 19 JUN 2019 UNCHECKED 15 JUL 2019 UNCHECKED UNCHECKED Other RD PROPHYL 40 mg QD Oral\n21 PREDNISONE 10 JUL 2019 UNCHECKED 12 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 2.5 mg QD Oral\n22 DAYQUIL 04 JUN 2019 UNCHECKED 09 JUN 2019 UNCHECKED UNCHECKED Adverse Event 5_MILD SORE THROAT NKNOWN DO mg PRN Oral\n23 LOVENOX 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Other VT PROPHYL 40 mg QD Subcutaneous\n24 RMAL SALINE 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 1 L QD Intravenous\n25 ANA(ARFOM 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 15 mcg q12h Inhaled\n26 CORT(BUDES 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 0.5 mg q12h Inhaled\n27 ONIX(PANTO 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 40 mg QD Intravenous\n28 ZOFRAN  15 JUL 2019 UNCHECKED 16 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 4 mg Other URS PRN (AS Intravenous\n29 LBUTEROL/IP 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 2.5 mg Other URS PRN (AS Inhaled\n30 TYLENOL 16 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 31_FEVER 650 mg Other 4 HOURS PR Oral\n31 ZOFRAN 16 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 8 mg Other URS PRN (AS Intravenous\n32 EXTROSE 50 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 25 g PRN Intravenous\n33 CAGEN(GLUC 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 1 mg PRN Intramuscular\n34 LUCOSE GEL 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 7.5 , 56.25 , 75 g PRN Oral\n35 GNESIUM SU 19 JUL 2019 UNCHECKED 19 JUL 2019 UNCHECKED UNCHECKED Adverse Event 27_HYPOMAGNESEMIA 2 g OTO Intravenous\n36 IUM BICARBO 19 JUL 2019 UNCHECKED 19 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_METABOLIC ACIDOSI 100 mEq OTO Intravenous\n37 ONIX(PANTO 19 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 17_GASTRITIS 40 mg QD Oral\n38 DROCORTIS 20 JUL 2019 UNCHECKED 30 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n39 DROCORTIS 20 JUL 2019 UNCHECKED 06 AUG 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n40 DROCORTIS 16 AUG 2019 UNCHECKED 04 OCT 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n41 DROCORTIS 16 AUG 2019 UNCHECKED 04 OCT 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n42 DROCORTIS 05 OCT 2019 UNCHECKED 28 JAN 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n43 DROCORTIS 05 OCT 2019 UNCHECKED 28 JAN 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 5 mg QD Oral\n44 TIZANIDINE 05 NOV 2019 UNCHECKED 06 NOV 2019 UNCHECKED UNCHECKED Adverse Event E BILATERAL LOWER B 4 mg TID Oral\n45 DONE/ACETA 04 NOV 2019 UNCHECKED 06 NOV 2019 UNCHECKED UNCHECKED Adverse Event E BILATERAL LOWER B 10/325 mg PRN Oral\n46 DROCORTIS 28 JAN 2020 UNCHECKED 25 FEB 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 5 mg BID Oral\n47 ONIX(PANTO 21 JUL 2019 UNCHECKED 20 AUG 2019 UNCHECKED UNCHECKED Adverse Event 47_GASTRISITS 40 mg QD Oral\n48 ONIX(PANTO 21 AUG 2019 UNCHECKED UNCHECKED CHECKED Other TRIC PROTE 40 mg QD Oral\n49 DROCORTIS 26 FEB 2020 UNCHECKED UNCHECKED CHECKED Adverse Event NDARY ADRENAL INSU 15 mg Other ING DOSE AC Oral\n50 KEFLEX 07 NOV 2019 UNCHECKED 14 NOV 2019 UNCHECKED UNCHECKED Adverse Event URINARY TRACT INFE 500 mg BID Oral\n51 EVOTHYROXI 30 APR 2020 UNCHECKED 03 MAY 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 50 mcg QD Oral\n52 EVOTHYROXI 07 MAY 2020 UNCHECKED 22 JUL 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 25 mcg QD Oral\n53 ASSIUM CHL 04 MAY 2020 UNCHECKED 04 MAY 2020 UNCHECKED UNCHECKED Adverse Event 52_HYPOKALEMIA 10 mEq QD Oral\n54 ALEVE 08 FEB 2019 UNCHECKED 18 FEB 2019 UNCHECKED UNCHECKED Adverse Event 14_HEADACHE 220 mg PRN Oral\n55 ZOFRAN 12 APR 2019 UNCHECKED 12 APR 2019 UNCHECKED UNCHECKED Adverse Event 9_VOMITING 4 mg PRN Oral\n56 ZOFRAN 15 JUL 2019 UNCHECKED 15 JUL 2019 UNCHECKED UNCHECKED Adverse Event 24_NAUSEA 8 mg PRN Intravenous\n57 TYLENOL 15 JUL 2019 UNCHECKED 17 JUL 2019 UNCHECKED UNCHECKED Adverse Event NON-CARDIAC CHEST  650 mg PRN Oral\n58 TYLENOL 18 JUL 2019 UNCHECKED 28 JUL 2019 UNCHECKED UNCHECKED Adverse Event NON-CARDIACCHEST  650 mg PRN Oral\n59 TYLENOL 13 JUL 2019 UNCHECKED 18 JUL 2019 UNCHECKED UNCHECKED Adverse Event 26_HEADACHE 650 mg PRN Oral\n60 PREDNISONE 19 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n61 EVOTHYROXI 23 JUL 2020 UNCHECKED 28 JUL 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 50 mcg QD Oral\n62 EVOTHYROXI 29 JUL 2020 UNCHECKED UNCHECKED CHECKED Adverse Event 51_HYPOTHYROIDISM 25 mcg QD Oral\n63 ZITHROMYCI 30 AUG 2020 UNCHECKED 2 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 500 mg QD Oral\n64 TESSALON 30 AUG 2020 UNCHECKED 06 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 200 mg TID Oral\n65 ALBUTEROL 30 AUG 2020 UNCHECKED 10 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 180 mcg q4h Inhaled\n66 ALLEGRA 22 OCT 2020 UNCHECKED UNCHECKED CHECKED Medical History 5_POLLEN ALLERGY 180 mg QD Oral\n67 ALEVE 23 JUL 2020 UNCHECKED 14 JAN 2021 UNCHECKED UNCHECKED Adverse Event 53_HEADACHE 220 mg PRN Oral\n69 ALEVE 12 FEB 2021 UNCHECKED 19 FEB 2021 UNCHECKED UNCHECKED Adverse Event 57_BODY ACHE 220 mg PRN Oral\n70 CEFIPIME 13 APR 2021 UNCHECKED UNCHECKED CHECKED Adverse Event 2 g BID Intravenous\n71 FLAGYL 13 APR 2021 UNCHECKED UNCHECKED CHECKED Adverse Event 500 mg TID Oral\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProcedures/Surgeries\nReason for Procedure / Date of Procedure /\nRecordPosition Procedure / Surgery Surgery If Other, specify Surgery  (dd-mon-yyyy)\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nIf Surgery Date of\nLocation is Surgery (dd- Check for\nRecordPosition Procedure Surgery Location Other, specify mon-yyyy) Unknown Date\nUNCHECKED\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nRegimen Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown UNCHECKED\nStop date (dd-mon-yyyy)\nStop Date Unknown UNCHECKED\nSubject’s Best Response\nIf best response is CR or PR, enter\nDate of Best Response (dd-mon-yyyy)\nDate of Best Response Unknown UNCHECKED\nIf subject  recurred/relapsed/\nprogressed after this therapy, please\nenter Date of Recurrence/ Relapse/\nProgression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/\nProgression Date of Progressive\nDisease Unknown UNCHECKED\nNumber of cycles\nNumber of cycles unknown/NA\nRegimen Name or Single Therapy\nIf Immunotherapy, Specify\nIf Other, specify\nRecordPosition Name of Drug (Generic Name)\nR2810-ONC-16111_SAE Report_11-JUN-2018']
apiLogger::2021-10-07 01:11:24,300::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:11:24,300::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:11:24,398::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:11:24,407::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:11:24,407::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk20zaw6o 
apiLogger::2021-10-07 01:11:24,408::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:11:24,408::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:11:24,649::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:11:24,649::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk20zaw6o
apiLogger::2021-10-07 01:11:29,474::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:11:29,474::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:11:29,474::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:11:29,474::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:11:29,478::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,478::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:11:29,478::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:11:29,478::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:11:29,481::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,481::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:11:29,481::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:11:29,481::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:11:29,484::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,484::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:11:29,484::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:11:29,484::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:11:29,487::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,487::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:11:29,487::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:11:29,487::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:11:29,489::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,489::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:11:29,489::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:11:29,490::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:11:29,492::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,493::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:11:29,493::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:11:29,493::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:11:29,497::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,497::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:11:29,497::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:11:29,498::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:11:29,500::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,500::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:11:29,500::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:11:29,500::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:11:29,503::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,503::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:11:29,503::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:11:29,503::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:11:29,506::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,506::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:11:29,506::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:11:29,506::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:33 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-16111. \nPlease review ASAP at https://protect-eu.mimecast.com/s/M_vbC7L8RCA1Wq81H8TvXl?\ndomain=login.imedidata.com\nAn SAE of ENTEROCOLITIS has been reported for Subject Number 840024007 with Start Date (dd-mon-\nyyyy) : 13 APR 2021  with AE suspected to be caused by REGN2810? : NOT APPLICABLE  and It required or \nprolonged inpatient hospitalization : CHECKED  with If Other, specify : BLANK \nWWRD (GMT): 15 Apr 2021 17:32:21 \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:37 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/NAlzCvoq1S7zyGMKSQQtap?domain=login.imedidata.com\nIs this an AE of Special interest (AESI)?  (If YES, complete SAE/AESI Form) :  has been updated from BLANK \nto NO,  for SAE ENTEROCOLITIS for Subject Number 840024007 WWRD (GMT): 15 Apr 2021 17:36:25 \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:43 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/Hhn3CVPpRHxoPDGQtGv-k1?domain=login.imedidata.com\nAction taken with REGN2810 :  has been updated from NOT APPLICABLE to BLANK,  for SAE \nENTEROCOLITIS for Subject Number 840024007 WWRD (GMT): 15 Apr 2021 17:41:57 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16111\nICON Study code 0456/0145\nenvironmentName Prod\nSite 840024- Pinellas Hematology and Oncology\nSubject details\nSubject Number 5\nSubject ID 840024007\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nstudy? Yes\nDate Subject Signed the First Informed\nConsent (dd-mon-yyyy) 31 OCT 2018\nHas the subject consented to\nparticipate in the genomics sub study? Yes\nDate of Genomics Consent (dd-mon-yyyy) 31 OCT 2018\nInformed Consent Version Version 1\nDemographic details\nDate of Birth (dd-mon-yyyy) 1958\nAge 59\nSex Female\nRace (choose only one primary race) White\n If Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 42\nNumber of Cigarettes Per Day 15\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking\nInformed\nDate subject Consent\nProtocol IRB signed Informed Approval Date\nProtocol version Approval Date Consent (dd- from IRB (dd-\nRecordPosition (Global) (dd-mon-yyyy) mon-yyyy) Consent Type mon-yyyy)\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nIf Ongoing\n Medical History /  Unknown Start Specify CTCAE Unknown\nRecordPosition Finding (Abnormality) Start Date Date Ongoing? Grade End Date End Date\n1 CHOLECYSTECTOMY UN UNK 2013 UNCHECKED Resolved UN UNK 2013 UNCHECKED\n2 TUBAL LIGATION UN UNK 1994 UNCHECKED Resolved UN UNK 1994 UNCHECKED\n3 SPINE SURGERY FOR SPO UN UNK 2016 UNCHECKED Resolved UN UNK 2016 UNCHECKED\n4 CATARACT UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n5 POLLEN ALLERGY UN UNK 1978 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n6 DRY THROAT 01 AUG 2018 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n7 HEMORRHOIDS UN UNK 1979 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n8 ERVICAL HERNIATED DISC UN UNK 2014 UNCHECKED Ongoing Grade 2 - Moderate UNCHECKED\n9 FATIGUE UN UNK 2014 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n10 LOW BACK PAIN UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n13 RIGHT HAND TINGLING  UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n14 RIGHT ARM PAIN UN UNK 2016 UNCHECKED Ongoing Grade 1 - Mild UNCHECKED\n15 EVEL LUMBAR SPINE SPON UN UNK 2016 UNCHECKED Ongoing Grade 2 - Moderate UNCHECKED\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nIf Indication is If Indication is\nMedical History, Adverse Event,\nPlease select the Please select the\nappropriate appropriate\nStart Date (dd- Stop Date (dd- If Other, Medical History Adverse Event If Other, If Other, If Other,\nRecordPosition Drug Name mon-yyyy) Unknown mon-yyyy) Unknown Ongoing Indication specify record. record. Dose Dose Unit specify Frequency specify Route specify\n2 EXAMETHAS 15 NOV 2018 UNCHECKED 15 NOV 2018 UNCHECKED UNCHECKED Pre Med 4 mg OTO Oral\n3 NDANSETRO 16 NOV 2018 UNCHECKED 16 NOV 2018 UNCHECKED UNCHECKED Pre Med 8 mg OTO Oral\n4 DONE/ACETA UN UNK 2016 UNCHECKED UNCHECKED CHECKED Medical History 10_LOW BACK PAIN 5/325 mg PRN Oral\n5 SENNA-S 19 NOV 2018 UNCHECKED 27 NOV 2018 UNCHECKED UNCHECKED Adverse Event 1_CONSTIPATION 8.6-50 mg PRN Oral\n6 ALEVE 28 JAN 2019 UNCHECKED 01 FEB 2019 UNCHECKED UNCHECKED Adverse Event 3_HEADACHE 220 mg PRN Oral\n7 ZYRTEC 21 FEB 2019 UNCHECKED UNCHECKED CHECKED Medical History 5_POLLEN ALLERGY 10 mg PRN Oral\n8 EVOFLOXACI 12 APR 2019 UNCHECKED 16 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 750 mg QD Oral\n9 REDNISONE  13 APR 2019 UNCHECKED 15 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 60 mg QD Oral\n10 ZOFRAN 12 APR 2019 UNCHECKED UNCHECKED CHECKED Adverse Event 8_NAUSEA 4 mg Other RN FOR NAU Oral\n11 STRENGTH T 10 APR 2019 UNCHECKED 20 APR 2019 UNCHECKED UNCHECKED Adverse Event _FLU LIKE SYMPTOMS 500 mg PRN Oral\n12 REDNISONE  16 APR 2019 UNCHECKED 18 APR 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 20 mg QD Oral\n13 NEULASTA 15 NOV 2018 UNCHECKED 16 NOV 2018 UNCHECKED UNCHECKED Other ROPHALAXIS 6 mg PRN Subcutaneous\n15 PREDNISONE 19 APR 2019 UNCHECKED 03 MAY 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 30 mg QD Oral\n16 PREDNISONE 07 MAY 2019 UNCHECKED 14 MAY 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 20 mg QD Oral\n17 COTINE PAT 15 MAR 2019 UNCHECKED 01 JAN 2020 UNCHECKED UNCHECKED Other OKING CESS 21 mg QD Transdermal\n18 PREDNISONE 15 MAY 2019 UNCHECKED 18 JUN 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 10 mg QD Oral\n19 PREDNISONE 19 JUN 2019 UNCHECKED 09 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 5 mg QD Oral\n20 MEPRAZOLE 19 JUN 2019 UNCHECKED 15 JUL 2019 UNCHECKED UNCHECKED Other RD PROPHYL 40 mg QD Oral\n21 PREDNISONE 10 JUL 2019 UNCHECKED 12 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_PNEUMONITIS 2.5 mg QD Oral\n22 DAYQUIL 04 JUN 2019 UNCHECKED 09 JUN 2019 UNCHECKED UNCHECKED Adverse Event 5_MILD SORE THROAT NKNOWN DO mg PRN Oral\n23 LOVENOX 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Other VT PROPHYL 40 mg QD Subcutaneous\n24 RMAL SALINE 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 1 L QD Intravenous\n25 ANA(ARFOM 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 15 mcg q12h Inhaled\n26 CORT(BUDES 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 0.5 mg q12h Inhaled\n27 ONIX(PANTO 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 40 mg QD Intravenous\n28 ZOFRAN  15 JUL 2019 UNCHECKED 16 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 4 mg Other URS PRN (AS Intravenous\n29 LBUTEROL/IP 15 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event TIONAL SHORTNESS O 2.5 mg Other URS PRN (AS Inhaled\n30 TYLENOL 16 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 31_FEVER 650 mg Other 4 HOURS PR Oral\n31 ZOFRAN 16 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event _INTRACTABLE VOMITI 8 mg Other URS PRN (AS Intravenous\n32 EXTROSE 50 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 25 g PRN Intravenous\n33 CAGEN(GLUC 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 1 mg PRN Intramuscular\n34 LUCOSE GEL 18 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 25_HYPOGLYCEMIA 7.5 , 56.25 , 75 g PRN Oral\n35 GNESIUM SU 19 JUL 2019 UNCHECKED 19 JUL 2019 UNCHECKED UNCHECKED Adverse Event 27_HYPOMAGNESEMIA 2 g OTO Intravenous\n36 IUM BICARBO 19 JUL 2019 UNCHECKED 19 JUL 2019 UNCHECKED UNCHECKED Adverse Event 7_METABOLIC ACIDOSI 100 mEq OTO Intravenous\n37 ONIX(PANTO 19 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event 17_GASTRITIS 40 mg QD Oral\n38 DROCORTIS 20 JUL 2019 UNCHECKED 30 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n39 DROCORTIS 20 JUL 2019 UNCHECKED 06 AUG 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n40 DROCORTIS 16 AUG 2019 UNCHECKED 04 OCT 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n41 DROCORTIS 16 AUG 2019 UNCHECKED 04 OCT 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n42 DROCORTIS 05 OCT 2019 UNCHECKED 28 JAN 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 10 mg QD Oral\n43 DROCORTIS 05 OCT 2019 UNCHECKED 28 JAN 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 5 mg QD Oral\n44 TIZANIDINE 05 NOV 2019 UNCHECKED 06 NOV 2019 UNCHECKED UNCHECKED Adverse Event E BILATERAL LOWER B 4 mg TID Oral\n45 DONE/ACETA 04 NOV 2019 UNCHECKED 06 NOV 2019 UNCHECKED UNCHECKED Adverse Event E BILATERAL LOWER B 10/325 mg PRN Oral\n46 DROCORTIS 28 JAN 2020 UNCHECKED 25 FEB 2020 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 5 mg BID Oral\n47 ONIX(PANTO 21 JUL 2019 UNCHECKED 20 AUG 2019 UNCHECKED UNCHECKED Adverse Event 47_GASTRISITS 40 mg QD Oral\n48 ONIX(PANTO 21 AUG 2019 UNCHECKED UNCHECKED CHECKED Other TRIC PROTE 40 mg QD Oral\n49 DROCORTIS 26 FEB 2020 UNCHECKED UNCHECKED CHECKED Adverse Event NDARY ADRENAL INSU 15 mg Other ING DOSE AC Oral\n50 KEFLEX 07 NOV 2019 UNCHECKED 14 NOV 2019 UNCHECKED UNCHECKED Adverse Event URINARY TRACT INFE 500 mg BID Oral\n51 EVOTHYROXI 30 APR 2020 UNCHECKED 03 MAY 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 50 mcg QD Oral\n52 EVOTHYROXI 07 MAY 2020 UNCHECKED 22 JUL 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 25 mcg QD Oral\n53 ASSIUM CHL 04 MAY 2020 UNCHECKED 04 MAY 2020 UNCHECKED UNCHECKED Adverse Event 52_HYPOKALEMIA 10 mEq QD Oral\n54 ALEVE 08 FEB 2019 UNCHECKED 18 FEB 2019 UNCHECKED UNCHECKED Adverse Event 14_HEADACHE 220 mg PRN Oral\n55 ZOFRAN 12 APR 2019 UNCHECKED 12 APR 2019 UNCHECKED UNCHECKED Adverse Event 9_VOMITING 4 mg PRN Oral\n56 ZOFRAN 15 JUL 2019 UNCHECKED 15 JUL 2019 UNCHECKED UNCHECKED Adverse Event 24_NAUSEA 8 mg PRN Intravenous\n57 TYLENOL 15 JUL 2019 UNCHECKED 17 JUL 2019 UNCHECKED UNCHECKED Adverse Event NON-CARDIAC CHEST  650 mg PRN Oral\n58 TYLENOL 18 JUL 2019 UNCHECKED 28 JUL 2019 UNCHECKED UNCHECKED Adverse Event NON-CARDIACCHEST  650 mg PRN Oral\n59 TYLENOL 13 JUL 2019 UNCHECKED 18 JUL 2019 UNCHECKED UNCHECKED Adverse Event 26_HEADACHE 650 mg PRN Oral\n60 PREDNISONE 19 JUL 2019 UNCHECKED 20 JUL 2019 UNCHECKED UNCHECKED Adverse Event NDARY ADRENAL INSU 20 mg QD Oral\n61 EVOTHYROXI 23 JUL 2020 UNCHECKED 28 JUL 2020 UNCHECKED UNCHECKED Adverse Event 51_HYPOTHYROIDISM 50 mcg QD Oral\n62 EVOTHYROXI 29 JUL 2020 UNCHECKED UNCHECKED CHECKED Adverse Event 51_HYPOTHYROIDISM 25 mcg QD Oral\n63 ZITHROMYCI 30 AUG 2020 UNCHECKED 2 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 500 mg QD Oral\n64 TESSALON 30 AUG 2020 UNCHECKED 06 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 200 mg TID Oral\n65 ALBUTEROL 30 AUG 2020 UNCHECKED 10 SEP 2020 UNCHECKED UNCHECKED Adverse Event 55_PNEUMONIA 180 mcg q4h Inhaled\n66 ALLEGRA 22 OCT 2020 UNCHECKED UNCHECKED CHECKED Medical History 5_POLLEN ALLERGY 180 mg QD Oral\n67 ALEVE 23 JUL 2020 UNCHECKED 14 JAN 2021 UNCHECKED UNCHECKED Adverse Event 53_HEADACHE 220 mg PRN Oral\n69 ALEVE 12 FEB 2021 UNCHECKED 19 FEB 2021 UNCHECKED UNCHECKED Adverse Event 57_BODY ACHE 220 mg PRN Oral\n70 CEFIPIME 13 APR 2021 UNCHECKED UNCHECKED CHECKED Adverse Event 2 g BID Intravenous\n71 FLAGYL 13 APR 2021 UNCHECKED UNCHECKED CHECKED Adverse Event 500 mg TID Oral\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProcedures/Surgeries\nReason for Procedure / Date of Procedure /\nRecordPosition Procedure / Surgery Surgery If Other, specify Surgery  (dd-mon-yyyy)\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nIf Surgery Date of\nLocation is Surgery (dd- Check for\nRecordPosition Procedure Surgery Location Other, specify mon-yyyy) Unknown Date\nUNCHECKED\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nRegimen Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown UNCHECKED\nStop date (dd-mon-yyyy)\nStop Date Unknown UNCHECKED\nSubject’s Best Response\nIf best response is CR or PR, enter\nDate of Best Response (dd-mon-yyyy)\nDate of Best Response Unknown UNCHECKED\nIf subject  recurred/relapsed/\nprogressed after this therapy, please\nenter Date of Recurrence/ Relapse/\nProgression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/\nProgression Date of Progressive\nDisease Unknown UNCHECKED\nNumber of cycles\nNumber of cycles unknown/NA\nRegimen Name or Single Therapy\nIf Immunotherapy, Specify\nIf Other, specify\nRecordPosition Name of Drug (Generic Name)\nR2810-ONC-16111_SAE Report_11-JUN-2018']
apiLogger::2021-10-07 01:11:29,507::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:11:29,507::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:11:29,604::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:11:29,605::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:11:29,605::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphwede0v9 
apiLogger::2021-10-07 01:11:29,605::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:11:29,605::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:11:29,617::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:11:29,617::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphwede0v9
apiLogger::2021-10-07 01:11:29,766::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:11:29,766::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:11:29,766::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:11:29,766::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:11:29,770::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,770::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:11:29,770::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:11:29,770::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:11:29,773::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:29,773::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:11:29,773::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:11:29,773::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:09:50 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R2810-ONC-16111_Initial_840024006_Enterocolitis\nFrom: .STUDY-PVSS-0456-0145 <STUDY-PVSS-0456-0145@iconplc.com> Sent: Thursday,\nApril 15, 2021 8:55 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>; Petra\nRietschel <petra.rietschel@regeneron.com>; Dona.Bianco@regeneron.com; Emmanuel Okoye\n<emmanuel.okoye@regeneron.com>; Manika Kaul <manika.kaul@regeneron.com>; Quasheeda\nFields <quasheeda.fields@regeneron.com>; Giuseppe Gullo <giuseppe.gullo@regeneron.com>;\nUsman Chaudhry <usman.chaudhry@regeneron.com>; Mark Navarro\n<mark.navarro@regeneron.com>; Pamela Snodgrass <pamela.snodgrass@regeneron.com>;\nKomal Sharma <komal.sharma@regeneron.com>; Galyna Ganieva\n<galyna.ganieva@regeneron.com>; Hamza Hasan-External <hamza.hasan@regeneron.com>;\nWilson Caldwell <wilson.caldwell@regeneron.com> Cc: .STUDY-DM-DL-0456-0145-DM\n<STUDY-DM-DL-0456-0145-DM@iconplc.com>; Roxana Mihalcea\n<Roxana.Mihalcea@iconplc.com> Subject: <External> R2810-ONC-\n16111_Initial_840024006_Enterocolitis \n \nEXTERNAL MESSAGE\n \n \nDear All,\n \nPlease find enclosed the Initial SAE Package for above named event of patient 840024006, received on 15Apr2021,\napplicable for study R2810-ONC-16111 (ICON # 0456-0145).\n \nProtocol: R2810-ONC-16111\nSite # / Investigator: 840024\nSubject #: 006\nSAE Term: Enterocolitis\nEvent Start Date: 13Apr2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related\nCountry: United States\nInvestigator: Desai, Pratibha          pkdesai@flhemonc.com\nDay 0 15Apr2021\n \n \nKind Regards !\n \nLucia Flores \nDrug Safety Associate ICON Clinical Research Internal Tel: 7240 4787 External Tel: +52 55 5063 4787 Email:\nLucia.Flores@iconplc.com Web: www.iconplc.com   \n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-07 01:11:29,773::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:11:29,774::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:11:29,954::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:11:29,955::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:11:29,955::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpozxzdsdr 
apiLogger::2021-10-07 01:11:29,956::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:11:29,956::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:11:29,968::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:11:29,968::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpozxzdsdr
apiLogger::2021-10-07 01:11:30,103::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:11:30,103::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:11:30,103::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:11:30,103::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:11:30,107::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:30,107::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:11:30,107::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:11:30,107::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:11:30,110::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:11:30,110::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:11:30,110::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:11:30,110::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:10:48 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R2810-ONC-16111_Initial_840024007_Enterocolitis\nFrom: .STUDY-PVSS-0456-0145 <STUDY-PVSS-0456-0145@iconplc.com> Sent: Thursday,\nApril 15, 2021 8:55 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>; Petra\nRietschel <petra.rietschel@regeneron.com>; Dona.Bianco@regeneron.com; Emmanuel Okoye\n<emmanuel.okoye@regeneron.com>; Manika Kaul <manika.kaul@regeneron.com>; Quasheeda\nFields <quasheeda.fields@regeneron.com>; Giuseppe Gullo <giuseppe.gullo@regeneron.com>;\nUsman Chaudhry <usman.chaudhry@regeneron.com>; Mark Navarro\n<mark.navarro@regeneron.com>; Pamela Snodgrass <pamela.snodgrass@regeneron.com>;\nKomal Sharma <komal.sharma@regeneron.com>; Galyna Ganieva\n<galyna.ganieva@regeneron.com>; Hamza Hasan-External <hamza.hasan@regeneron.com>;\nWilson Caldwell <wilson.caldwell@regeneron.com> Cc: .STUDY-DM-DL-0456-0145-DM\n<STUDY-DM-DL-0456-0145-DM@iconplc.com>; Roxana Mihalcea\n<Roxana.Mihalcea@iconplc.com> Subject: <External> R2810-ONC-\n16111_Initial_840024007_Enterocolitis \n \nEXTERNAL MESSAGE\n \n \nDear All,\n \nPlease find enclosed the Initial SAE Package for above named event of patient 840024007, received on 15Apr2021,\napplicable for study R2810-ONC-16111 (ICON # 0456-0145).\n \nProtocol: R2810-ONC-16111\nSite # / Investigator: 840024\nSubject #: 007\nSAE Term: Enterocolitis\nEvent Start Date: 13Apr2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related\nCountry: United States\nInvestigator: Desai, Pratibha          pkdesai@flhemonc.com\nDay 0 15Apr2021\n \n \nKind Regards !\n \nLucia Flores \nDrug Safety Associate ICON Clinical Research Internal Tel: 7240 4787 External Tel: +52 55 5063 4787 Email:\nLucia.Flores@iconplc.com Web: www.iconplc.com   \n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-07 01:11:30,110::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:11:30,110::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:43:19,426::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:43:19,610::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:43:19,611::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxbajxex_ 
apiLogger::2021-10-07 01:43:19,621::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:43:19,621::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:43:53,176::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:43:53,176::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxbajxex_
apiLogger::2021-10-07 01:43:55,925::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:43:55,925::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:43:55,925::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:43:55,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:43:55,929::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,929::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:43:55,929::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:43:55,929::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:43:55,932::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,932::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:43:55,932::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:43:55,932::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:43:55,935::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,935::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:43:55,935::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:43:55,935::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:43:55,938::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,938::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:43:55,938::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:43:55,938::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:43:55,941::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,941::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:43:55,941::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:43:55,941::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:43:55,944::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,944::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:43:55,944::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:43:55,944::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:43:55,947::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,947::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:43:55,947::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:43:55,947::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:43:55,949::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,950::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:43:55,950::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:43:55,950::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:43:55,952::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,953::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:43:55,953::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:43:55,953::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:43:55,955::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:55,956::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:43:55,956::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:43:55,956::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Project Details\nProtocol Number R5459-ONC-1888\nPHASE 1/2 FIH STUDY OF REGN5459 (ANTI-BCMA X ANTI-CD3\nProtocol Title BISPECIFIC ANTIBODY) IN PATIENTS WITH RELAPSED OR\nREFRACTORY MULTIPLE MYELOMA\ninVentiv Health Study Code 7005156\nCompound  REGN5459\nSubject Details\nSite Name 840004 - Kapoor - USA\nSite Number 1888840004\nSubject ID: 840004005\nDisease Indication: Multiple Myeloma \nStudy Phase: 1/2\nScreening Date 17 MAY 2021\nDate of first dose 02 JUN 2021\nTime of first dose 09:16 Demographics\nYear of Birth Age Sex Race Other, specify Ethnicity\nNot Hispanic or\n1966 55 Female White -\nLatino\nInformed Consent\nDate Subject Signed\nSubject Protocol Version Consent Type\nInformed Consent\n840004005 Amendment 1 17 MAY 2021 Main\nVital Signs Screening - Height and Weight\nHeight and Unit Weight and Unit\n177 cm 83.7 kg\nStudy Part-Phase\nStudy Phase Cohort Dose Level\nDose Escalation\nDL8\n(Phase 1) Medical History\nIf Ongoing\nMedical History / Start Ongoing at Date resolved (End\nMH # UNK Specify CTCAE UNK\nFinding (Abnormality) Date study entry? date)\nGrade\nCLOSED HEAD INJURY\n1 - X - X\n@ AGE 17\nHYPERTRIGLYCERIDEM\n2 05 OCT 2016 - Resolved - X\nIA\nJUVENILE\n3 RHEUMATOID - X - X\nARTHRITIS AGE 12\n4 PALPITATIONS 25 JUL 2019 - Resolved 21 SEP 2020 -\nMALIGNANT NEOPLASM\n5 OF THYROID 07 JUN 2016 - Resolved 07 JUN 2016 -\nPAPILLARY\nBRIEF LOSS OF\n6 CONSCIOUSNESS @ - X Resolved - X\nAGE 17\n7 VAGINAL ATROPHY 26 AUG 2014 - Resolved - X Concomitant Medication\n# Drug Name Indication Other, AE #1 AE #2 MH #1 MH #2 Dose Frequency Route Start date Stop date  Ongoing\nspecify\n5_MALI\nGNANT\nNEOPLA\nSM OF\nACETAMONIOPH THYROI\n1 Medical History 1000 mg PRN Oral 10 AUG 2016 Yes\nEN D\nPAPILLA\nRY_07\nJUN\n2016\n2 ACYCLOVIR Prophylaxis 400 mg bid Oral 12 JUL 2017 Yes\nB COMPLEX-\n3 Prophylaxis TWO Unknown bid Oral 09 AUG 2017 Yes\nVITAMIN \n4 CALCIUM ORAL Prophylaxis 1200 mg bid Oral 26 AUG 2014 Yes\nCHOLECALCIFER\n5 Prophylaxis 2000 Unit QD Oral 08 OCT 2013 Yes\nO\nCYANOCOBALAM\n6 Prophylaxis 500 mcg bid Oral 11 SEP 2014 Yes\nIN \n7_VAGI\nNAL\nATROPH\n7 ESTRADIOL Medical History 1 g Other Vaginal 26 AUG 2014 Yes\nY_26\nAUG\n2014\n5_MALI\nGNANT\nNEOPLA\nSM OF\nTHYROI\n8 LEVOTHYROXINE Medical History 125 mcg QD Oral 24 JAN 2018 Yes\nD\nPAPILLA\nRY_07\nJUN\n2016\n9 LYSINE Prophylaxis 50 mg QD Oral 26 AUG 2014 Yes\nMAGNESIUM\n10 Prophylaxis 250 mg bid Oral 05 APR 2021 Yes\nOXIDE \n11 MELATONIN Prophylaxis 3 mg PRN Oral 05 APR 2021 Yes METHYLPHENIDA\n12 Prophylaxis 10 mg PRN Oral 26 APR 2019 Yes\nTE HCL \n13 MORPHINE Prophylaxis 15 mg PRN Oral 17 MAY 1921 Yes\nPANCREATIN-\n14 POTASS-SOD Prophylaxis 1 Unknown QD Oral 26 AUG 2014 Yes\nBICARB \n15 PROPRANOLOL Prophylaxis 40 mg QD Oral 25 SEP 2019 Yes\n16 RALOXIFENE Prophylaxis 60 mg QD Oral 14 OCT 2020 Yes\n17 SELENIUM Prophylaxis 100 mcg QD Oral 20 FEB 2019 Yes\n18 ZINC Prophylaxis 50 mg Other Oral 16 JUL 2014 Yes\nZOLEDRONIC\n19 Prophylaxis 4 mg Other Intravenous 03 JUL 2019 Yes\nACID  Study Drug Administration\nWas the dose\nDate of Start Time of End of Planned Planned dose Actual Dose\nadministered\n# Visit Name Administratio Infusion (24 Infusion (24 IP Lot # Diluent Lot # Dose Level to be Other, specify Administered\nover two\nn hour clock) hour clock) (Derived) administered (mg)\ndays?\n1 Week 1 Day 1 02 JUN 2021 09:16 14:35 8285100002 DL8 5 mg - 5 No Study Drug Administration - con't\nDid the\nsubject stay in\nIf planned If planned the Hospital\nWas the If interrupted,\ndose was dose was for\nIf Yes, Was date of infusion length of Time of\nWas dose modified, modified, If Yes, specify Observation Date of Date of\n# Visit Name specify administratio slowed, interruption Other, specify Admission (24\nmodified? was planned was planned reason period? Admission Discharge\nreason n delayed? interrupted or (24 hour hour clock)\ndose dose If Yes, provide\nterminated? clock)\nincreased? decreased? Date/Time\nAdmission/\nDischarge\n1 Week 1 Day 1 No - No - No - - Yes 02 JUN 2021 14:57 04 JUN 2021 Time of\nDate of\nDischarge (24\nDischarge\nhour clock)\n04 JUN 2021 14:38 Adverse Event Details\nAE Number 6\nMain Adverse Event Description (Term) FEVER\nEvent Start Date 10 JUN 2021\nDid the event occur on Study Day 1 prior to first study drug? No\nDoes this AE qualify as Serious? Yes\nDoes this AE qualify as an AE of Special Interest (AESI)? No\nIs AE intermittent? Yes\nAE suspected to be caused by REGN5459? Yes\nAction Taken with REGN5459 None\nAE suspected to be caused by study conduct? No\nIf yes, specify study conduct -\nOutcome of AE? Recovering/Resolving\nIf Outcome is Recovered/Resolved with Sequelae, specify the\n-\nSequelae\nResolution Date\nAE initial severity grade Grade 1\nAE most extreme severity Grade 2\nDate AE Became Grade 3 or higher N/A\nDate AE Became less than Grade 3 N/A AE Event Details_con't\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7 -\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\n    Procedure/Surgery # 1\n    Procedure/Surgery # 2\n    Procedure/Surgery # 3 -\n    Procedure/Surgery # 4\n    Procedure/Surgery # 5"]
apiLogger::2021-10-07 01:43:55,956::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:43:55,956::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:43:57,800::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:43:57,805::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:43:57,805::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5zm91c_0 
apiLogger::2021-10-07 01:43:57,806::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:43:57,806::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:43:58,028::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:43:58,028::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5zm91c_0
apiLogger::2021-10-07 01:43:58,320::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:43:58,321::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:43:58,321::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:43:58,321::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:43:58,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:58,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:43:58,324::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:43:58,324::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety; DL_R5459ONC1888_AEAlert\nSubject: [EXTERNAL] ATTENTION! R5459-ONC-1888 SAE Alert: A new SAE has been reported for the Site : 1888840004, Subject : 840004005, AE Number : 6 \nDate: Saturday, June 12, 2021 2:07:14 AM\nDear Project Member,\nPlease be informed that a new SAE has been reported for Study R5459-ONC-1888.\nCountry : World\nSite Number : 1888840004\nSite Name : 840004 - Kapoor - USA\nSubject number : 840004005\nAdverse event number : 6\nMain Adverse Event Description (Term) - FEVER\nStart date - 10 JUN 2021\nDoes this AE qualify as Serious? - Yes\nDeath - Not Checked\nLife-threatening - Not Checked\nHospitalization or prolongation of existing hospitalization - Checked\nPersistent or significant disability/incapacity - Not Checked\nCongenital anomaly/birth defect - Not Checked\nOther medically serious important event - Not Checked\nWWRD (GMT): 11 Jun 2021 08:37\nThank you,\nSyneos Health Data Management\nCreated by : Melanie Thompson [thompson.melanie@mayo.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=96136163__;!!OR9aRoiw!byzBAVbrR2iKLI8eEAI51BHoMr0lEqOcEMbPHZS2rV44BQVGxdLdJrnOb98_sv0TrAhHOCU$\n***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-07 01:43:58,325::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:43:58,325::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:43:59,099::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:43:59,100::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:43:59,100::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfow5bb0p 
apiLogger::2021-10-07 01:43:59,100::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:43:59,101::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:43:59,110::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:43:59,111::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfow5bb0p
apiLogger::2021-10-07 01:43:59,241::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:43:59,241::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:43:59,241::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:43:59,241::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:43:59,245::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:59,245::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:43:59,245::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:43:59,245::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:43:59,248::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:43:59,248::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:43:59,248::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:43:59,248::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:42:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R5459-ONC-1888/Subject: 840004-005/SAE Term: Fever/ MFR date 11-Jun-2021\nFrom: Yadav, Varsha <varsha.yadav@syneoshealth.com> Sent: Monday, June 14, 2021 5:39\nAM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Dhruti Chokshi\n<dhruti.chokshi@regeneron.com>; ipa.kumar@regeneron.com; Saager Parmar\n<saager.parmar@regeneron.com>; Prerna Kapur-External <prerna.kapur@regeneron.com>;\nLieve Adriaens <lieve.adriaens@regeneron.com>; Nikhil Singh <nikhil.singh@regeneron.com>;\nGlenn Kroog <glenn.kroog@regeneron.com>; Amiera Salib <amiera.salib@regeneron.com>;\nMartha Makaratzi <martha.makaratzi@regeneron.com>; Jevtovic, Jelena\n<jelena.jevtovic@syneoshealth.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com>; Paul, Shannon <shannon.paul@syneoshealth.com>;\nKimberly.dailey@syneoshealth.com:; Barwick, Ashley <ashley.barwick@syneoshealth.com>\nSubject: <External> Initial/R5459-ONC-1888/Subject: 840004-005/SAE Term: Fever/ MFR date\n11-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial  information for R5459-ONC-1888/Subject: 840004-005. \n \nProtocol: R5459-ONC-1888\nDay 0: 11-Jun-2021\nCountry: USA\nSite # /Investigator: 840004/ Kapoor\nSubject ID: 840004-005\nStudy Drug(s): REGN5459\nEvent Term: Fever\nOnset date: 10-Jun-2021\nSeverity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Serious (Hospitalization)/AESI: NO\nInvestigator Relationship to Study Drug: Related to REGN5459\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n  Thanks &Regards \nVarsha Yadav \nSafety &PV Specialist II \nMobile: +91 8884015248\n \nEMAIL DISCLAIMER NOTICE: Syneos Health, (the “Company”). This email and any files\ntransmitted may contain information that is privileged, confidential and exempt from disclosure and\nis intended solely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct transactions by\nelectronic means nor creates any legally binding contract or enforceable obligation in the absence\nof a fully signed written contract. Any views or opinions expressed are solely those of the author\nand do not necessarily represent those of the Company. Although the Company has taken\nreasonable precautions to ensure no viruses are present in this email, the Company cannot accept\nresponsibility for any loss or damage arising from the use of this email or attachments. ']
apiLogger::2021-10-07 01:43:59,249::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:43:59,249::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:45:19,367::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:45:19,549::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:45:19,549::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfuu600d7 
apiLogger::2021-10-07 01:45:19,559::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:45:19,559::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:45:53,137::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:45:53,137::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfuu600d7
apiLogger::2021-10-07 01:45:55,872::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:45:55,872::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:45:55,872::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:45:55,872::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:45:55,875::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,876::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:45:55,876::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:45:55,876::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:45:55,878::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,879::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:45:55,879::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:45:55,879::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 01:45:55,881::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,882::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 01:45:55,882::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 01:45:55,882::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 01:45:55,885::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,885::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 01:45:55,885::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 01:45:55,885::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 01:45:55,887::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,888::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 01:45:55,888::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 01:45:55,888::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 01:45:55,890::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,890::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 01:45:55,890::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 01:45:55,890::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 01:45:55,893::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,893::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 01:45:55,893::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 01:45:55,893::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 01:45:55,896::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,896::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 01:45:55,896::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 01:45:55,896::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 01:45:55,899::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,899::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 01:45:55,899::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 01:45:55,899::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 01:45:55,902::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:55,902::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 01:45:55,902::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 01:45:55,902::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Project Details\nProtocol Number R5459-ONC-1888\nPHASE 1/2 FIH STUDY OF REGN5459 (ANTI-BCMA X ANTI-CD3\nProtocol Title BISPECIFIC ANTIBODY) IN PATIENTS WITH RELAPSED OR\nREFRACTORY MULTIPLE MYELOMA\ninVentiv Health Study Code 7005156\nCompound  REGN5459\nSubject Details\nSite Name 840004 - Kapoor - USA\nSite Number 1888840004\nSubject ID: 840004006\nDisease Indication: Multiple Myeloma \nStudy Phase: 1/2\nScreening Date 17 MAY 2021\nDate of first dose 02 JUN 2021\nTime of first dose 09:16 Demographics\nYear of Birth Age Sex Race Other, specify Ethnicity\nNot Hispanic or\n1966 55 Female White -\nLatino\nInformed Consent\nDate Subject Signed\nSubject Protocol Version Consent Type\nInformed Consent\n840004006 Amendment 1 17 MAY 2021 Main\nVital Signs Screening - Height and Weight\nHeight and Unit Weight and Unit\n177 cm 83.7 kg\nStudy Part-Phase\nStudy Phase Cohort Dose Level\nDose Escalation\nDL8\n(Phase 1) Medical History\nIf Ongoing\nMedical History / Start Ongoing at Date resolved (End\nMH # UNK Specify CTCAE UNK\nFinding (Abnormality) Date study entry? date)\nGrade\nCLOSED HEAD INJURY\n1 - X - X\n@ AGE 17\nHYPERTRIGLYCERIDEM\n2 05 OCT 2016 - Resolved - X\nIA\nJUVENILE\n3 RHEUMATOID - X - X\nARTHRITIS AGE 12\n4 PALPITATIONS 25 JUL 2019 - Resolved 21 SEP 2020 -\nMALIGNANT NEOPLASM\n5 OF THYROID 07 JUN 2016 - Resolved 07 JUN 2016 -\nPAPILLARY\nBRIEF LOSS OF\n6 CONSCIOUSNESS @ - X Resolved - X\nAGE 17\n7 VAGINAL ATROPHY 26 AUG 2014 - Resolved - X Concomitant Medication\n# Drug Name Indication Other, AE #1 AE #2 MH #1 MH #2 Dose Frequency Route Start date Stop date  Ongoing\nspecify\n5_MALI\nGNANT\nNEOPLA\nSM OF\nACETAMONIOPH THYROI\n1 Medical History 1000 mg PRN Oral 10 AUG 2016 Yes\nEN D\nPAPILLA\nRY_07\nJUN\n2016\n2 ACYCLOVIR Prophylaxis 400 mg bid Oral 12 JUL 2017 Yes\nB COMPLEX-\n3 Prophylaxis TWO Unknown bid Oral 09 AUG 2017 Yes\nVITAMIN \n4 CALCIUM ORAL Prophylaxis 1200 mg bid Oral 26 AUG 2014 Yes\nCHOLECALCIFER\n5 Prophylaxis 2000 Unit QD Oral 08 OCT 2013 Yes\nO\nCYANOCOBALAM\n6 Prophylaxis 500 mcg bid Oral 11 SEP 2014 Yes\nIN \n7_VAGI\nNAL\nATROPH\n7 ESTRADIOL Medical History 1 g Other Vaginal 26 AUG 2014 Yes\nY_26\nAUG\n2014\n5_MALI\nGNANT\nNEOPLA\nSM OF\nTHYROI\n8 LEVOTHYROXINE Medical History 125 mcg QD Oral 24 JAN 2018 Yes\nD\nPAPILLA\nRY_07\nJUN\n2016\n9 LYSINE Prophylaxis 50 mg QD Oral 26 AUG 2014 Yes\nMAGNESIUM\n10 Prophylaxis 250 mg bid Oral 05 APR 2021 Yes\nOXIDE \n11 MELATONIN Prophylaxis 3 mg PRN Oral 05 APR 2021 Yes METHYLPHENIDA\n12 Prophylaxis 10 mg PRN Oral 26 APR 2019 Yes\nTE HCL \n13 MORPHINE Prophylaxis 15 mg PRN Oral 17 MAY 1921 Yes\nPANCREATIN-\n14 POTASS-SOD Prophylaxis 1 Unknown QD Oral 26 AUG 2014 Yes\nBICARB \n15 PROPRANOLOL Prophylaxis 40 mg QD Oral 25 SEP 2019 Yes\n16 RALOXIFENE Prophylaxis 60 mg QD Oral 14 OCT 2020 Yes\n17 SELENIUM Prophylaxis 100 mcg QD Oral 20 FEB 2019 Yes\n18 ZINC Prophylaxis 50 mg Other Oral 16 JUL 2014 Yes\nZOLEDRONIC\n19 Prophylaxis 4 mg Other Intravenous 03 JUL 2019 Yes\nACID  Study Drug Administration\nWas the dose\nDate of Start Time of End of Planned Planned dose Actual Dose\nadministered\n# Visit Name Administratio Infusion (24 Infusion (24 IP Lot # Diluent Lot # Dose Level to be Other, specify Administered\nover two\nn hour clock) hour clock) (Derived) administered (mg)\ndays?\n1 Week 1 Day 1 02 JUN 2021 09:16 14:35 8285100002 DL8 5 mg - 5 No Study Drug Administration - con't\nDid the\nsubject stay in\nIf planned If planned the Hospital\nWas the If interrupted,\ndose was dose was for\nIf Yes, Was date of infusion length of Time of\nWas dose modified, modified, If Yes, specify Observation Date of Date of\n# Visit Name specify administratio slowed, interruption Other, specify Admission (24\nmodified? was planned was planned reason period? Admission Discharge\nreason n delayed? interrupted or (24 hour hour clock)\ndose dose If Yes, provide\nterminated? clock)\nincreased? decreased? Date/Time\nAdmission/\nDischarge\n1 Week 1 Day 1 No - No - No - - Yes 02 JUN 2021 14:57 04 JUN 2021 Time of\nDate of\nDischarge (24\nDischarge\nhour clock)\n04 JUN 2021 14:38 Adverse Event Details\nAE Number 6\nMain Adverse Event Description (Term) FEVER\nEvent Start Date 10 JUN 2021\nDid the event occur on Study Day 1 prior to first study drug? No\nDoes this AE qualify as Serious? Yes\nDoes this AE qualify as an AE of Special Interest (AESI)? No\nIs AE intermittent? Yes\nAE suspected to be caused by REGN5459? Yes\nAction Taken with REGN5459 None\nAE suspected to be caused by study conduct? No\nIf yes, specify study conduct -\nOutcome of AE? Recovering/Resolving\nIf Outcome is Recovered/Resolved with Sequelae, specify the\n-\nSequelae\nResolution Date\nAE initial severity grade Grade 1\nAE most extreme severity Grade 2\nDate AE Became Grade 3 or higher N/A\nDate AE Became less than Grade 3 N/A AE Event Details_con't\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7 -\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\n    Procedure/Surgery # 1\n    Procedure/Surgery # 2\n    Procedure/Surgery # 3 -\n    Procedure/Surgery # 4\n    Procedure/Surgery # 5"]
apiLogger::2021-10-07 01:45:55,902::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:45:55,902::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:45:57,797::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:45:57,802::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:45:57,802::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwzcwrdbj 
apiLogger::2021-10-07 01:45:57,803::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:45:57,803::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:45:58,025::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:45:58,026::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwzcwrdbj
apiLogger::2021-10-07 01:45:58,311::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:45:58,311::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:45:58,311::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:45:58,311::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:45:58,315::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:58,315::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:45:58,315::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:45:58,315::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety; DL_R5459ONC1888_AEAlert\nSubject: [EXTERNAL] ATTENTION! R5459-ONC-1888 SAE Alert: A new SAE has been reported for the Site : 1888840004, Subject : 840004006, AE Number : 6 \nDate: Saturday, June 12, 2021 2:07:14 AM\nDear Project Member,\nPlease be informed that a new SAE has been reported for Study R5459-ONC-1888.\nCountry : World\nSite Number : 1888840004\nSite Name : 840004 - Kapoor - USA\nSubject number : 840004006\nAdverse event number : 6\nMain Adverse Event Description (Term) - FEVER\nStart date - 10 JUN 2021\nDoes this AE qualify as Serious? - Yes\nDeath - Not Checked\nLife-threatening - Not Checked\nHospitalization or prolongation of existing hospitalization - Checked\nPersistent or significant disability/incapacity - Not Checked\nCongenital anomaly/birth defect - Not Checked\nOther medically serious important event - Not Checked\nWWRD (GMT): 11 Jun 2021 08:37\nThank you,\nSyneos Health Data Management\nCreated by : Melanie Thompson [thompson.melanie@mayo.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=96136163__;!!OR9aRoiw!byzBAVbrR2iKLI8eEAI51BHoMr0lEqOcEMbPHZS2rV44BQVGxdLdJrnOb98_sv0TrAhHOCU$\n***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-07 01:45:58,315::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:45:58,315::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 01:45:59,070::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 01:45:59,071::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 01:45:59,072::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo5zqzyym 
apiLogger::2021-10-07 01:45:59,072::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 01:45:59,072::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 01:45:59,082::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 01:45:59,082::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo5zqzyym
apiLogger::2021-10-07 01:45:59,202::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 01:45:59,202::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 01:45:59,202::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 01:45:59,202::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 01:45:59,206::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:59,206::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 01:45:59,206::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 01:45:59,206::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 01:45:59,209::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 01:45:59,209::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 01:45:59,209::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 01:45:59,209::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 01:43:25 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R5459-ONC-1888/Subject: 840004-006/SAE Term: Fever/ MFR date 11-Jun-2021\nFrom: Yadav, Varsha <varsha.yadav@syneoshealth.com> Sent: Monday, June 14, 2021 5:39\nAM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Dhruti Chokshi\n<dhruti.chokshi@regeneron.com>; ipa.kumar@regeneron.com; Saager Parmar\n<saager.parmar@regeneron.com>; Prerna Kapur-External <prerna.kapur@regeneron.com>;\nLieve Adriaens <lieve.adriaens@regeneron.com>; Nikhil Singh <nikhil.singh@regeneron.com>;\nGlenn Kroog <glenn.kroog@regeneron.com>; Amiera Salib <amiera.salib@regeneron.com>;\nMartha Makaratzi <martha.makaratzi@regeneron.com>; Jevtovic, Jelena\n<jelena.jevtovic@syneoshealth.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com>; Paul, Shannon <shannon.paul@syneoshealth.com>;\nKimberly.dailey@syneoshealth.com:; Barwick, Ashley <ashley.barwick@syneoshealth.com>\nSubject: <External> Initial/R5459-ONC-1888/Subject: 840004-006/SAE Term: Fever/ MFR date\n11-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial  information for R5459-ONC-1888/Subject: 840004-006. \n \nProtocol: R5459-ONC-1888\nDay 0: 11-Jun-2021\nCountry: USA\nSite # /Investigator: 840004/ Kapoor\nSubject ID: 840004-006\nStudy Drug(s): REGN5459\nEvent Term: Fever\nOnset date: 10-Jun-2021\nSeverity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Serious (Hospitalization)/AESI: NO\nInvestigator Relationship to Study Drug: Related to REGN5459\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n  Thanks &Regards \nVarsha Yadav \nSafety &PV Specialist II \nMobile: +91 8884015248\n \nEMAIL DISCLAIMER NOTICE: Syneos Health, (the “Company”). This email and any files\ntransmitted may contain information that is privileged, confidential and exempt from disclosure and\nis intended solely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct transactions by\nelectronic means nor creates any legally binding contract or enforceable obligation in the absence\nof a fully signed written contract. Any views or opinions expressed are solely those of the author\nand do not necessarily represent those of the Company. Although the Company has taken\nreasonable precautions to ensure no viruses are present in this email, the Company cannot accept\nresponsibility for any loss or damage arising from the use of this email or attachments. ']
apiLogger::2021-10-07 01:45:59,210::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 01:45:59,210::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:51:19,214::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:51:19,221::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:51:19,221::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx3olv473 
apiLogger::2021-10-07 02:51:19,222::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:51:19,222::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:51:19,429::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:51:19,430::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx3olv473
apiLogger::2021-10-07 02:51:22,557::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:51:22,557::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:51:22,557::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:51:22,557::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:51:22,560::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:51:22,560::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:51:22,560::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:51:22,560::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 02:51:22,563::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 02:51:22,563::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 02:51:22,563::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 02:51:22,563::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 02:51:22,564::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event -SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event -SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 02:51:22,564::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 02:51:22,564::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 02:51:22,564::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 02:51:22,564::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 02:51:22,564::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 02:51:41,255::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 02:51:41,256::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:51:41,358::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:51:41,365::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:51:41,365::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgprok_t5 
apiLogger::2021-10-07 02:51:41,365::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:51:41,366::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:51:41,569::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:51:41,570::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgprok_t5
apiLogger::2021-10-07 02:51:44,748::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:51:44,748::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:51:44,748::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:51:44,748::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:51:44,752::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:51:44,752::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:51:44,752::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:51:44,752::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 02:51:44,755::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 02:51:44,755::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 02:51:44,755::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 02:51:44,755::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 02:51:44,755::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 02:51:44,755::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 02:51:44,755::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 02:51:44,755::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 02:51:44,755::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 02:51:44,755::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 02:52:03,444::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 02:52:03,444::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:57:18,782::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:57:18,802::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:57:18,802::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsax4jpdf 
apiLogger::2021-10-07 02:57:18,803::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:57:18,803::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:57:18,957::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:57:18,957::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsax4jpdf
apiLogger::2021-10-07 02:57:20,668::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:57:20,668::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:57:20,669::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:57:20,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:57:20,672::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,673::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:57:20,673::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:57:20,673::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 02:57:20,676::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,676::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 02:57:20,676::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 02:57:20,676::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 02:57:20,679::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,680::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 02:57:20,680::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 02:57:20,680::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 02:57:20,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 02:57:20,683::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 02:57:20,683::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 02:57:20,686::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,686::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 02:57:20,686::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 02:57:20,686::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 02:57:20,689::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,689::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 02:57:20,689::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 02:57:20,689::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 02:57:20,693::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:20,693::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 02:57:20,693::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 02:57:20,693::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-07 02:57:20,693::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 02:57:20,693::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:57:21,151::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:57:21,152::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:57:21,152::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1ogbj64q 
apiLogger::2021-10-07 02:57:21,153::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:57:21,153::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:57:21,158::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:57:21,158::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1ogbj64q
apiLogger::2021-10-07 02:57:21,174::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:57:21,175::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:57:21,175::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:57:21,175::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:57:21,178::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:57:21,178::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:57:21,178::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:57:21,178::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma <ritu.sharma@rxlogix.com>\nReceived Date : 07-Oct-2021 02:52:02 +0000\nTo : "medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> sc 13 - test 1\nEXTERNAL MESSAGE \n \nSc 13 ']
apiLogger::2021-10-07 02:57:21,178::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 02:57:21,178::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:59:19,008::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:59:19,016::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:59:19,016::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkxewvmp4 
apiLogger::2021-10-07 02:59:19,017::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:59:19,017::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:59:19,325::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:59:19,325::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkxewvmp4
apiLogger::2021-10-07 02:59:22,501::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:59:22,501::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:59:22,501::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:59:22,501::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:59:22,504::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:59:22,505::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:59:22,505::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:59:22,505::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 02:59:22,508::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 02:59:22,508::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 02:59:22,508::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 02:59:22,508::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 02:59:22,508::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 02:59:22,508::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 02:59:22,508::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 02:59:22,508::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 02:59:22,508::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 02:59:22,508::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 02:59:41,395::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 02:59:41,395::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 02:59:41,498::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 02:59:41,506::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 02:59:41,506::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj21n55zl 
apiLogger::2021-10-07 02:59:41,507::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 02:59:41,507::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 02:59:41,815::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 02:59:41,815::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj21n55zl
apiLogger::2021-10-07 02:59:44,996::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 02:59:44,996::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 02:59:44,996::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 02:59:44,996::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 02:59:45,000::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 02:59:45,000::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 02:59:45,000::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 02:59:45,000::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 02:59:45,003::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 02:59:45,003::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 02:59:45,003::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 02:59:45,004::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 02:59:45,004::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,005\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 02:59:45,004::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 02:59:45,004::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 02:59:45,004::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 02:59:45,004::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 02:59:45,004::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 03:00:03,768::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 03:00:03,768::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 03:10:23,675::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 03:10:23,684::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 03:10:23,685::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwcmi4atn 
apiLogger::2021-10-07 03:10:23,685::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 03:10:23,685::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 03:10:23,992::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 03:10:23,992::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwcmi4atn
apiLogger::2021-10-07 03:10:27,161::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 03:10:27,161::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 03:10:27,161::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 03:10:27,161::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 03:10:27,165::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 03:10:27,165::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 03:10:27,165::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 03:10:27,165::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 03:10:27,168::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 03:10:27,168::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 03:10:27,168::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 03:10:27,168::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 03:10:27,168::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 03:10:27,168::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 03:10:27,168::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 03:10:27,168::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 03:10:27,168::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 03:10:27,168::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 03:10:45,863::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 03:10:45,863::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 04:19:18,781::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 04:19:18,787::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 04:19:18,787::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxh49heuo 
apiLogger::2021-10-07 04:19:18,787::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 04:19:18,787::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 04:19:18,887::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 04:19:18,887::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxh49heuo
apiLogger::2021-10-07 04:19:20,942::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 04:19:20,942::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 04:19:20,942::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 04:19:20,942::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 04:19:20,946::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 04:19:20,946::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 04:19:20,946::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 04:19:20,946::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 04:19:20,949::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 04:19:20,949::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 04:19:20,949::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 04:19:20,949::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 04:19:20,949::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-07 04:19:20,949::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 04:19:20,949::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 04:19:20,949::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 04:19:20,949::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 04:19:20,949::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 04:19:35,903::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 04:19:35,903::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:03:18,706::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:03:18,713::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:03:18,713::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8izez0ov 
apiLogger::2021-10-07 05:03:18,713::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:03:18,714::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:03:18,829::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:03:18,829::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8izez0ov
apiLogger::2021-10-07 05:03:20,501::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:03:20,501::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:03:20,501::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:03:20,501::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:03:20,505::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:03:20,505::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:03:20,505::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 05:03:20,505::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 05:03:20,508::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:03:20,508::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 05:03:20,508::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 05:03:20,508::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 05:03:20,511::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 05:03:20,511::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 05:03:20,511::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 05:03:20,511::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-07 05:03:20,511::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-07 05:03:20,512::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 05:03:20,512::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 05:03:20,512::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 05:03:20,512::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 05:03:20,512::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fc285f257b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 05:03:35,233::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 05:03:35,233::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:35:48,299::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:35:48,346::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:35:48,356::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyg_n8ats 
apiLogger::2021-10-07 05:35:49,829::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:35:49,830::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:35:51,059::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:35:51,059::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyg_n8ats
apiLogger::2021-10-07 05:35:55,718::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:35:55,719::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:35:55,719::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:35:55,719::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:35:55,727::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:35:55,727::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:35:55,727::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 05:35:55,727::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 05:35:55,730::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:35:55,730::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 05:35:55,731::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 05:35:55,731::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 05:35:55,733::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 05:35:55,733::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 05:35:55,733::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 05:35:55,734::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-07 05:35:55,734::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n1 AUGMENTIN Adverse Event - - 1000 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n2 CIPRINOL Adverse Event - - 0.4 g - BID\nINFECTION_25 JAN\n2021\n1_HYPERTENSION_\n3 COVALSACOR Medical History - - 160+12.5 mg - QD\nUNK\nHYPERURICEMIA\n4 MILURIT Prophylaxis - - 100 mg - QD\nPROPHYLAXIS\n2_OSTEOARTHRITI\n5 DORETA Medical History - - 75 mg - QD\nS_UNK\nPremedication for\n6 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n7 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n8 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n9 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n10 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n11 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n25 JAN 09 FEB\nTID - Oral - unchecked unchecked\n2021 2021\n25 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nUN UNK\nQD - Oral - unchecked - checked\n2010\nUN UNK\nQD - Oral - unchecked - checked\n2017\nUN UNK\nQD - Oral - unchecked - checked\n2018\n04 NOV 04 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n05 NOV 05 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n16 NOV 16 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n17 NOV 17 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n23 NOV 23 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 NOV 30 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n12 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n13 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n14 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n15 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n16 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n17 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n18 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n1_RESPIRATORY\nFRAXIPARINE TRACT\n19 Adverse Event - - 0.8 mL - QD\nMULTI INFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n20 CLEMASTIN Adverse Event - - 1 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n21 TRIMESOLPHAR Adverse Event - - 1920 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n22 VORYCONAZOOL Adverse Event - - 200 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n23 MORFINA Adverse Event - - 5 mg - PRN\nINFECTION_25 JAN\n2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n07 DEC 07 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n14 DEC 14 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n21 DEC 21 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n28 DEC 28 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n04 JAN 04 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n11 JAN 11 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n18 JAN 18 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\nSubcutaneo 25 JAN 09 FEB\nQD - - unchecked unchecked\nus 2021 2021\n25 JAN 09 FEB\nQD - Oral - unchecked unchecked\n2021 2021\n05 FEB 09 FEB\nTID - Intravenous - unchecked unchecked\n2021 2021\n30 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nSubcutaneo 08 FEB 09 FEB\nPRN - - unchecked unchecked\nus 2021 2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n24 ATROVENT Adverse Event - - 40 Drop - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n25 PULMICORT Adverse Event - - 1 g - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n26 VENTOLIN Adverse Event - - 2.5 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n27 FUROSEMID Adverse Event - - 20 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n28 HEVIRAN Adverse Event - - 400 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n29 BISEPTOL Adverse Event - - 1920 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n30 BUDEZONID Adverse Event - - 0.5 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n31 METOCARD Adverse Event - - 25 mg - Unknown\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n32 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n33 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n34 NEOPARIN Adverse Event - - 40 mg - QD\nINFECTION_25 JAN\n2021']
apiLogger::2021-10-07 05:35:55,734::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 05:35:55,734::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 05:35:55,734::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 05:35:55,734::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 05:35:55,734::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe9cd20aa20>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 05:36:23,469::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 05:36:23,470::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:37:30,411::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:37:30,412::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:37:30,415::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3gaabxsg 
apiLogger::2021-10-07 05:37:30,415::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:37:30,415::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:37:30,420::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:37:30,420::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3gaabxsg
apiLogger::2021-10-07 05:37:30,432::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:37:30,432::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:37:30,433::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:37:30,433::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:37:30,436::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:37:30,436::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:37:30,436::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 05:37:30,436::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 07-Oct-2021 05:35:44 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : group testing\n ']
apiLogger::2021-10-07 05:37:30,436::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 05:37:30,436::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:39:19,174::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:39:19,182::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:39:19,182::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp09qwack2 
apiLogger::2021-10-07 05:39:19,183::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:39:19,183::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:39:19,478::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:39:19,478::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp09qwack2
apiLogger::2021-10-07 05:39:22,598::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:39:22,598::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:39:22,598::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:39:22,598::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:39:22,601::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:39:22,601::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:39:22,601::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 05:39:22,601::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 05:39:22,604::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 05:39:22,604::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 05:39:22,604::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 05:39:22,604::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 05:39:22,604::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 05:39:22,604::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 05:39:22,604::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 05:39:22,604::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 05:39:22,605::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 05:39:22,605::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 05:39:41,197::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 05:39:41,197::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:39:41,281::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:39:41,282::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:39:41,282::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfquosyin 
apiLogger::2021-10-07 05:39:41,282::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:39:41,282::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:39:41,288::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:39:41,288::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfquosyin
apiLogger::2021-10-07 05:39:41,308::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:39:41,308::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:39:41,308::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:39:41,308::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:39:41,311::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 05:39:41,312::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:39:41,312::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 05:39:41,312::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 07-Oct-2021 05:37:40 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: group testing - 2\n \n \nFrom: Ritu Sharma-External Sent: Thursday, October 7, 2021 1:36 AM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: group testing \n \n ']
apiLogger::2021-10-07 05:39:41,312::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 05:39:41,312::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 05:51:18,755::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 05:51:18,783::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 05:51:18,783::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpphovuryy 
apiLogger::2021-10-07 05:51:18,784::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 05:51:18,784::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 05:51:19,157::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 05:51:19,157::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpphovuryy
apiLogger::2021-10-07 05:51:22,500::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 05:51:22,500::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 05:51:22,500::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 05:51:22,500::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 05:51:22,504::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 05:51:22,504::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 05:51:22,504::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 05:51:22,504::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 05:51:22,504::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-07 05:51:22,504::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 05:51:22,504::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 05:51:22,504::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 05:51:22,504::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 05:51:22,504::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 05:51:42,083::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 05:51:42,083::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:05:18,853::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:05:18,907::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:05:18,919::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptgjxzqc7 
apiLogger::2021-10-07 06:05:18,922::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:05:18,922::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:05:19,607::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:05:19,607::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptgjxzqc7
apiLogger::2021-10-07 06:05:24,008::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:05:24,008::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:05:24,008::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:05:24,008::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:05:24,012::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-07 06:05:24,013::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:05:24,013::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 06:05:24,013::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 06:05:24,013::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 26 January 2021 18:25\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-eu.mimecast.com/s/jM-\nzC9Q6WCkWGEANSou9t2?domain=login.imedidata.com\nAn AESI of AMILASE INCREASE has been reported for Subject Number 643004026 with Start Date (dd-mon-yyyy) : 13 \nAPR 2020  with AE suspected to be caused by blinded study drug? : YES \n \nWWRD (GMT): 26 Jan 2021 12:54:41 \n \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 643004-Arkhangelsk Regional Clinical Oncology Dispensary\nSubject details\nSubject Number 26\nSubject ID 643004026\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n05 MAR 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n05 MAR 2020\nyyyy)\nInformed Consent Version Version 2\nDemographic details\nDate of Birth (dd-mon-yyyy) 1954\nAge (Derived) (All EXCEPT German\n65\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 43\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nARTERIA\nL\nGrade 2 -\n1 HYPERT UN UNK 2016 UNCHECKED Ongoing UNCHECKED\nModerate\nENSION,\nRISK 3\nMYOCAR\nGrade 1 -\n2 DIODIST UN UNK 2017 UNCHECKED Ongoing UNCHECKED\nMild\nROPHY\nCHRONIC\nGrade 1 -\n3 PROSTA UN UNK 2016 UNCHECKED Ongoing UNCHECKED\nMild\nTITIS\nOSTEOC\nGrade 1 -\n4 HONDRO UN UNK 2016 UNCHECKED Ongoing UNCHECKED\nMild\nSIS\nCHRONIC\nOBSTRU\nCTIVE Grade 1 -\n5 UN UNK 2009 UNCHECKED Ongoing UNCHECKED\nPULMON Mild\nARY\nDISEASE\nPULMON\nARY Grade 1 -\n6 UN UNK 2009 UNCHECKED Ongoing UNCHECKED\nINSUFFIC Mild\nIENCY\nCHRONIC\nGrade 1 -\n7 HEPATO 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nSIS\nCHRONIC\nGrade 1 -\n8 PANCRE 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nATITIS\nLEFT\nGrade 1 -\n9 KIDNEY 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nCYST\nMIXED\nHYDROC Grade 1 -\n10 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nEPHALU Mild\nS\nASTHENI Grade 2 -\n11 CHECKED Ongoing UNCHECKED\nA Moderate\nCRAMPIN\nG Grade 1 -\n12 CHECKED Ongoing UNCHECKED\nABDOMI Mild\nNAL PAIN\nDYSPEP Grade 1 -\n13 CHECKED Ongoing UNCHECKED\nSIA Mild\nGrade 1 -\n14 ANEMIA 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nAST\nGrade 1 -\n15 INCREAS 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nE\nALT\nGrade 1 -\n16 INCREAS 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nE \nALKALIN\nE\nPHOSPH Grade 1 -\n17 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nATASE Mild\nINCREAS\nE\nALBUMIN\nGrade 1 -\n18 DECREA 17 MAR 2020 UNCHECKED Ongoing UNCHECKED\nMild\nSE\nIMPOSITI\nON OF A\nGASTRO\n19 06 FEB 2020 UNCHECKED Resolved 06 FEB 2020 UNCHECKED\nENTERO\nANASTO\nMOSIS\nBROWNI\nAN\nANASTO\nMOSIS\n20 06 FEB 2020 UNCHECKED Resolved 06 FEB 2020 UNCHECKED\nOF\nSMALL\nINTESTIN\nE\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nASPARCAM\n[MAGNESIU\nMedical 2_MYOCARDIODIS UN UNK CHECKE\nM\n1 History TROPHY 1 Tablet TID Oral 2017 D\nASPARTATE;\nGASTRITI\nS\nOMEPRAZOL CHECKE\nPROPHYL\n2 E Other 20 mg BID Oral 16 MAR 2020 D\nAXIS\nNAUSEA\nMETOCLOPR PROPHYL CHECKE\n3 AMIDE Other AXIS 10 mg TID Oral 16 MAR 2020 D\nHAPETOP\nATHY\nCHECKE\nPROPHYL\n4 HEPTOR Other 400 mg BID Oral 17 MAR 2020 D\nAXIS\nWEIGHT\nLOSS\nNUTRICOMP UNCHEC\nPROPHYL\n5 DRINK Other 200 mL QD Oral 18 MAR 2020 27 MAR 2020 KED\nAXIS\nMedical UNCHEC\n6 FOLIC ACID History 14_ANEMIA 1 Tablet QD Oral 18 MAR 2020 07 JUL 2020 KED\nRINGER SUPPORTI UNCHEC\n7 SOLUTION Other VE CARE 500 mL QD Intravenous 16 MAR 2020 22 MAR 2020 KED\nPOTASSIUM\nCHLORIDE SUPPORTI UNCHEC\n8 4% Other VE CARE 10 mL QD Intravenous 16 MAR 2020 22 MAR 2020 KED\nGLUCOSE SUPPORTI UNCHEC\n9 5% Other VE CARE 500 mL QD Intravenous 16 MAR 2020 22 MAR 2020 KED\nVITAMIN C SUPPORTI UNCHEC\n10 5% Other VE CARE 4 mL QD Intravenous 16 MAR 2020 22 MAR 2020 KED\nSUPPORTI UNCHEC\n11 NO-SPA Other VE CARE 2 mL QD Intravenous 16 MAR 2020 22 MAR 2020 KED\nFERRUM\nLEK [FERRIC\nMedical UNCHEC\nHYDROXIDE\n12 History 14_ANEMIA 100 mg QD Intramuscular 24 MAR 2020 27 MAR 2020 KED\nPOLYMALTO\nBEFORE\nEACH\nDEXAMETHA CHECKE\nPACLITA\n13 SONE Pre Med 20 mg Other Intravenous 24 MAR 2020 D\nXEL\nBEFORE\nEACH\nCHECKE\nPACLITA\n14 DIMEDROL Pre Med 50 mg Other Intravenous 24 MAR 2020 D\nXEL\nBEFORE\nEACH\nCHECKE\nPACLITA\n15 RANITIDIN Pre Med 50 mg Other Intravenous 24 MAR 2020 D\nXEL\nBEFORE\nEACH\nONDANSETR CHECKE\nCARBOP\n16 ON Pre Med 8 mg Other Intravenous 24 MAR 2020 D\nLATIN\nRINGER SUPPORTI UNCHEC\n17 SOLUTION Other VE CARE 500 mL QD Intravenous 25 MAR 2020 27 MAR 2020 KED\nPOTASSIUM\nCHLORIDE SUPPORTI UNCHEC\n18 4% Other VE CARE 10 mL QD Intravenous 25 MAR 2020 27 MAR 2020 KED\nVITAMIN C SUPPORTI UNCHEC\n19 5% Other VE CARE 4 mL QD Intravenous 25 MAR 2020 27 MAR 2020 KED\nAdverse UNCHEC\n20 MAGNE B6 Event 1_HYPOMAGNESEMIA 1 Tablet TID Oral 13 APR 2020 29 SEP 2020 KED\nAdverse CHECKE\n21 CREON Event 2_AMILASE INCREASE 10000 IU TID Oral 13 APR 2020 D\nAdverse UNCHEC\n22 SUPRASTIN Event 3_RASH 25 mg BID Oral 07 APR 2020 11 APR 2020 KED\nTRIDERM\n(CLOTRIMAZ\nAdverse Not UNCHEC\nOLE,\n23 Event 3_RASH Applicable BID Topical 07 APR 2020 11 APR 2020 KED\nGENTAMICIN\nKETOPROFE Adverse UNCHEC\n24 N Event 4_JOINT PAIN 150 mg QD Oral 26 MAR 2020 28 MAR 2020 KED\nAdverse UNCHEC\n25 SUPRASTIN Event 6_RASH 1 Tablet QD Oral 16 APR 2020 22 JUL 2020 KED\nTRIDERM\n(CLOTRIMAZ\nAdverse Not UNCHEC\nOLE,\n26 Event 6_RASH Applicable QD Topical 16 APR 2020 22 JUL 2020 KED\nGENTAMICIN\nAdverse 8_NUMBNESS OF THE CHECKE\n27 PENTOVIT Event FINGERS AND TOES 1 Tablet TID Oral 28 MAY 2020 D\nAdverse UNCHEC\n28 DICYNONE Event 9_THROMBOCYTOPENIA 250 mg TID Oral 17 JUN 2020 06 JUL 2020 KED\nTHROMBO\nEMBOLIC\nUNCHEC\nPROPHYL\n29 ENIXUM Other 0.4 mL QD Subcutaneous 17 JUN 2020 18 JUN 2020 KED\nAXIS\nMedical UNCHEC\n30 BINOCRIT History 14_ANEMIA 10000 IU OTO Subcutaneous 18 JUN 2020 18 JUN 2020 KED\nTHROMBO\nEMBOLIC\nENOXAPARI UNCHEC\nPROPHYL\n31 N Other 0.4 mL QD Subcutaneous 07 JUL 2020 08 JUL 2020 KED\nAXIS\nTHROMBO\nEMBOLIC\nENOXAPARI UNCHEC\nPROPHYL\n32 N Other 0.4 mL QD Subcutaneous 28 JUL 2020 29 JUL 2020 KED\nAXIS\nTHROMBO\nEMBOLIC\nUNCHEC\nPROPHYL\n33 ENIXUM Other 0.4 mL QD Subcutaneous 18 AUG 2020 19 AUG 2020 KED\nAXIS\nAdverse CHECKE\n34 L-THYROXIN Event 11_HYPOTHYROIDISM 50 mcg QD Oral 21 AUG 2020 D\nTHROMBO\nEMBOLIC\nENOXAPARI UNCHEC\nPROPHYL\n35 N Other 0.4 mL OTO Subcutaneous 23 DEC 2020 23 DEC 2020 KED\nAXIS\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure Treatment\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\n1 Lung 01 FEB 2018 0\n3 Lung 01 FEB 2018 0\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number 1\nTherapy setting Adjuvant\nIf Other, specify\nLine of therapy 1st line\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown 1\nStop date (dd-mon-yyyy) UN JUL 2018\nStop Date Unknown 0\nSubject’s Best Response PD (Progressive disease)\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown 0\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/ 06 FEB 2020\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\n0\nDate of Progressive Disease Unknown\nNumber of cycles 4\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify EP\nRegimen Name or Single Therapy Other, specify\nRecord\nName of Drug (Generic Name)\nPosition\n1 CISPLATIN\n2 ETOPOSIDE  \n1 CISPLATIN\n2 ETOPOSIDE  \nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_27-JAN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) AMILASE INCREASE\nStart date (dd-mon-yyyy) 13 APR 2020\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and\ncomplete IRR CRF\nIs this AE immune related? Yes\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nYes\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Dose Not Changed\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Not recovered/Not resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy)\nAE initial severity CTCAE grade Grade 3\nAE most extreme severity CTCAE grade Grade 3\nDate Event Became Grade 3 or higher -\n13 APR 2020\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nNOT CHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n21_CREON\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_27-JAN-2021"]
apiLogger::2021-10-07 06:05:24,013::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 06:05:24,013::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-07 06:05:24,013::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 06:05:24,013::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 06:05:24,013::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 06:05:45,841::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 06:05:45,841::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:11:19,147::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:11:19,167::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:11:19,168::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3a5ilswm 
apiLogger::2021-10-07 06:11:19,169::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:11:19,169::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:11:19,372::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:11:19,372::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3a5ilswm
apiLogger::2021-10-07 06:11:22,175::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:11:22,175::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:11:22,175::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:11:22,176::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:11:22,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 06:11:22,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:11:22,179::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 06:11:22,179::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 06:11:22,179::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-07 06:11:22,179::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 06:11:22,179::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 06:11:22,179::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 06:11:22,179::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 06:11:22,180::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 06:11:41,024::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 06:11:41,024::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:37:18,858::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:37:18,923::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:37:18,923::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7fbbuwty 
apiLogger::2021-10-07 06:37:18,926::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:37:18,926::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:37:20,922::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:37:20,922::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7fbbuwty
apiLogger::2021-10-07 06:37:24,850::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:37:24,851::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:37:24,851::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:37:24,851::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:37:24,854::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:37:24,854::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 06:37:24,854::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 06:37:24,857::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,858::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 06:37:24,858::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 06:37:24,858::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 06:37:24,861::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,861::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 06:37:24,861::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 06:37:24,861::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 06:37:24,864::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,864::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 06:37:24,864::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 06:37:24,864::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 06:37:24,868::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,868::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 06:37:24,868::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 06:37:24,868::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 06:37:24,871::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,871::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 06:37:24,871::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 06:37:24,871::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 06:37:24,874::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,874::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 06:37:24,874::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 06:37:24,874::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 06:37:24,877::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,877::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 06:37:24,877::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 06:37:24,877::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 06:37:24,880::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,880::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 06:37:24,880::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 06:37:24,880::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 06:37:24,883::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:24,883::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 06:37:24,883::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 06:37:24,883::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24 \x00\x01\x02\x02\x03ÿ\x05\x06\x07\x08\t\n\x0b\x0c\rÿ\x0eÿ\x0f\x02\x10\x11\x01ÿ\x0f\x11\x12\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x13\x1eÿ\x11\x0b\n\x03\x02\n\t\x14!\n\x16\x11\nÿ\x11 \x1b\x11\x0b\x07ÿ\x02\x1e "\t\n\t\x0b\x1dÿ#\x11\n \x00\x01\x02\x02\x03 (\n\x18\x11\x0c\x0b\x11\x0b\x07 (\x01\x11\x14\t\x14\x07\n\x1a\x07\x11\n\x02\x14 &\x01$\x10\x02\n\x07\n\x13\x14\n\x0b\x11\x14\x10\x07 \x17\x11\x08\x18\x01\x07 \x1c\x0b\x06\x07\x0c\x1d \x05\x02\x01\x01\x07\x10\x0b\t\x02\x14 \x0b\x06\x07 %\x02\x0b\x11\n\n\t$ )\x02\x0b\x11\x01 \x05\x0c\x07\x11\x0b\t\x14\t $\x0c\x07\x11 (\x08\t\x14\x02\x0b\x0c\x11\x14 (\x08\t\x14\x02\x0b\x0c\x11\x14\n\x15\x02\x0b \x17\x02\x03\t$\x08 \x05\x06\x01\x02\x0c\t\x03\x07 \x05\x11\x01\x10\t$\x08 \x1f\x15\x02\x14\x0e (\x01\x12$\x08\t\x14 *\x0c\x07\x11\n\x15\x11\x08\x07 \x05\x02\x01\x01\x07\x10\x0b\x07 \x17\x18\x07\x10\t\x1e\r \x1f\x03\x03\x0e\x08\x02\x14\x0e \n\x11\x08\x18\x01\x07 \x08 %\x0c\x02\x0b\x07\t\x14 \x14\x07 \x14\t\x0b\x0c\x02!\x07\x14 \n\x1e\x07\x0c\x11\n\x07 \n\x1e\x07\x0c\x11\n\x07\n\x1b\x02\x14\x07 \'\x11\n\x0b\t\x14! \n\x03\x19 \r\r\r\r  \x10\x02\x01\x01\x07\x10\x0b\x07\x03 \x1f\x00*\x15  \x1f(\x17)  \x1f(\x0f) \n\x18\x0c\t\x02\x0cÿ\x0b\x02\n\x03\x02\n\t\x14!\x19\n/;<\n+,-.. 67ÿ+.9 6DEFG JKLFGG 677FG :KDFGG 67MFGN JKJFNH MK:FNH 6K6MFG LJFGNH\n234 5 5 =>>?@ABC? FGNHOI 6EFPHI 6QKDFPHI\n/0/1 :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\n3\nRS3B<G3\nT<ÿU33V 6Jÿ+.9 6DMFG JKDFGG E[FGG :KDFGG 666FGN JKDFNH MK:FNH 6K7JFG JMFGNH\n234 5 5 234 FGNHOI :DFPHI :DFPHI\n6ÿWBXÿ6 :7:6 G;?HI ;?HI ;?HI ;?HI HOI OI OI NHOI OI\nY6Z\nRS3B<G3\nT<ÿU33V 6Lÿ+.9 6DQFG JKDFGG 67:FG :K:FGG 6QMFGN JKDFNH LKLFNH 6K6LFG M6FGNH\n234 5 5 234 FGNHOI :MK6FPHI :7FPHI\n6ÿWBXÿ: :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\nY6Z REG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x01\x02\x03\x01\x04 \x1f\x14\x06\x03\x0c\x04\x05\x04\n!\x03\x1d\x1d\x03" \x1f\t\x14\x14\x06\x10\x0c\x06\n\x05\x06 \x0e\x03\x10\x0c\x03\x0c\x06 \x07\x08\t\n\x0b\x08 \x1f\x14\x06\x03\x0c\x04\x05\x06 \x17\x14\x04\x15\x01\x12\x10\x06 \x05\x06\n\x1f\x14\x06\x03\x0c\x04\x05\x06 \x15\x01\x19\x0c\x03\x1d\x12\x01 \x13ÿ&\x06\x14\x19\x1d\n\x07\x08\t\n \x11\x06\x08\x12\x13\x14\t \x17\t\x0c\x03\x01 \x11\x04\x14\x06\x10\x0c \x1b\x05\n\x0c\x03\x05\x10\x06 \x1e\x14\x04\x10 \t\x14\x19\n \x0b\x08\t\n\x0b\x08 \x14\x04\x13\x06\n \x18\x04\x10\x03\x14\x1a\t \x1f\x03\x14\x1a\t\x05 \x1f\x01\x06\x03\x14\x03\x05\n \x04\x05\x03\n\x06 \x0c\x14\x03\x05\n#\x06\x14 \x1f\x03\x01\x10\x04\x19\x1d\n\x0b\x08\x03\x0c\x03 \x15\x06\x05\x03\n\x06 \x18\x04\x01\x04\x14\x19\x1a\x04\x05 \x1a\x04\x01\x04\x14\x19\x1a\x04\x05 \x1c\x03\x1d\x06 \x00\x10\x04\x13 \r\x07\x08\t\n\x0b\x08 \t\x02\x04\x05\x03\n\x06 \r\x05\t\x05" \x05\x03\x0c\x06 \x13\x04\t$\x04\x13\x06 \x10\x06\n\r\x1f \x0f \x03\n\x06 \r\x13\x06\x14\x04\'\x06\x13\n\n\x06 \r\x0e\x11\x16\x0f \x03\x0c\x06\x0f \r\x1f\x07 \x0f #\x03\n\x0c\x04\x05\x15\x0f \r\x13\x06\x14\x04\'\x06\x13\n\r!!\x17\x0f \x0f\n\r\x00\x0e\x07\x0f \x0f\n()*+ )/*+,- *01+23- 56788 (*0(+2 (0((+2 )((0>+ 1)+23- )10?+2\n+23-4. + )1+,-. + )0)) >@0>?\n,-. . 4. 9:9; 3-4. 2<=-. ,-. 4. 2<=-.\nABCDE2C\n((?+ )>?+,- *0/+23- FEÿHCCI ?0/+23- (0*1+2 )>(01+ O?+23- )>0/+2\n+23-4. + N1+,-. + )0)> //0(@\n,-. . 4. (ÿJDKÿ( 4. 2<=-. ,-. 4. 2<=-.\nL(M\nABCDE2C\n@N+, ))?+,- *0/+23- FEÿHCCI *0)+23- (0N)+2 )>101+ O/+23- ))0O+2\n+23-4. + N)+,-. + )0(> >@0@(\n-. . 4. (ÿJDKÿ) 4. 2<=-. ,-. 4. 2<=-.\nL(M \x06\x07\x08\t\n\x0b\tÿ\x0c\x08\t\x05\r\x0b\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n$\x1aÿ\x11\x1b\r\x0f\x11\x14\t\n\x04\x0b\n\x06\x0c \x06\x0c\n\x02\x03\x04\x05 \x1d\t\x0f\x11\x08\t\n\t\x07\n\x16\t\x19\t\x0f\rÿ\x04\x1a \x0b\x1b\x0b\x10\t\x0f\r\t\x07 \x0b\x1b\x0b\x10\t\x0f\r\t\x07 $\x1aÿ\x18\t\x0b%\n\x06\x07\x08\t\n\x0b\t \x16\r\x03\n\rÿ\x07\x03\r\t \'\x1d\t\x0b\x11\x19\x08\t\x07 \x1d\t\x0b\x11\x19\x1b\r\x04\x11\x05\n\x06\x0cÿ\x04\x0b \r\x11ÿ\x1c\t \r\x11ÿ\x1c\t \x0b\x10\t\x0f\x04\x1a\x18 &\x1b\r\x0f\x11\x14\t\nÿ\x01 \x0c\x08\t\x05\r \x12\x07\x07\x17\x14\x11\x05\x17 (\x04\r) \x07\x03\r\tÿ\x12\x07\x07\x17\n\x04\x05\r\t\n\x14\x04\r\r\t\x05 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0b\r\x1b\x07\x18 \x11\x1aÿ\x06\x0c\n\x0e\t\x0b\x0f\n\x04\x10\r\x04\x11 \x18\x18\x18\x18\x15 \x16\t*\x1b\t\x19\x03\t+ \x14\x11\x05\x17\x18\x18\x18\x18\x15\n\r \x1d\x0c\x1e\x1f !"! \x0b\r\x1b\x07\x18 \x0f\x11\x05\x07\x1b\x0f\r\n\x05ÿ\x12\x13\t\n\x14\x15 \x16\x10\t\x0f\x04\x1a\x18\n# \x0f\x11\x05\x07\x1b\x0f\r#\n\r)\t\n\x0b\t*\x1b\t\x19\x03\t,\n/AB\n./0.123 89ÿ;.1 C?DAE?C?FG\n- > 7?@ /A > >\n4513627 <=<8 /AB\nC?@AHE?F \x00\x01\x02\x03\x04\x05\x03ÿ\x07\x02\x03\x08\tÿ\n\x03\t\x0b\x0c\r\x05\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x07ÿ\x0c\x08\x0c\t\x0c\x0b\rÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x10\x11\x12\x13\x14ÿ\x16\n\x00\x07ÿ\x17\x18\x05\tÿ\x03\x19\t\x04\x03\x17\x03ÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x1a\x04\x0b\x01\x03ÿ\x1b\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ\x1c\x03\x1d\x0b\x17\x03ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ\x18\x04ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ ÿ\x0c!ÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n$\x01\x01 \x17\x18\x08 \x0e\x0e\x0e\x0e%\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03 \'\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\r\x03\x05\x05\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n\x00\x1d\t\x0c\x18\x08ÿ\t\x0b(\x03\x08ÿ)\x0c\t\x1fÿ*\x07\x1a&+,-, ./0ÿ122345\x1263\x14\n\n\x18\x03\x05ÿ\t\x1f\x0c\x05ÿ\x00\x07ÿ78\x0b\r\x0c!\x0eÿ\x0b\x05ÿ9\x03\x04\x0c\x188\x05: ;\x14<\n=\x05ÿ\t\x1f\x0c\x05ÿ\x0b\x08ÿ\x00\x07ÿ\x18!ÿ9"\x03\x1d\x0c\x0b\rÿ\x0c\x08\t\x03\x04\x03\x05\tÿ$\x00\x079=%: ./\n9\x03\x04\x0c\x188\x08\x03\x05\x05ÿ>\x04\x0c\t\x03\x04\x0c\x0b\n=\tÿ\x04\x03\x058\r\t\x03\x01ÿ\x0c\x08ÿ\x01\x03\x0b\t\x1f ./\n=\tÿ)\x0b\x05ÿ\r\x0c!\x03 \t\x1f\x04\x03\x0b\t\x03\x08\x0c\x08\x0f ./\n=\tÿ\x04\x0378\x0c\x04\x03\x01ÿ\x18\x04ÿ"\x04\x18\r\x18\x08\x0f\x03\x01ÿ\x0c\x08"\x0b\t\x0c\x03\x08\tÿ\x1f\x18\x05"\x0c\t\x0b\r\x0c?\x0b\t\x0c\x18\x08 @\x03\x05\nA\x03\x04\x05\x0c\x05\t\x03\x08\tÿ\x18\x04ÿ\x05\x0c\x0f\x08\x0c!\x0c\x1d\x0b\x08\tÿ\x01\x0c\x05\x0b#\x0c\r\x0c\t\x0eÿBÿ\x0c\x08\x1d\x0b"\x0b\x1d\x0c\t\x0e ./\n=\tÿ\x0c\x05ÿ\x0bÿ\x1d\x18\x08\x0f\x03\x08\x0c\t\x0b\rÿ\x0b\x08\x18\x17\x0b\r\x0eB#\x0c\x04\t\x1fÿ\x01\x03!\x03\x1d\tÿ\x0c\x08ÿ\x18!!\x05"\x04\x0c\x08\x0fÿ\x18!\n./\n\x05\t8\x01\x0eÿ\x058#C\x03\x1d\t\nD\t\x1f\x03\x04ÿ\x17\x03\x01\x0c\x1d\x0b\r\r\x0eÿ\x05\x03\x04\x0c\x188\x05ÿ\x0c\x17"\x18\x04\t\x0b\x08\tÿ\x03\x02\x03\x08\t ./ \x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\r\x0e\x08\x0b\x00\x0f\n\x08\x0bÿ\x10\x05\x11\x12\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\rÿ\x14\x01\x06\x15\x02\x03\x16\r\x03\x04\x0cÿ\x17\x18\x01\x02\x11\x19 \x13\n\x00\r$\x02\rÿ\x14$\r\x01 \x1a\x1b\x1c\x1a\x1d\x1e\x1f !\x1d\x1f"\x1e#\n\x14$\r\x01ÿ\x01\n\x01\x0c\rÿ\x12\x01\x15$\x11\x01ÿ\x06\x01\x02\x03\x04\x05\x06ÿ\x17\t\t+\x11\x04\x0c+,,,,\x19 %&ÿ(\x1a\x1dÿ)*)%\n-\r.\x01\x02ÿ\x06\x05\x06\x16\x01\x15\r\x01\tÿ\x15$\x05\x06\x01\x06 %&ÿ(\x1a\x1dÿ)*)%\n/\x08\x18\x0f-\x10\x080\x0bÿ1-/ÿ2\x083\x00\x080\x0f\x184ÿ\x08\x00\x00\x0b\x00\x005\x0b\x10\x18\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ/$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ2$\x05\x06$7\x03\r,ÿ\r\x04\n/\x0b8\x109:;:\n!"\x1e\x1a<ÿ\x1c\x1f=(\x1a(ÿ\x1f<\x1aÿ\x1c \x1f<>?>\x1a@\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ\x02$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ\x15$\x05\x06$7\x03\r,ÿ\r\x04ÿ\x06\r\x05\t,\n\x15\x04\x0c\t\x05\x15\r\n>\x1bÿ"\x1e\x1aÿ\x1aB\x1a\x1b>\x1bCÿ !\x1c\x1f  #ÿ@>(!<>\x1a\x1b"\x1a@ÿ\x1f\x1b@ÿ=\x1b("\x1a\x1f@#ÿ>\x1bÿC\x1f>"DÿE<>">\x1bCÿ>(\n\x1c!\x1b(\x1d>\x1c=!=(Dÿ>\x1c\x1aÿ"\x1a("ÿ&ÿ\x1d!>\x1b"(Fÿ>\x1c\x1f\x1b(ÿ)\n\x00\x08\x0b\x0e\x08\x0b\x00\x0fÿ\x10\x08//\x08\x18\x0fA\x0b']
apiLogger::2021-10-07 06:37:24,883::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 06:37:24,884::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:37:25,586::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:37:25,587::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:37:25,587::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsvwjro2a 
apiLogger::2021-10-07 06:37:25,587::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:37:25,588::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:37:25,593::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:37:25,593::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsvwjro2a
apiLogger::2021-10-07 06:37:25,604::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:37:25,605::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:37:25,605::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:37:25,605::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:37:25,608::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:37:25,608::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:37:25,608::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 06:37:25,608::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 07-Oct-2021 06:37:00 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : 1625\n ']
apiLogger::2021-10-07 06:37:25,608::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 06:37:25,608::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:39:49,155::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:39:49,225::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:39:49,225::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpon173dem 
apiLogger::2021-10-07 06:39:49,227::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:39:49,227::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:39:51,225::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:39:51,225::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpon173dem
apiLogger::2021-10-07 06:39:55,112::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:39:55,112::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:39:55,112::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:39:55,112::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:39:55,115::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,115::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:39:55,115::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 06:39:55,115::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 06:39:55,118::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,118::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 06:39:55,119::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 06:39:55,119::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 06:39:55,121::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,122::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 06:39:55,122::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 06:39:55,122::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 06:39:55,125::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,125::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 06:39:55,125::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 06:39:55,125::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 06:39:55,128::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,128::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 06:39:55,128::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 06:39:55,128::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 06:39:55,131::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,131::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 06:39:55,131::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 06:39:55,131::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 06:39:55,134::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,134::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 06:39:55,134::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 06:39:55,134::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 06:39:55,137::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,137::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 06:39:55,137::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 06:39:55,137::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 06:39:55,140::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,140::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 06:39:55,140::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 06:39:55,140::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 06:39:55,142::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:39:55,143::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 06:39:55,143::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 06:39:55,143::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24 \x00\x01\x02\x02\x03ÿ\x05\x06\x07\x08\t\n\x0b\x0c\rÿ\x0eÿ\x0f\x02\x10\x11\x01ÿ\x0f\x11\x12\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x13\x1eÿ\x11\x0b\n\x03\x02\n\t\x14!\n\x16\x11\nÿ\x11 \x1b\x11\x0b\x07ÿ\x02\x1e "\t\n\t\x0b\x1dÿ#\x11\n \x00\x01\x02\x02\x03 (\n\x18\x11\x0c\x0b\x11\x0b\x07 (\x01\x11\x14\t\x14\x07\n\x1a\x07\x11\n\x02\x14 &\x01$\x10\x02\n\x07\n\x13\x14\n\x0b\x11\x14\x10\x07 \x17\x11\x08\x18\x01\x07 \x1c\x0b\x06\x07\x0c\x1d \x05\x02\x01\x01\x07\x10\x0b\t\x02\x14 \x0b\x06\x07 %\x02\x0b\x11\n\n\t$ )\x02\x0b\x11\x01 \x05\x0c\x07\x11\x0b\t\x14\t $\x0c\x07\x11 (\x08\t\x14\x02\x0b\x0c\x11\x14 (\x08\t\x14\x02\x0b\x0c\x11\x14\n\x15\x02\x0b \x17\x02\x03\t$\x08 \x05\x06\x01\x02\x0c\t\x03\x07 \x05\x11\x01\x10\t$\x08 \x1f\x15\x02\x14\x0e (\x01\x12$\x08\t\x14 *\x0c\x07\x11\n\x15\x11\x08\x07 \x05\x02\x01\x01\x07\x10\x0b\x07 \x17\x18\x07\x10\t\x1e\r \x1f\x03\x03\x0e\x08\x02\x14\x0e \n\x11\x08\x18\x01\x07 \x08 %\x0c\x02\x0b\x07\t\x14 \x14\x07 \x14\t\x0b\x0c\x02!\x07\x14 \n\x1e\x07\x0c\x11\n\x07 \n\x1e\x07\x0c\x11\n\x07\n\x1b\x02\x14\x07 \'\x11\n\x0b\t\x14! \n\x03\x19 \r\r\r\r  \x10\x02\x01\x01\x07\x10\x0b\x07\x03 \x1f\x00*\x15  \x1f(\x17)  \x1f(\x0f) \n\x18\x0c\t\x02\x0cÿ\x0b\x02\n\x03\x02\n\t\x14!\x19\n/;<\n+,-.. 67ÿ+.9 6DEFG JKLFGG 677FG :KDFGG 67MFGN JKJFNH MK:FNH 6K6MFG LJFGNH\n234 5 5 =>>?@ABC? FGNHOI 6EFPHI 6QKDFPHI\n/0/1 :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\n3\nRS3B<G3\nT<ÿU33V 6Jÿ+.9 6DMFG JKDFGG E[FGG :KDFGG 666FGN JKDFNH MK:FNH 6K7JFG JMFGNH\n234 5 5 234 FGNHOI :DFPHI :DFPHI\n6ÿWBXÿ6 :7:6 G;?HI ;?HI ;?HI ;?HI HOI OI OI NHOI OI\nY6Z\nRS3B<G3\nT<ÿU33V 6Lÿ+.9 6DQFG JKDFGG 67:FG :K:FGG 6QMFGN JKDFNH LKLFNH 6K6LFG M6FGNH\n234 5 5 234 FGNHOI :MK6FPHI :7FPHI\n6ÿWBXÿ: :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\nY6Z REG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x01\x02\x03\x01\x04 \x1f\x14\x06\x03\x0c\x04\x05\x04\n!\x03\x1d\x1d\x03" \x1f\t\x14\x14\x06\x10\x0c\x06\n\x05\x06 \x0e\x03\x10\x0c\x03\x0c\x06 \x07\x08\t\n\x0b\x08 \x1f\x14\x06\x03\x0c\x04\x05\x06 \x17\x14\x04\x15\x01\x12\x10\x06 \x05\x06\n\x1f\x14\x06\x03\x0c\x04\x05\x06 \x15\x01\x19\x0c\x03\x1d\x12\x01 \x13ÿ&\x06\x14\x19\x1d\n\x07\x08\t\n \x11\x06\x08\x12\x13\x14\t \x17\t\x0c\x03\x01 \x11\x04\x14\x06\x10\x0c \x1b\x05\n\x0c\x03\x05\x10\x06 \x1e\x14\x04\x10 \t\x14\x19\n \x0b\x08\t\n\x0b\x08 \x14\x04\x13\x06\n \x18\x04\x10\x03\x14\x1a\t \x1f\x03\x14\x1a\t\x05 \x1f\x01\x06\x03\x14\x03\x05\n \x04\x05\x03\n\x06 \x0c\x14\x03\x05\n#\x06\x14 \x1f\x03\x01\x10\x04\x19\x1d\n\x0b\x08\x03\x0c\x03 \x15\x06\x05\x03\n\x06 \x18\x04\x01\x04\x14\x19\x1a\x04\x05 \x1a\x04\x01\x04\x14\x19\x1a\x04\x05 \x1c\x03\x1d\x06 \x00\x10\x04\x13 \r\x07\x08\t\n\x0b\x08 \t\x02\x04\x05\x03\n\x06 \r\x05\t\x05" \x05\x03\x0c\x06 \x13\x04\t$\x04\x13\x06 \x10\x06\n\r\x1f \x0f \x03\n\x06 \r\x13\x06\x14\x04\'\x06\x13\n\n\x06 \r\x0e\x11\x16\x0f \x03\x0c\x06\x0f \r\x1f\x07 \x0f #\x03\n\x0c\x04\x05\x15\x0f \r\x13\x06\x14\x04\'\x06\x13\n\r!!\x17\x0f \x0f\n\r\x00\x0e\x07\x0f \x0f\n()*+ )/*+,- *01+23- 56788 (*0(+2 (0((+2 )((0>+ 1)+23- )10?+2\n+23-4. + )1+,-. + )0)) >@0>?\n,-. . 4. 9:9; 3-4. 2<=-. ,-. 4. 2<=-.\nABCDE2C\n((?+ )>?+,- *0/+23- FEÿHCCI ?0/+23- (0*1+2 )>(01+ O?+23- )>0/+2\n+23-4. + N1+,-. + )0)> //0(@\n,-. . 4. (ÿJDKÿ( 4. 2<=-. ,-. 4. 2<=-.\nL(M\nABCDE2C\n@N+, ))?+,- *0/+23- FEÿHCCI *0)+23- (0N)+2 )>101+ O/+23- ))0O+2\n+23-4. + N)+,-. + )0(> >@0@(\n-. . 4. (ÿJDKÿ) 4. 2<=-. ,-. 4. 2<=-.\nL(M \x06\x07\x08\t\n\x0b\tÿ\x0c\x08\t\x05\r\x0b\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n$\x1aÿ\x11\x1b\r\x0f\x11\x14\t\n\x04\x0b\n\x06\x0c \x06\x0c\n\x02\x03\x04\x05 \x1d\t\x0f\x11\x08\t\n\t\x07\n\x16\t\x19\t\x0f\rÿ\x04\x1a \x0b\x1b\x0b\x10\t\x0f\r\t\x07 \x0b\x1b\x0b\x10\t\x0f\r\t\x07 $\x1aÿ\x18\t\x0b%\n\x06\x07\x08\t\n\x0b\t \x16\r\x03\n\rÿ\x07\x03\r\t \'\x1d\t\x0b\x11\x19\x08\t\x07 \x1d\t\x0b\x11\x19\x1b\r\x04\x11\x05\n\x06\x0cÿ\x04\x0b \r\x11ÿ\x1c\t \r\x11ÿ\x1c\t \x0b\x10\t\x0f\x04\x1a\x18 &\x1b\r\x0f\x11\x14\t\nÿ\x01 \x0c\x08\t\x05\r \x12\x07\x07\x17\x14\x11\x05\x17 (\x04\r) \x07\x03\r\tÿ\x12\x07\x07\x17\n\x04\x05\r\t\n\x14\x04\r\r\t\x05 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0b\r\x1b\x07\x18 \x11\x1aÿ\x06\x0c\n\x0e\t\x0b\x0f\n\x04\x10\r\x04\x11 \x18\x18\x18\x18\x15 \x16\t*\x1b\t\x19\x03\t+ \x14\x11\x05\x17\x18\x18\x18\x18\x15\n\r \x1d\x0c\x1e\x1f !"! \x0b\r\x1b\x07\x18 \x0f\x11\x05\x07\x1b\x0f\r\n\x05ÿ\x12\x13\t\n\x14\x15 \x16\x10\t\x0f\x04\x1a\x18\n# \x0f\x11\x05\x07\x1b\x0f\r#\n\r)\t\n\x0b\t*\x1b\t\x19\x03\t,\n/AB\n./0.123 89ÿ;.1 C?DAE?C?FG\n- > 7?@ /A > >\n4513627 <=<8 /AB\nC?@AHE?F \x00\x01\x02\x03\x04\x05\x03ÿ\x07\x02\x03\x08\tÿ\n\x03\t\x0b\x0c\r\x05\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x07ÿ\x0c\x08\x0c\t\x0c\x0b\rÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x10\x11\x12\x13\x14ÿ\x16\n\x00\x07ÿ\x17\x18\x05\tÿ\x03\x19\t\x04\x03\x17\x03ÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x1a\x04\x0b\x01\x03ÿ\x1b\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ\x1c\x03\x1d\x0b\x17\x03ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ\x18\x04ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ ÿ\x0c!ÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n$\x01\x01 \x17\x18\x08 \x0e\x0e\x0e\x0e%\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03 \'\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\r\x03\x05\x05\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n\x00\x1d\t\x0c\x18\x08ÿ\t\x0b(\x03\x08ÿ)\x0c\t\x1fÿ*\x07\x1a&+,-, ./0ÿ122345\x1263\x14\n\n\x18\x03\x05ÿ\t\x1f\x0c\x05ÿ\x00\x07ÿ78\x0b\r\x0c!\x0eÿ\x0b\x05ÿ9\x03\x04\x0c\x188\x05: ;\x14<\n=\x05ÿ\t\x1f\x0c\x05ÿ\x0b\x08ÿ\x00\x07ÿ\x18!ÿ9"\x03\x1d\x0c\x0b\rÿ\x0c\x08\t\x03\x04\x03\x05\tÿ$\x00\x079=%: ./\n9\x03\x04\x0c\x188\x08\x03\x05\x05ÿ>\x04\x0c\t\x03\x04\x0c\x0b\n=\tÿ\x04\x03\x058\r\t\x03\x01ÿ\x0c\x08ÿ\x01\x03\x0b\t\x1f ./\n=\tÿ)\x0b\x05ÿ\r\x0c!\x03 \t\x1f\x04\x03\x0b\t\x03\x08\x0c\x08\x0f ./\n=\tÿ\x04\x0378\x0c\x04\x03\x01ÿ\x18\x04ÿ"\x04\x18\r\x18\x08\x0f\x03\x01ÿ\x0c\x08"\x0b\t\x0c\x03\x08\tÿ\x1f\x18\x05"\x0c\t\x0b\r\x0c?\x0b\t\x0c\x18\x08 @\x03\x05\nA\x03\x04\x05\x0c\x05\t\x03\x08\tÿ\x18\x04ÿ\x05\x0c\x0f\x08\x0c!\x0c\x1d\x0b\x08\tÿ\x01\x0c\x05\x0b#\x0c\r\x0c\t\x0eÿBÿ\x0c\x08\x1d\x0b"\x0b\x1d\x0c\t\x0e ./\n=\tÿ\x0c\x05ÿ\x0bÿ\x1d\x18\x08\x0f\x03\x08\x0c\t\x0b\rÿ\x0b\x08\x18\x17\x0b\r\x0eB#\x0c\x04\t\x1fÿ\x01\x03!\x03\x1d\tÿ\x0c\x08ÿ\x18!!\x05"\x04\x0c\x08\x0fÿ\x18!\n./\n\x05\t8\x01\x0eÿ\x058#C\x03\x1d\t\nD\t\x1f\x03\x04ÿ\x17\x03\x01\x0c\x1d\x0b\r\r\x0eÿ\x05\x03\x04\x0c\x188\x05ÿ\x0c\x17"\x18\x04\t\x0b\x08\tÿ\x03\x02\x03\x08\t ./ \x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\r\x0e\x08\x0b\x00\x0f\n\x08\x0bÿ\x10\x05\x11\x12\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\rÿ\x14\x01\x06\x15\x02\x03\x16\r\x03\x04\x0cÿ\x17\x18\x01\x02\x11\x19 \x13\n\x00\r$\x02\rÿ\x14$\r\x01 \x1a\x1b\x1c\x1a\x1d\x1e\x1f !\x1d\x1f"\x1e#\n\x14$\r\x01ÿ\x01\n\x01\x0c\rÿ\x12\x01\x15$\x11\x01ÿ\x06\x01\x02\x03\x04\x05\x06ÿ\x17\t\t+\x11\x04\x0c+,,,,\x19 %&ÿ(\x1a\x1dÿ)*)%\n-\r.\x01\x02ÿ\x06\x05\x06\x16\x01\x15\r\x01\tÿ\x15$\x05\x06\x01\x06 %&ÿ(\x1a\x1dÿ)*)%\n/\x08\x18\x0f-\x10\x080\x0bÿ1-/ÿ2\x083\x00\x080\x0f\x184ÿ\x08\x00\x00\x0b\x00\x005\x0b\x10\x18\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ/$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ2$\x05\x06$7\x03\r,ÿ\r\x04\n/\x0b8\x109:;:\n!"\x1e\x1a<ÿ\x1c\x1f=(\x1a(ÿ\x1f<\x1aÿ\x1c \x1f<>?>\x1a@\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ\x02$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ\x15$\x05\x06$7\x03\r,ÿ\r\x04ÿ\x06\r\x05\t,\n\x15\x04\x0c\t\x05\x15\r\n>\x1bÿ"\x1e\x1aÿ\x1aB\x1a\x1b>\x1bCÿ !\x1c\x1f  #ÿ@>(!<>\x1a\x1b"\x1a@ÿ\x1f\x1b@ÿ=\x1b("\x1a\x1f@#ÿ>\x1bÿC\x1f>"DÿE<>">\x1bCÿ>(\n\x1c!\x1b(\x1d>\x1c=!=(Dÿ>\x1c\x1aÿ"\x1a("ÿ&ÿ\x1d!>\x1b"(Fÿ>\x1c\x1f\x1b(ÿ)\n\x00\x08\x0b\x0e\x08\x0b\x00\x0fÿ\x10\x08//\x08\x18\x0fA\x0b']
apiLogger::2021-10-07 06:39:55,143::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 06:39:55,143::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 06:40:04,835::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 06:40:04,907::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 06:40:04,907::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp50_rnlc7 
apiLogger::2021-10-07 06:40:04,909::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 06:40:04,909::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 06:40:06,902::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 06:40:06,902::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp50_rnlc7
apiLogger::2021-10-07 06:40:10,785::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 06:40:10,785::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 06:40:10,785::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 06:40:10,785::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 06:40:10,788::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,788::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 06:40:10,788::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 06:40:10,789::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 06:40:10,791::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,791::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 06:40:10,792::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 06:40:10,792::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 06:40:10,794::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,795::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 06:40:10,795::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 06:40:10,795::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 06:40:10,798::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,798::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 06:40:10,798::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 06:40:10,798::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 06:40:10,801::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,801::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 06:40:10,801::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 06:40:10,801::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 06:40:10,804::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,804::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 06:40:10,804::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 06:40:10,804::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 06:40:10,807::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,807::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 06:40:10,807::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 06:40:10,807::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 06:40:10,809::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,809::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 06:40:10,809::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 06:40:10,810::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 06:40:10,812::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,812::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 06:40:10,812::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 06:40:10,812::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 06:40:10,815::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 06:40:10,815::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 06:40:10,815::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 06:40:10,815::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24 \x00\x01\x02\x02\x03ÿ\x05\x06\x07\x08\t\n\x0b\x0c\rÿ\x0eÿ\x0f\x02\x10\x11\x01ÿ\x0f\x11\x12\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x13\x1eÿ\x11\x0b\n\x03\x02\n\t\x14!\n\x16\x11\nÿ\x11 \x1b\x11\x0b\x07ÿ\x02\x1e "\t\n\t\x0b\x1dÿ#\x11\n \x00\x01\x02\x02\x03 (\n\x18\x11\x0c\x0b\x11\x0b\x07 (\x01\x11\x14\t\x14\x07\n\x1a\x07\x11\n\x02\x14 &\x01$\x10\x02\n\x07\n\x13\x14\n\x0b\x11\x14\x10\x07 \x17\x11\x08\x18\x01\x07 \x1c\x0b\x06\x07\x0c\x1d \x05\x02\x01\x01\x07\x10\x0b\t\x02\x14 \x0b\x06\x07 %\x02\x0b\x11\n\n\t$ )\x02\x0b\x11\x01 \x05\x0c\x07\x11\x0b\t\x14\t $\x0c\x07\x11 (\x08\t\x14\x02\x0b\x0c\x11\x14 (\x08\t\x14\x02\x0b\x0c\x11\x14\n\x15\x02\x0b \x17\x02\x03\t$\x08 \x05\x06\x01\x02\x0c\t\x03\x07 \x05\x11\x01\x10\t$\x08 \x1f\x15\x02\x14\x0e (\x01\x12$\x08\t\x14 *\x0c\x07\x11\n\x15\x11\x08\x07 \x05\x02\x01\x01\x07\x10\x0b\x07 \x17\x18\x07\x10\t\x1e\r \x1f\x03\x03\x0e\x08\x02\x14\x0e \n\x11\x08\x18\x01\x07 \x08 %\x0c\x02\x0b\x07\t\x14 \x14\x07 \x14\t\x0b\x0c\x02!\x07\x14 \n\x1e\x07\x0c\x11\n\x07 \n\x1e\x07\x0c\x11\n\x07\n\x1b\x02\x14\x07 \'\x11\n\x0b\t\x14! \n\x03\x19 \r\r\r\r  \x10\x02\x01\x01\x07\x10\x0b\x07\x03 \x1f\x00*\x15  \x1f(\x17)  \x1f(\x0f) \n\x18\x0c\t\x02\x0cÿ\x0b\x02\n\x03\x02\n\t\x14!\x19\n/;<\n+,-.. 67ÿ+.9 6DEFG JKLFGG 677FG :KDFGG 67MFGN JKJFNH MK:FNH 6K6MFG LJFGNH\n234 5 5 =>>?@ABC? FGNHOI 6EFPHI 6QKDFPHI\n/0/1 :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\n3\nRS3B<G3\nT<ÿU33V 6Jÿ+.9 6DMFG JKDFGG E[FGG :KDFGG 666FGN JKDFNH MK:FNH 6K7JFG JMFGNH\n234 5 5 234 FGNHOI :DFPHI :DFPHI\n6ÿWBXÿ6 :7:6 G;?HI ;?HI ;?HI ;?HI HOI OI OI NHOI OI\nY6Z\nRS3B<G3\nT<ÿU33V 6Lÿ+.9 6DQFG JKDFGG 67:FG :K:FGG 6QMFGN JKDFNH LKLFNH 6K6LFG M6FGNH\n234 5 5 234 FGNHOI :MK6FPHI :7FPHI\n6ÿWBXÿ: :7:6 G;?HI ;?HI G;?HI ;?HI HOI OI OI NHOI OI\nY6Z REG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x01\x02\x03\x01\x04 \x1f\x14\x06\x03\x0c\x04\x05\x04\n!\x03\x1d\x1d\x03" \x1f\t\x14\x14\x06\x10\x0c\x06\n\x05\x06 \x0e\x03\x10\x0c\x03\x0c\x06 \x07\x08\t\n\x0b\x08 \x1f\x14\x06\x03\x0c\x04\x05\x06 \x17\x14\x04\x15\x01\x12\x10\x06 \x05\x06\n\x1f\x14\x06\x03\x0c\x04\x05\x06 \x15\x01\x19\x0c\x03\x1d\x12\x01 \x13ÿ&\x06\x14\x19\x1d\n\x07\x08\t\n \x11\x06\x08\x12\x13\x14\t \x17\t\x0c\x03\x01 \x11\x04\x14\x06\x10\x0c \x1b\x05\n\x0c\x03\x05\x10\x06 \x1e\x14\x04\x10 \t\x14\x19\n \x0b\x08\t\n\x0b\x08 \x14\x04\x13\x06\n \x18\x04\x10\x03\x14\x1a\t \x1f\x03\x14\x1a\t\x05 \x1f\x01\x06\x03\x14\x03\x05\n \x04\x05\x03\n\x06 \x0c\x14\x03\x05\n#\x06\x14 \x1f\x03\x01\x10\x04\x19\x1d\n\x0b\x08\x03\x0c\x03 \x15\x06\x05\x03\n\x06 \x18\x04\x01\x04\x14\x19\x1a\x04\x05 \x1a\x04\x01\x04\x14\x19\x1a\x04\x05 \x1c\x03\x1d\x06 \x00\x10\x04\x13 \r\x07\x08\t\n\x0b\x08 \t\x02\x04\x05\x03\n\x06 \r\x05\t\x05" \x05\x03\x0c\x06 \x13\x04\t$\x04\x13\x06 \x10\x06\n\r\x1f \x0f \x03\n\x06 \r\x13\x06\x14\x04\'\x06\x13\n\n\x06 \r\x0e\x11\x16\x0f \x03\x0c\x06\x0f \r\x1f\x07 \x0f #\x03\n\x0c\x04\x05\x15\x0f \r\x13\x06\x14\x04\'\x06\x13\n\r!!\x17\x0f \x0f\n\r\x00\x0e\x07\x0f \x0f\n()*+ )/*+,- *01+23- 56788 (*0(+2 (0((+2 )((0>+ 1)+23- )10?+2\n+23-4. + )1+,-. + )0)) >@0>?\n,-. . 4. 9:9; 3-4. 2<=-. ,-. 4. 2<=-.\nABCDE2C\n((?+ )>?+,- *0/+23- FEÿHCCI ?0/+23- (0*1+2 )>(01+ O?+23- )>0/+2\n+23-4. + N1+,-. + )0)> //0(@\n,-. . 4. (ÿJDKÿ( 4. 2<=-. ,-. 4. 2<=-.\nL(M\nABCDE2C\n@N+, ))?+,- *0/+23- FEÿHCCI *0)+23- (0N)+2 )>101+ O/+23- ))0O+2\n+23-4. + N)+,-. + )0(> >@0@(\n-. . 4. (ÿJDKÿ) 4. 2<=-. ,-. 4. 2<=-.\nL(M \x06\x07\x08\t\n\x0b\tÿ\x0c\x08\t\x05\r\x0b\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n$\x1aÿ\x11\x1b\r\x0f\x11\x14\t\n\x04\x0b\n\x06\x0c \x06\x0c\n\x02\x03\x04\x05 \x1d\t\x0f\x11\x08\t\n\t\x07\n\x16\t\x19\t\x0f\rÿ\x04\x1a \x0b\x1b\x0b\x10\t\x0f\r\t\x07 \x0b\x1b\x0b\x10\t\x0f\r\t\x07 $\x1aÿ\x18\t\x0b%\n\x06\x07\x08\t\n\x0b\t \x16\r\x03\n\rÿ\x07\x03\r\t \'\x1d\t\x0b\x11\x19\x08\t\x07 \x1d\t\x0b\x11\x19\x1b\r\x04\x11\x05\n\x06\x0cÿ\x04\x0b \r\x11ÿ\x1c\t \r\x11ÿ\x1c\t \x0b\x10\t\x0f\x04\x1a\x18 &\x1b\r\x0f\x11\x14\t\nÿ\x01 \x0c\x08\t\x05\r \x12\x07\x07\x17\x14\x11\x05\x17 (\x04\r) \x07\x03\r\tÿ\x12\x07\x07\x17\n\x04\x05\r\t\n\x14\x04\r\r\t\x05 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0f\x03\x1b\x0b\t\x07ÿ\x1c\x18 \x0b\r\x1b\x07\x18 \x11\x1aÿ\x06\x0c\n\x0e\t\x0b\x0f\n\x04\x10\r\x04\x11 \x18\x18\x18\x18\x15 \x16\t*\x1b\t\x19\x03\t+ \x14\x11\x05\x17\x18\x18\x18\x18\x15\n\r \x1d\x0c\x1e\x1f !"! \x0b\r\x1b\x07\x18 \x0f\x11\x05\x07\x1b\x0f\r\n\x05ÿ\x12\x13\t\n\x14\x15 \x16\x10\t\x0f\x04\x1a\x18\n# \x0f\x11\x05\x07\x1b\x0f\r#\n\r)\t\n\x0b\t*\x1b\t\x19\x03\t,\n/AB\n./0.123 89ÿ;.1 C?DAE?C?FG\n- > 7?@ /A > >\n4513627 <=<8 /AB\nC?@AHE?F \x00\x01\x02\x03\x04\x05\x03ÿ\x07\x02\x03\x08\tÿ\n\x03\t\x0b\x0c\r\x05\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x00\x07ÿ\x0c\x08\x0c\t\x0c\x0b\rÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x10\x11\x12\x13\x14ÿ\x16\n\x00\x07ÿ\x17\x18\x05\tÿ\x03\x19\t\x04\x03\x17\x03ÿ\x05\x03\x02\x03\x04\x0c\t\x0eÿ\x0f\x04\x0b\x01\x03 \x1a\x04\x0b\x01\x03ÿ\x1b\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ\x1c\x03\x1d\x0b\x17\x03ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ\x18\x04ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ ÿ\x0c!ÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n$\x01\x01 \x17\x18\x08 \x0e\x0e\x0e\x0e%\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\x1f\x0c\x0f\x1f\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03 \'\n\n\x0b\t\x03ÿ\x03\x02\x03\x08\tÿ#\x03\x1d\x0b\x17\x03ÿ\r\x03\x05\x05\x03\x04ÿ\t\x1f\x0b\x08ÿ\x1a\x04\x0b\x01\x03ÿ\x1eÿ ÿ&\x18\tÿ\x0b""\r\x0c\x1d\x0b#\r\x03\n\x00\x1d\t\x0c\x18\x08ÿ\t\x0b(\x03\x08ÿ)\x0c\t\x1fÿ*\x07\x1a&+,-, ./0ÿ122345\x1263\x14\n\n\x18\x03\x05ÿ\t\x1f\x0c\x05ÿ\x00\x07ÿ78\x0b\r\x0c!\x0eÿ\x0b\x05ÿ9\x03\x04\x0c\x188\x05: ;\x14<\n=\x05ÿ\t\x1f\x0c\x05ÿ\x0b\x08ÿ\x00\x07ÿ\x18!ÿ9"\x03\x1d\x0c\x0b\rÿ\x0c\x08\t\x03\x04\x03\x05\tÿ$\x00\x079=%: ./\n9\x03\x04\x0c\x188\x08\x03\x05\x05ÿ>\x04\x0c\t\x03\x04\x0c\x0b\n=\tÿ\x04\x03\x058\r\t\x03\x01ÿ\x0c\x08ÿ\x01\x03\x0b\t\x1f ./\n=\tÿ)\x0b\x05ÿ\r\x0c!\x03 \t\x1f\x04\x03\x0b\t\x03\x08\x0c\x08\x0f ./\n=\tÿ\x04\x0378\x0c\x04\x03\x01ÿ\x18\x04ÿ"\x04\x18\r\x18\x08\x0f\x03\x01ÿ\x0c\x08"\x0b\t\x0c\x03\x08\tÿ\x1f\x18\x05"\x0c\t\x0b\r\x0c?\x0b\t\x0c\x18\x08 @\x03\x05\nA\x03\x04\x05\x0c\x05\t\x03\x08\tÿ\x18\x04ÿ\x05\x0c\x0f\x08\x0c!\x0c\x1d\x0b\x08\tÿ\x01\x0c\x05\x0b#\x0c\r\x0c\t\x0eÿBÿ\x0c\x08\x1d\x0b"\x0b\x1d\x0c\t\x0e ./\n=\tÿ\x0c\x05ÿ\x0bÿ\x1d\x18\x08\x0f\x03\x08\x0c\t\x0b\rÿ\x0b\x08\x18\x17\x0b\r\x0eB#\x0c\x04\t\x1fÿ\x01\x03!\x03\x1d\tÿ\x0c\x08ÿ\x18!!\x05"\x04\x0c\x08\x0fÿ\x18!\n./\n\x05\t8\x01\x0eÿ\x058#C\x03\x1d\t\nD\t\x1f\x03\x04ÿ\x17\x03\x01\x0c\x1d\x0b\r\r\x0eÿ\x05\x03\x04\x0c\x188\x05ÿ\x0c\x17"\x18\x04\t\x0b\x08\tÿ\x03\x02\x03\x08\t ./ \x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\r\x0e\x08\x0b\x00\x0f\n\x08\x0bÿ\x10\x05\x11\x12\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x08\t\n\x01\x02\x06\x01ÿ\x0b\n\x01\x0c\rÿ\x14\x01\x06\x15\x02\x03\x16\r\x03\x04\x0cÿ\x17\x18\x01\x02\x11\x19 \x13\n\x00\r$\x02\rÿ\x14$\r\x01 \x1a\x1b\x1c\x1a\x1d\x1e\x1f !\x1d\x1f"\x1e#\n\x14$\r\x01ÿ\x01\n\x01\x0c\rÿ\x12\x01\x15$\x11\x01ÿ\x06\x01\x02\x03\x04\x05\x06ÿ\x17\t\t+\x11\x04\x0c+,,,,\x19 %&ÿ(\x1a\x1dÿ)*)%\n-\r.\x01\x02ÿ\x06\x05\x06\x16\x01\x15\r\x01\tÿ\x15$\x05\x06\x01\x06 %&ÿ(\x1a\x1dÿ)*)%\n/\x08\x18\x0f-\x10\x080\x0bÿ1-/ÿ2\x083\x00\x080\x0f\x184ÿ\x08\x00\x00\x0b\x00\x005\x0b\x10\x18\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ/$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ2$\x05\x06$7\x03\r,ÿ\r\x04\n/\x0b8\x109:;:\n!"\x1e\x1a<ÿ\x1c\x1f=(\x1a(ÿ\x1f<\x1aÿ\x1c \x1f<>?>\x1a@\n\x00\x16\x01\x15\x036,ÿ\r.\x01ÿ\x02$\r\x03\x04\x0c$7\x01ÿ6\x04\x02ÿ\x15$\x05\x06$7\x03\r,ÿ\r\x04ÿ\x06\r\x05\t,\n\x15\x04\x0c\t\x05\x15\r\n>\x1bÿ"\x1e\x1aÿ\x1aB\x1a\x1b>\x1bCÿ !\x1c\x1f  #ÿ@>(!<>\x1a\x1b"\x1a@ÿ\x1f\x1b@ÿ=\x1b("\x1a\x1f@#ÿ>\x1bÿC\x1f>"DÿE<>">\x1bCÿ>(\n\x1c!\x1b(\x1d>\x1c=!=(Dÿ>\x1c\x1aÿ"\x1a("ÿ&ÿ\x1d!>\x1b"(Fÿ>\x1c\x1f\x1b(ÿ)\n\x00\x08\x0b\x0e\x08\x0b\x00\x0fÿ\x10\x08//\x08\x18\x0fA\x0b']
apiLogger::2021-10-07 06:40:10,816::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 06:40:10,816::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 07:07:18,774::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 07:07:18,778::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 07:07:18,778::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo2r0p9n8 
apiLogger::2021-10-07 07:07:18,779::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 07:07:18,779::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 07:07:18,852::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 07:07:18,852::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo2r0p9n8
apiLogger::2021-10-07 07:07:20,893::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 07:07:20,893::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 07:07:20,893::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 07:07:20,893::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 07:07:20,897::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 07:07:20,897::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 07:07:20,897::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 07:07:20,897::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 07:07:20,897::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-07 07:07:20,897::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 07:07:20,897::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 07:07:20,897::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 07:07:20,897::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 07:07:20,897::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 07:07:35,202::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 07:07:35,202::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 07:11:18,674::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 07:11:18,680::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 07:11:18,681::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3gh8488_ 
apiLogger::2021-10-07 07:11:18,681::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 07:11:18,681::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 07:11:18,792::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 07:11:18,792::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3gh8488_
apiLogger::2021-10-07 07:11:20,411::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 07:11:20,412::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 07:11:20,412::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 07:11:20,412::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 07:11:20,415::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 07:11:20,415::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 07:11:20,415::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 07:11:20,415::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 07:11:20,418::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 07:11:20,418::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 07:11:20,418::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 07:11:20,418::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 07:11:20,421::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 07:11:20,421::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 07:11:20,421::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 07:11:20,421::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-07 07:11:20,421::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-07 07:11:20,421::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 07:11:20,421::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 07:11:20,421::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 07:11:20,421::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 07:11:20,421::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 07:11:34,513::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 07:11:34,513::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 09:27:18,715::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 09:27:18,720::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 09:27:18,721::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0ce9487c 
apiLogger::2021-10-07 09:27:18,721::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 09:27:18,721::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 09:27:18,812::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 09:27:18,812::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0ce9487c
apiLogger::2021-10-07 09:27:20,668::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 09:27:20,668::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 09:27:20,668::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 09:27:20,668::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 09:27:20,671::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 09:27:20,672::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 09:27:20,672::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 09:27:20,672::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 09:27:20,675::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 09:27:20,675::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 09:27:20,675::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 09:27:20,675::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 09:27:20,675::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-07 09:27:20,675::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 09:27:20,675::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 09:27:20,675::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 09:27:20,675::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 09:27:20,675::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fea02f016d8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 09:27:34,772::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 09:27:34,772::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 10:15:43,113::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 10:15:43,114::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 10:15:43,114::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqmftapci 
apiLogger::2021-10-07 10:15:43,114::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 10:15:43,115::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 10:15:43,120::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 10:15:43,120::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqmftapci
apiLogger::2021-10-07 10:15:43,131::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 10:15:43,131::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 10:15:43,131::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 10:15:43,131::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 10:15:43,134::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 10:15:43,135::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 10:15:43,135::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 10:15:43,135::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 07-Oct-2021 10:14:33 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : report\n ']
apiLogger::2021-10-07 10:15:43,135::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 10:15:43,135::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 11:22:46,692::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 11:22:46,743::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 11:22:46,743::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxfgj94ix 
apiLogger::2021-10-07 11:22:48,094::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 11:22:48,094::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 11:22:49,327::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 11:22:49,327::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxfgj94ix
apiLogger::2021-10-07 11:22:54,000::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 11:22:54,000::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 11:22:54,000::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 11:22:54,000::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 11:22:54,008::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 11:22:54,008::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 11:22:54,008::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 11:22:54,008::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 11:22:54,012::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 11:22:54,012::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 11:22:54,012::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 11:22:54,012::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 11:22:54,015::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 11:22:54,015::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 11:22:54,015::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 11:22:54,015::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-07 11:22:54,015::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n1 AUGMENTIN Adverse Event - - 1000 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n2 CIPRINOL Adverse Event - - 0.4 g - BID\nINFECTION_25 JAN\n2021\n1_HYPERTENSION_\n3 COVALSACOR Medical History - - 160+12.5 mg - QD\nUNK\nHYPERURICEMIA\n4 MILURIT Prophylaxis - - 100 mg - QD\nPROPHYLAXIS\n2_OSTEOARTHRITI\n5 DORETA Medical History - - 75 mg - QD\nS_UNK\nPremedication for\n6 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n7 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n8 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n9 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n10 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n11 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n25 JAN 09 FEB\nTID - Oral - unchecked unchecked\n2021 2021\n25 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nUN UNK\nQD - Oral - unchecked - checked\n2010\nUN UNK\nQD - Oral - unchecked - checked\n2017\nUN UNK\nQD - Oral - unchecked - checked\n2018\n04 NOV 04 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n05 NOV 05 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n16 NOV 16 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n17 NOV 17 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n23 NOV 23 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 NOV 30 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n12 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n13 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n14 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n15 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n16 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n17 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n18 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n1_RESPIRATORY\nFRAXIPARINE TRACT\n19 Adverse Event - - 0.8 mL - QD\nMULTI INFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n20 CLEMASTIN Adverse Event - - 1 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n21 TRIMESOLPHAR Adverse Event - - 1920 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n22 VORYCONAZOOL Adverse Event - - 200 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n23 MORFINA Adverse Event - - 5 mg - PRN\nINFECTION_25 JAN\n2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n07 DEC 07 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n14 DEC 14 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n21 DEC 21 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n28 DEC 28 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n04 JAN 04 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n11 JAN 11 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n18 JAN 18 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\nSubcutaneo 25 JAN 09 FEB\nQD - - unchecked unchecked\nus 2021 2021\n25 JAN 09 FEB\nQD - Oral - unchecked unchecked\n2021 2021\n05 FEB 09 FEB\nTID - Intravenous - unchecked unchecked\n2021 2021\n30 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nSubcutaneo 08 FEB 09 FEB\nPRN - - unchecked unchecked\nus 2021 2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n24 ATROVENT Adverse Event - - 40 Drop - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n25 PULMICORT Adverse Event - - 1 g - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n26 VENTOLIN Adverse Event - - 2.5 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n27 FUROSEMID Adverse Event - - 20 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n28 HEVIRAN Adverse Event - - 400 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n29 BISEPTOL Adverse Event - - 1920 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n30 BUDEZONID Adverse Event - - 0.5 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n31 METOCARD Adverse Event - - 25 mg - Unknown\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n32 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n33 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n34 NEOPARIN Adverse Event - - 40 mg - QD\nINFECTION_25 JAN\n2021']
apiLogger::2021-10-07 11:22:54,015::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 11:22:54,015::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 11:22:54,015::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 11:22:54,015::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 11:22:54,015::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa30ad5d048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 11:23:21,439::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 11:23:21,440::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:25:18,736::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:25:18,744::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:25:18,747::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu0q38kje 
apiLogger::2021-10-07 13:25:18,748::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:25:18,748::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:25:19,049::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:25:19,049::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu0q38kje
apiLogger::2021-10-07 13:25:22,199::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:25:22,200::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:25:22,200::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:25:22,200::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:25:22,203::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 13:25:22,203::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:25:22,203::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 13:25:22,203::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 13:25:22,206::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 13:25:22,206::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 13:25:22,206::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:25:22,206::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 13:25:22,206::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 13:25:22,207::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:25:22,207::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 13:25:22,207::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:25:22,207::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:25:22,207::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:25:40,379::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:25:40,379::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:27:18,791::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:27:18,799::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:27:18,800::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbg3g1gcp 
apiLogger::2021-10-07 13:27:18,800::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:27:18,800::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:27:19,098::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:27:19,098::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbg3g1gcp
apiLogger::2021-10-07 13:27:22,188::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:27:22,188::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:27:22,188::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:27:22,188::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:27:22,191::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 13:27:22,192::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:27:22,192::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 13:27:22,192::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 13:27:22,194::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 13:27:22,194::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 13:27:22,195::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:27:22,195::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 13:27:22,195::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,005\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 13:27:22,195::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:27:22,195::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 13:27:22,195::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:27:22,195::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:27:22,195::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:27:40,349::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:27:40,349::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:29:18,768::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:29:18,774::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:29:18,774::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp66blbglj 
apiLogger::2021-10-07 13:29:18,775::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:29:18,775::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:29:18,866::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:29:18,866::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp66blbglj
apiLogger::2021-10-07 13:29:20,737::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:29:20,737::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:29:20,737::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:29:20,737::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:29:20,740::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 13:29:20,740::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:29:20,740::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 13:29:20,740::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 13:29:20,743::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 13:29:20,743::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 13:29:20,743::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:29:20,743::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 13:29:20,743::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-07 13:29:20,744::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:29:20,744::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 13:29:20,744::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:29:20,744::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:29:20,744::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:29:34,725::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:29:34,725::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:35:18,833::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:35:18,841::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:35:18,842::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpanzq4wgq 
apiLogger::2021-10-07 13:35:18,843::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:35:18,843::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:35:19,243::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:35:19,243::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpanzq4wgq
apiLogger::2021-10-07 13:35:22,332::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:35:22,333::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:35:22,333::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:35:22,333::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:35:22,336::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 13:35:22,336::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:35:22,336::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 13:35:22,336::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 13:35:22,339::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 13:35:22,339::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 13:35:22,339::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:35:22,339::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 13:35:22,339::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,006\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 13:35:22,339::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:35:22,339::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 13:35:22,339::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:35:22,339::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:35:22,340::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:35:40,603::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:35:40,603::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:37:18,694::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:37:18,702::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:37:18,703::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpefhbhub2 
apiLogger::2021-10-07 13:37:18,703::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:37:18,703::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:37:19,103::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:37:19,104::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpefhbhub2
apiLogger::2021-10-07 13:37:22,197::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:37:22,197::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:37:22,197::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:37:22,198::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:37:22,201::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 13:37:22,201::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:37:22,201::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 13:37:22,201::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 13:37:22,204::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 13:37:22,204::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 13:37:22,204::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:37:22,204::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 13:37:22,204::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,007\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 13:37:22,204::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:37:22,204::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 13:37:22,204::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:37:22,204::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:37:22,204::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:37:40,428::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:37:40,428::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 13:51:44,597::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 13:51:44,639::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 13:51:44,640::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpcpz9h1xf 
apiLogger::2021-10-07 13:51:44,642::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 13:51:44,642::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 13:51:45,830::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 13:51:45,830::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpcpz9h1xf
apiLogger::2021-10-07 13:51:50,684::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 13:51:50,684::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 13:51:50,684::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 13:51:50,684::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 13:51:50,688::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 13:51:50,688::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 13:51:50,688::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 13:51:50,688::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 13:51:50,688::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-07 13:51:50,688::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 13:51:50,688::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 13:51:50,688::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 13:51:50,688::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 13:51:50,688::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 13:52:14,787::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 13:52:14,788::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 14:09:19,149::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 14:09:19,305::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 14:09:19,305::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpza4_xne3 
apiLogger::2021-10-07 14:09:19,311::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 14:09:19,311::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 14:09:19,949::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 14:09:19,950::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpza4_xne3
apiLogger::2021-10-07 14:09:20,373::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 14:09:20,373::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 14:09:20,373::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 14:09:20,373::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 14:09:20,376::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,376::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 14:09:20,376::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 14:09:20,376::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 14:09:20,378::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,378::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 14:09:20,378::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 14:09:20,378::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 14:09:20,379::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,379::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 14:09:20,380::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 14:09:20,380::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 14:09:20,381::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,381::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 14:09:20,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 14:09:20,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 14:09:20,383::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,383::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 14:09:20,383::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 14:09:20,383::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 14:09:20,385::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,385::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 14:09:20,385::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 14:09:20,385::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 14:09:20,386::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,387::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 14:09:20,387::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 14:09:20,387::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 14:09:20,388::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,388::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 14:09:20,388::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 14:09:20,388::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 14:09:20,390::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,390::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 14:09:20,390::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 14:09:20,390::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 14:09:20,392::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:20,392::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 14:09:20,392::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 14:09:20,392::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-07 14:09:20,392::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-07 14:09:20,392::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 14:09:21,803::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 14:09:21,804::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 14:09:21,804::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_xj3w2za 
apiLogger::2021-10-07 14:09:21,805::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 14:09:21,805::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 14:09:21,810::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 14:09:21,810::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_xj3w2za
apiLogger::2021-10-07 14:09:21,828::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 14:09:21,828::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 14:09:21,828::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 14:09:21,828::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 14:09:21,831::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:09:21,831::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 14:09:21,831::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 14:09:21,831::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Priyanka Gupta-External <priyanka.gupta@regeneron.com>\nReceived Date : 07-Oct-2021 14:08:41 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11- Follow Up <<< Priyanka Gupta>\nScenario 11 Follow Up <<<07- Oct- 2021>>> \n \nThanks and Regards \nPriyanka Gupta \n ']
apiLogger::2021-10-07 14:09:21,831::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 14:09:21,831::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 14:29:18,898::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 14:29:18,899::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 14:29:18,899::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphvdxdtos 
apiLogger::2021-10-07 14:29:18,900::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 14:29:18,900::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 14:29:18,908::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 14:29:18,908::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphvdxdtos
apiLogger::2021-10-07 14:29:18,957::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 14:29:18,957::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 14:29:18,957::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 14:29:18,957::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 14:29:18,961::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:29:18,961::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 14:29:18,961::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 14:29:18,961::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 14:29:06 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Evkeeza Event - Mount Sinai Hospital\nFrom: Larry David <larry.david@regeneron.com> Sent: Friday, September 13, 2021 2:03 PM To:\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Cc: kevin.mchale@mssm.edu \nSubject: Evkeeza Event - Mount Sinai Hospital \n \nGood Afternoon, \n \nPlease see below for a note from Larry Mchale Rosenson cc’d. Reach out to him with further\nquestions. \n \n“We had a patient with a large decrease in blood pressure with the infusion. Subsequently, she\nhad a high fever. \nCan the medication be administered in quarter normal saline?” \n \nThank you, \n \nLarry David | Senior Manager, CMC Program Management REGENERON | 1 Global View, Troy NY\n12180 USA Office: +1.518.477-8789| Mobile: +1.518.249-8916\n ']
apiLogger::2021-10-07 14:29:18,961::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 14:29:18,961::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 14:33:29,756::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 14:33:29,756::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 14:33:29,757::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfw6ah067 
apiLogger::2021-10-07 14:33:29,757::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 14:33:29,757::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 14:33:29,766::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 14:33:29,766::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfw6ah067
apiLogger::2021-10-07 14:33:29,811::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 14:33:29,811::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 14:33:29,811::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 14:33:29,811::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 14:33:29,814::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 14:33:29,814::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 14:33:29,814::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 14:33:29,814::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 07-Oct-2021 14:32:09 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : RE: Evkeeza Event - Mount Sinai Hospital\nFrom: Larry David <larry.david@regeneron.com> Sent: Friday, September 13, 2021 2:03 PM To:\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Cc: kevin.mchale@mssm.edu \nSubject: Evkeeza Event - Mount Sinai Hospital \n \nGood Afternoon, \n \nPlease see below for a note from Kevin Mchale cc’d. Reach out to him with further questions. \n \n“We had a patient with a large decrease in blood pressure with the infusion. Subsequently, she\nhad a high fever. Can the medication be administered in quarter normal saline?” \n \nThank you, \n \nLarry David | Senior Manager, CMC Program Management REGENERON | 1 Global View, Troy NY\n12180 USA Office: +1.518.477-8789| Mobile: +1.518.249-8916\n ']
apiLogger::2021-10-07 14:33:29,815::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 14:33:29,815::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 15:11:19,216::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 15:11:19,225::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 15:11:19,225::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpaocp404o 
apiLogger::2021-10-07 15:11:19,226::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 15:11:19,226::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 15:11:19,627::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 15:11:19,627::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpaocp404o
apiLogger::2021-10-07 15:11:22,712::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 15:11:22,712::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 15:11:22,712::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 15:11:22,712::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 15:11:22,715::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 15:11:22,715::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 15:11:22,715::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 15:11:22,715::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 15:11:22,718::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 15:11:22,718::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 15:11:22,718::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 15:11:22,718::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-07 15:11:22,718::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,007\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-07 15:11:22,719::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 15:11:22,719::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 15:11:22,719::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 15:11:22,719::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 15:11:22,719::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 15:11:40,985::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 15:11:40,985::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 17:37:18,891::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 17:37:18,912::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 17:37:18,912::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqsr2coeg 
apiLogger::2021-10-07 17:37:18,914::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 17:37:18,914::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 17:37:19,120::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 17:37:19,120::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqsr2coeg
apiLogger::2021-10-07 17:37:21,948::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 17:37:21,948::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 17:37:21,948::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 17:37:21,948::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 17:37:21,952::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 17:37:21,952::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 17:37:21,952::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 17:37:21,952::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 17:37:21,952::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-07 17:37:21,952::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 17:37:21,952::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 17:37:21,952::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 17:37:21,952::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 17:37:21,952::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 17:37:40,362::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 17:37:40,363::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 18:33:18,810::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 18:33:18,828::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 18:33:18,829::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph5hsr3go 
apiLogger::2021-10-07 18:33:18,830::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 18:33:18,830::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 18:33:18,980::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 18:33:18,980::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph5hsr3go
apiLogger::2021-10-07 18:33:20,649::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 18:33:20,649::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 18:33:20,649::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 18:33:20,649::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 18:33:20,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,653::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 18:33:20,653::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 18:33:20,653::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 18:33:20,656::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,656::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 18:33:20,656::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 18:33:20,656::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 18:33:20,660::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,660::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 18:33:20,660::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 18:33:20,660::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 18:33:20,663::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,663::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 18:33:20,663::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 18:33:20,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 18:33:20,665::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,666::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 18:33:20,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 18:33:20,666::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 18:33:20,669::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,669::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 18:33:20,669::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 18:33:20,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 18:33:20,672::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:20,672::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 18:33:20,672::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 18:33:20,672::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-07 18:33:20,672::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 18:33:20,672::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 18:33:21,135::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 18:33:21,135::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 18:33:21,136::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzy7ppcg_ 
apiLogger::2021-10-07 18:33:21,136::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 18:33:21,136::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 18:33:21,141::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 18:33:21,141::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzy7ppcg_
apiLogger::2021-10-07 18:33:21,157::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 18:33:21,157::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 18:33:21,157::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 18:33:21,157::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 18:33:21,160::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:33:21,160::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 18:33:21,160::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 18:33:21,160::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Yuvraj Singh-External <yuvraj.singh@regeneron.com>\nReceived Date : 07-Oct-2021 18:31:26 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Sc13 YS\nYS \n \nKind regards, \nYuvraj Singh \n \n \n ']
apiLogger::2021-10-07 18:33:21,160::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 18:33:21,160::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 18:43:18,821::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 18:43:18,842::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 18:43:18,842::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpy5y57fv_ 
apiLogger::2021-10-07 18:43:18,844::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 18:43:18,844::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 18:43:19,739::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 18:43:19,740::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpy5y57fv_
apiLogger::2021-10-07 18:43:21,918::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 18:43:21,918::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 18:43:21,918::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 18:43:21,919::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 18:43:21,922::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:43:21,922::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 18:43:21,922::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 18:43:21,922::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 18:43:21,925::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:43:21,925::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 18:43:21,925::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 18:43:21,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 18:43:21,928::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:43:21,928::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 18:43:21,928::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 18:43:21,928::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 18:43:21,931::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 18:43:21,931::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 18:43:21,931::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 18:43:21,931::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 3
apiLogger::2021-10-07 18:43:21,931::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036012-Sir Charles Gairdner Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 36,012\nPatient ID 36,012,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1956\nAge 64\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 06 NOV 2020\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 19 OCT 2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? No\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 19 OCT 2020 Original\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 08 JUN 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nMedical 1_OSTEOPOROSIS_U Subcuta\n1 DENOSUMAB History N UNK 2012 UN/UNK/2012 Yes 60 mg Other 6 MONTHLY neous\nAdverse 4_LEFT ARM PAIN_25 18 FEB\n2 TRAMADOL Event JAN 2021 09 FEB 2021 No 2021 50 mg PRN Oral\nAdverse 4_LEFT ARM PAIN_25 13 MAY\n3 PREGABALIN Event JAN 2021 18 FEB 2021 No 2021 5 mg BID Oral\n6_LEFT ARM\nMedical LYMPHEDEMA_23 JUL 22 FEB\n4 APIXABAN History 2020 09 FEB 2021 No 2021 5 mg BID Oral\n5_DEEP VEIN\nAdverse THROMBOSIS_09 FEB\n5 CLEXANE Event 2021 09 FEB 2021 Yes 60 mg BID Oral\nAdverse 10_HYPOTHYROIDIS\n6 THYROXINE Event M_17 MAY 2021 17 MAY 2021 Yes 50 mcg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n7 PREGABALIN Event JAN 2021 13 MAY 2021 Yes 300 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25 08 JUN\n8 PREGABALIN Event JAN 2021 13 MAY 2021 No 2021 75 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n9 PREGABALIN Event JAN 2021 09 JUN 2021 Yes 150 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n10 ENDONE Event JAN 2021 09 FEB 2021 Yes 10 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDOPPLER\n1 ULTRASOUND Adverse Event 22 FEB 2021\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-07 18:43:21,932::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 18:43:21,932::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 18:43:21,932::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 18:43:21,932::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 18:43:21,932::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 18:43:43,346::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 18:43:43,346::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 18:49:18,975::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 18:49:18,996::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 18:49:18,996::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm5cb5yv1 
apiLogger::2021-10-07 18:49:18,997::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 18:49:18,997::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 18:49:19,885::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 18:49:19,885::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm5cb5yv1
apiLogger::2021-10-07 18:49:22,063::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 18:49:22,063::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 18:49:22,063::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 18:49:22,063::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 18:49:22,066::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:49:22,067::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 18:49:22,067::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 18:49:22,067::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 18:49:22,070::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:49:22,070::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 18:49:22,070::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 18:49:22,070::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 18:49:22,073::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 18:49:22,073::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 18:49:22,073::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 18:49:22,073::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 18:49:22,076::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-07 18:49:22,076::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 18:49:22,076::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 18:49:22,076::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 3
apiLogger::2021-10-07 18:49:22,076::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036012-Sir Charles Gairdner Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 36,012\nPatient ID 36,012,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1956\nAge 64\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 06 NOV 2020\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 19 OCT 2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? No\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 19 OCT 2020 Original\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 08 JUN 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nMedical 1_OSTEOPOROSIS_U Subcuta\n1 DENOSUMAB History N UNK 2012 UN/UNK/2012 Yes 60 mg Other 6 MONTHLY neous\nAdverse 4_LEFT ARM PAIN_25 18 FEB\n2 TRAMADOL Event JAN 2021 09 FEB 2021 No 2021 50 mg PRN Oral\nAdverse 4_LEFT ARM PAIN_25 13 MAY\n3 PREGABALIN Event JAN 2021 18 FEB 2021 No 2021 5 mg BID Oral\n6_LEFT ARM\nMedical LYMPHEDEMA_23 JUL 22 FEB\n4 APIXABAN History 2020 09 FEB 2021 No 2021 5 mg BID Oral\n5_DEEP VEIN\nAdverse THROMBOSIS_09 FEB\n5 CLEXANE Event 2021 09 FEB 2021 Yes 60 mg BID Oral\nAdverse 10_HYPOTHYROIDIS\n6 THYROXINE Event M_17 MAY 2021 17 MAY 2021 Yes 50 mcg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n7 PREGABALIN Event JAN 2021 13 MAY 2021 Yes 300 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25 08 JUN\n8 PREGABALIN Event JAN 2021 13 MAY 2021 No 2021 75 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n9 PREGABALIN Event JAN 2021 09 JUN 2021 Yes 150 mg QD Oral\nAdverse 4_LEFT ARM PAIN_25\n10 ENDONE Event JAN 2021 09 FEB 2021 Yes 10 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDOPPLER\n1 ULTRASOUND Adverse Event 22 FEB 2021\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-07 18:49:22,076::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 18:49:22,076::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-07 18:49:22,076::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 18:49:22,076::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 18:49:22,076::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 18:49:43,337::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 18:49:43,337::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 19:03:19,179::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 19:03:19,331::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 19:03:19,332::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn75uoao_ 
apiLogger::2021-10-07 19:03:19,338::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 19:03:19,338::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 19:03:19,980::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 19:03:19,980::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn75uoao_
apiLogger::2021-10-07 19:03:20,405::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 19:03:20,405::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 19:03:20,405::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 19:03:20,405::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 19:03:20,408::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,408::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 19:03:20,408::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 19:03:20,408::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-07 19:03:20,410::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,410::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-07 19:03:20,410::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-07 19:03:20,410::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-07 19:03:20,412::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,412::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-07 19:03:20,412::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-07 19:03:20,412::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-07 19:03:20,414::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,414::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-07 19:03:20,414::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-07 19:03:20,414::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-07 19:03:20,416::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,416::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-07 19:03:20,416::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-07 19:03:20,416::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-07 19:03:20,418::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,418::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-07 19:03:20,418::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-07 19:03:20,418::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-07 19:03:20,420::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,420::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-07 19:03:20,420::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-07 19:03:20,420::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-07 19:03:20,422::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,422::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-07 19:03:20,422::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-07 19:03:20,422::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-07 19:03:20,424::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,424::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-07 19:03:20,424::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-07 19:03:20,424::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-07 19:03:20,426::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:20,426::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-07 19:03:20,426::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-07 19:03:20,426::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-07 19:03:20,426::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-07 19:03:20,426::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 19:03:21,903::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 19:03:21,904::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 19:03:21,904::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6mj68m8a 
apiLogger::2021-10-07 19:03:21,904::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 19:03:21,904::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 19:03:21,909::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 19:03:21,909::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6mj68m8a
apiLogger::2021-10-07 19:03:21,924::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 19:03:21,924::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 19:03:21,924::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 19:03:21,924::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 19:03:21,928::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-07 19:03:21,928::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 19:03:21,928::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-07 19:03:21,928::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Yuvraj Singh-External <yuvraj.singh@regeneron.com>\nReceived Date : 07-Oct-2021 19:02:25 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : y\nys \n \nKind regards, \nYuvraj Singh \n \n \n ']
apiLogger::2021-10-07 19:03:21,928::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-07 19:03:21,928::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 20:27:18,769::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 20:27:18,775::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 20:27:18,776::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgmwq86f4 
apiLogger::2021-10-07 20:27:18,776::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 20:27:18,776::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 20:27:18,870::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 20:27:18,870::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgmwq86f4
apiLogger::2021-10-07 20:27:21,197::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 20:27:21,198::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 20:27:21,198::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 20:27:21,198::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 20:27:21,201::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-07 20:27:21,201::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 20:27:21,201::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 20:27:21,202::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 20:27:21,202::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-07 20:27:21,202::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 20:27:21,202::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-07 20:27:21,202::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 20:27:21,202::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 20:27:21,202::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 20:27:31,649::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 20:27:31,649::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 21:29:19,768::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 21:29:19,786::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 21:29:19,787::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8zhfchmy 
apiLogger::2021-10-07 21:29:19,788::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 21:29:19,788::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 21:29:20,093::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 21:29:20,094::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8zhfchmy
apiLogger::2021-10-07 21:29:23,520::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 21:29:23,520::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 21:29:23,520::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 21:29:23,520::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 21:29:23,524::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-07 21:29:23,524::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 21:29:23,524::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 21:29:23,524::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 21:29:23,524::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-07 21:29:23,524::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 21:29:23,525::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-07 21:29:23,525::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 21:29:23,525::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 21:29:23,525::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 21:29:45,303::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 21:29:45,303::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-07 22:03:18,845::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-07 22:03:18,874::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-07 22:03:18,874::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpaxf9qr0x 
apiLogger::2021-10-07 22:03:18,876::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-07 22:03:18,876::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-07 22:03:19,249::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-07 22:03:19,249::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpaxf9qr0x
apiLogger::2021-10-07 22:03:22,591::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-07 22:03:22,592::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-07 22:03:22,592::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-07 22:03:22,592::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-07 22:03:22,595::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-07 22:03:22,595::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-07 22:03:22,595::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-07 22:03:22,596::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-07 22:03:22,596::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-07 22:03:22,596::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-07 22:03:22,596::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-07 22:03:22,596::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-07 22:03:22,596::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-07 22:03:22,596::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-07 22:03:41,684::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-07 22:03:41,684::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 00:11:18,943::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 00:11:18,953::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 00:11:18,953::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpeaei1h9t 
apiLogger::2021-10-08 00:11:18,954::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 00:11:18,954::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 00:11:19,454::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 00:11:19,454::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpeaei1h9t
apiLogger::2021-10-08 00:11:22,546::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 00:11:22,546::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 00:11:22,546::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 00:11:22,547::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 00:11:22,550::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 00:11:22,550::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 00:11:22,550::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 00:11:22,550::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 00:11:22,553::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 00:11:22,553::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 00:11:22,553::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 00:11:22,554::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 00:11:22,554::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,009\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-08 00:11:22,554::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 00:11:22,554::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 00:11:22,554::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 00:11:22,554::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 00:11:22,554::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 00:11:40,834::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 00:11:40,834::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 00:13:19,734::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 00:13:19,743::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 00:13:19,744::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgvycx4q8 
apiLogger::2021-10-08 00:13:19,744::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 00:13:19,744::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 00:13:20,245::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 00:13:20,245::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgvycx4q8
apiLogger::2021-10-08 00:13:23,342::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 00:13:23,342::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 00:13:23,342::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 00:13:23,342::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 00:13:23,346::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 00:13:23,346::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 00:13:23,346::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 00:13:23,346::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 00:13:23,349::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 00:13:23,349::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 00:13:23,349::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 00:13:23,349::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 00:13:23,349::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-08 00:13:23,349::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 00:13:23,349::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 00:13:23,349::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 00:13:23,349::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 00:13:23,349::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 00:13:41,837::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 00:13:41,837::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 00:59:36,453::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 00:59:36,455::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 00:59:36,455::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzlrpc8m8 
apiLogger::2021-10-08 00:59:36,455::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 00:59:36,455::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 00:59:36,486::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 00:59:36,486::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzlrpc8m8
apiLogger::2021-10-08 00:59:36,825::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 00:59:36,825::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 00:59:36,825::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 00:59:36,825::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 00:59:36,828::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-08 00:59:36,828::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 00:59:36,828::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 00:59:36,828::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 00:59:36,828::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-08 00:59:36,828::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 00:59:36,829::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-08 00:59:36,829::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 00:59:36,829::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 00:59:36,829::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 00:59:37,780::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 00:59:37,780::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 00:59:38,042::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 00:59:38,043::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 00:59:38,043::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_sxaiaco 
apiLogger::2021-10-08 00:59:38,044::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 00:59:38,044::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 00:59:38,049::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 00:59:38,049::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_sxaiaco
apiLogger::2021-10-08 00:59:38,074::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 00:59:38,075::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 00:59:38,075::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 00:59:38,075::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 00:59:38,079::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 00:59:38,079::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 00:59:38,079::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 00:59:38,079::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 08-Oct-2021 00:57:26 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 7 Justin Staley\nScenario 7 07Oct2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-08 00:59:38,079::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 00:59:38,079::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 01:15:46,492::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 01:15:46,494::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 01:15:46,494::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdh2by64a 
apiLogger::2021-10-08 01:15:46,494::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 01:15:46,494::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 01:15:46,525::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 01:15:46,525::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdh2by64a
apiLogger::2021-10-08 01:15:46,931::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 01:15:46,931::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 01:15:46,931::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 01:15:46,931::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 01:15:46,934::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-08 01:15:46,934::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 01:15:46,934::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 01:15:46,934::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 01:15:46,934::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-08 01:15:46,935::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 01:15:46,935::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-08 01:15:46,935::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 01:15:46,935::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 01:15:46,935::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 01:15:48,019::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 01:15:48,019::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 01:15:48,285::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 01:15:48,285::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 01:15:48,286::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjspugavl 
apiLogger::2021-10-08 01:15:48,286::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 01:15:48,286::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 01:15:48,291::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 01:15:48,291::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjspugavl
apiLogger::2021-10-08 01:15:48,316::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 01:15:48,316::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 01:15:48,316::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 01:15:48,316::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 01:15:48,319::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 01:15:48,319::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 01:15:48,320::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 01:15:48,320::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 08-Oct-2021 01:14:33 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 8 Justin Staley\nScenario 8 07Oct2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-08 01:15:48,320::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 01:15:48,320::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 01:25:18,771::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 01:25:18,773::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 01:25:18,773::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpepier0zy 
apiLogger::2021-10-08 01:25:18,774::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 01:25:18,774::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 01:25:18,778::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 01:25:18,778::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpepier0zy
apiLogger::2021-10-08 01:25:19,702::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 01:25:19,702::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 01:25:19,702::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 01:25:19,702::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 01:25:19,706::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-08 01:25:19,706::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 01:25:19,706::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 01:25:19,706::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 01:25:19,706::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-08 01:25:19,707::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 01:25:19,707::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-08 01:25:19,707::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 01:25:19,707::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 01:25:19,707::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 01:25:24,901::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 01:25:24,901::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 01:25:25,184::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 01:25:25,184::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 01:25:25,185::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4l3g0cmq 
apiLogger::2021-10-08 01:25:25,185::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 01:25:25,185::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 01:25:25,190::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 01:25:25,190::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4l3g0cmq
apiLogger::2021-10-08 01:25:25,215::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 01:25:25,215::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 01:25:25,215::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 01:25:25,215::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 01:25:25,219::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 01:25:25,219::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 01:25:25,219::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 01:25:25,219::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 08-Oct-2021 01:24:42 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 9 Justin Staley\nScenario 9 07Oct2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-08 01:25:25,219::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 01:25:25,219::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 02:21:26,185::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 02:21:26,192::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 02:21:26,193::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplkoj1mmy 
apiLogger::2021-10-08 02:21:26,193::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 02:21:26,193::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 02:21:26,472::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 02:21:26,472::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplkoj1mmy
apiLogger::2021-10-08 02:21:29,327::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 02:21:29,327::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 02:21:29,327::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 02:21:29,327::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 02:21:29,331::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 02:21:29,331::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 02:21:29,331::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 02:21:29,331::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 02:21:29,334::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 02:21:29,334::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 02:21:29,334::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 02:21:29,334::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 02:21:29,334::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036019-Calvary Mater Newcastle\nEnvironment Prod\nSubject Details\nStudy Site Number 36,019\nPatient ID 36,019,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1937\nAge 83\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 8/SEP/2020\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 8/SEP/2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25/AUG/2020\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25/AUG/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nMedical 2_HYPERTENSION_UN\n1 IRBESARTAN History /UNK/2010 UN/UNK/2010 Yes 300 mg QD Oral\nMedical 2_HYPERTENSION_UN\n2 ATENOLOL History /UNK/2010 UN/UNK/2010 Yes 25 mg QD Oral\nMedical 2_HYPERTENSION_UN\n3 AMLODIPINE History /UNK/2010 UN/UNK/2010 Yes 5 mg QD Oral\nATORVASTA\n4 TIN Prophylaxis HIGH CHOLESTEROL UN/UNK/2010 Yes 20 mg QD Oral\nPANTOPRAZ Medical\n5 OLE History 8_GORD_UN/UNK/2015 UN/UNK/2015 Yes 40 mg QD Oral\nMedical 4_HYPOTHYROIDISM_ 4 DAYS A\n6 THYROXINE History UN/UNK/1999 UN/UNK/2001 Yes 75 mcg Other WEEK Oral\nMedical 4_HYPOTHYROIDISM_ 3 DAYS A\n7 THYROXINE History UN/UNK/1999 UN/UNK/2001 Yes 50 mcg Other WEEK Oral\n10_ORAL\nMedical MUCOSITIS_UN/JUL/\n9 LIGNOCAINE History 2020 11/NOV/2020 Yes 2 % QID Topical\nMedical 6_OSTEOPOROSIS_U Subcuta\n10 DENOSUMAB History N/UNK/2013 UN/MAR/2013 Yes 60 mg Other 6 MONTHLY neous\n11 FISH OIL Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 1000 mg QD Oral\n5_VITAMIN D\nHIGH DOSE Medical DEFICIENCY_UN/UNK/\n12 VITAMIN D History 2015 UN/UNK/2015 Yes 50000 IU Q4wk Oral\n13 VITAMIN E Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 500 IU QD Oral\n14 VITAMIN C Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 500 mg QD Oral\nAdverse 3_MUCOSITIS_30/\n15 LIGNOCAINE Event OCT/2020 11/NOV/2020 Yes 2 % QID Topical\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 ACTINIC KERATOSIS CHECKED CHECKED\n2 HYPERTENSION UN/UNK/2010 UNCHECKED Yes Grade 1 UNCHECKED\n3 HYPERTHYROIDISM UN/UNK/1999 UNCHECKED No UN/UNK/1999 UNCHECKED\n4 HYPOTHYROIDISM UN/UNK/1999 UNCHECKED Yes Grade 1 UNCHECKED\nVITAMIN D\n5 DEFICIENCY UN/UNK/2015 UNCHECKED Yes Grade 1 UNCHECKED\n6 OSTEOPOROSIS UN/UNK/2013 UNCHECKED Yes Grade 1 UNCHECKED\n7 CELLULITIS LEFT LEG UN/UNK/2009 UNCHECKED Yes Grade 1 UNCHECKED\n8 GORD UN/UNK/2015 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n9 LEMIA UN/UNK/2010 UNCHECKED Yes Grade 1 UNCHECKED\n10 ORAL MUCOSITIS UN/JUL/2020 UNCHECKED No 30/OCT/2020 UNCHECKED\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 11 FEB 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N3b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_08-JAN-2021']
apiLogger::2021-10-08 02:21:29,334::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 02:21:29,335::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 02:21:29,335::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 02:21:29,335::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 02:21:29,335::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 02:21:46,606::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 02:21:46,606::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 02:23:27,164::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 02:23:27,171::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 02:23:27,171::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpq9ntmu6h 
apiLogger::2021-10-08 02:23:27,172::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 02:23:27,172::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 02:23:27,450::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 02:23:27,450::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpq9ntmu6h
apiLogger::2021-10-08 02:23:30,292::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 02:23:30,293::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 02:23:30,293::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 02:23:30,293::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 02:23:30,296::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 02:23:30,296::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 02:23:30,296::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 02:23:30,297::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 02:23:30,300::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 02:23:30,300::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 02:23:30,300::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 02:23:30,300::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 02:23:30,300::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036019-Calvary Mater Newcastle\nEnvironment Prod\nSubject Details\nStudy Site Number 36,019\nPatient ID 36,019,005\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1937\nAge 83\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 8/SEP/2020\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 8/SEP/2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25/AUG/2020\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25/AUG/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nMedical 2_HYPERTENSION_UN\n1 IRBESARTAN History /UNK/2010 UN/UNK/2010 Yes 300 mg QD Oral\nMedical 2_HYPERTENSION_UN\n2 ATENOLOL History /UNK/2010 UN/UNK/2010 Yes 25 mg QD Oral\nMedical 2_HYPERTENSION_UN\n3 AMLODIPINE History /UNK/2010 UN/UNK/2010 Yes 5 mg QD Oral\nATORVASTA\n4 TIN Prophylaxis HIGH CHOLESTEROL UN/UNK/2010 Yes 20 mg QD Oral\nPANTOPRAZ Medical\n5 OLE History 8_GORD_UN/UNK/2015 UN/UNK/2015 Yes 40 mg QD Oral\nMedical 4_HYPOTHYROIDISM_ 4 DAYS A\n6 THYROXINE History UN/UNK/1999 UN/UNK/2001 Yes 75 mcg Other WEEK Oral\nMedical 4_HYPOTHYROIDISM_ 3 DAYS A\n7 THYROXINE History UN/UNK/1999 UN/UNK/2001 Yes 50 mcg Other WEEK Oral\n10_ORAL\nMedical MUCOSITIS_UN/JUL/\n9 LIGNOCAINE History 2020 11/NOV/2020 Yes 2 % QID Topical\nMedical 6_OSTEOPOROSIS_U Subcuta\n10 DENOSUMAB History N/UNK/2013 UN/MAR/2013 Yes 60 mg Other 6 MONTHLY neous\n11 FISH OIL Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 1000 mg QD Oral\n5_VITAMIN D\nHIGH DOSE Medical DEFICIENCY_UN/UNK/\n12 VITAMIN D History 2015 UN/UNK/2015 Yes 50000 IU Q4wk Oral\n13 VITAMIN E Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 500 IU QD Oral\n14 VITAMIN C Prophylaxis GENERAL HEALTH UN/UNK/2010 Yes 500 mg QD Oral\nAdverse 3_MUCOSITIS_30/\n15 LIGNOCAINE Event OCT/2020 11/NOV/2020 Yes 2 % QID Topical\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 ACTINIC KERATOSIS CHECKED CHECKED\n2 HYPERTENSION UN/UNK/2010 UNCHECKED Yes Grade 1 UNCHECKED\n3 HYPERTHYROIDISM UN/UNK/1999 UNCHECKED No UN/UNK/1999 UNCHECKED\n4 HYPOTHYROIDISM UN/UNK/1999 UNCHECKED Yes Grade 1 UNCHECKED\nVITAMIN D\n5 DEFICIENCY UN/UNK/2015 UNCHECKED Yes Grade 1 UNCHECKED\n6 OSTEOPOROSIS UN/UNK/2013 UNCHECKED Yes Grade 1 UNCHECKED\n7 CELLULITIS LEFT LEG UN/UNK/2009 UNCHECKED Yes Grade 1 UNCHECKED\n8 GORD UN/UNK/2015 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n9 LEMIA UN/UNK/2010 UNCHECKED Yes Grade 1 UNCHECKED\n10 ORAL MUCOSITIS UN/JUL/2020 UNCHECKED No 30/OCT/2020 UNCHECKED\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 11 FEB 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N3b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_08-JAN-2021']
apiLogger::2021-10-08 02:23:30,300::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 02:23:30,300::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 02:23:30,300::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 02:23:30,300::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 02:23:30,300::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 02:23:47,670::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 02:23:47,670::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 03:07:18,724::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 03:07:18,732::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 03:07:18,732::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwyfv1db_ 
apiLogger::2021-10-08 03:07:18,733::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 03:07:18,733::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 03:07:19,045::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 03:07:19,045::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwyfv1db_
apiLogger::2021-10-08 03:07:20,866::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 03:07:20,866::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 03:07:20,866::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 03:07:20,866::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 03:07:20,870::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:07:20,870::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 03:07:20,870::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 03:07:20,870::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 03:07:20,873::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:07:20,873::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 03:07:20,873::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 03:07:20,873::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 03:07:20,876::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 03:07:20,876::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 03:07:20,876::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 03:07:20,877::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-08 03:07:20,877::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 46,028\nPatient ID 46,028,005\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1964\nAge 57\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-08 03:07:20,877::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 03:07:20,877::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 03:07:20,877::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 03:07:20,877::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 03:07:20,877::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 03:07:35,491::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 03:07:35,491::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 03:09:18,788::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 03:09:18,798::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 03:09:18,798::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpg5duuw_r 
apiLogger::2021-10-08 03:09:18,799::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 03:09:18,799::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 03:09:19,226::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 03:09:19,226::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpg5duuw_r
apiLogger::2021-10-08 03:09:21,154::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 03:09:21,154::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 03:09:21,154::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 03:09:21,154::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 03:09:21,157::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:09:21,158::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 03:09:21,158::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 03:09:21,158::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 03:09:21,161::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:09:21,161::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 03:09:21,161::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 03:09:21,161::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 03:09:21,164::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 03:09:21,164::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 03:09:21,164::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 03:09:21,164::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-08 03:09:21,164::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 46,028\nPatient ID 46,028,006\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1964\nAge 57\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-08 03:09:21,164::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 03:09:21,164::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 03:09:21,164::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 03:09:21,164::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 03:09:21,164::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 03:09:36,094::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 03:09:36,094::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 03:25:32,945::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 03:25:32,956::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 03:25:32,956::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfhc7myw3 
apiLogger::2021-10-08 03:25:32,957::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 03:25:32,957::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 03:25:33,494::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 03:25:33,494::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfhc7myw3
apiLogger::2021-10-08 03:25:35,419::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 03:25:35,419::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 03:25:35,420::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 03:25:35,420::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 03:25:35,423::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:25:35,423::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 03:25:35,423::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 03:25:35,423::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 03:25:35,426::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:25:35,427::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 03:25:35,427::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 03:25:35,427::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 03:25:35,430::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 03:25:35,430::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 03:25:35,430::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 03:25:35,430::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-08 03:25:35,430::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 46,028\nPatient ID 46,028,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1964\nAge 57\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-08 03:25:35,430::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 03:25:35,430::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 03:25:35,430::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 03:25:35,430::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 03:25:35,430::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 03:25:50,677::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 03:25:50,677::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 03:25:50,761::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 03:25:50,762::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 03:25:50,763::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpe7u42z09 
apiLogger::2021-10-08 03:25:50,918::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 03:25:50,929::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 03:25:50,929::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu_vj0xzy 
apiLogger::2021-10-08 03:25:50,930::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 03:25:50,930::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 03:25:51,468::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 03:25:51,468::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu_vj0xzy
apiLogger::2021-10-08 03:25:53,396::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 03:25:53,396::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 03:25:53,396::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 03:25:53,396::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 03:25:53,400::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:25:53,400::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 03:25:53,400::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 03:25:53,400::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 03:25:53,403::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 03:25:53,403::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 03:25:53,403::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 03:25:53,403::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 03:25:53,406::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 03:25:53,406::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 03:25:53,406::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 03:25:53,406::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-08 03:25:53,406::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 46,028\nPatient ID 46,028,007\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1964\nAge 57\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-08 03:25:53,406::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 03:25:53,406::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 03:25:53,406::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 03:25:53,407::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 03:25:53,407::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 03:26:08,456::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 03:26:08,456::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 05:33:37,386::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 05:33:37,395::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 05:33:37,396::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_b0sb5c9 
apiLogger::2021-10-08 05:33:37,396::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 05:33:37,397::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 05:33:37,897::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 05:33:37,897::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_b0sb5c9
apiLogger::2021-10-08 05:33:40,988::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 05:33:40,989::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 05:33:40,989::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 05:33:40,989::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 05:33:40,992::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 05:33:40,993::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 05:33:40,993::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 05:33:40,993::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 05:33:40,996::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 05:33:40,996::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 05:33:40,996::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 05:33:40,996::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 05:33:40,996::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-08 05:33:40,996::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 05:33:40,996::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 05:33:40,996::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 05:33:40,996::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 05:33:40,996::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 05:33:59,814::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 05:33:59,814::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 05:43:18,677::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 05:43:18,683::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 05:43:18,683::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp398trkp1 
apiLogger::2021-10-08 05:43:18,683::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 05:43:18,683::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 05:43:18,781::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 05:43:18,781::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp398trkp1
apiLogger::2021-10-08 05:43:20,787::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 05:43:20,787::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 05:43:20,787::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 05:43:20,787::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 05:43:20,791::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 05:43:20,791::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 05:43:20,791::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 05:43:20,791::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 05:43:20,795::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 05:43:20,795::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 05:43:20,795::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 05:43:20,795::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 05:43:20,795::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-08 05:43:20,795::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 05:43:20,795::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 05:43:20,795::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 05:43:20,795::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 05:43:20,795::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 05:43:35,688::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 05:43:35,688::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 06:21:24,890::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 06:21:24,912::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 06:21:24,922::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwhj0eunz 
apiLogger::2021-10-08 06:21:24,923::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 06:21:24,924::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 06:21:25,131::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 06:21:25,131::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwhj0eunz
apiLogger::2021-10-08 06:21:27,941::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 06:21:27,941::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 06:21:27,941::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 06:21:27,941::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 06:21:27,945::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 06:21:27,945::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 06:21:27,945::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 06:21:27,945::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 06:21:27,945::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-08 06:21:27,946::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 06:21:27,946::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 06:21:27,946::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 06:21:27,946::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 06:21:27,946::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 06:21:46,936::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 06:21:46,936::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 06:27:25,188::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 06:27:25,209::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 06:27:25,209::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpni9ocofi 
apiLogger::2021-10-08 06:27:25,210::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 06:27:25,210::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 06:27:25,418::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 06:27:25,418::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpni9ocofi
apiLogger::2021-10-08 06:27:28,236::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 06:27:28,236::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 06:27:28,236::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 06:27:28,236::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 06:27:28,240::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 06:27:28,240::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 06:27:28,240::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 06:27:28,240::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 06:27:28,240::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-08 06:27:28,240::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 06:27:28,240::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 06:27:28,240::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 06:27:28,240::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 06:27:28,240::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fa340acb2b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 06:27:46,885::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 06:27:46,885::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 06:31:19,098::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 06:31:19,259::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 06:31:19,259::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprpmnp7hy 
apiLogger::2021-10-08 06:31:19,265::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 06:31:19,266::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 06:31:19,910::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 06:31:19,910::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprpmnp7hy
apiLogger::2021-10-08 06:31:20,340::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 06:31:20,341::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 06:31:20,341::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 06:31:20,341::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 06:31:20,343::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,343::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 06:31:20,343::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 06:31:20,343::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 06:31:20,346::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,346::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 06:31:20,346::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 06:31:20,346::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 06:31:20,348::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,348::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 06:31:20,348::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-08 06:31:20,348::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-08 06:31:20,350::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,350::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-08 06:31:20,350::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-08 06:31:20,350::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-08 06:31:20,352::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,352::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-08 06:31:20,352::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-08 06:31:20,352::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-08 06:31:20,354::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,355::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-08 06:31:20,355::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-08 06:31:20,355::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-08 06:31:20,357::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,357::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-08 06:31:20,357::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-08 06:31:20,357::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-08 06:31:20,359::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,359::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-08 06:31:20,359::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-08 06:31:20,359::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-08 06:31:20,361::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,361::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-08 06:31:20,361::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-08 06:31:20,361::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-08 06:31:20,363::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:20,363::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-08 06:31:20,363::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-08 06:31:20,363::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-08 06:31:20,363::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-08 06:31:20,363::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 06:31:22,032::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 06:31:22,032::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 06:31:22,033::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnofrt9bh 
apiLogger::2021-10-08 06:31:22,033::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 06:31:22,033::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 06:31:22,038::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 06:31:22,038::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnofrt9bh
apiLogger::2021-10-08 06:31:22,048::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 06:31:22,048::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 06:31:22,049::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 06:31:22,049::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 06:31:22,052::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:31:22,052::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 06:31:22,052::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 06:31:22,052::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 08-Oct-2021 06:30:09 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\n ']
apiLogger::2021-10-08 06:31:22,052::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 06:31:22,052::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 06:59:32,492::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 06:59:32,549::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 06:59:32,549::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0ft8nugd 
apiLogger::2021-10-08 06:59:34,037::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 06:59:34,037::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 06:59:35,266::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 06:59:35,266::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0ft8nugd
apiLogger::2021-10-08 06:59:39,908::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 06:59:39,909::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 06:59:39,909::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 06:59:39,909::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 06:59:39,916::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:59:39,916::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 06:59:39,916::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 06:59:39,916::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 06:59:39,920::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 06:59:39,920::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 06:59:39,920::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 06:59:39,920::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 06:59:39,923::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 06:59:39,923::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 06:59:39,923::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 06:59:39,923::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-08 06:59:39,923::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616004 - Knopinska Posluszny - Poland\nSite Number 1625616004\nSubject ID: 616004004\nScreening Date 05 OCT 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Original\n1 5 OCT 2020 Main consent 04 FEB 2020 05 OCT 2020\nProtocol\nR1979-ONC-1625 Original Genomics Sub-Study\n2 5 OCT 2020 04 FEB 2020 05 OCT 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n3 5 OCT 2020 Research Sub-Study 04 FEB 2020 05 OCT 2020\nProtocol\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616004004 1951 69 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERTENSION checked Ongoing Grade 1 - unchecked\n2 OSTEOARTHRITIS checked Ongoing Grade 1 - unchecked REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n1 AUGMENTIN Adverse Event - - 1000 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n2 CIPRINOL Adverse Event - - 0.4 g - BID\nINFECTION_25 JAN\n2021\n1_HYPERTENSION_\n3 COVALSACOR Medical History - - 160+12.5 mg - QD\nUNK\nHYPERURICEMIA\n4 MILURIT Prophylaxis - - 100 mg - QD\nPROPHYLAXIS\n2_OSTEOARTHRITI\n5 DORETA Medical History - - 75 mg - QD\nS_UNK\nPremedication for\n6 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n7 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n8 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n9 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n10 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n11 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n25 JAN 09 FEB\nTID - Oral - unchecked unchecked\n2021 2021\n25 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nUN UNK\nQD - Oral - unchecked - checked\n2010\nUN UNK\nQD - Oral - unchecked - checked\n2017\nUN UNK\nQD - Oral - unchecked - checked\n2018\n04 NOV 04 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n05 NOV 05 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n16 NOV 16 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n17 NOV 17 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n23 NOV 23 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 NOV 30 NOV\nQD - Intravenous - unchecked unchecked\n2020 2020 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n12 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n13 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n14 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n15 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n16 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n17 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n18 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n1_RESPIRATORY\nFRAXIPARINE TRACT\n19 Adverse Event - - 0.8 mL - QD\nMULTI INFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n20 CLEMASTIN Adverse Event - - 1 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n21 TRIMESOLPHAR Adverse Event - - 1920 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n22 VORYCONAZOOL Adverse Event - - 200 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n23 MORFINA Adverse Event - - 5 mg - PRN\nINFECTION_25 JAN\n2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n07 DEC 07 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n14 DEC 14 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n21 DEC 21 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n28 DEC 28 DEC\nQD - Intravenous - unchecked unchecked\n2020 2020\n04 JAN 04 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n11 JAN 11 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\n18 JAN 18 JAN\nQD - Intravenous - unchecked unchecked\n2021 2021\nSubcutaneo 25 JAN 09 FEB\nQD - - unchecked unchecked\nus 2021 2021\n25 JAN 09 FEB\nQD - Oral - unchecked unchecked\n2021 2021\n05 FEB 09 FEB\nTID - Intravenous - unchecked unchecked\n2021 2021\n30 JAN 09 FEB\nBID - Oral - unchecked unchecked\n2021 2021\nSubcutaneo 08 FEB 09 FEB\nPRN - - unchecked unchecked\nus 2021 2021 REG-2021-00021 GSPV RECEIPT DATE 01APR2021 JM 37 pages\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\n1_RESPIRATORY\nTRACT\n24 ATROVENT Adverse Event - - 40 Drop - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n25 PULMICORT Adverse Event - - 1 g - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n26 VENTOLIN Adverse Event - - 2.5 mg - TID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n27 FUROSEMID Adverse Event - - 20 mg - QD\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n28 HEVIRAN Adverse Event - - 400 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n29 BISEPTOL Adverse Event - - 1920 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n30 BUDEZONID Adverse Event - - 0.5 mg - BID\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n31 METOCARD Adverse Event - - 25 mg - Unknown\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n32 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n33 DEXAVEN Adverse Event - - 2 mg - Other\nINFECTION_25 JAN\n2021\n1_RESPIRATORY\nTRACT\n34 NEOPARIN Adverse Event - - 40 mg - QD\nINFECTION_25 JAN\n2021']
apiLogger::2021-10-08 06:59:39,923::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 06:59:39,923::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 06:59:39,923::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 06:59:39,923::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 06:59:39,924::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648c7320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 07:00:07,229::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 07:00:07,229::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 07:02:39,120::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 07:02:39,121::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 07:02:39,121::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppvgfz84q 
apiLogger::2021-10-08 07:02:39,122::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 07:02:39,122::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 07:02:39,151::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 07:02:39,151::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppvgfz84q
apiLogger::2021-10-08 07:02:40,016::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 07:02:40,016::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 07:02:40,016::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 07:02:40,016::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 07:02:40,019::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-08 07:02:40,019::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 07:02:40,019::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 07:02:40,019::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 07:02:40,019::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\n26(fi1rst0, l0as1t)9\xa0 KOREA, REPUBLIC OF\xa0 Day AMUonGth 1Y9e5ar5 Ye6a5rs\xa0 Male\xa0 67k.g60 2Da4y AMUonGth 2Y0e2ar0 AAPDPVREORSPER IRATEEA CTTOION\nPATIENT DIED\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas)\nINVOLVED OR\nOther Serious Criteria: Medically Significant PROLONGED INPATIENT\nPulmonary Tuberculosis [Pulmonary tuberculosis] HOSPITALISATION\nINVOLVED PERSISTENT\nOR SIGNIFICANT\nCase Description: PULMONARY TUBERCULOSIS (MedDRA Preferred Term: Pulmonary tuberculosis),  DISABILITY OR\nINCAPACITY\nMedDRA v21.0\nLIFE\nSeverity: Grade 2 THREATENING\nCausality Assessment: Pexa-Vec: Not Related; REGN2810: Not Related; Study Drug Administration \nCONGENITAL\nProcedure: Not Related ANOMALY\nOTHER\nPatient 2610019\xa0  (Continued on Additional Information Page)\xa0\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) Pexastimogene Devacirepvec (PEXASTIMOGENE DEVACIREPVEC) Intravenous infusion\xa0 ABATE AFTER STOPPING\nDRUG?\n#2 ) REGN2810 (REGN2810) Intravenous infusion\xa0  (Continued on Additional Information Page)\xa0\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 1.0^9 pfu, single\xa0 #1 ) Intratumor\xa0 YES NO NA\n#2 ) 350 milligram, single\xa0 #2 ) Intravenous\xa0\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) RCC (Renal cell carcinoma)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n#2 ) RCC (Renal cell carcinoma)\xa0\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) 15-JAN-2020 14:30:00 / 15-JAN-2020 14:35:00\xa0 #1 ) 5 min\xa0 YES NO NA\n#2 ) 22-JAN-2020 12:05:00 / 22-JAN-2020 12:35:00\xa0 #2 ) 30 min\xa0\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n#1 ) TYLENOL ER (PARACETAMOL)   ; 15-JAN-2020 / Ongoing\xa0\n#2 ) DUPHALAC EASY (LACTULOSE)   ; 03-JAN-2020 / Ongoing\xa0\n#3 ) TARGIN (NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLO\xa0\n#4 ) LYRICA (PREGABALIN)   ; 03-JAN-2020 / Ongoing\xa0\n#5 ) CELEBREX (CELECOXIB)   ; 03-JAN-2020 / Ongoing\xa0\n#6 ) MORPHINE SULFATE (MORPHINE SULFATE)   ; 06-JAN-2020 / Ongoing\xa0  (Continued on Additional Information Page)\xa0\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\n2009 to Ongoing Current Condition\xa0 Renal cell carcinoma (Renal cell carcinoma)\xa0\nClear Cell with tongue metastasis\xa0\n07-DEC-2019 to 13-DEC-2019 Historical Condition\xa0 Cholangitis (Cholangitis)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nSillaJen Biotherapeutics Medically Confirmed: Yes\nSuite 740, 475 Sansome Street\nPatient ID: 2610019\nSan Francisco, CA 94111  UNITED STATES\xa0\nStudy ID: JX594-REN026\nCenter ID: 2610\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nDr, Sun Young  Rha \nSJN-2020-000019\xa0\n \n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE KOREA, REPUBLIC OF\xa0\n15-OCT-2020\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n30-OCT-2020\xa0\nINITIAL FOLLOWUP: 1\n30-Oct-2020 19:42 Page 2 of 5\nMfr. Control Number: SJN-2020-000019\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nThis report concerns a 65-year-old Asian male who was enrolled in study JX594-REN026 entitled, “A Phase 1b Dose-escalation \nStudy of Pexa-Vec (Thymidine Kinase-Deactivated Vaccinia Virus plus GM-CSF) in Combination with REGN2810 (anti-PD-1) in \nPatients with Metastatic or Unresectable Renal Cell Carcinoma (RCC).” On 13-Jan-2020, the patient was enrolled in Part 2, Arm A.\nOncologic history included clear cell type RCC (initial diagnosis 2009) with tongue metastasis. Prior surgical intervention included \nnephrectomy (2009). He had received no previous medications or radiotherapy treatment for RCC.\nRelevant medical history included cholangitis (07-Dec-2019 – 13-Dec-2019), primary cancer pain (since Dec-2019), and constipation \n(since Dec-2019). \nThe subject’s concomitant medications included Tylenol (paracetamol) extended release (ER), Duphalac Easy (lactulose), Targin \n(naloxone hydrochloride, oxycodone hydrochloride), Lyrica (pregabalin), Celebrex (celecoxib), morphine sulfate, Hysone \n(hydrocortisone), Feroba You (ferrous sulfate), Resotran (prucalopride succinate), oxycodone, Duragesic D-trans (orphenadrine \ncitrate, paracetamol), Exoperin tablet (eperisone hydrochloride), Rhinathiol capsule (dextromethorphan hydrobromide), Erdos capsule \n(erdosteine), and surfolase capsule (ambroxol acefyllinate).   \nThe subject received Pexa-Vec 1.0E9 pfu intratumoral (IT) on 15-Jan-2020 (Day -7). \nThe subject received REGN2810 350 mg intravenous (IV) on 22 Jan 2020 (Day 1), 11-Feb-2020 (Day 22), 03-Mar-2020 (Day 43), \n24-Mar-2020 (Day 64), 14-Apr-2020 (Week 12), 07-May-2020 (Week 15), 28-May-2020 (Week 18), 18-Jun-2020 (Week 21), \n09-Jul-2020 (Week 24), 30-Jul-2020 (Week 27), and 20-Aug-2020 (Week 30). \nOn 24-Aug-2020, the subject was hospitalized due to suspicion of pneumonitis, which was later diagnosed as pulmonary \ntuberculosis. At that time, he complained of mild fever.  Vital signs and physical exam findings at admission were unknown; limited \npertinent hospital records are available as the patient was hospitalized at a hospital not affiliated with his study oncologist.  \nTreatment medications administered during the hospitalization included ceftriaxone, tabaxin injection, Paceta (paracetamol) injection, \nand morphine sulfate injection. \nOn 07-Sep-2020, the patient was discharged from the hospital.\nOn 08-Sep-2020, C-reactive protein (CRP) was 92.4 mg/L (normal range 0-8).\nOn 13-Sep-2020, the patient visited the outpatient oncology clinic and he was admitted to the hospital that day for study drug \ntreatment, which was not given. Also, he had failed to improve despite the antibiotics given during the previous hospitalization, and he \nwas still experiencing ongoing/unresolved issues; however, his symptoms had not worsened.  Vital signs were blood pressure 110/72, \nheart rate 94, respiratory rate 20 and temperature 36.7. CRP was 52.9.\nOn 14-Sep-2020, sputum Mycobacterium tuberculosis (TB) polymerase chain reaction (PCR) and Rifampin-Resistance PCR reported \nas positive (+) and CRP was 49.0. CT of chest showed an increased large right pleural effusion, obstruction of the right bronchus \nintermedius and persistent obstructive consolidation in the right middle and lower lobes.\nOn 14-Sep-2020, AFB sputum cultures (expectorated sputum) showed 3+ acid-fast bacilli (AFB).   AFB fluorescent smear was 3+.\nOn 15-Sep-2020, AFB sputum cultures showed 3+ AFB.  Mycobacteruim tuberculosis complex polymerase chain reaction (MTB PCR) \non the sputum was positive.  Rifampin resistance PCR was positive.  AFB fluorescent smear was 3+. \nOn 16-Sep-2020, AFB sputum cultures showed 3+ AFB.  AFB fluorescent smear was 2+.\n \nHe was diagnosed with tuberculosis based on the sputum tests and it was decided that the patient would end the study.  He withdrew \nhis consent to provide further information.  \nOn 18-Sep-2020, the patient started TB medications as pyrazinamide, amikacin sulfate, lapren soft capsule (clofazimine), and \nCloSErine (cycloserin), and Levoplus (lactulose).   He was transferred to the department of respiratory medicine for treatment on \n21-Sep-2020.  A thoracentesis was performed.  Pleural fluid liquid-based cytology was negative form malignancy.  MTB and RIF \nresistance PCR were negative. \nOn 22-Sep-2020 a second thoracentesis was performed.  Pleural fluid-based cytology was negative for malignancy.  AFB fluorescent \nsmear was negative.  MTB PCR was negative.  \nOn 28-Sep-2020, CRP was 15.3.\n30-Oct-2020 19:42 Page 3 of 5\nMfr. Control Number: SJN-2020-000019\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nOn 06-Oct-2020, the patient was discharged from the hospital based on AFB test results. He received negative results 3 times \nsequentially.  His symptoms were improving with the anti-tuberculosis medications. \nAt the time of this report, the event of pulmonary tuberculosis was recovering/resolving. \nAction taken with Pexa-Vec as a result of the event was reported as not applicable, and there was no action taken with REGN-2810 \nas a result of the event.  \n~\nThe investigator assessed the event of pulmonary tuberculosis as Grade 2, serious due to hospitalization and medically important \nevent, not related to Pexa-Vec, not related to REGN-2810, and not related to study drug administration procedure. The investigator \nstated that the event was related to the patient’s condition. \nThe sponsor assessed the event of pulmonary tuberculosis as not related to Pexa-Vec, not related to REGN2810, not related to study \ndrug administration procedure and considered the event to be unexpected for Pexa-Vec as per IB version 15 and unexpected for \nREGN2810 as per IB v7.\xa0\n13. Lab Data\n# Date Test / Assessment / Notes Results Normal High / Low\n1 13-SEP-2020\xa0 Blood pressure measurement 110/72 \xa0\n2 13-SEP-2020\xa0 Body temperature 36.7 \xa0\n3 08-SEP-2020\xa0 C-reactive protein 92.4 mg/L \xa0 8\n0\xa0\n4 13-SEP-2020\xa0 C-reactive protein 52.9 mg/L \xa0 8\n0\xa0\n5 28-SEP-2020\xa0 C-reactive protein 15.3 mg/L \xa0 8\n0\xa0\n6 14-SEP-2020\xa0 Computerised tomogram thorax  \xa0\nincreased large right pleural effusion, obstruction of the right bronchus intermedius and \npersistent obstructive consolidation in the right middle and lower lobes\xa0\n7 13-SEP-2020\xa0 Heart rate 94 \xa0\n8 16-SEP-2020\xa0 Mycobacterium test Positive \xa0\n3+\xa0\n9 14-SEP-2020\xa0 Mycobacterium tuberculosis   \xa0\ncomplex test\nsputum PCR +\xa0\n10 14-SEP-2020\xa0 Polymerase chain reaction  \xa0\nRifampin-Resistance +\xa0\n11 13-SEP-2020\xa0 Respiratory rate 20 \xa0\n14-19. SUSPECT DRUG(S) continued\n15. DAILY DOSE(S); 18. THERAPY DATES (from/to);\n14. SUSPECT DRUG(S) (include generic name) 16. ROUTE(S) OF ADMIN 17. INDICATION(S) FOR USE 19. THERAPY DURATION\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 11-FEB-2020 14:55:00 \n30-Oct-2020 19:42 Page 4 of 5\nMfr. Control Number: SJN-2020-000019\nADDITIONAL INFORMATION\n14-19. SUSPECT DRUG(S) continued\n15. DAILY DOSE(S); 18. THERAPY DATES (from/to);\n14. SUSPECT DRUG(S) (include generic name) 16. ROUTE(S) OF ADMIN 17. INDICATION(S) FOR USE 19. THERAPY DURATION\ninfusion; Regimen #2\xa0 Intravenous\xa0 / 11-FEB-2020 \n15:25:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 03-MAR-2020 \ninfusion; Regimen #3\xa0 Intravenous\xa0 13:25:00 / \n03-MAR-2020 \n13:55:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 24-MAR-2020 11:25:00 \ninfusion; Regimen #4\xa0 Intravenous\xa0 / 24-MAR-2020 \n11:55:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 14-APR-2020 13:25:00 \ninfusion; Regimen #5\xa0 Intravenous\xa0 / 14-APR-2020 \n13:55:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 07-MAY-2020 15:30:00 \ninfusion; Regimen #6\xa0 Intravenous\xa0 / 07-MAY-2020 \n16:00:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 28-MAY-2020 15:15:00 \ninfusion; Regimen #7\xa0 Intravenous\xa0 / 28-MAY-2020 \n15:45:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 18-JUN-2020 16:35:00 \ninfusion; Regimen #8\xa0 Intravenous\xa0 / 18-JUN-2020 \n17:05:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 09-JUL-2020 15:55:00 \ninfusion; Regimen #9\xa0 Intravenous\xa0 / 09-JUL-2020 \n16:25:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 30-JUL-2020 16:00:00 \ninfusion; Regimen #10\xa0 Intravenous\xa0 / 30-JUL-2020 \n16:30:00;\n30 min\xa0\n#2 ) REGN2810 (REGN2810) Intravenous  350 milligram, single;  RCC (Renal cell carcinoma)\xa0 20-AUG-2020 16:25:00 \ninfusion; Regimen #11\xa0 Intravenous\xa0 / 20-AUG-2020 \n16:55:00;\n30 min\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION continued\n#3 ) TARGIN (NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE)   ; 03-JAN-2020 / Ongoing\xa0\n30-Oct-2020 19:42 Page 5 of 5\nMfr. Control Number: SJN-2020-000019\nADDITIONAL INFORMATION\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION continued\n#7 ) HYSONE                             /00028601/ (HYDROCORTISONE)   ; 26-MAR-2020 / Ongoing\xa0\n#8 ) FEROBA YOU (FERROUS SULFATE)   ; 22-MAR-2020 / Ongoing\xa0\n#9 ) RESOTRAN (PRUCALOPRIDE SUCCINATE)   ; 14-APR-2020 / Ongoing\xa0\n#10 ) OXYCODONE (OXYCODONE)   ; 14-APR-2020 / Ongoing\xa0\n#11 ) DURAGESIC                          /00070401/ (ORPHENADRINE CITRATE, PARACETAMOL)   ; 2020 / Ongoing\xa0\n#12 ) EXOPERIN (EPERISONE HYDROCHLORIDE)   ; 11-FEB-2020 / Ongoing\xa0\n#13 ) RHINATHIOL                         /00048102/ (DEXTROMETHORPHAN HYDROBROMIDE)   ; 07-MAY-2020 / Ongoing\xa0\n#14 ) ERDOS (ERDOSTEINE)   ; 07-MAY-2020 / Ongoing\xa0\n#15 ) SURFOLASE (AMBROXOL ACEFYLLINATE)   ; 07-MAY-2020 / Ongoing\xa0\n23. OTHER RELEVANT HISTORY  continued\xa0\nFrom/To Dates\xa0 Type of History / Notes\xa0 Description\xa0\nDEC-2019 to Ongoing\xa0 Current Condition\xa0 Cancer pain (Cancer pain); \xa0\nDEC-2019 to Ongoing\xa0 Current Condition\xa0 Constipation (Constipation); \xa0\n2009 to 2009\xa0 Procedure\xa0 Nephrectomy (Nephrectomy); \xa0\n30-Oct-2020 19:42']
apiLogger::2021-10-08 07:02:40,019::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 07:02:40,019::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-08 07:02:40,019::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 07:02:40,020::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 07:02:40,020::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 07:03:12,318::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 07:03:12,318::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 07:23:18,746::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 07:23:18,788::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 07:23:18,788::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2n3rksg8 
apiLogger::2021-10-08 07:23:18,790::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 07:23:18,790::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 07:23:19,973::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 07:23:19,973::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2n3rksg8
apiLogger::2021-10-08 07:23:24,775::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 07:23:24,775::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 07:23:24,775::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 07:23:24,775::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 07:23:24,779::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 07:23:24,779::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 07:23:24,779::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 07:23:24,779::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 07:23:24,779::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-08 07:23:24,779::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 07:23:24,779::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 07:23:24,779::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 07:23:24,779::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 07:23:24,779::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 07:23:49,301::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 07:23:49,301::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 07:47:31,406::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 07:47:31,421::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 07:47:31,421::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpeuv7t041 
apiLogger::2021-10-08 07:47:31,422::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 07:47:31,422::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 07:47:32,711::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 07:47:32,711::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpeuv7t041
apiLogger::2021-10-08 07:47:34,021::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 07:47:34,021::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 07:47:34,021::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 07:47:34,021::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 07:47:34,025::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 07:47:34,025::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 07:47:34,025::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 07:47:34,025::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 07:47:34,028::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 07:47:34,028::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 07:47:34,028::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 07:47:34,028::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-08 07:47:34,028::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 07:47:34,028::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 07:47:34,470::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 07:47:34,470::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 07:47:34,471::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfc7_0q5f 
apiLogger::2021-10-08 07:47:34,471::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 07:47:34,471::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 07:47:34,476::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 07:47:34,477::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfc7_0q5f
apiLogger::2021-10-08 07:47:34,493::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 07:47:34,493::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 07:47:34,493::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 07:47:34,493::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 07:47:34,496::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 07:47:34,496::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 07:47:34,496::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 07:47:34,496::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh <reshabh.reshabh@rxlogix.com>\nReceived Date : 08-Oct-2021 07:45:14 +0000\nTo : "Medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> Scenario 1\nEXTERNAL MESSAGE \n \n ']
apiLogger::2021-10-08 07:47:34,496::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 07:47:34,496::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 08:49:18,780::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 08:49:18,784::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 08:49:18,784::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwbwjmkio 
apiLogger::2021-10-08 08:49:18,785::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 08:49:18,785::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 08:49:18,948::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 08:49:18,949::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwbwjmkio
apiLogger::2021-10-08 08:49:19,666::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 08:49:19,666::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 08:49:19,666::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 08:49:19,666::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 08:49:19,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 08:49:19,670::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 08:49:19,670::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 08:49:19,670::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 08:49:19,673::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 08:49:19,673::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 08:49:19,673::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 08:49:19,673::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 08:49:19,676::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 08:49:19,676::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 08:49:19,676::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-08 08:49:19,676::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-08 08:49:19,676::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 08:49:19,676::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 08:49:19,996::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 08:49:19,997::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 08:49:19,997::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj391mz1x 
apiLogger::2021-10-08 08:49:19,997::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 08:49:19,997::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 08:49:20,003::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 08:49:20,003::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj391mz1x
apiLogger::2021-10-08 08:49:20,018::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 08:49:20,018::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 08:49:20,018::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 08:49:20,018::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 08:49:20,021::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 08:49:20,021::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 08:49:20,021::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 08:49:20,021::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh <reshabh.reshabh@rxlogix.com>\nReceived Date : 08-Oct-2021 08:47:43 +0000\nTo : "Medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> Follow Up eylea\nEXTERNAL MESSAGE \n \n ']
apiLogger::2021-10-08 08:49:20,021::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 08:49:20,022::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 10:37:36,286::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 10:37:36,328::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 10:37:36,329::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqnpwk6an 
apiLogger::2021-10-08 10:37:36,330::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 10:37:36,331::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 10:37:37,510::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 10:37:37,510::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqnpwk6an
apiLogger::2021-10-08 10:37:42,227::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 10:37:42,227::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 10:37:42,227::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 10:37:42,227::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 10:37:42,230::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 10:37:42,230::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 10:37:42,230::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 10:37:42,230::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 10:37:42,230::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-08 10:37:42,231::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 10:37:42,231::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 10:37:42,231::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 10:37:42,231::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 10:37:42,231::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 10:38:06,797::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 10:38:06,797::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 10:43:36,375::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 10:43:36,385::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 10:43:36,385::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphkyk8s1o 
apiLogger::2021-10-08 10:43:36,386::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 10:43:36,386::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 10:43:36,881::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 10:43:36,882::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphkyk8s1o
apiLogger::2021-10-08 10:43:39,993::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 10:43:39,994::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 10:43:39,994::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 10:43:39,994::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 10:43:39,997::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 10:43:39,997::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 10:43:39,997::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 10:43:39,997::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 10:43:40,000::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 10:43:40,000::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 10:43:40,000::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 10:43:40,000::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 10:43:40,000::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-08 10:43:40,000::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 10:43:40,000::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 10:43:40,000::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 10:43:40,000::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 10:43:40,000::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 10:43:58,825::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 10:43:58,825::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 10:51:36,792::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 10:51:36,813::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 10:51:36,814::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpa1virsch 
apiLogger::2021-10-08 10:51:36,815::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 10:51:36,815::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 10:51:37,019::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 10:51:37,019::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpa1virsch
apiLogger::2021-10-08 10:51:39,819::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 10:51:39,820::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 10:51:39,820::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 10:51:39,820::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 10:51:39,823::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 10:51:39,823::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 10:51:39,823::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 10:51:39,823::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 10:51:39,823::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-08 10:51:39,824::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 10:51:39,824::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 10:51:39,824::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 10:51:39,824::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 10:51:39,824::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 10:51:58,836::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 10:51:58,836::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 10:52:20,840::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 10:52:20,848::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 10:52:20,852::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7l2ivm4x 
apiLogger::2021-10-08 10:52:20,852::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 10:52:20,852::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 10:52:20,949::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 10:52:20,949::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7l2ivm4x
apiLogger::2021-10-08 10:52:23,421::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 10:52:23,421::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 10:52:23,421::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 10:52:23,421::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 10:52:23,425::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 10:52:23,425::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 10:52:23,425::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 10:52:23,425::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 10:52:23,428::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-08 10:52:23,428::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 10:52:23,428::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 10:52:23,428::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 10:52:23,428::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036001-Peter Maccallum Cancer Centre (PMCC)\nEnvironment Prod\nSubject Details\nStudy Site Number 36,001\nPatient ID 36,001,006\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1946\nAge 74\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 19/MAY/2020\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 28/APR/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 28/APR/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 28/APR/2020 Amendment 1\n2 10/JUN/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCANDESART\nAN Medical 2_HYPERTENSION_UN\n1 CILEXETIL History /UNK/2008 UN/UNK/2015 Yes 4 mg QD Oral\nESOMEPRAZ Adverse 1_DYSPEPSIA_24/ 22/JUL/\n2 OLE Event MAY/2020 10/JUN/2020 No 2020 20 mg QD Oral\nVENLAFAXIN Adverse 2_DEPRESSION_24/ 16/DEC/\n3 E Event MAY/2020 26/JUN/2020 No 2020 75 mg QD Oral\nESOPRAMAZ Adverse 1_DYSPEPSIA_24/ 03/SEP/\n4 OLE Event MAY/2020 10/AUG/2020 No 2020 40 mg QD Oral\nESOMEPRAZ Adverse 1_DYSPEPSIA_24/ 16/DEC/\n5 OLE Event MAY/2020 23/SEP/2020 No 2020 40 mg QD Oral\nVENLAFAXIN Adverse 2_DEPRESSION_24/ 23/DEC/ ALTERNATE\n6 E Event MAY/2020 17/DEC/2020 No 2020 75 mg Other DAYS Oral\nESOMEPRAZ Medical 3_DYSPEPSIA_UN/ 23/DEC/\n7 OLE History UNK/2007 17/DEC/2020 No 2020 20 mg QD Oral\nAdverse 4_ATAXIA_17/FEB/\n8 ASPIRIN Event 2021 17/FEB/2021 Yes 100 mg QD Oral\nCLOPIDOGR Adverse 4_ATAXIA_17/FEB/\n9 EL Event 2021 17/FEB/2021 Yes 75 mg QD Oral\nATORVASTA Adverse 4_ATAXIA_17/FEB/\n10 TIN Event 2021 17/FEB/2021 Yes 80 mg QD Oral\nPANTOPRAZ Adverse 4_ATAXIA_17/FEB/\n11 OLE Event 2021 17/FEB/2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\n1 CT SCAN  Diagnostic 17/FEB/2021\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 MENINGIOMA UN/UNK/1999 UNCHECKED No UN/UNK/1999 UNCHECKED\n2 HYPERTENSION UN/UNK/2008 UNCHECKED Yes Grade 2 UNCHECKED\n3 DYSPEPSIA UN/UNK/2007 UNCHECKED No UN/UNK/2007 UNCHECKED\n4 DEPRESSION UN/UNK/2007 UNCHECKED No 11/DEC/2007 UNCHECKED\nOBSTRUCTIVE SLEEP\n6 APNEA 01/JAN/2007 UNCHECKED No UN/UNK/2007 UNCHECKED\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis UN MAR 2019\nStage Based on Surgical Pathology Stage IV\nT T4a\nN N1\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) CHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_19-FEB-2021']
apiLogger::2021-10-08 10:52:23,428::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 10:52:23,428::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-08 10:52:23,428::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 10:52:23,428::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 10:52:23,428::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 10:52:40,088::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 10:52:40,088::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 10:58:04,305::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 10:58:04,324::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 10:58:04,325::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5_y5msv4 
apiLogger::2021-10-08 10:58:04,325::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 10:58:04,326::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 10:58:04,741::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 10:58:04,741::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5_y5msv4
apiLogger::2021-10-08 10:58:07,189::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 10:58:07,189::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 10:58:07,189::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 10:58:07,189::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 10:58:07,193::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 10:58:07,193::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 10:58:07,193::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 10:58:07,193::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 10:58:07,196::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 10:58:07,196::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 10:58:07,196::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 10:58:07,196::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 10:58:07,196::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', ' \nProtocol: R1979-ONC-1625\nDay 0: 28-SEP-2020\nCountry: Taiwan\nSite # /Investigator: 1625158003/ Yeh, Su Peng\nSubject ID: 158003002\nStudy Drug(s): REGN1979\nEvent Term: PNEUMONIA and SUSPECTED SEPSIS\nOnset date: 26-SEP-2020\nSeverity/Grade: Grade 3 (PNEUMONIA) Grade 4 (SUSPECTED SEPSIS)\nSAE Criteria and/or AESI Criteria: Hospitalization/Yes (PNEUMONIA) Life\nthreatening, Hospitalization/Yes (SUSPECTED SEPSIS)\nInvestigator Relationship to Study Drug: Not Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00295\n \n \nKind regards,\n \nAmy\n \nAmy Amazeen\nSafety Data Coordinator I, Safety and Pharmacovigilance\nSyneos Health\n5430 Data Court, Suite 200\nMobile  +1 734 265 6653\namy.amazeen@syneoshealth.com\nsyneoshealth.com  \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:51)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:39)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85) (cid:53)(cid:20)(cid:28)(cid:26)(cid:28)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:21)(cid:24)(cid:3)\n(cid:36)(cid:49)(cid:3)(cid:50)(cid:51)(cid:40)(cid:49)(cid:16)(cid:47)(cid:36)(cid:37)(cid:40)(cid:47)(cid:3)(cid:54)(cid:55)(cid:56)(cid:39)(cid:60)(cid:3)(cid:55)(cid:50)(cid:3)(cid:36)(cid:54)(cid:54)(cid:40)(cid:54)(cid:54)(cid:3)(cid:55)(cid:43)(cid:40)(cid:3)(cid:36)(cid:49)(cid:55)(cid:44)(cid:16)(cid:55)(cid:56)(cid:48)(cid:50)(cid:53)(cid:3)(cid:36)(cid:38)(cid:55)(cid:44)(cid:57)(cid:44)(cid:55)(cid:60)(cid:3)(cid:36)(cid:49)(cid:39)\n(cid:54)(cid:36)(cid:41)(cid:40)(cid:55)(cid:60)(cid:3)(cid:50)(cid:41)(cid:3)(cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:15)(cid:3)(cid:36)(cid:49)(cid:3)(cid:36)(cid:49)(cid:55)(cid:44)(cid:16)(cid:38)(cid:39)(cid:21)(cid:19)(cid:3)(cid:59)(cid:3)(cid:36)(cid:49)(cid:55)(cid:44)(cid:16)(cid:38)(cid:39)(cid:22)(cid:3)(cid:37)(cid:44)(cid:54)(cid:51)(cid:40)(cid:38)(cid:44)(cid:41)(cid:44)(cid:38)\n(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:55)(cid:76)(cid:87)(cid:79)(cid:72)\n(cid:36)(cid:49)(cid:55)(cid:44)(cid:37)(cid:50)(cid:39)(cid:60)(cid:15)(cid:3)(cid:44)(cid:49)(cid:3)(cid:51)(cid:36)(cid:55)(cid:44)(cid:40)(cid:49)(cid:55)(cid:54)(cid:3)(cid:58)(cid:44)(cid:55)(cid:43)(cid:3)(cid:53)(cid:40)(cid:47)(cid:36)(cid:51)(cid:54)(cid:40)(cid:39)(cid:3)(cid:50)(cid:53)(cid:3)(cid:53)(cid:40)(cid:41)(cid:53)(cid:36)(cid:38)(cid:55)(cid:50)(cid:53)(cid:60)(cid:3)(cid:37)(cid:16)(cid:38)(cid:40)(cid:47)(cid:47)\n(cid:49)(cid:50)(cid:49)(cid:16)(cid:43)(cid:50)(cid:39)(cid:42)(cid:46)(cid:44)(cid:49)(cid:3)(cid:47)(cid:60)(cid:48)(cid:51)(cid:43)(cid:50)(cid:48)(cid:36)\n(cid:76)(cid:81)(cid:57)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:3)(cid:43)(cid:72)(cid:68)(cid:79)(cid:87)(cid:75)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72) (cid:20)(cid:26)(cid:53)(cid:42)(cid:51)(cid:16)(cid:19)(cid:19)(cid:19)(cid:27)\n(cid:38)(cid:82)(cid:80)(cid:83)(cid:82)(cid:88)(cid:81)(cid:71) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:39)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:76)(cid:87)(cid:72)(cid:3)(cid:49)(cid:68)(cid:80)(cid:72) (cid:20)(cid:24)(cid:27)(cid:19)(cid:19)(cid:22)(cid:3)(cid:16)(cid:3)(cid:60)(cid:72)(cid:75)(cid:3)(cid:16)(cid:3)(cid:55)(cid:68)(cid:76)(cid:90)(cid:68)(cid:81)\n(cid:54)(cid:76)(cid:87)(cid:72)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85) (cid:20)(cid:25)(cid:21)(cid:24)(cid:20)(cid:24)(cid:27)(cid:19)(cid:19)(cid:22)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:44)(cid:39)(cid:29) (cid:20)(cid:24)(cid:27)(cid:19)(cid:19)(cid:22)(cid:19)(cid:19)(cid:21)\n(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:39)(cid:68)(cid:87)(cid:72) (cid:20)(cid:27)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:55)(cid:85)(cid:68)(cid:70)(cid:78)(cid:76)(cid:81)(cid:74)\n(cid:58)(cid:72)(cid:85)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92) (cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:54)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71) (cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87) (cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)\n(cid:6) (cid:42)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:3)(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:30) (cid:79)(cid:82)(cid:70)(cid:68)(cid:79) (cid:3)(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87) (cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:44)(cid:53)(cid:37)(cid:3)(cid:36)(cid:83)(cid:83)(cid:85)(cid:82)(cid:89)(cid:68)(cid:79)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72) (cid:44)(cid:38)(cid:41) (cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87) (cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:55)(cid:92)(cid:83)(cid:72) (cid:36)(cid:83)(cid:83)(cid:85)(cid:82)(cid:89)(cid:68)(cid:79)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80) (cid:79)(cid:82)(cid:70)(cid:68)(cid:79)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)\n(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:68)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:34) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:11)(cid:47)(cid:82)(cid:70)(cid:68)(cid:79)(cid:12)(cid:3) (cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:40)(cid:38)(cid:18)(cid:44)(cid:53)(cid:37)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)\n(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:92)(cid:92)(cid:92)(cid:92)(cid:12)(cid:15)(cid:3)(cid:76)(cid:73)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:69)(cid:79)(cid:72)\n(cid:20) (cid:53)(cid:20)(cid:28)(cid:26)(cid:28)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:21)(cid:24) (cid:20)(cid:27)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:48)(cid:68)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87) (cid:19)(cid:28)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:27)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:20)(cid:3)(cid:42)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)\n(cid:21) (cid:53)(cid:20)(cid:28)(cid:26)(cid:28)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:21)(cid:24) (cid:20)(cid:27)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:54)(cid:88)(cid:69)(cid:16)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92) (cid:19)(cid:28)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:27)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:20)(cid:3)(cid:42)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79) (cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)\n(cid:39)(cid:72)(cid:80)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75)(cid:92)(cid:3)(cid:39)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:49)(cid:68)(cid:80)(cid:72) (cid:60)(cid:72)(cid:68)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:37)(cid:76)(cid:85)(cid:87)(cid:75) (cid:36)(cid:74)(cid:72) (cid:54)(cid:72)(cid:91) (cid:40)(cid:87)(cid:75)(cid:81)(cid:76)(cid:70)(cid:76)(cid:87)(cid:92) (cid:53)(cid:68)(cid:70)(cid:72) (cid:53)(cid:68)(cid:70)(cid:72)(cid:15)(cid:3)(cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:16)\n(cid:54)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92)\n(cid:49)(cid:82)(cid:87)(cid:3)(cid:43)(cid:76)(cid:86)(cid:83)(cid:68)(cid:81)(cid:76)(cid:70)\n(cid:20)(cid:24)(cid:27)(cid:19)(cid:19)(cid:22)(cid:19)(cid:19)(cid:21) (cid:20)(cid:28)(cid:24)(cid:27) (cid:25)(cid:20) (cid:41)(cid:72)(cid:80)(cid:68)(cid:79)(cid:72) (cid:36)(cid:86)(cid:76)(cid:68)(cid:81) (cid:16)\n(cid:82)(cid:85)(cid:3)(cid:47)(cid:68)(cid:87)(cid:76)(cid:81)(cid:82)\n(cid:39)(cid:76)(cid:86)(cid:72)(cid:68)(cid:86)(cid:72)(cid:16)(cid:54)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)(cid:38)(cid:82)(cid:75)(cid:82)(cid:85)(cid:87)\n(cid:39)(cid:76)(cid:86)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)(cid:70)(cid:82)(cid:75)(cid:82)(cid:85)(cid:87)(cid:18)(cid:74)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:11)(cid:76)(cid:81)(cid:87)(cid:72)(cid:74)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:12) (cid:41)(cid:82)(cid:79)(cid:79)(cid:76)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85)(cid:3)(cid:47)(cid:92)(cid:80)(cid:83)(cid:75)(cid:82)(cid:80)(cid:68)(cid:3)(cid:42)(cid:85)(cid:68)(cid:71)(cid:72) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)\n(cid:44)(cid:73)(cid:3)(cid:82)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:39)(cid:68)(cid:87)(cid:72)\n(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:18)(cid:41)(cid:76)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74) (cid:54)(cid:87)(cid:68)(cid:85)(cid:87)(cid:3)(cid:39)(cid:68)(cid:87)(cid:72) (cid:38)(cid:75)(cid:72)(cid:70)(cid:78)(cid:3)(cid:73)(cid:82)(cid:85) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:87) (cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:85)(cid:72)(cid:86)(cid:82)(cid:79)(cid:89)(cid:72)(cid:71) (cid:38)(cid:75)(cid:72)(cid:70)(cid:78)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:6) (cid:11)(cid:36)(cid:69)(cid:81)(cid:82)(cid:85)(cid:80)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:12) (cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:88)(cid:81)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:86)(cid:87)(cid:68)(cid:85)(cid:87) (cid:86)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:72)(cid:81)(cid:87)(cid:85)(cid:92)(cid:34) (cid:38)(cid:55)(cid:38)(cid:36)(cid:40) (cid:11)(cid:40)(cid:81)(cid:71)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:12) (cid:88)(cid:81)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:72)(cid:81)(cid:71)\n(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:71)(cid:68)(cid:87)(cid:72) (cid:42)(cid:85)(cid:68)(cid:71)(cid:72) (cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:71)(cid:68)(cid:87)(cid:72)\n(cid:92)(cid:92)(cid:92)(cid:92)(cid:12)\n(cid:20) (cid:49)(cid:40)(cid:56)(cid:53)(cid:55)(cid:50)(cid:51)(cid:40)(cid:49)(cid:44)(cid:36) (cid:21)(cid:19)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:20)(cid:26) (cid:16) (cid:53)(cid:72)(cid:86)(cid:82)(cid:79)(cid:89)(cid:72)(cid:71) (cid:16) (cid:21)(cid:26)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:20)(cid:26) (cid:16)\n(cid:21) (cid:43)(cid:37)(cid:57)(cid:3)(cid:38)(cid:36)(cid:53)(cid:53)(cid:44)(cid:40)(cid:53) (cid:3) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:49)(cid:82)(cid:87)(cid:3)(cid:36)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72) (cid:16) (cid:16) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:38)(cid:82)(cid:81)(cid:70)(cid:82)(cid:80)(cid:76)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:44)(cid:73)(cid:3)(cid:44)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86) (cid:44)(cid:73)(cid:3)(cid:44)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86)\n(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:75)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:15) (cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:72)(cid:89)(cid:72)(cid:81)(cid:87)(cid:15)\n(cid:6) (cid:39)(cid:85)(cid:88)(cid:74)(cid:3)(cid:49)(cid:68)(cid:80)(cid:72) (cid:44)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:44)(cid:73)(cid:3)(cid:51)(cid:85)(cid:82)(cid:83)(cid:75)(cid:92)(cid:79)(cid:68)(cid:91)(cid:76)(cid:86)(cid:3)(cid:50)(cid:85) (cid:51)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72) (cid:51)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72) (cid:39)(cid:82)(cid:86)(cid:72) (cid:39)(cid:82)(cid:86)(cid:72)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:41)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:92)\n(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:83)(cid:85)(cid:76)(cid:68)(cid:87)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79) (cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:83)(cid:85)(cid:76)(cid:68)(cid:87)(cid:72)\n(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:17) (cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)\n(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:17)\n(cid:20) (cid:55)(cid:40)(cid:49)(cid:50)(cid:41)(cid:50)(cid:53)(cid:57)(cid:44)(cid:53) (cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92) (cid:16) (cid:21)(cid:66)(cid:43)(cid:37)(cid:57) (cid:16) (cid:22)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:52)(cid:39)\n(cid:38)(cid:36)(cid:53)(cid:53)(cid:44)(cid:40)(cid:53)(cid:66)(cid:56)(cid:49)(cid:46)\n(cid:41)(cid:50)(cid:53)(cid:3)(cid:37)(cid:50)(cid:49)(cid:40)\n(cid:21) (cid:47)(cid:44)(cid:39)(cid:50)(cid:38)(cid:36)(cid:44)(cid:49)(cid:40)(cid:3)(cid:21)(cid:8) (cid:51)(cid:85)(cid:82)(cid:83)(cid:75)(cid:92)(cid:79)(cid:68)(cid:91)(cid:76)(cid:86) (cid:48)(cid:36)(cid:53)(cid:53)(cid:50)(cid:58) (cid:16) (cid:16) (cid:21)(cid:19) (cid:80)(cid:47) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:40)(cid:59)(cid:36)(cid:48)(cid:44)(cid:49)(cid:36)(cid:55)(cid:44)(cid:50)(cid:49)\n(cid:51)(cid:53)(cid:50)(cid:51)(cid:43)(cid:60)(cid:47)(cid:36)(cid:59)(cid:44)(cid:54)(cid:3)(cid:41)(cid:50)(cid:53)\n(cid:22) (cid:36)(cid:47)(cid:47)(cid:50)(cid:51)(cid:56)(cid:53)(cid:44)(cid:49)(cid:50)(cid:47) (cid:51)(cid:85)(cid:82)(cid:83)(cid:75)(cid:92)(cid:79)(cid:68)(cid:91)(cid:76)(cid:86) (cid:55)(cid:56)(cid:48)(cid:50)(cid:53)(cid:3)(cid:47)(cid:60)(cid:54)(cid:44)(cid:54) (cid:16) (cid:16) (cid:20)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:55)(cid:44)(cid:39)\n(cid:54)(cid:60)(cid:49)(cid:39)(cid:53)(cid:50)(cid:48)(cid:40)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:23) (cid:36)(cid:38)(cid:40)(cid:55)(cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:51)(cid:43)(cid:40)(cid:49) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:24) (cid:48)(cid:50)(cid:49)(cid:55)(cid:40)(cid:47)(cid:56)(cid:46)(cid:36)(cid:54)(cid:55) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:40)(cid:59)(cid:36)(cid:48)(cid:40)(cid:55)(cid:43)(cid:36)(cid:54)(cid:50)(cid:49)(cid:40) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:25) (cid:51)(cid:43)(cid:50)(cid:54)(cid:51)(cid:43)(cid:36)(cid:55)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:21)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:26) (cid:53)(cid:36)(cid:49)(cid:44)(cid:55)(cid:44)(cid:39)(cid:44)(cid:49)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:24)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:44)(cid:51)(cid:43)(cid:40)(cid:49)(cid:43)(cid:60)(cid:39)(cid:53)(cid:36)(cid:48)(cid:44)(cid:49) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:27) (cid:40)(cid:3)(cid:43)(cid:38)(cid:47) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:25)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:22)(cid:66)(cid:44)(cid:49)(cid:41)(cid:56)(cid:54)(cid:44)(cid:50)(cid:49)(cid:16)\n(cid:28) (cid:39)(cid:44)(cid:51)(cid:43)(cid:40)(cid:49)(cid:43)(cid:60)(cid:39)(cid:53)(cid:36)(cid:48)(cid:44)(cid:49) (cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87) (cid:16) (cid:16) (cid:53)(cid:40)(cid:47)(cid:36)(cid:55)(cid:40)(cid:39) (cid:22)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:40)(cid:3)(cid:43)(cid:38)(cid:47) (cid:53)(cid:40)(cid:36)(cid:38)(cid:55)(cid:44)(cid:50)(cid:49)(cid:66)(cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)\n(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:22)(cid:66)(cid:44)(cid:49)(cid:41)(cid:56)(cid:54)(cid:44)(cid:50)(cid:49)(cid:16)\n(cid:20)(cid:19) (cid:36)(cid:38)(cid:40)(cid:55)(cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:51)(cid:43)(cid:40)(cid:49) (cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87) (cid:16) (cid:16) (cid:53)(cid:40)(cid:47)(cid:36)(cid:55)(cid:40)(cid:39) (cid:24)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:52)(cid:76)(cid:71)\n(cid:53)(cid:40)(cid:36)(cid:38)(cid:55)(cid:44)(cid:50)(cid:49)(cid:66)(cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)\n(cid:21)(cid:19)(cid:21)(cid:19) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:54)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:53)(cid:82)(cid:88)(cid:87)(cid:72) (cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:54)(cid:87)(cid:68)(cid:85)(cid:87)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:54)(cid:87)(cid:68)(cid:85)(cid:87)(cid:3)(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:56)(cid:81)(cid:78) (cid:54)(cid:87)(cid:82)(cid:83)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74)\n(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:92)(cid:92)(cid:92)(cid:92)(cid:12)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:19)(cid:28)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:20)(cid:26) (cid:16) (cid:16) (cid:3)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:54)(cid:88)(cid:69)(cid:70)(cid:88)(cid:87)(cid:68)(cid:81)(cid:72)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:23)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:23)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:19)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:22)(cid:66)(cid:44)(cid:49)(cid:41)(cid:56)(cid:54)(cid:44)(cid:50)(cid:49)(cid:16)\n(cid:20)(cid:20) (cid:39)(cid:44)(cid:38)(cid:47)(cid:50)(cid:41)(cid:40)(cid:49)(cid:36)(cid:38)(cid:3)(cid:51)(cid:50)(cid:55) (cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87) (cid:16) (cid:16) (cid:53)(cid:40)(cid:47)(cid:36)(cid:55)(cid:40)(cid:39) (cid:21)(cid:24) (cid:80)(cid:74) (cid:16) (cid:55)(cid:44)(cid:39)\n(cid:53)(cid:40)(cid:36)(cid:38)(cid:55)(cid:44)(cid:50)(cid:49)(cid:66)(cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)\n(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:20)(cid:21) (cid:36)(cid:38)(cid:40)(cid:55)(cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:51)(cid:43)(cid:40)(cid:49) (cid:51)(cid:85)(cid:82)(cid:83)(cid:75)(cid:92)(cid:79)(cid:68)(cid:91)(cid:76)(cid:86) (cid:51)(cid:53)(cid:50)(cid:51)(cid:43)(cid:60)(cid:47)(cid:36)(cid:59)(cid:44)(cid:54)(cid:3)(cid:41)(cid:50)(cid:53) (cid:16) (cid:16) (cid:24)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:84)(cid:25)(cid:75)\n(cid:41)(cid:40)(cid:57)(cid:40)(cid:53)\n(cid:23)(cid:66)(cid:36)(cid:54)(cid:51)(cid:36)(cid:53)(cid:55)(cid:36)(cid:55)(cid:40)\n(cid:20)(cid:22) (cid:54)(cid:44)(cid:47)(cid:60)(cid:48)(cid:36)(cid:53)(cid:44)(cid:49) (cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87) (cid:16) (cid:16) (cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:55)(cid:53)(cid:36)(cid:49)(cid:54)(cid:41)(cid:40)(cid:53)(cid:36) (cid:20)(cid:24)(cid:19) (cid:80)(cid:74) (cid:16) (cid:55)(cid:44)(cid:39)\n(cid:54)(cid:40)(cid:3)(cid:44)(cid:49)(cid:38)(cid:53)(cid:40)(cid:36)(cid:54)(cid:40)(cid:39)(cid:66)(cid:20)(cid:24)\n(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:51)(cid:53)(cid:50)(cid:51)(cid:43)(cid:60)(cid:47)(cid:36)(cid:59)(cid:44)(cid:54)(cid:3)(cid:41)(cid:50)(cid:53)\n(cid:20)(cid:23) (cid:36)(cid:47)(cid:47)(cid:50)(cid:51)(cid:56)(cid:53)(cid:44)(cid:49)(cid:50)(cid:47) (cid:51)(cid:85)(cid:82)(cid:83)(cid:75)(cid:92)(cid:79)(cid:68)(cid:91)(cid:76)(cid:86) (cid:55)(cid:56)(cid:48)(cid:50)(cid:53)(cid:3)(cid:47)(cid:60)(cid:54)(cid:44)(cid:54) (cid:16) (cid:16) (cid:20)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:37)(cid:44)(cid:39)\n(cid:54)(cid:60)(cid:49)(cid:39)(cid:53)(cid:50)(cid:48)(cid:40)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:20)(cid:24) (cid:36)(cid:38)(cid:40)(cid:55)(cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:51)(cid:43)(cid:40)(cid:49) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:20)(cid:25) (cid:48)(cid:50)(cid:49)(cid:55)(cid:40)(cid:47)(cid:56)(cid:46)(cid:36)(cid:54)(cid:55) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:40)(cid:59)(cid:36)(cid:48)(cid:40)(cid:55)(cid:43)(cid:36)(cid:54)(cid:50)(cid:49)(cid:40) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:20)(cid:26) (cid:51)(cid:43)(cid:50)(cid:54)(cid:51)(cid:43)(cid:36)(cid:55)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:21)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:20)(cid:27) (cid:53)(cid:36)(cid:49)(cid:44)(cid:55)(cid:44)(cid:39)(cid:44)(cid:49)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:24)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:44)(cid:51)(cid:43)(cid:40)(cid:49)(cid:43)(cid:60)(cid:39)(cid:53)(cid:36)(cid:48)(cid:44)(cid:49) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:20)(cid:28) (cid:40)(cid:3)(cid:43)(cid:38)(cid:47) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:25)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:21)(cid:19) (cid:54)(cid:44)(cid:47)(cid:60)(cid:48)(cid:36)(cid:53)(cid:44)(cid:49) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:47)(cid:44)(cid:57)(cid:40)(cid:53) (cid:16) (cid:16) (cid:20)(cid:24)(cid:19) (cid:80)(cid:74) (cid:16) (cid:55)(cid:44)(cid:39)\n(cid:51)(cid:53)(cid:50)(cid:55)(cid:40)(cid:38)(cid:55)(cid:44)(cid:50)(cid:49)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:21)(cid:20) (cid:36)(cid:38)(cid:40)(cid:55)(cid:36)(cid:48)(cid:44)(cid:49)(cid:50)(cid:51)(cid:43)(cid:40)(cid:49) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:21)(cid:21) (cid:48)(cid:50)(cid:49)(cid:55)(cid:40)(cid:47)(cid:56)(cid:46)(cid:36)(cid:54)(cid:55) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:20)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:40)(cid:59)(cid:36)(cid:48)(cid:40)(cid:55)(cid:43)(cid:36)(cid:54)(cid:50)(cid:49)(cid:40) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:21)(cid:22) (cid:51)(cid:43)(cid:50)(cid:54)(cid:51)(cid:43)(cid:36)(cid:55)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:21)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:21)(cid:23) (cid:53)(cid:36)(cid:49)(cid:44)(cid:55)(cid:44)(cid:39)(cid:44)(cid:49)(cid:40) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:24)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)\n(cid:39)(cid:44)(cid:51)(cid:43)(cid:40)(cid:49)(cid:43)(cid:60)(cid:39)(cid:53)(cid:36)(cid:48)(cid:44)(cid:49) (cid:51)(cid:85)(cid:72)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)\n(cid:21)(cid:24) (cid:40)(cid:3)(cid:43)(cid:38)(cid:47) (cid:53)(cid:40)(cid:42)(cid:49)(cid:20)(cid:28)(cid:26)(cid:28)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92) (cid:16) (cid:16) (cid:16) (cid:25)(cid:19) (cid:80)(cid:74) (cid:16) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)\n(cid:71)(cid:85)(cid:88)(cid:74)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) REG-2020-00295 GSPV RECEIPT DATE 28SEP2020 AKA 72 pages\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:23)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:24)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:20)(cid:24)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:19)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:20)(cid:22)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:20)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:16) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:19)(cid:23)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:50)(cid:85)(cid:68)(cid:79) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)\n(cid:54)(cid:55)(cid:36)(cid:55) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:16)']
apiLogger::2021-10-08 10:58:07,197::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 10:58:07,197::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 10:58:07,197::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 10:58:07,197::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 10:58:07,197::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 10:58:39,106::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 10:58:39,106::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 11:03:37,259::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 11:03:37,280::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 11:03:37,280::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxxs5_n23 
apiLogger::2021-10-08 11:03:37,281::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 11:03:37,281::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 11:03:37,461::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 11:03:37,462::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxxs5_n23
apiLogger::2021-10-08 11:03:39,387::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 11:03:39,388::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 11:03:39,388::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 11:03:39,388::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 11:03:39,391::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 11:03:39,391::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 11:03:39,391::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 11:03:39,391::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 11:03:39,391::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 826009 - Tucker - UK\nSite Number 1625826009\nSubject ID: 826009002\nScreening Date 21 SEP 2020 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 21 SEP 2020 Main consent 21 SEP 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n826009002 1958 62 Female Not reported White -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 CHOLECYSTECTOMY   Resolved - -  \n2 HERNIA REPAIR MIDLINE   Resolved - -  \n3 TONSILLECTOMY   Resolved - -  \n4 APPENDECTOMY   Resolved - -  \n5 HYSTERECTOMY   Resolved - -  \n6 OSTEOARTHRITIS    Ongoing Not Available - -\n7 HYPERTENSION   Ongoing Not Available - - REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1_INFUSION\nRELATED\n1 CHLORPHENAMINE Adverse Event - - 10 mg - OTO\nREACTION_19 OCT\n2020\n1_INFUSION\nRELATED\n2 HYDROCORTISONE Adverse Event - - 200 mg - OTO\nREACTION_19 OCT\n2020 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nOTO - Intravenous - 19 OCT 2020 - 19 OCT 2020 -\nOTO - Intravenous - 19 OCT 2020 - 19 OCT 2020 - REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\n2.44_mmol/\nSCREENING Yes - - 21 SEP 2020 Not Applicable 143_mmol/L 3.8_mmol/L 103_mmol/L 5.1_mmol/L\nL\nTreatment Week 1 2.21_mmol/\nYes - - 19 OCT 2020 Yes 141_mmol/L 3.7_mmol/L 103_mmol/L 5.4_mmol/L\nDay 1 (1) L\nTreatment Week 1 2.19_mmol/\nYes - - 20 OCT 2020 Yes 138_mmol/L 3.4_mmol/L 102_mmol/L 8_mmol/L\nDay 2 (1) L\nTreatment Week 1 2.31_mmol/\nYes - - 21 OCT 2020 Not Applicable 140_mmol/L 4_mmol/L _mmol/L 6.5_mmol/L\nDay 3 (1) L\nTreatment Week 2 2.22_mmol/\nYes - - 26 OCT 2020 Yes 139_mmol/L 3.5_mmol/L 100_mmol/L 6.4_mmol/L\nDay 1 (1) L REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nGlucose Blood urea Aspartate Alanine Alkaline Lactate\nTotal Total Direct Phosphorus\n(Non- Albumin Creatinine nitrogen Urea Aminotransf Aminotransferase Phosphatase Dehydrogenase Uric Acid\nProtein Bilirubin bilirubin (Phosphate)\nFasting) (BUN) erase (AST) (ALT) (ALP) (LDH)\n5.1_mmol/L 41_g/L 59_g/L 63_umol/L _ 5.9_mmol/L 21_U/L 10_U/L 87_U/L 408_U/L 10_umol/L 2.9_umol/L 0.43_mmol/L 1.4_mmol/L\n5.4_mmol/L 16_g/L 54_g/L 68_umol/L _ 5.5_mmol/L 25_U/L 11_U/L 78_U/L 487_U/L _umol/L _umol/L 0.32_mmol/L 1.3_mmol/L\n8_mmol/L 39_g/L 56_g/L 68_umol/L _ 6.8_mmol/L 28_U/L 14_U/L 104_U/L 537_U/L 9_umol/L 3.8_umol/L 0.33_mmol/L 104_mmol/L\n6.5_mmol/L 38_g/L 58_g/L 62_umol/L _ 7.7_mmol/L 22_U/L 15_U/L 93_U/L _U/L 6_umol/L 2.5_umol/L 0.32_mmol/L 0.9_mmol/L\n6.4_mmol/L 37_g/L 54_g/L 67_umol/L _ 4.4_mmol/L 16_U/L 13_U/L 80_U/L 320_U/L 9_umol/L 3_umol/L 0.32_mmol/L 0.9_mmol/L REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nGamma- Corrected\nCreatine Creatinine\nPhosphorus Creatine glutamyl Triglycerides Carbon Serum\nphosphokinase Bicarbonate Clearance\n(Phosphate) Kinase (CK) transferase (non-fasting) dioxide Calcium\n(CPK) (derived)\n(GGT) (derived)\n1.4_mmol/L _ 91_UI/L 43_ 1.2_mmol/L 29_mmol/L _mmol/L 2.42 143.68\n1.3_mmol/L _ 76_UI/L 34_ 1.7_mmol/L 27_mmol/L _mmol/L 2.69 133.12\n104_mmol/L _ 76_UI/L 119_ 1.4_mmol/L 27_mmol/L _mmol/L 2.21 133.12\n0.9_mmol/L _ 43_UI/L 99_ 2.2_mmol/L _mmol/L _mmol/L 2.35 146\n0.9_mmol/L _ 28_UI/L 60_ 2.1_mmol/L 26_mmol/L _mmol/L 2.28 135.1 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nAdverse Events\nIf outcome is\nRecovered/\nStart date AE suspected AE suspected Resolution\nMain Adverse Event Select if AE is If yes, specify Resolved with\n # (dd-mon- to be caused by to be caused by Outcome of AE date (dd-\nDescription (Term) intermittent study conduct Sequelae;\nyyyy) REGN1979? study conduct? mon-yyyy)\nSpecify the\nsequelae.\n26 OCT Not recovered/\n2 ALT INCREASED - Yes No - -\n2020 Not resolved REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nAdverse Event Details\nAE initial severity grade Grade 3\nAE most extreme severity grade Grade 3\nDate event Became Grade 3 or higher - if applicable\n26 OCT 2020\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 0\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Drug Interrupted\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No']
apiLogger::2021-10-08 11:03:39,391::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 11:03:39,391::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 11:03:39,392::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 11:03:39,392::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 11:03:39,392::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 11:03:51,668::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 11:03:51,668::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 11:05:37,610::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 11:05:37,757::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 11:05:37,757::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp48vmg0bn 
apiLogger::2021-10-08 11:05:37,763::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 11:05:37,763::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 11:05:38,392::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 11:05:38,392::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp48vmg0bn
apiLogger::2021-10-08 11:05:38,811::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 11:05:38,812::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 11:05:38,812::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 11:05:38,812::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 11:05:38,814::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,814::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 11:05:38,814::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 11:05:38,814::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 11:05:38,816::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,816::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 11:05:38,816::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 11:05:38,816::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 11:05:38,818::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,818::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 11:05:38,818::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-08 11:05:38,818::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-08 11:05:38,820::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,820::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-08 11:05:38,820::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-08 11:05:38,820::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-08 11:05:38,822::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,822::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-08 11:05:38,822::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-08 11:05:38,822::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-08 11:05:38,823::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,824::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-08 11:05:38,824::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-08 11:05:38,824::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-08 11:05:38,825::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,825::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-08 11:05:38,825::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-08 11:05:38,825::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-08 11:05:38,827::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,827::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-08 11:05:38,827::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-08 11:05:38,827::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-08 11:05:38,829::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,829::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-08 11:05:38,829::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-08 11:05:38,829::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-08 11:05:38,831::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:38,831::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-08 11:05:38,831::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-08 11:05:38,831::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-08 11:05:38,831::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-08 11:05:38,831::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 11:05:40,232::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 11:05:40,233::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 11:05:40,233::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp48o0lxh8 
apiLogger::2021-10-08 11:05:40,233::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 11:05:40,233::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 11:05:40,239::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 11:05:40,239::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp48o0lxh8
apiLogger::2021-10-08 11:05:40,259::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 11:05:40,259::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 11:05:40,259::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 11:05:40,259::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 11:05:40,262::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 11:05:40,262::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 11:05:40,262::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 11:05:40,262::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 08-Oct-2021 11:04:02 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: \n \n \nFrom: Ritu Sharma-External Sent: Friday, October 8, 2021 12:00 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: \n \n ']
apiLogger::2021-10-08 11:05:40,262::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 11:05:40,262::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 15:05:37,302::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 15:05:37,458::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 15:05:37,459::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7mdah6a9 
apiLogger::2021-10-08 15:05:37,465::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 15:05:37,465::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 15:05:38,095::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 15:05:38,095::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7mdah6a9
apiLogger::2021-10-08 15:05:38,516::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 15:05:38,516::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 15:05:38,516::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 15:05:38,516::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 15:05:38,518::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,518::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 15:05:38,518::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 15:05:38,518::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 15:05:38,520::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,520::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 15:05:38,520::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 15:05:38,520::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 15:05:38,522::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,522::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 15:05:38,522::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-08 15:05:38,522::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-08 15:05:38,524::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,524::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-08 15:05:38,524::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-08 15:05:38,524::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-08 15:05:38,526::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,526::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-08 15:05:38,526::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-08 15:05:38,526::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-08 15:05:38,528::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,528::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-08 15:05:38,528::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-08 15:05:38,528::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-08 15:05:38,529::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,530::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-08 15:05:38,530::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-08 15:05:38,530::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-08 15:05:38,531::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,531::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-08 15:05:38,531::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-08 15:05:38,532::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-08 15:05:38,533::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,533::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-08 15:05:38,533::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-08 15:05:38,533::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-08 15:05:38,535::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:38,535::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-08 15:05:38,535::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-08 15:05:38,535::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-08 15:05:38,535::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-08 15:05:38,535::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 15:05:39,901::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 15:05:39,902::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 15:05:39,902::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwsk2unv_ 
apiLogger::2021-10-08 15:05:39,903::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 15:05:39,903::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 15:05:39,908::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 15:05:39,908::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwsk2unv_
apiLogger::2021-10-08 15:05:39,925::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 15:05:39,925::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 15:05:39,925::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 15:05:39,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 15:05:39,928::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 15:05:39,928::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 15:05:39,928::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 15:05:39,928::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Priyanka Gupta-External <priyanka.gupta@regeneron.com>\nReceived Date : 08-Oct-2021 15:04:49 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11- Follow Up <<Priyanka Gupta>\nScenario 11 Follow Up <<<08-Oct-2021>>> \n \nThanks and Regards \nPriyanka Gupta \n ']
apiLogger::2021-10-08 15:05:39,928::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 15:05:39,929::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 16:23:20,946::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 16:23:21,163::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 16:23:21,163::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdc2n0d0t 
apiLogger::2021-10-08 16:23:21,173::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 16:23:21,173::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 16:23:22,695::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 16:23:22,695::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdc2n0d0t
apiLogger::2021-10-08 16:23:24,266::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 16:23:24,266::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 16:23:24,267::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 16:23:24,267::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 16:23:24,271::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-08 16:23:24,271::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 16:23:24,271::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 16:23:24,271::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 16:23:24,271::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:27\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/zMl4CKZXDH2K728XHMvTWS?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) \nCOMBINED WITH PLATINUM-BASED DUAL-DRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT \nOF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, \nPHASE 3 STUDY", SCREENING NUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT \nPLAN: PEMETREXED + CARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST \nMEDICATION WAS AUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL to SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) COMBINED WITH PLATINUM-BASED DUAL-\nDRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR \nMETASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, PHASE 3 STUDY", SCREENING \nNUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT PLAN: PEMETREXED + \nCARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST MEDICATION WAS \nAUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL\'S UROLOGY DEPARTMENT FOR AN ULTRASOUND EXAMINATION. THE RESULTS SHOWED: RIGHT KIDNEY CYST, \nBENIGN PROSTATIC HYPERPLASIA WITH CALCIFICATION FORMATION, RESIDUAL URINE ABOUT 468ML, THE LOCAL \nHOSPITAL ORDERED HIM TO PREPARE FOR HOSPITALIZATION IN 2021.8.15 FOR MINIMALLY INVASIVE SURGICAL \nTREATMENT, THE SPECIFIC TREATMENT SITUATION IS UNKNOWN, AND WILL BE UPDATED AFTER COLLECTION. \nTHE PATIENT HAS NOW BEEN HOSPITALIZED AND REPORTED THE FIRST SAE REPORT OF "URINARY RETENTION", DEGREE \nIII, NOT RELATED TO CEMIPLIMAB/PLACEBO, NOT RELATED TO IMMUNITY, NOT IRAE, RELATED TO PROSTATE \nHYPERPLASIA (THE PATIENT’S BASELINE EXAMINATION DID NOT PERFORM BPH-RELATED TESTS, THE PROSTATE \nHYPERPLASIA WAS A COMMON DISEASE IN ELDERLY MEN THAT IS LIKELY TO CONTINUE TO PROGRESS; ACCORDING TO \nTHE INVESTIGATOR’S MANUAL AND THE CURRENT ADVERSE REACTION RECORDS OF OTHER PATIENTS IN THE STUDY, \nTHERE IS NO ADVERSE REACTION RECORD OF DRUGS-INDUCED PROSTATIC HYPERPLASIA), for SAE UROSCHESIS for \nSubject Number 156001005 \n \n1 Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:28\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/eNvzCBLoqC7qW7zoUz__tv?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) \nCOMBINED WITH PLATINUM-BASED DUAL-DRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT \nOF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, \nPHASE 3 STUDY", SCREENING NUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT \nPLAN: PEMETREXED + CARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST \nMEDICATION WAS AUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL to SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) COMBINED WITH PLATINUM-BASED DUAL-\nDRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR \nMETASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, PHASE 3 STUDY", SCREENING \nNUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT PLAN: PEMETREXED + \nCARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST MEDICATION WAS \nAUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL\'S UROLOGY DEPARTMENT FOR AN ULTRASOUND EXAMINATION. THE RESULTS SHOWED: RIGHT KIDNEY CYST, \nBENIGN PROSTATIC HYPERPLASIA WITH CALCIFICATION FORMATION, RESIDUAL URINE ABOUT 468ML, THE LOCAL \nHOSPITAL ORDERED HIM TO PREPARE FOR HOSPITALIZATION IN 2021.8.15 FOR MINIMALLY INVASIVE SURGICAL \nTREATMENT, THE SPECIFIC TREATMENT SITUATION IS UNKNOWN, AND WILL BE UPDATED AFTER COLLECTION. \nTHE PATIENT HAS NOW BEEN HOSPITALIZED AND REPORTED THE FIRST SAE REPORT OF "URINARY RETENTION", DEGREE \nIII, NOT RELATED TO CEMIPLIMAB/PLACEBO, NOT RELATED TO IMMUNITY, NOT IRAE, RELATED TO PROSTATE \nHYPERPLASIA (THE PATIENT’S BASELINE EXAMINATION DID NOT PERFORM BPH-RELATED TESTS, THE PROSTATE \nHYPERPLASIA WAS A COMMON DISEASE IN ELDERLY MEN THAT IS LIKELY TO CONTINUE TO PROGRESS; ACCORDING TO \nTHE INVESTIGATOR’S MANUAL AND THE CURRENT ADVERSE REACTION RECORDS OF OTHER PATIENTS IN THE STUDY, \nTHERE IS NO ADVERSE REACTION RECORD OF DRUGS-INDUCED PROSTATIC HYPERPLASIA), for SAE UROSCHESIS for \nSubject Number 156001005 \n \n1 Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/Z2dMC0VqKCGvz7BLuwrwdR?domain=login.imedidata.com\nAn SAE of UROSCHESIS has been reported for Subject Number 156001005 with Start Date (dd-mon-yyyy) : 15 AUG 2021  \nwith AE suspected to be caused by blinded study drug? : NO  and It required or prolonged inpatient hospitalization : \nCHECKED  with If Other, specify : BLANK \n \nWWRD (GMT): 17 Aug 2021 11:37:44 \n \n1 R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Screening\nForm: Diagnosis and Extent of Cancer\nData signed: (fkzlkzhoudr@126.com1) 05 Feb 2021 07:57:36\nGenerated On: 18 Aug 2021 06:11:27\nProtocol: R2810-ONC-16113\nHistology/Cytology Non-Squamous\nIf non-squamous, specify Adenocarcinoma\nMetastatic Sites (check all that apply):\nLung True\nLymph nodes intrathoracic True\nLymph nodes other False\nLymph Node Other, specify\nLiver False\nBone False\nAdrenal False\nBrain False\nOther True\nOther, specify PLEURAL\nHistologic grade: Poorly differentiated\nMutation Status:\nEGFR Wildtype\nALK Translocation Not Present\nROS1 Not Rearranged\nTNM Stage at Initial Diagnosis\nT T3\nN N2\nM M1a\nCancer Stage at Screening Stage IV\nTNM Stage at Screening\nT T3\nN N2\nM M1a\nDate of Initial Diagnosis (dd-mon-yyyy) 14 APR 2020\nDate of Recurrence/Relapse (dd-mon-yyyy)\nDate of most recent Recurrence/Relapse - Not Applicable True\nDate of Diagnosis of Metastatic Disease (dd-mon-yyyy) 14 APR 2020\nDate of Diagnosis of Metastatic Disease - Not Applicable False\nCPPC12 R2810-ONC-16113 0027 1 of 12\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2\nGenerated On: 18 Aug 2021 06:15:24\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 1 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (1)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C1D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 11 MAY 2020\nStart Time of Infusion (00:00 – 23:59) 13:58\nStop Time of Infusion (00:00 – 23:59) 14:20\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 2 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (2)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C2D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 2 JUN 2020\nStart Time of Infusion (00:00 – 23:59) 14:10\nStop Time of Infusion (00:00 – 23:59) 14:40\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 3 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (3)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C3D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 23 JUN 2020\nStart Time of Infusion (00:00 – 23:59) 14:50\nStop Time of Infusion (00:00 – 23:59) 15:20\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 4 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (4)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C4D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 15 JUL 2020\nStart Time of Infusion (00:00 – 23:59) 15:20\nStop Time of Infusion (00:00 – 23:59) 16:00\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 5 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (5)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C5D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 11 SEP 2020\nStart Time of Infusion (00:00 – 23:59) 14:05\nStop Time of Infusion (00:00 – 23:59) 14:35\nWas date of administration delayed? (dd-mon-yyyy) Yes\nIf Yes, specify AE #9 \'RENAL DYSFUNCTION\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 6 of 87\n(9074)']
apiLogger::2021-10-08 16:23:24,271::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 16:23:24,271::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-08 16:23:24,271::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 16:23:24,271::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 16:23:24,271::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 16:24:22,897::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 16:24:22,897::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 16:25:21,516::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 16:25:21,735::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 16:25:21,735::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnmh4u8xm 
apiLogger::2021-10-08 16:25:21,746::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 16:25:21,746::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 16:25:23,262::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 16:25:23,262::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnmh4u8xm
apiLogger::2021-10-08 16:25:24,787::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 16:25:24,787::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 16:25:24,787::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 16:25:24,787::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 16:25:24,791::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-08 16:25:24,791::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 16:25:24,791::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 16:25:24,791::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 16:25:24,791::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:27\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/zMl4CKZXDH2K728XHMvTWS?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) \nCOMBINED WITH PLATINUM-BASED DUAL-DRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT \nOF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, \nPHASE 3 STUDY", SCREENING NUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT \nPLAN: PEMETREXED + CARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST \nMEDICATION WAS AUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL to SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) COMBINED WITH PLATINUM-BASED DUAL-\nDRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR \nMETASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, PHASE 3 STUDY", SCREENING \nNUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT PLAN: PEMETREXED + \nCARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST MEDICATION WAS \nAUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL\'S UROLOGY DEPARTMENT FOR AN ULTRASOUND EXAMINATION. THE RESULTS SHOWED: RIGHT KIDNEY CYST, \nBENIGN PROSTATIC HYPERPLASIA WITH CALCIFICATION FORMATION, RESIDUAL URINE ABOUT 468ML, THE LOCAL \nHOSPITAL ORDERED HIM TO PREPARE FOR HOSPITALIZATION IN 2021.8.15 FOR MINIMALLY INVASIVE SURGICAL \nTREATMENT, THE SPECIFIC TREATMENT SITUATION IS UNKNOWN, AND WILL BE UPDATED AFTER COLLECTION. \nTHE PATIENT HAS NOW BEEN HOSPITALIZED AND REPORTED THE FIRST SAE REPORT OF "URINARY RETENTION", DEGREE \nIII, NOT RELATED TO CEMIPLIMAB/PLACEBO, NOT RELATED TO IMMUNITY, NOT IRAE, RELATED TO PROSTATE \nHYPERPLASIA (THE PATIENT’S BASELINE EXAMINATION DID NOT PERFORM BPH-RELATED TESTS, THE PROSTATE \nHYPERPLASIA WAS A COMMON DISEASE IN ELDERLY MEN THAT IS LIKELY TO CONTINUE TO PROGRESS; ACCORDING TO \nTHE INVESTIGATOR’S MANUAL AND THE CURRENT ADVERSE REACTION RECORDS OF OTHER PATIENTS IN THE STUDY, \nTHERE IS NO ADVERSE REACTION RECORD OF DRUGS-INDUCED PROSTATIC HYPERPLASIA), for SAE UROSCHESIS for \nSubject Number 156001005 \n \n1 Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:28\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/eNvzCBLoqC7qW7zoUz__tv?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) \nCOMBINED WITH PLATINUM-BASED DUAL-DRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT \nOF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, \nPHASE 3 STUDY", SCREENING NUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT \nPLAN: PEMETREXED + CARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST \nMEDICATION WAS AUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL to SUBJECT LHJI SIGNED A "CEMIPLIMAB (ANTI-PD-1 ANTIBODY) COMBINED WITH PLATINUM-BASED DUAL-\nDRUG CHEMOTHERAPY FOR THE TWO PARTS OF THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR \nMETASTATIC NON-SMALL CELL LUNG CANCER" ON APRIL 25, 2020 , RANDOMIZED, PHASE 3 STUDY", SCREENING \nNUMBER 156001005, RANDOMIZED INTO THE GROUP ON MAY 9, 2020, TREATMENT PLAN: PEMETREXED + \nCARBOPLATIN + CEMIPLIMAB/PLACEBO, 15 CYCLES OF VISITS HAVE BEEN COMPLETED, THE LAST MEDICATION WAS \nAUGUST 12, 2021. \nTODAY, THE PATIENT INFORMED THAT IT WAS DIFFICULT TO URINATE ON 2021.8.14 AND WENT TO THE LOCAL \nHOSPITAL\'S UROLOGY DEPARTMENT FOR AN ULTRASOUND EXAMINATION. THE RESULTS SHOWED: RIGHT KIDNEY CYST, \nBENIGN PROSTATIC HYPERPLASIA WITH CALCIFICATION FORMATION, RESIDUAL URINE ABOUT 468ML, THE LOCAL \nHOSPITAL ORDERED HIM TO PREPARE FOR HOSPITALIZATION IN 2021.8.15 FOR MINIMALLY INVASIVE SURGICAL \nTREATMENT, THE SPECIFIC TREATMENT SITUATION IS UNKNOWN, AND WILL BE UPDATED AFTER COLLECTION. \nTHE PATIENT HAS NOW BEEN HOSPITALIZED AND REPORTED THE FIRST SAE REPORT OF "URINARY RETENTION", DEGREE \nIII, NOT RELATED TO CEMIPLIMAB/PLACEBO, NOT RELATED TO IMMUNITY, NOT IRAE, RELATED TO PROSTATE \nHYPERPLASIA (THE PATIENT’S BASELINE EXAMINATION DID NOT PERFORM BPH-RELATED TESTS, THE PROSTATE \nHYPERPLASIA WAS A COMMON DISEASE IN ELDERLY MEN THAT IS LIKELY TO CONTINUE TO PROGRESS; ACCORDING TO \nTHE INVESTIGATOR’S MANUAL AND THE CURRENT ADVERSE REACTION RECORDS OF OTHER PATIENTS IN THE STUDY, \nTHERE IS NO ADVERSE REACTION RECORD OF DRUGS-INDUCED PROSTATIC HYPERPLASIA), for SAE UROSCHESIS for \nSubject Number 156001005 \n \n1 Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 17 August 2021 17:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/Z2dMC0VqKCGvz7BLuwrwdR?domain=login.imedidata.com\nAn SAE of UROSCHESIS has been reported for Subject Number 156001005 with Start Date (dd-mon-yyyy) : 15 AUG 2021  \nwith AE suspected to be caused by blinded study drug? : NO  and It required or prolonged inpatient hospitalization : \nCHECKED  with If Other, specify : BLANK \n \nWWRD (GMT): 17 Aug 2021 11:37:44 \n \n1 R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Screening\nForm: Diagnosis and Extent of Cancer\nData signed: (fkzlkzhoudr@126.com1) 05 Feb 2021 07:57:36\nGenerated On: 18 Aug 2021 06:11:27\nProtocol: R2810-ONC-16113\nHistology/Cytology Non-Squamous\nIf non-squamous, specify Adenocarcinoma\nMetastatic Sites (check all that apply):\nLung True\nLymph nodes intrathoracic True\nLymph nodes other False\nLymph Node Other, specify\nLiver False\nBone False\nAdrenal False\nBrain False\nOther True\nOther, specify PLEURAL\nHistologic grade: Poorly differentiated\nMutation Status:\nEGFR Wildtype\nALK Translocation Not Present\nROS1 Not Rearranged\nTNM Stage at Initial Diagnosis\nT T3\nN N2\nM M1a\nCancer Stage at Screening Stage IV\nTNM Stage at Screening\nT T3\nN N2\nM M1a\nDate of Initial Diagnosis (dd-mon-yyyy) 14 APR 2020\nDate of Recurrence/Relapse (dd-mon-yyyy)\nDate of most recent Recurrence/Relapse - Not Applicable True\nDate of Diagnosis of Metastatic Disease (dd-mon-yyyy) 14 APR 2020\nDate of Diagnosis of Metastatic Disease - Not Applicable False\nCPPC12 R2810-ONC-16113 0027 1 of 12\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2\nGenerated On: 18 Aug 2021 06:15:24\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 1 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (1)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C1D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 11 MAY 2020\nStart Time of Infusion (00:00 – 23:59) 13:58\nStop Time of Infusion (00:00 – 23:59) 14:20\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 2 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (2)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C2D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 2 JUN 2020\nStart Time of Infusion (00:00 – 23:59) 14:10\nStop Time of Infusion (00:00 – 23:59) 14:40\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 3 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (3)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C3D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 23 JUN 2020\nStart Time of Infusion (00:00 – 23:59) 14:50\nStop Time of Infusion (00:00 – 23:59) 15:20\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 4 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (4)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C4D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 15 JUL 2020\nStart Time of Infusion (00:00 – 23:59) 15:20\nStop Time of Infusion (00:00 – 23:59) 16:00\nWas date of administration delayed? (dd-mon-yyyy) No\nIf Yes, specify\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 5 of 87\n(9074) R2810-ONC-16113: 156001-Shanghai Pulmonary Hospital: 156001005\nFolder: Dosing\nForm: Dosing Part 2 (5)\nGenerated On: 18 Aug 2021 06:15:24\nStudy Visit C5D1\nDid the subject receive blinded study drug Yes\nIf No, please specify reason\nPlanned blinded study drug Dose Level 350 mg\nActual Dose Administered 350 mg\nDate of Administration (dd-mon-yyyy) 11 SEP 2020\nStart Time of Infusion (00:00 – 23:59) 14:05\nStop Time of Infusion (00:00 – 23:59) 14:35\nWas date of administration delayed? (dd-mon-yyyy) Yes\nIf Yes, specify AE #9 \'RENAL DYSFUNCTION\nWas the Infusion interrupted? No\nIf Interrupted, Length of Interruption\nReason for Interruption:\nIf Infusion interrupted due to AE, specify:\nIf Infusion interrupted due to planned or Other, specify:\nDid the subject receive platinum-based chemotherapy? Yes\nChemotherapy type Pemetrexed 500 mg/m2 IV plus\ncarboplatin AUC of 5 or 6\nmg/mL/minute IV (Non\nsquamous histology only)\nComplete the Chemotherapy Administration form.\nCPPC12 R2810-ONC-16113 0027 6 of 87\n(9074)']
apiLogger::2021-10-08 16:25:24,792::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 16:25:24,792::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-08 16:25:24,792::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 16:25:24,792::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 16:25:24,792::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 16:26:24,068::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 16:26:24,068::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 17:39:25,366::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 17:39:25,388::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 17:39:25,388::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpc00me5gr 
apiLogger::2021-10-08 17:39:25,390::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 17:39:25,390::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 17:39:25,859::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 17:39:25,859::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpc00me5gr
apiLogger::2021-10-08 17:39:27,703::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 17:39:27,703::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 17:39:27,703::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 17:39:27,703::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 17:39:27,706::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 17:39:27,707::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 17:39:27,707::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 17:39:27,707::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 17:39:27,707::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616003 - Walewski - Poland\nSite Number 1626616013\nSubject ID: 826003014\nScreening Date 10 SEP 2020 REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 09 SEP 2020 Main consent 04 FEB 2020 09 SEP 2020\nAmendment 1 EU\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616003004 1945 75 Female White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 DIABETES MELLITUS UN UNK 2008   Ongoing Not Available - -\n2 HYPOTHYREOSIS UN UNK 1994   Ongoing Not Available - -\nHYPERTENSION\n3   Ongoing Not Available - -\nARTERIALIS\n4 HEPATITIS B   Resolved Not Available -   REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n2_HYPOTHYREOSI\n1 EUTHYROX Medical History - - 125  mg - Continuous\nS_UN UNK 1994\n1_DIABETES\n2 METFORMINA Medical History - MELLITUS_UN UNK - 850 mg - TID\n2008\n1_DIABETES\n3 APIDRA SOLOSTAR Medical History - MELLITUS_UN UNK - 8 Other UNIT BID\n2008\n1_DIABETES\n4 ABASAGLAR Medical History - MELLITUS_UN UNK - 14 Other UNIT Other\n2008\n3_HYPERTENSION\n5 VIVACE Medical History - - 5 mg - Other\nARTERIALIS_UNK\n3_HYPERTENSION\n6 DIURESIN SR Medical History - - 1.5 mg - Other\nARTERIALIS_UNK\n1_DIABETES\n7 CROSUVO Medical History - MELLITUS_UN UNK - 5 mg - Other\n2008\n1_DIABETES\n8 GROFIBRAT Medical History - MELLITUS_UN UNK - 100 mg - Other\n2008 REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nContinuous - Oral - UN UNK 1994 - -  \nTID - Oral -   -  \nBID - Subcutaneous -   -  \nOther ONCE A DAY Subcutaneous -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -   REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\n4.32_mmol/ 100.6_mmol 2.52_mmol/\nSCREENING Yes - - 10 SEP 2020 Not Applicable 138_mmol/L 169_\nL /L L REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nGlucose Blood urea Aspartate Alanine Alkaline Lactate\nTotal Total Direct Phosphorus\n(Non- Albumin Creatinine nitrogen Urea Aminotransf Aminotransferase Phosphatase Dehydrogenase Uric Acid\nProtein Bilirubin bilirubin (Phosphate)\nFasting) (BUN) erase (AST) (ALT) (ALP) (LDH)\n169_ 44.5_g/L 70.8_g/L 0.72_mg/dL _ 30.4_mg/dl 62_U/L 66_U/L 37_IU/L 176_IU/L 6.5_umol/L 1.7_umol/L 5.7_mg/dL 1.07_mmol/L REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nGamma- Corrected\nCreatine Creatinine\nPhosphorus Creatine glutamyl Triglycerides Carbon Serum\nphosphokinase Bicarbonate Clearance\n(Phosphate) Kinase (CK) transferase (non-fasting) dioxide Calcium\n(CPK) (derived)\n(GGT) (derived)\n1.07_mmol/L _ 82_UI/L _UI/L 146.3_mg/dL 26.4_ _ 2.43 87.55 REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nAdverse Events\nIf outcome is\nRecovered/\nStart date AE suspected AE suspected Resolution\nMain Adverse Event Select if AE is If yes, specify Resolved with\n # (dd-mon- to be caused by to be caused by Outcome of AE date (dd-\nDescription (Term) intermittent study conduct Sequelae;\nyyyy) REGN1979? study conduct? mon-yyyy)\nSpecify the\nsequelae.\nNEUROLOGICAL\n30 SEP Not recovered/\n1 SYMPTOMS = - No No - -\n2020 Not resolved\nNUBNESS OF LIMBS REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nAdverse Event Details\nAE initial severity grade Grade 1\nAE most extreme severity grade Grade 3\nDate event Became Grade 3 or higher - if applicable\n05 OCT 2020\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 0\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Not Applicable\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No']
apiLogger::2021-10-08 17:39:27,707::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 17:39:27,707::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 17:39:27,707::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 17:39:27,707::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 17:39:27,707::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 17:39:40,502::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 17:39:40,502::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 19:01:20,723::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 19:01:20,872::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 19:01:20,872::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkk9zdx25 
apiLogger::2021-10-08 19:01:20,879::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 19:01:20,879::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 19:01:21,512::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 19:01:21,512::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkk9zdx25
apiLogger::2021-10-08 19:01:21,931::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 19:01:21,931::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 19:01:21,931::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 19:01:21,931::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 19:01:21,934::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,934::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 19:01:21,934::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 19:01:21,934::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 19:01:21,936::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,936::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 19:01:21,936::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-08 19:01:21,936::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-08 19:01:21,938::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,939::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-08 19:01:21,939::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-08 19:01:21,939::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-08 19:01:21,941::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,941::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-08 19:01:21,941::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-08 19:01:21,941::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-08 19:01:21,943::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,943::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-08 19:01:21,943::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-08 19:01:21,943::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-08 19:01:21,945::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,945::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-08 19:01:21,945::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-08 19:01:21,945::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-08 19:01:21,947::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,947::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-08 19:01:21,947::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-08 19:01:21,947::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-08 19:01:21,949::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,949::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-08 19:01:21,949::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-08 19:01:21,949::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-08 19:01:21,951::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,951::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-08 19:01:21,951::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-08 19:01:21,951::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-08 19:01:21,953::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:21,953::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-08 19:01:21,953::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-08 19:01:21,954::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-08 19:01:21,954::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-08 19:01:21,954::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 19:01:23,896::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 19:01:23,896::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 19:01:23,897::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsobsxtls 
apiLogger::2021-10-08 19:01:23,897::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 19:01:23,897::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 19:01:23,902::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 19:01:23,902::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsobsxtls
apiLogger::2021-10-08 19:01:23,916::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 19:01:23,917::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 19:01:23,917::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 19:01:23,917::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 19:01:23,920::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:01:23,920::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 19:01:23,920::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 19:01:23,920::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Yuvraj Singh-External <yuvraj.singh@regeneron.com>\nReceived Date : 08-Oct-2021 19:00:47 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\n \n \nKind regards, \nYuvraj Singh \n \n \n ']
apiLogger::2021-10-08 19:01:23,920::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 19:01:23,920::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 19:15:32,896::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 19:15:32,897::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 19:15:32,897::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbn7p_p03 
apiLogger::2021-10-08 19:15:32,898::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 19:15:32,898::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 19:15:32,903::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 19:15:32,903::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbn7p_p03
apiLogger::2021-10-08 19:15:32,915::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 19:15:32,916::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 19:15:32,916::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 19:15:32,916::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 19:15:32,919::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 19:15:32,919::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 19:15:32,919::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 19:15:32,919::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Spam Daily Digest <digest@regeneron.com>\nReceived Date : 08-Oct-2021 15:14:15 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Spam Daily Digest: 0 New Messages  (1 Valid Emails)\nProofpoint']
apiLogger::2021-10-08 19:15:32,919::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-08 19:15:32,919::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 20:43:39,914::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 20:43:39,916::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 20:43:39,916::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoqzogro7 
apiLogger::2021-10-08 20:43:39,916::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 20:43:39,916::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 20:43:39,946::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 20:43:39,946::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoqzogro7
apiLogger::2021-10-08 20:43:40,273::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 20:43:40,273::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 20:43:40,273::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 20:43:40,273::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 20:43:40,276::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-08 20:43:40,276::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 20:43:40,276::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 20:43:40,276::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-08 20:43:40,276::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-08 20:43:40,276::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 20:43:40,276::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-08 20:43:40,276::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 20:43:40,276::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 20:43:40,276::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 20:43:49,016::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 20:43:49,016::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:07:18,984::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:07:19,018::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:07:19,018::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpplvywuii 
apiLogger::2021-10-08 21:07:19,020::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:07:19,020::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:07:19,924::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:07:19,924::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpplvywuii
apiLogger::2021-10-08 21:07:29,850::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:07:29,850::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:07:29,850::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:07:29,850::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:07:29,854::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:07:29,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:07:29,854::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:07:29,854::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:07:29,857::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:07:29,857::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:07:29,857::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:07:29,857::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:07:29,857::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:07:29,858::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:07:29,858::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:07:29,858::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:07:29,858::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:07:29,858::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:08:05,361::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:08:05,361::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:09:19,154::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:09:19,188::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:09:19,189::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyl104f1h 
apiLogger::2021-10-08 21:09:19,190::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:09:19,190::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:09:20,095::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:09:20,095::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyl104f1h
apiLogger::2021-10-08 21:09:29,796::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:09:29,797::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:09:29,797::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:09:29,797::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:09:29,800::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:09:29,801::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:09:29,801::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:09:29,801::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:09:29,804::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:09:29,804::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:09:29,804::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:09:29,804::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:09:29,804::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:09:29,805::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:09:29,805::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:09:29,805::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:09:29,805::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:09:29,805::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:10:05,402::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:10:05,402::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:11:19,333::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:11:19,414::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:11:19,414::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7ob3lhim 
apiLogger::2021-10-08 21:11:19,419::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:11:19,419::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:11:20,332::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:11:20,332::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7ob3lhim
apiLogger::2021-10-08 21:11:35,066::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:11:35,067::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:11:35,067::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:11:35,067::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:11:35,070::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:11:35,071::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:11:35,071::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:11:35,071::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:11:35,074::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:11:35,074::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:11:35,074::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:11:35,074::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:11:35,074::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:11:35,075::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:11:35,075::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:11:35,075::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:11:35,075::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:11:35,075::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:12:26,128::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:12:26,128::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:12:26,266::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:12:26,300::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:12:26,300::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3ptj_1ts 
apiLogger::2021-10-08 21:12:26,302::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:12:26,302::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:12:27,207::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:12:27,207::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3ptj_1ts
apiLogger::2021-10-08 21:12:36,926::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:12:36,926::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:12:36,926::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:12:36,926::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:12:36,930::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:12:36,930::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:12:36,930::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:12:36,930::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:12:36,934::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:12:36,934::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:12:36,934::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:12:36,934::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:12:36,934::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:12:36,934::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:12:36,934::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:12:36,934::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:12:36,934::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:12:36,934::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:13:12,627::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:13:12,627::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:13:29,061::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:13:29,142::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:13:29,142::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv11do3kq 
apiLogger::2021-10-08 21:13:29,147::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:13:29,147::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:13:30,059::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:13:30,059::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv11do3kq
apiLogger::2021-10-08 21:13:44,712::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:13:44,713::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:13:44,713::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:13:44,713::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:13:44,717::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:13:44,717::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:13:44,717::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:13:44,717::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:13:44,720::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:13:44,720::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:13:44,720::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:13:44,720::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:13:44,720::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:13:44,721::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:13:44,721::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:13:44,721::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:13:44,721::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:13:44,721::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:14:35,752::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:14:35,753::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-08 21:15:19,285::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-08 21:15:19,368::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-08 21:15:19,368::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv347q8du 
apiLogger::2021-10-08 21:15:19,373::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-08 21:15:19,373::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-08 21:15:20,286::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-08 21:15:20,287::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv347q8du
apiLogger::2021-10-08 21:15:34,934::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-08 21:15:34,934::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-08 21:15:34,934::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-08 21:15:34,934::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-08 21:15:34,938::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-08 21:15:34,938::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-08 21:15:34,938::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-08 21:15:34,938::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-08 21:15:34,942::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-08 21:15:34,942::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-08 21:15:34,942::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-08 21:15:34,942::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-08 21:15:34,942::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-08 21:15:34,942::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-08 21:15:34,942::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-08 21:15:34,943::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-08 21:15:34,943::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-08 21:15:34,943::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-08 21:16:26,234::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-08 21:16:26,234::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 02:51:31,434::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 02:51:31,435::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 02:51:31,435::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbpk5s_kx 
apiLogger::2021-10-09 02:51:31,435::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 02:51:31,435::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 02:51:31,440::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 02:51:31,440::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbpk5s_kx
apiLogger::2021-10-09 02:51:31,451::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 02:51:31,452::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 02:51:31,452::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 02:51:31,452::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 02:51:31,455::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 02:51:31,455::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 02:51:31,455::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 02:51:31,455::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 09-Oct-2021 02:49:40 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : test\n ']
apiLogger::2021-10-09 02:51:31,455::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-09 02:51:31,455::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 03:35:18,770::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 03:35:18,780::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 03:35:18,780::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfcjzpe4t 
apiLogger::2021-10-09 03:35:18,780::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 03:35:18,781::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 03:35:19,274::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 03:35:19,274::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfcjzpe4t
apiLogger::2021-10-09 03:35:22,340::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 03:35:22,340::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 03:35:22,340::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 03:35:22,340::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 03:35:22,344::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 03:35:22,344::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 03:35:22,344::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 03:35:22,344::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 03:35:22,347::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-09 03:35:22,347::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 03:35:22,347::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 03:35:22,347::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 03:35:22,347::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-09 03:35:22,347::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 03:35:22,347::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-09 03:35:22,347::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 03:35:22,347::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 03:35:22,347::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 03:35:41,003::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 03:35:41,003::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:47:38,630::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:47:38,669::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:47:38,671::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwtrd2rol 
apiLogger::2021-10-09 12:47:38,672::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:47:38,673::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:47:39,579::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:47:39,579::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwtrd2rol
apiLogger::2021-10-09 12:47:49,296::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:47:49,296::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:47:49,296::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:47:49,296::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:47:49,301::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:47:49,301::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:47:49,301::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:47:49,301::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:47:49,304::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:47:49,304::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:47:49,304::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:47:49,304::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:47:49,304::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:47:49,305::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:47:49,305::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:47:49,305::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:47:49,305::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:47:49,305::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:48:24,675::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:48:24,675::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:48:24,799::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:48:24,880::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:48:24,880::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpq_u966eu 
apiLogger::2021-10-09 12:48:24,885::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:48:24,885::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:48:25,800::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:48:25,800::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpq_u966eu
apiLogger::2021-10-09 12:48:40,452::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:48:40,453::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:48:40,453::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:48:40,453::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:48:40,457::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:48:40,457::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:48:40,457::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:48:40,457::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:48:40,460::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:48:40,461::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:48:40,461::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:48:40,461::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:48:40,461::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:48:40,461::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:48:40,461::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:48:40,461::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:48:40,461::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:48:40,462::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:49:31,294::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:49:31,294::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:49:48,593::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:49:48,674::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:49:48,675::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnalw7dlv 
apiLogger::2021-10-09 12:49:48,680::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:49:48,680::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:49:49,592::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:49:49,592::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnalw7dlv
apiLogger::2021-10-09 12:50:04,219::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:50:04,219::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:50:04,219::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:50:04,219::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:50:04,223::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:50:04,223::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:50:04,223::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:50:04,223::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:50:04,226::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:50:04,226::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:50:04,227::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:50:04,227::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:50:04,227::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:50:04,227::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:50:04,227::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:50:04,227::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:50:04,227::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:50:04,227::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:50:55,250::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:50:55,250::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:50:55,390::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:50:55,424::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:50:55,425::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5qfx5nze 
apiLogger::2021-10-09 12:50:55,427::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:50:55,427::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:50:56,331::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:50:56,331::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5qfx5nze
apiLogger::2021-10-09 12:51:06,032::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:51:06,032::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:51:06,032::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:51:06,032::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:51:06,036::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:51:06,036::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:51:06,036::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:51:06,037::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:51:06,040::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:51:06,040::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:51:06,040::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:51:06,040::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:51:06,040::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:51:06,040::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:51:06,041::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:51:06,041::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:51:06,041::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:51:06,041::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:51:41,447::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:51:41,447::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:51:59,406::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:51:59,440::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:51:59,441::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpplk_y4ya 
apiLogger::2021-10-09 12:51:59,442::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:51:59,443::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:52:00,347::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:52:00,347::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpplk_y4ya
apiLogger::2021-10-09 12:52:10,059::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:52:10,059::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:52:10,059::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:52:10,059::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:52:10,063::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:52:10,064::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:52:10,064::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:52:10,064::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:52:10,067::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:52:10,067::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:52:10,067::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:52:10,067::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:52:10,067::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:52:10,068::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:52:10,068::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:52:10,068::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:52:10,068::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:52:10,068::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:52:45,637::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:52:45,637::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 12:52:45,756::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 12:52:45,837::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 12:52:45,838::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpscvhzsv7 
apiLogger::2021-10-09 12:52:45,843::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 12:52:45,843::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 12:52:46,756::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 12:52:46,756::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpscvhzsv7
apiLogger::2021-10-09 12:53:01,400::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 12:53:01,400::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 12:53:01,400::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 12:53:01,400::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 12:53:01,404::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 12:53:01,404::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 12:53:01,404::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 12:53:01,404::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 12:53:01,408::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 12:53:01,408::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 12:53:01,408::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 12:53:01,408::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 12:53:01,408::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004003\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\nKind regards,\nAnna\nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com EMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004003 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004003\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\nApply to Record\nClick here to return to "Complete View".\nCRF History\n616004003 - Adverse  Main Adverse Event Description (Term) DEATH\nEvent\nSOC 10018065General disorders and administration site conditions\n616004003 - Adverse \nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\n616004003\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: \n616004003\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n - Serious DEATH\n616004003  \nAdverse Event/AESI #1\n - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\n616004003  \nEvent\nCurrently viewing line 1 of 1.\n - Adverse Apply to Record\n616004003   Click here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Demography\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland SCREENING Medical History (including any cancers oth...\n616004003\nSCREENING\nVisit Subject: \n616004003\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including\nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2\n12-Lead\nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT MEDICATIONS Concomitant Medications\n616004003\nCONCOMITANT\nMEDICATIONS\nSubject: \n616004003\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n - Concomitant\n6M1e6d0ic0a4t0io0n3s   2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n - Concomitant\n616004003  \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n - Medical\n616004003   CRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\n616004003\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: \n616004003\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\n616004003  \nProcedures/Surgeries\n \nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\n616004003\nPROTOCOL/ICF\nTRACKING\nSubject: \n616004003\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n - Informed\n616004003  \nConsent and Protocol\n  Derived Date Subject Signed Informed Consent (dd-mon-yyyy) 10 JUN 2020\nAmendment Tracking\n616004003 - Concomitant  Printable Version  View PDF   Icon Key Save   Cancel\nProcedures/Surgeries\n  CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n - Concomitant\n616004003  \nMedications\n - Concomitant\n616004003  \nMedications Yes/No\n - Medical\n616004003  \nHistory (including any\n \ncancers other than\n \nlymphoma)\n - Demography\n616004003  \n - Visit\n616004003\n - Serious\n616004003  \nAdverse Event/AESI #1\n - Adverse\n616004003  \nEvent\n - Adverse\n616004003  \nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 12:53:01,409::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 12:53:01,409::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 12:53:01,409::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 12:53:01,409::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 12:53:01,409::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 12:53:52,218::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 12:53:52,218::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 13:43:18,974::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:43:18,975::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:43:18,975::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxrxqvn8i 
apiLogger::2021-10-09 13:43:18,976::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 13:43:18,976::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 13:43:18,983::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 13:43:18,983::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxrxqvn8i
apiLogger::2021-10-09 13:43:19,013::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 13:43:19,013::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 13:43:19,013::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 13:43:19,013::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 13:43:19,017::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:43:19,017::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 13:43:19,017::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 13:43:19,017::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma <ritu.sharma@rxlogix.com>\nReceived Date : 09-Oct-2021 13:42:29 +0000\nTo : "medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> test\nEXTERNAL MESSAGE \n \n \n \nInspired by Patient Safety, Driven by Technology! \nRitu Sharma | Sr. BQA \nMobile: +91 9990334208 \nRxLogix Corporation \nrd\nA-1, Windsor IT Park, 3  Floor, Tower B, Sec-125,NOIDA 201301 \nEmail: ritu.sharma@rxlogix.com\n ']
apiLogger::2021-10-09 13:43:19,017::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-09 13:43:19,017::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 13:47:19,366::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:47:19,400::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:47:19,400::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp36i4dp58 
apiLogger::2021-10-09 13:47:19,402::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 13:47:19,402::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 13:47:20,308::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 13:47:20,308::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp36i4dp58
apiLogger::2021-10-09 13:47:30,007::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 13:47:30,008::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 13:47:30,008::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 13:47:30,008::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 13:47:30,012::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:47:30,012::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 13:47:30,012::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 13:47:30,012::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 13:47:30,016::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 13:47:30,016::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 13:47:30,016::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 13:47:30,016::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 13:47:30,016::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 13:47:30,016::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 13:47:30,016::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 13:47:30,016::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 13:47:30,017::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 13:47:30,017::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 13:48:05,394::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 13:48:05,394::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 13:48:05,518::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:48:05,576::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:48:05,576::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3dqggrm4 
apiLogger::2021-10-09 13:48:06,147::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:48:06,149::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:48:06,150::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0yaradfe 
apiLogger::2021-10-09 13:48:06,150::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 13:48:06,150::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 13:48:06,177::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 13:48:06,177::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0yaradfe
apiLogger::2021-10-09 13:48:06,348::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 13:48:06,348::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 13:48:06,348::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 13:48:06,348::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 13:48:06,352::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:48:06,352::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 13:48:06,352::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 13:48:06,352::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 13:48:06,356::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:48:06,356::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 13:48:06,356::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-09 13:48:06,356::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-09 13:48:06,359::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:48:06,359::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-09 13:48:06,359::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-09 13:48:06,359::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-09 13:48:06,362::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:48:06,362::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-09 13:48:06,362::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-09 13:48:06,362::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma <ritu.sharma@rxlogix.com>\nReceived Date : 09-Oct-2021 13:42:20 +0000\nTo : "medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> FW: REGN : PVIT : Emails received from medical safety mailbox\nEXTERNAL MESSAGE \n \n \n \nFrom: Marc Lamberti-External <marc.lamberti@regeneron.com> Sent: 09 October 2021 18:25\nTo: Ritu Sharma <ritu.sharma@rxlogix.com> Cc: Nitin Chandok <nitin.chandok@rxlogix.com>;\nReshabh Reshabh <reshabh.reshabh@rxlogix.com> Subject: RE: REGN : PVIT : Emails\nreceived from medical safety mailbox \n \nHi Ritu &All, \n \nAttached are the cases sent over to PV Intake at 5:06 and 5:11pm. Note I received no\nacknowledgement email nor did they show up in the system. \n \nI just resent them at 8:47am and they are not showing up in PV Intake as of yet and it is 8:54am. \n \nBest- \nMarc \n \nMarc Lamberti \n617.515.6030 \n \nFrom: Ritu Sharma <ritu.sharma@rxlogix.com> Sent: Saturday, October 9, 2021 1:01 AM To:\nMarc Lamberti-External <marc.lamberti@regeneron.com> Cc: Nitin Chandok <\nnitin.chandok@rxlogix.com>; Reshabh Reshabh <reshabh.reshabh@rxlogix.com> Subject:\n<External> RE: REGN : PVIT : Emails received from medical safety mailbox \n \nEXTERNAL MESSAGE\n \n \nHi Marc, \n \nPlease refer the below screenshots for the cases created for your emails. \n   \n \nThanks, \nRitu \n \n \nFrom: Ritu Sharma Sent: 09 October 2021 10:25 To: Marc Lamberti-External <\nmarc.lamberti@regeneron.com> Cc: Nitin Chandok <nitin.chandok@rxlogix.com>; Reshabh\nReshabh <reshabh.reshabh@rxlogix.com> Subject: REGN : PVIT : Emails received from medical\nsafety mailbox \n \nHi Marc, \n \nWe tried sending emails to medsaf.dev3@regeneron.com .  The cases got created in PVIT for\nthem and the acknowledgement email is also received from medsaf.dev3@regeneron.com. \n \nPlease let us know if you need any additional information. \n \nThanks, \nRitu \n  Inspired by Patient Safety, Driven by Technology! \nRitu Sharma | Sr. BQA \nMobile: +91 9990334208 \nRxLogix Corporation \nrd\nA-1, Windsor IT Park, 3  Floor, Tower B, Sec-125,NOIDA 201301 \nEmail: ritu.sharma@rxlogix.com\n \n******************************************************************** This e-mail and any attachment\nhereto, is intended only for use by the addressee(s) named above and may contain legally\nprivileged and/or confidential information. If you are not the intended recipient of this e-mail, any\ndissemination, distribution or copying of this email, or any attachment hereto, is strictly prohibited.\nIf you receive this email in error please immediately notify me by return electronic mail and\npermanently delete this email and any attachment hereto, any copy of this e-mail and of any such\nattachment, and any printout thereof. Finally, please note that only authorized representatives of\nRegeneron Pharmaceuticals, Inc. have the power and authority to enter into business dealings\nwith any third party. ******************************************************************** \nPlease be cautious \nThis email is sent from outside of your organisation.Avoid clicking links or replying with sensitive information unless\nyou ensure that this email is legitimate.   ']
apiLogger::2021-10-09 13:48:06,362::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-09 13:48:06,362::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 13:49:19,188::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:49:19,224::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:49:19,224::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpht45u_nd 
apiLogger::2021-10-09 13:49:19,226::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 13:49:19,226::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 13:49:20,126::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 13:49:20,126::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpht45u_nd
apiLogger::2021-10-09 13:49:29,837::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 13:49:29,837::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 13:49:29,837::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 13:49:29,837::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 13:49:29,841::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:49:29,841::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 13:49:29,841::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 13:49:29,841::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 13:49:29,845::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 13:49:29,845::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 13:49:29,845::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 13:49:29,845::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 13:49:29,845::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 13:49:29,845::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 13:49:29,845::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 13:49:29,846::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 13:49:29,846::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 13:49:29,846::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 13:50:05,294::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 13:50:05,294::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 13:51:21,113::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 13:51:21,148::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 13:51:21,148::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnc83zycy 
apiLogger::2021-10-09 13:51:21,150::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 13:51:21,150::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 13:51:22,053::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 13:51:22,053::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnc83zycy
apiLogger::2021-10-09 13:51:31,769::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 13:51:31,769::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 13:51:31,769::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 13:51:31,769::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 13:51:31,773::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 13:51:31,773::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 13:51:31,773::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 13:51:31,773::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-09 13:51:31,777::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-09 13:51:31,777::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-09 13:51:31,777::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-09 13:51:31,777::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-09 13:51:31,777::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-09 13:51:31,777::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-09 13:51:31,777::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-09 13:51:31,777::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-09 13:51:31,777::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-09 13:51:31,777::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-09 13:52:07,299::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-09 13:52:07,299::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-09 18:43:18,819::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-09 18:43:18,820::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-09 18:43:18,820::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1oii_1ie 
apiLogger::2021-10-09 18:43:18,821::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-09 18:43:18,821::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-09 18:43:18,826::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-09 18:43:18,826::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1oii_1ie
apiLogger::2021-10-09 18:43:18,838::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-09 18:43:18,838::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-09 18:43:18,838::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-09 18:43:18,838::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-09 18:43:18,842::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-09 18:43:18,842::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-09 18:43:18,842::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-09 18:43:18,842::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Spam Daily Digest <digest@regeneron.com>\nReceived Date : 09-Oct-2021 14:41:55 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Spam Daily Digest: 0 New Messages  (1 Valid Emails)\nProofpoint']
apiLogger::2021-10-09 18:43:18,842::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-09 18:43:18,842::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:37:18,783::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:37:18,802::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:37:18,802::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn6f3dklc 
apiLogger::2021-10-10 21:37:18,803::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:37:18,804::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:37:20,411::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:37:20,411::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn6f3dklc
apiLogger::2021-10-10 21:37:21,604::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:37:21,604::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:37:21,604::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:37:21,604::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:37:21,608::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:37:21,609::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:37:21,609::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:37:21,609::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-10 21:37:21,612::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:37:21,612::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-10 21:37:21,612::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-10 21:37:21,612::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88295 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88295 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88295 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-10 21:37:21,612::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:37:21,612::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:37:21,968::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:37:21,982::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:37:21,982::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp122sy9xf 
apiLogger::2021-10-10 21:37:21,983::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:37:21,983::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:37:22,128::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:37:22,128::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp122sy9xf
apiLogger::2021-10-10 21:37:22,635::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:37:22,635::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:37:22,636::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:37:22,636::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:37:22,640::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:37:22,640::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:37:22,640::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:37:22,640::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-10 21:37:22,641::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:37:22,641::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:37:23,156::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:37:23,157::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:37:23,158::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjbhvp3a8 
apiLogger::2021-10-10 21:37:23,158::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:37:23,158::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:37:23,175::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:37:23,175::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjbhvp3a8
apiLogger::2021-10-10 21:37:23,289::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:37:23,289::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:37:23,289::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:37:23,289::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:37:23,293::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:37:23,293::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:37:23,294::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:37:23,294::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-10 21:37:23,297::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:37:23,297::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-10 21:37:23,297::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-10 21:37:23,297::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 10-Oct-2021 21:35:49 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88295 Version 1\n \n \nMarc Lamberti \n617.515.6030 \n \nFrom: Marc Lamberti-External Sent: Wednesday, October 6, 2021 2:22 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: <External> Regeneron Adverse Event Report for Eylea\nVial: REGEMC-88295 Version 1 \n \nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1   \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-10 21:37:23,298::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:37:23,298::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:53:18,990::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:53:18,991::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:53:18,991::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5au9d3__ 
apiLogger::2021-10-10 21:53:18,992::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:53:18,992::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:53:19,012::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:53:19,012::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5au9d3__
apiLogger::2021-10-10 21:53:19,135::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:53:19,135::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:53:19,135::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:53:19,135::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:53:19,139::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:53:19,139::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:53:19,139::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:53:19,139::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-10 21:53:19,143::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:53:19,143::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-10 21:53:19,143::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-10 21:53:19,143::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-10 21:53:19,146::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:53:19,147::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-10 21:53:19,147::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-10 21:53:19,147::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 10-Oct-2021 21:51:32 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : test\n \n \nMarc Lamberti \n617.515.6030 \n \nFrom: Marc Lamberti-External Sent: Sunday, October 10, 2021 5:36 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: <External> Regeneron Adverse Event Report for Eylea\nVial: REGEMC-88295 Version 1 \n \n \n \nMarc Lamberti \n617.515.6030   \nFrom: Marc Lamberti-External Sent: Wednesday, October 6, 2021 2:22 PM To: Medsaf.dev3 <\nMedsaf.dev3@regeneron.com> Subject: <External> Regeneron Adverse Event Report for Eylea\nVial: REGEMC-88295 Version 1 \n \nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n  ******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-10 21:53:19,147::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:53:19,147::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:57:18,885::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:57:18,902::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:57:18,902::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnp7c9e0z 
apiLogger::2021-10-10 21:57:18,903::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:57:18,903::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:57:20,537::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:57:20,538::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnp7c9e0z
apiLogger::2021-10-10 21:57:21,743::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:57:21,743::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:57:21,743::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:57:21,743::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:57:21,747::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:57:21,747::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:57:21,747::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:57:21,747::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-10 21:57:21,751::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:57:21,751::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-10 21:57:21,751::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-10 21:57:21,751::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88295 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88295 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88295 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-10 21:57:21,751::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:57:21,751::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:57:22,113::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:57:22,127::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:57:22,127::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbw4gugqf 
apiLogger::2021-10-10 21:57:22,128::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:57:22,128::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:57:22,273::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:57:22,273::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbw4gugqf
apiLogger::2021-10-10 21:57:22,761::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:57:22,761::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:57:22,761::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:57:22,761::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:57:22,766::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:57:22,766::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:57:22,766::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:57:22,766::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-10 21:57:22,766::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:57:22,766::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 21:57:23,217::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 21:57:23,218::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 21:57:23,218::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1i2n63_e 
apiLogger::2021-10-10 21:57:23,218::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 21:57:23,218::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 21:57:23,232::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 21:57:23,233::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1i2n63_e
apiLogger::2021-10-10 21:57:23,323::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 21:57:23,323::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 21:57:23,323::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 21:57:23,323::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 21:57:23,328::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 21:57:23,328::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 21:57:23,328::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 21:57:23,328::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 10-Oct-2021 21:55:23 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88295 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer <\njeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88295 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88295, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-10 21:57:23,328::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 21:57:23,328::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 23:09:46,253::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 23:09:46,258::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 23:09:46,258::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvnzyxii2 
apiLogger::2021-10-10 23:09:46,259::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 23:09:46,259::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 23:09:46,588::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 23:09:46,588::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvnzyxii2
apiLogger::2021-10-10 23:09:47,389::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 23:09:47,389::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 23:09:47,389::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 23:09:47,389::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 23:09:47,393::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 23:09:47,393::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 23:09:47,393::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 23:09:47,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-10 23:09:47,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 23:09:47,397::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-10 23:09:47,397::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-10 23:09:47,397::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-10 23:09:47,397::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 23:09:47,397::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-10 23:09:47,758::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-10 23:09:47,759::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-10 23:09:47,759::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk8gih6sm 
apiLogger::2021-10-10 23:09:47,760::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-10 23:09:47,760::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-10 23:09:47,767::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-10 23:09:47,767::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk8gih6sm
apiLogger::2021-10-10 23:09:47,802::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-10 23:09:47,802::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-10 23:09:47,802::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-10 23:09:47,802::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-10 23:09:47,806::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-10 23:09:47,806::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-10 23:09:47,806::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-10 23:09:47,806::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Robin Fultz <robin.fultz@regeneron.com>\nReceived Date : 10-Oct-2021 23:08:49 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - <Robin Fultz>\nScenario 1 10Oct2021 \n \n \n \nRobin Fultz, RN \nAssociate Mgr Case Management, GPS Case Evaluation and Reporting Management \nREGENERON\n  SCIENCE TO MEDICINE® \n(914) 255-8338 cell \nRobin.Fultz@regeneron.com\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \nUpcoming Out of office dates: N/A\n \n \n \n ']
apiLogger::2021-10-10 23:09:47,806::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-10 23:09:47,806::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 00:37:38,629::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 00:37:38,634::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 00:37:38,635::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpud46tvjo 
apiLogger::2021-10-11 00:37:38,635::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 00:37:38,635::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 00:37:38,753::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 00:37:38,753::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpud46tvjo
apiLogger::2021-10-11 00:37:40,377::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 00:37:40,377::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 00:37:40,377::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 00:37:40,377::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 00:37:40,381::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 00:37:40,381::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 00:37:40,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 00:37:40,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 00:37:40,385::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 00:37:40,385::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 00:37:40,385::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 00:37:40,385::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-11 00:37:40,388::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 00:37:40,389::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-11 00:37:40,389::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 00:37:40,389::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-11 00:37:40,389::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-11 00:37:40,389::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 00:37:40,389::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 00:37:40,389::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 00:37:40,389::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 00:37:40,389::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 00:37:54,793::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 00:37:54,794::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 02:49:22,860::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 02:49:22,878::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 02:49:22,878::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpko4kkv9e 
apiLogger::2021-10-11 02:49:22,879::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 02:49:22,879::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 02:49:23,121::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 02:49:23,121::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpko4kkv9e
apiLogger::2021-10-11 02:49:23,893::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 02:49:23,893::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 02:49:23,893::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 02:49:23,893::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 02:49:23,898::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:23,898::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 02:49:23,898::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 02:49:23,898::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 02:49:23,901::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:23,902::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 02:49:23,902::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 02:49:23,902::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-11 02:49:23,904::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:23,904::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-11 02:49:23,904::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-11 02:49:23,904::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-11 02:49:23,906::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:23,907::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-11 02:49:23,907::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-11 02:49:23,907::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-11 02:49:23,909::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:23,909::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-11 02:49:23,909::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-11 02:49:23,909::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-11 02:49:23,909::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-11 02:49:23,909::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 02:49:24,163::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 02:49:24,165::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 02:49:24,165::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphi6ld_ku 
apiLogger::2021-10-11 02:49:24,165::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 02:49:24,165::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 02:49:24,173::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 02:49:24,173::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphi6ld_ku
apiLogger::2021-10-11 02:49:24,178::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 02:49:24,178::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 02:49:24,179::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 02:49:24,179::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 02:49:24,181::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:24,181::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 02:49:24,181::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 02:49:24,181::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-11 02:49:24,181::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-11 02:49:24,182::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 02:49:24,319::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 02:49:24,323::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 02:49:24,323::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5sj8_1oz 
apiLogger::2021-10-11 02:49:24,324::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 02:49:24,324::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 02:49:24,489::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 02:49:24,489::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5sj8_1oz
apiLogger::2021-10-11 02:49:25,212::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 02:49:25,212::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 02:49:25,212::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 02:49:25,212::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 02:49:25,216::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:25,216::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 02:49:25,216::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 02:49:25,216::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 02:49:25,220::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:25,220::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 02:49:25,220::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 02:49:25,220::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-11 02:49:25,223::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:25,223::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-11 02:49:25,223::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-11 02:49:25,223::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-11 02:49:25,223::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-11 02:49:25,223::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 02:49:25,647::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 02:49:25,648::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 02:49:25,648::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxs1a7kd3 
apiLogger::2021-10-11 02:49:25,649::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 02:49:25,649::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 02:49:25,655::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 02:49:25,655::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxs1a7kd3
apiLogger::2021-10-11 02:49:25,674::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 02:49:25,674::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 02:49:25,674::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 02:49:25,674::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 02:49:25,678::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 02:49:25,678::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 02:49:25,678::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 02:49:25,678::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 11-Oct-2021 02:49:05 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88291 Version 2\nScenario 1 Follow Up \n \nMarc Lamberti \n617.515.6030 \n ']
apiLogger::2021-10-11 02:49:25,678::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-11 02:49:25,678::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 05:16:27,668::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 05:16:27,689::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 05:16:27,689::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwwacpp_9 
apiLogger::2021-10-11 05:16:27,690::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 05:16:27,690::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 05:16:27,872::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 05:16:27,872::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwwacpp_9
apiLogger::2021-10-11 05:16:29,792::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 05:16:29,792::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 05:16:29,792::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 05:16:29,792::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 05:16:29,796::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 05:16:29,796::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 05:16:29,796::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 05:16:29,796::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 05:16:29,796::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 826009 - Tucker - UK\nSite Number 1625826009\nSubject ID: 826009002\nScreening Date 21 SEP 2020 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 21 SEP 2020 Main consent 21 SEP 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n826009002 1958 62 Female Not reported White -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 CHOLECYSTECTOMY   Resolved - -  \n2 HERNIA REPAIR MIDLINE   Resolved - -  \n3 TONSILLECTOMY   Resolved - -  \n4 APPENDECTOMY   Resolved - -  \n5 HYSTERECTOMY   Resolved - -  \n6 OSTEOARTHRITIS    Ongoing Not Available - -\n7 HYPERTENSION   Ongoing Not Available - - REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1_INFUSION\nRELATED\n1 CHLORPHENAMINE Adverse Event - - 10 mg - OTO\nREACTION_19 OCT\n2020\n1_INFUSION\nRELATED\n2 HYDROCORTISONE Adverse Event - - 200 mg - OTO\nREACTION_19 OCT\n2020 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nOTO - Intravenous - 19 OCT 2020 - 19 OCT 2020 -\nOTO - Intravenous - 19 OCT 2020 - 19 OCT 2020 - REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\n2.44_mmol/\nSCREENING Yes - - 21 SEP 2020 Not Applicable 143_mmol/L 3.8_mmol/L 103_mmol/L 5.1_mmol/L\nL\nTreatment Week 1 2.21_mmol/\nYes - - 19 OCT 2020 Yes 141_mmol/L 3.7_mmol/L 103_mmol/L 5.4_mmol/L\nDay 1 (1) L\nTreatment Week 1 2.19_mmol/\nYes - - 20 OCT 2020 Yes 138_mmol/L 3.4_mmol/L 102_mmol/L 8_mmol/L\nDay 2 (1) L\nTreatment Week 1 2.31_mmol/\nYes - - 21 OCT 2020 Not Applicable 140_mmol/L 4_mmol/L _mmol/L 6.5_mmol/L\nDay 3 (1) L\nTreatment Week 2 2.22_mmol/\nYes - - 26 OCT 2020 Yes 139_mmol/L 3.5_mmol/L 100_mmol/L 6.4_mmol/L\nDay 1 (1) L REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nGlucose Blood urea Aspartate Alanine Alkaline Lactate\nTotal Total Direct Phosphorus\n(Non- Albumin Creatinine nitrogen Urea Aminotransf Aminotransferase Phosphatase Dehydrogenase Uric Acid\nProtein Bilirubin bilirubin (Phosphate)\nFasting) (BUN) erase (AST) (ALT) (ALP) (LDH)\n5.1_mmol/L 41_g/L 59_g/L 63_umol/L _ 5.9_mmol/L 21_U/L 10_U/L 87_U/L 408_U/L 10_umol/L 2.9_umol/L 0.43_mmol/L 1.4_mmol/L\n5.4_mmol/L 16_g/L 54_g/L 68_umol/L _ 5.5_mmol/L 25_U/L 11_U/L 78_U/L 487_U/L _umol/L _umol/L 0.32_mmol/L 1.3_mmol/L\n8_mmol/L 39_g/L 56_g/L 68_umol/L _ 6.8_mmol/L 28_U/L 14_U/L 104_U/L 537_U/L 9_umol/L 3.8_umol/L 0.33_mmol/L 104_mmol/L\n6.5_mmol/L 38_g/L 58_g/L 62_umol/L _ 7.7_mmol/L 22_U/L 15_U/L 93_U/L _U/L 6_umol/L 2.5_umol/L 0.32_mmol/L 0.9_mmol/L\n6.4_mmol/L 37_g/L 54_g/L 67_umol/L _ 4.4_mmol/L 16_U/L 13_U/L 80_U/L 320_U/L 9_umol/L 3_umol/L 0.32_mmol/L 0.9_mmol/L REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nGamma- Corrected\nCreatine Creatinine\nPhosphorus Creatine glutamyl Triglycerides Carbon Serum\nphosphokinase Bicarbonate Clearance\n(Phosphate) Kinase (CK) transferase (non-fasting) dioxide Calcium\n(CPK) (derived)\n(GGT) (derived)\n1.4_mmol/L _ 91_UI/L 43_ 1.2_mmol/L 29_mmol/L _mmol/L 2.42 143.68\n1.3_mmol/L _ 76_UI/L 34_ 1.7_mmol/L 27_mmol/L _mmol/L 2.69 133.12\n104_mmol/L _ 76_UI/L 119_ 1.4_mmol/L 27_mmol/L _mmol/L 2.21 133.12\n0.9_mmol/L _ 43_UI/L 99_ 2.2_mmol/L _mmol/L _mmol/L 2.35 146\n0.9_mmol/L _ 28_UI/L 60_ 2.1_mmol/L 26_mmol/L _mmol/L 2.28 135.1 REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nAdverse Events\nIf outcome is\nRecovered/\nStart date AE suspected AE suspected Resolution\nMain Adverse Event Select if AE is If yes, specify Resolved with\n # (dd-mon- to be caused by to be caused by Outcome of AE date (dd-\nDescription (Term) intermittent study conduct Sequelae;\nyyyy) REGN1979? study conduct? mon-yyyy)\nSpecify the\nsequelae.\n26 OCT Not recovered/\n2 ALT INCREASED - Yes No - -\n2020 Not resolved REG-2020-00346 GSPV Date of Receipt 29 OCT 2020 AN 20 pages \nAdverse Event Details\nAE initial severity grade Grade 3\nAE most extreme severity grade Grade 3\nDate event Became Grade 3 or higher - if applicable\n26 OCT 2020\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 0\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Drug Interrupted\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No']
apiLogger::2021-10-11 05:16:29,797::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 05:16:29,797::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 05:16:29,797::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 05:16:29,797::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 05:16:29,797::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 05:16:42,357::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 05:16:42,357::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 06:12:33,872::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 06:12:33,884::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 06:12:33,886::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqu9ojhr_ 
apiLogger::2021-10-11 06:12:33,886::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 06:12:33,886::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 06:12:33,910::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 06:12:33,910::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqu9ojhr_
apiLogger::2021-10-11 06:12:34,313::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 06:12:34,313::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 06:12:34,313::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 06:12:34,313::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 06:12:34,317::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-11 06:12:34,317::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 06:12:34,317::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 06:12:34,317::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 06:12:34,317::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-11 06:12:34,317::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 06:12:34,317::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-11 06:12:34,317::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 06:12:34,317::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 06:12:34,317::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 06:12:45,523::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 06:12:45,523::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
